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ABSTRACT 
BACKGROUND: Health locus of control (HLOC) is a person’s belief of where 
responsibilities for his/her health condition lies. It is associated with health attitudes, 
behaviours and outcomes in non-specific chronic low back pain (NSCLBP). It is unknown 
whether a physiotherapy cognitive-behavioural chronic low back pain (CBCLBP) programme 
affects patients’ HLOC. 
AIMS: To examine: (1) the effect of a six-week CBCLBP programme on the patients’ 
primary outcome-HLOC, and also pain intensity, disability, fear-avoidance belief (FAB) and 
self-care attitude; (2) the association between changes in pain intensity, disability and FAB 
and changes in HLOC; and (3) the cost of producing any effect.  
METHODS: In an A-B-A same-subject design, patients referred to the CBCLBP programme 
with high FAB (TSK score> 37) were recruited. Patients attended a six-week programme. 
Outcomes were measured four weeks before (-4 weeks), at the start, at completion, 3- and 6-
months after the programme. Friedman’s ANOVA and Wilcoxon signed-rank tests 
determined changes between phases. Multiple regression determined the relationship between 
HLOC and outcome of interest. Significance was set at 0.05.  
RESULTS: A total of 70 patients were recruited. Fifty-five patients entered the programme 
and all completed 6-months follow-up. The CBCLBP programme significantly improved 
HLOC (p<0.001), pain intensity (p<0.001), disability (p<0.001), FAB (p<0.001) and self-
care attitude (p<0.001), with such improvement being sustained for 6 months. Changes in 
HLOC explained 6%, 0.5% and 31.9% variances in changes in pain, disability and FAB 
respectively, after controlling other variables. Increased internal locus of control (ILOC) was 
a significant predictor of reduction in FAB (p=0.002). HLOC was not predictive of reduction 
in pain intensity or disability. Mean provider cost of the programme was £285.82 per patient. 
CONCLUSION: Our 6-week CBCLBP programme was effective in changing a person’s 
belief about where responsibility for his/her health condition lies. It also improved their pain, 
disability, FAB and attitude to self-care. Making patients believe that they can take control, 
and they are the one responsible for their NSCLBP management is linked to reduction in 
FAB, highlighting the potential importance of improving ILOC in attaining better FAB 
outcome. We have also provided guidance to managers and budget allocators that this costs 
£285.82 per patient. 
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CHAPTER 1 INTRODUCTION TO THE STUDY 
1.1 Introduction 
This chapter provides the introduction and conceptual framework of this 
study. First, it briefly explains the complexity and the issues surrounding 
non-specific chronic low back pain (NSCLBP). Second, it describes how the 
research questions of this study were developed, underpinned by clinical 
experiences, and how they were interpreted in relation to the health locus of 
control (HLOC) and its potential importance within the major physiotherapy 
management tool for NSCLBP. Finally, this chapter explains how this study 
may contribute to the current knowledge of physiotherapy management of 
NSCLBP, and how new knowledge that emerged from this study may 
potentially impact on future physiotherapy practice and patients’ care. 
1.2 The complexity of NSCLBP 
At first glance, pain seems to be fairly straightforward, hitting one’s thumb 
with a hammer hurts one’s thumb. Such experience is easily understood 
with a structural-pathology model, which supposes pain provides a reliable 
indication of the state of the tissues (Moseley, 2007). However, much of the 
NSCLBP patients we see in clinical practice do not fit into this 
straightforward category. Patients being diagnosed with NSCLBP continue 
to experience persistent or recurrent LBP (i.e. tension, soreness and/or 
stiffness in the lower back region) with or without leg pain, despite it being 
beyond the normal healing time (more than three months) and in the 
absence of any meaningful spinal pathology (Savigny et al., 2009; Chou, 
2011).  
1.2.1 Category of pain  
Broadly speaking, pain can be categorized based on its duration (acute vs 
chronic) as well as its underlying pathophysiology (nociceptive, 
inflammatory and neuropathic) (Merskey & Bogduk, 1994). Nociceptive 
and inflammatory pain (producing mechanical and chemical pain) is often 
associated with identifiable painful stimuli and is frequently self-limiting 
(Woolf, 2004). Neuropathic pain is maybe caused by a lesion, resulting 
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from nerve damage or sensitization in the peripheral nervous system (PNS) 
and/ or central nervous system (CNS) (Clong & Bajwa, 2003; Van Wilgen 
& Keizer, 2012).  
From a pathophysiological perspective, many patients with chronic pain 
such as NSCLBP, share the same mechanism: sensitization of the nervous 
system (Merskey & Bogduk, 1994; Van Wilgen & Keizer, 2012). It is 
typically persistent and frequently involves perception of spontaneous pain 
(to varying degrees) in the absence of an identifiable stimulus, as well as 
exaggerated responses to painful stimuli (hyperalgesia) or normally non-
painful stimuli (allodynia) (Merskey & Bogduk, 1994; Woolf, 2004).  
Not all pain syndromes are easily categorized, for instance, NSCLBP may 
involve a mix of two or more types of pain (Woolf, 2004). Evidence also 
suggested that nociception is neither sufficient nor necessary to evoke pain 
(Wall & Melzack, 1999). The maintenance and disability levels of NSCLBP 
are more closely associated with cognitive and behavioural aspects of pain 
than the sensory and biomedical ones (Gatchel et al., 2007; Campbell & 
Edwards, 2009).  
1.2.2 Pain is a product of the brain 
It is now clear from brain imaging studies that there is no single ‘pain centre 
in the brain’ as we used to believe. Rather, many areas in the brain (known 
as pain neuromatrix) are actively involved simultaneously in constructing 
and modulating a pain experience (Moseley, 2003a; Moseley, 2007). Figure 
1.1 shows a possible pain neurotag, where the parts of the brain are usually 
active during a pain experience. These parts all link up to each other 
electrically and chemically to create a perception of pain (Butler & 
Moseley, 2003).  
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Figure 1.1: Pain neuromatrix and pain neurotag (Butler & Moseley, 
2003; Melzack, 1999)  
           
 
Although consistent patterns can be seen during pain experience, the exact 
parts and amount of activity vary between people, and even between 
different occasions in the same person (Butler & Moseley, 2003). Therefore, 
every pain experience is unique and complex. 
1.2.3 Definition of pain 
The most popular and frequently used definition of pain is ‘an unpleasant 
sensory and emotional experience associated with actual or potential 
damage or described in terms of such damage’ (Merskey & Bogduk, 1994: 
209).  This definition about pain highlights that: (1) pain is both a sensory 
and an emotional experience that is unique to each individual; and (2) 
damage and pain do not always match. More recently, one of the world 
leading pain researchers Lorimer Moseley re-conceptualized ‘pain as a 
conscious correlate of the implicate perception that tissue is in danger’ 
(Moseley, 2007: 172). His way of thinking about pain shifts the concept of 
pain from one of pain as an accurate indicator of the state of the tissues, as 
many lay public have been conditioned to believe, to one of pain as an 
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indicator of threat and a conscious need for protection, especially as pain 
persists (Moseley, 2007).  
According to Moseley, pain is the product of the brain that is based on the 
perception of threat. Many inputs across the physical, somatic, contextual, 
psychological and social domains into the brain determine the perceived 
degree of threat to body tissues, and pain is a multi-systematic output of the 
brain whenever the brain concludes the body tissue is in danger and 
protection is required (Moseley 2003a; Moseley, 2007). In chronic pain 
such as NSCLBP, the threat value of pain is more likely to be primarily 
contributed by psychosocial, behavioural and cognitive realm (such as 
attitudes and beliefs), rather than physical factors (Moseley, 2003a; Moseley 
2007). The implication of increased threatening input includes: 
overprotective response (such as fear, anxiety, negative beliefs and 
avoidance behavior) and increased sensitivity of the pain neuromatrix 
(Moseley, 2003a). These responses consequently lead to increased 
disability, persistent pain, reduced movements, negative pain cognitions and 
diminished quality of life, results in a vicious downward cycle of pain and 
deterioration.  
Moseley’s conceptualization about pain acknowledges the multi-
dimensional nature of pain, as in other experts in this field (Merskey & 
Bogduk, 1994; Waddell, 2004; O’ Sullivan, 2005; Moseley, 2007; Wand & 
O’Connell, 2008). His research work also leads to an increased focus of 
addressing patients’ pain belief and attitudes through pain education as a 
means of lowering threatening input that activates pain neuromatrix, 
normalizing pain cognition and improving physical performance in patients 
with NSCLBP (Moseley, 2002; Moseley, 2004; Moseley et al., 2004).   
1.2.4 Different theoretical models in explaining NSCLBP 
With pain being a multi-dimensional phenomenon, the biopsychosocial 
model of pain is still currently the most widely accepted model to 
understand chronic pain and its associated disability since it is proposed by 
Waddell in 1987 (Gifford, 2000; Waddell, 2004; Gatchel et al., 2007; 
Savigny et al., 2009). 
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The biopsychosocial model of pain integrates the psychological, social and 
biological factors (Waddell & Burton, 2005; World Health Organization, 
2001) (Figure 1.2). It recognizes that all the three elements have a 
significant impact on the persistence of pain and the development of 
disability, and that the mind and body interact with and affect each other 
(Ogden, 2012). 
 
Figure 1.2: The biopsychosocial model of NSCLBP (Waddell, 1987) 
 
 
Other than the biopsychosocial model, there are also alternative theoretical 
models in the literature which help explain how NSCLBP is maintained and 
therapeutically reduced.  
 
For example: (1) the pain-gate theory (Malzack & Wall, 1965) and the 
subsequent pain neuromatrix model (Melzack,1999) acknowledge the role 
of multiple parts of the brain and spinal cord working together to contribute 
to the various aspects of experience of pain: the sensory, emotional, 
cognitive, motor, behavioral and conscious aspects. Briefly, these theories 
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posit that psychological and physiological processes interact to affect 
perception, transmission and evaluation of pain, and recognize the influence 
of these processes as maintenance factors in NSCLBP; (2) the sensitization 
model provides a neurophysiological mechanism for understanding how 
peripheral and central sensitization are associated with pain hypersensitivity, 
in which they can be both modulated by cognitive and psychological factors 
in a positive or negative manner (Woolf, 2011; Nijs et al., 2011); (3) the 
fear-avoidance model (Vlaeyen & Linton, 2000) is seen as a central 
psychological mechanism in the maintenance of NSCLBP (Leeuw et al., 
2007), in which pain-related fear and catastrophic beliefs are recognised as 
the primary force drives avoidance behaviour, which then leads to various 
associated physical (such as disuse and physical deconditioning) and 
psychological consequences (such as depression, anxiety, fear and distress); 
and (4) the motor control model (O’Sullivan, 2005) provides an 
understanding of NSCLBP from a motor control perspective. This model 
proposes that mal-adaptive movement and motor control impairment in 
response to pathophysiological pain and psychological factors lead to 
abnormal tissue loading of the lumbar spine and ongoing production of 
peripheral nociceptor sensitization, hence resulting in chronic pain.  
 
These various explanatory models not only highlight the multi-faceted 
nature and complexity of NSCLBP, they also consistently recognize the 
influence of cognitive and behavioural factors involved in: (1) the 
maintenance of NSCLBP; (2) the variety of NSCLBP expression (severity 
and duration of clinical symptoms, and physical and psychological effects 
on the person); (3) patients’ sensory and behavioural response to pain; and 
(4) patients’ responses to treatment.  
 
It is in this area that the ‘top-down’ treatment approach (i.e. altering pain by 
altering what people think and believe such as psychological and cognitive 
behavioural treatment) (Figure 1.3) may have more to offer to patients with 
NSCLBP than the traditional ‘bottom-up’ treatment model (i.e. intervene 
pain  
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on tissues levels such as manual therapy, electrotherapy and exercises) 
(Gifford, 1998).  
 
Figure 1.3: The ‘top-down’ treatment approach (Gifford, 1998)  
                                  
 
Consequently, the combination of physical exercises and cognitive-
behavioural approach education (CBA) delivered in a group (namely the 
cognitive-behavioural chronic low back pain (CBCLBP) programme) has 
become one major and common physiotherapy treatment for patients with 
NSCLBP. This is also the most consistently recommended evidence-based 
treatment for NSCLBP in both the UK (Savigny et al., 2009) and 
international clinical guidelines (Chou et al., 2009; Koes et al., 2010).   
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1.3 Theory of the cognitive-behavioural principles  
The key principle of the CBA is based on recognising that the aim is not 
directly to treat the pain or intervene at tissue level (i.e. bottom-up 
approach), but to modify patients’ negative thoughts, feelings and 
behaviour, and thereby their experience of pain (i.e. top-down approach). 
The CBT model presumes a direct link between cognitions and behaviours. 
In other words, if maladaptive cognitions (such as FAB, catastrophizing 
thinking, problem-solving abilities, coping strategies, self-efficacy and 
appraisal of control) can be changed, positive behaviour change will follow. 
This then often inadvertently reinforces patients’ positive thoughts, feelings 
and behaviour, hence creating a cycle effect (Adams et al., 1996; Beck, 
1979a; Beck, 1979b; Kerns et al., 2011) (Figure 1.4). 
 
Figure 1.4: The CBT model (Kerns et al., 2011)  
                            
The principle based upon the CBT model has consequently formed the basis 
of the treatment philosophy for physiotherapists. Although the composition 
of programmes may vary according to clinical settings and resources, the 
programme generally involves similar components (i.e. combined physical 
and CBA education) and has similar treatment philosophies. It is commonly 
considered that the general goal of a physiotherapy CBCLBP programme is 
to: reduce disability, minimize pain or increase control over pain, reduce 
avoidance of movement and increase self-management (Woby et al., 2004a; 
Smeets et al., 2006a; Critchley et al., 2007; Johnson et al., 2007; Woby et 
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al., 2008; Lamb et al, 2010). These goals are achieved by addressing the 
patients’ cognitive, behavioural, and emotional facets of NSCLBP, as well 
as those physical and functional factors that contribute to its maintenance, 
severity and exacerbation. 
 
Having recognised that an individuals’ belief is the main driving force for 
behaviour (Greene & Murdock, 2013), one potential way to optimise 
patient’s treatment outcome and improve their continued self-care abilities 
is to understand those cognitive factors which relate to patients’ beliefs on 
how they deal with their NSCLBP, and their beliefs about who influences 
and is responsible for their health outcome. For example, physiotherapy 
advice to keep active and engage in self-care may not make much sense for 
patients who have a weak perception of personal control belief.   
1.4 Conceptual framework underpinned by clinical 
experiences 
In this current study, the Principal Investigator’s (PI) clinical interest in 
NSCLBP grew as a consequence of treating patients with NSCLBP for over 
fourteen years in the NHS. The PI had had basic CBT and chronic pain 
training over the years. Despite being investigated and treated, many 
patients still faced pain, frustration and some level of disability. The chronic 
nature of the condition means patients are moved onto a management model 
rather than a curative model. However, the idea of pain chronicity, self-
management and patients being told that a cure was not possible, was often 
received differently by patients. Some patients were positive and proactive, 
some were negative and passive; some believed that their actions and own 
responsibility would make a difference in managing pain; and some 
believed that their condition was solely attributed to fate or others such as 
their doctors, physiotherapists or families.  
 
Despite patients undertaking the exact same CBCLBP programme, the 
treatment outcome varied. Clinical impressions indicate that patients who 
accept personal responsibility for their pain were generally more compliant 
to treatment recommendations than those who leave it to others. Those who 
feel it is entirely up to doctors or therapists or someone else to cure them 
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tend to be less proactive, less compliant and often seek further treatment 
following the CBCLBP programme. Furthermore, patients who perceive 
their actions as directly related to improved management are generally more 
engaged, have less fear to move, and report better physical and 
psychological health, than those who feel that they cannot do much about it 
for themselves. Gaining some feelings of personal control over back pain 
means patients actually managing the pain and disability so that they can 
master ordinary activities of daily living, and become less dependent on 
health care services. These clinical experiences show that patients’ 
perceptions of control belief over their NSCLBP not only have an influence 
on their clinical outcomes, health attitudes and healthcare usage, they also 
have an influence on how patients behave, react and respond to the 
CBCLBP programme and the self-management skills taught by 
physiotherapists. In psychology, this belief is called health locus of control 
(HLOC).   
 
If the ultimate goal of physiotherapy management is to engage patients to 
adopt a more active role in their rehabilitation process and to promote their 
continued ability to self-manage, these goals may only succeed if patients 
believe that they are the one responsible for, and able to feel control of their 
own chronic back condition. As a clinician, we would also like to think our 
treatment can improve patient’s HLOC. However, the potential importance 
of HLOC in NSCLBP and how HLOC may change over the CBCLBP 
programme, were not being evaluated in both research and current practice.   
 
This was when the PI began to study HLOC in NSCLBP, and develop the 
use of HLOC in the Trust’s CBCLBP programme. Questions were 
developed, such as: What is the treatment effect of the physiotherapy 
CBCLBP programme on patients’ HLOC? Is there any relationship between 
patients’ HLOC and other important clinical outcomes such as pain, 
disability and fear-avoidance belief (FAB)? How do patients’ HLOC beliefs 
change over time? Would HLOC be a predictor of treatment outcomes and a 
potential important cognitive factor to assess and target in future practice?  
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A brief introduction of the HLOC provides a useful starting point of the 
theories underpinning the present study, and demonstrates how the research 
questions developed.  
  
1.5 A brief introduction of HLOC 
The concept of locus of control was originally developed from Rotter’s 
social learning theory of personality (Rotter, 1966), which discussed how 
the degree of control individuals believe they over events will affect their 
behaviour and the outcome (Rotter, 1966). Sources of locus of control are 
either internal (i.e. people who believe their own action and behaviour can 
influence outcome) and external (i.e. people who believe their actions and 
behaviour have little influence on outcomes, and that one’s outcome is 
determined by others or fate and luck). The locus of control concept is later 
adapted and applied in medical or health related-condition and health 
behaviour, known as HLOC (Wallston et al., 1976).  
1.5.1 Definition and a brief overview of HLOC in health 
research 
HLOC is the concept used to understand a person’s locus of control belief 
over their health condition, and a person’s perception of who is responsible 
for his/her health condition (Wallston & Wallston, 1982). It is defined as 
“the degree to which individuals believe that their health is controlled by 
internal versus external factors” (Wallston & Wallston, 1982: 68), and is 
measured by the Multidimensional Health Locus of Control (MHLC) scale 
(Wallston et al., 1978).  
 
Wallston et al. (1976) proposed that HLOC should be viewed as a multi-
dimensional construct, with relatively independent dimensions. These 
dimensions reflect differences in attributions people hold about their 
responsibility for and control of their health. The three major categories of 
HLOC are (Wallston et al., 1978):  
 Internal locus of control (ILOC)- the belief that the responsibility 
for one’s health is attributed to oneself, and that one’s behaviour 
will have an effect on one’s health status; 
CHAPTER 1 Introduction to the study Page 12 
 
 External locus of control (ELOC)- the belief that others, such as 
health professionals or family, are responsible for and have control 
over one’s health status, and 
 Chance locus of control (CLOC)- the belief that one’s health 
condition is a matter of fate, chance or luck. 
 
HLOC is associated with health behaviour, health outcomes and the 
utilization of health care (Luszczynska & Schwarzer, 2005). This health 
belief has been widely studied in health research for over thirty years, 
examples are: treatment compliance (Gopalkrishnan, 2014; Shneerson et al., 
2015), substance abuse (Dielman et al., 1987), cancer practices (Park & 
Gaffey, 2007; Shneerson et al., 2015), diabetes (Schlenk & Hart, 1984; 
Tillotson & Smith, 1996; Gopalkrishnan, 2014),  depression (Mollard, 2015; 
Aarts et al., 2015) and chronic pain such as arthritis and back pain 
(Harkapaa et al., 1991; Gustafsson & Gaston-Johansson, 1996; Cross et al., 
2006; Richard et al., 2011).  
 
Wallston and Wallston (1982), the developers of HLOC, summed up the 
common findings among numerous studies of a variety of patient 
population, including patients with chronic pain. Relationships have been 
found between HLOC and reports of physical symptoms, adherence to 
health recommendations, information-seeking behaviours, physical and 
mental health; and the desire for personal control over healthcare services 
(Wallston & Wallston, 1982).  
1.5.2 Relevancy of HLOC for physiotherapy management of 
NSCLBP  
The existing literature mainly offers evidence on HLOC for a variety of 
patient population, whilst studies that specifically examine patients with 
NSCLBP are very limited. Research commenting on back pain population, 
has suggested that HLOC is associated with both the risk and prognosis of 
LBP (Clays et al., 2007; Koleck et al., 2006; Linton, 2000; Waddell & 
Burton, 2001). Significant relationship has also been reported between 
HLOC and quality of life, disability and pain in NSCLBP (Sengul et al., 
2010).  
CHAPTER 1 Introduction to the study Page 13 
 
Literature has demonstrated that NSCLBP patients with higher ILOC report 
lower level of pain (Sengul et al., 2010; Harkapaa, 1991), lower level of 
disability (Harkapaa et al., 1991; Haldorsen et al., 1998; Sengul et al., 
2010), use more active coping strategies (Harkapaa, 1991), have better 
physical function (Keedy et al., 2014; Sengul et al., 2011), have more active 
involvement with health intervention, respond better with CBA treatment, 
learn their exercises better and practise them more frequently during follow-
up (Harkapaa et al., 1991). Patients with back pain would do better if they 
believe that they have a role in managing their condition (Watson & 
Kendall, 2000), and would be more likely to agree with the goals of active 
interventions (Braman & Gomez, 2004; Hashimoto & Fukuhara, 2004).  
 
Conversely, patients with chronic pain with high ELOC or high CLOC do 
not believe they are one responsible for their own health and their behaviour 
influence outcome, thus avoiding increasing their activity level, and report 
poor ability to reduce and control their pain (Wallston & Wallston, 1982; 
Crisson & Keefe, 1988; Cross et al., 2006). NSCLBP patients with a higher 
level of ELOC and CLOC are more likely to report higher level of pain 
(Sengul et al., 2010), more likely to rely on maladaptive coping strategies 
(Harkapaa, 1991), and have a higher level of pain-related fear (Richard & 
Dionne, 2011).  
 
In short, ILOC belief is associated with increased ability to control pain, 
more effective coping strategies, less impairment, less distress, and 
increased functioning, whilst ELOC and CLOC are associated with passive 
coping strategies, greater impairment, and more distress and decreased 
functioning.  
 
In light of the above, it can be implied that patients’ HLOC belief may 
influence their uptake of and responses to treatment modalities and self-
management tasks. Their HLOC belief may directly or indirectly relate to 
other key clinical elements of NSCLBP such as pain intensity, disability, 
FAB, coping strategies use, self-care and general functioning. These are all 
key areas physiotherapists seek to address in their treatment.  
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It is acknowledged that HLOC is only one piece of the much wider 
psychological context in understanding NSCLBP. Nevertheless, assessment 
of HLOC may provide some clues and new knowledge to help unravel the 
complexity of this condition. It may also give new direction for clinicians 
and researchers to further improve the exiting physiotherapy management 
programme in order to achieve better treatment outcomes. This is particular 
important in the current climate of the NHS, where physiotherapists are 
under constant pressure to prove their service to be clinically effective and 
value for money. 
1.6 A gap in literature 
Having considered the theoretical construct of HLOC, and the extant 
research in the area, it is reasonable to suggest that HLOC may be an 
important cognitive factor to explore and assess when evaluating the 
physiotherapy CBCLBP programme. However, none is known about 
whether a physiotherapy CBCLBP programme may alter patients’ HLOC in 
short-term and longer-term, and if there is any association between HLOC 
and the main clinical elements of NSCLBP such as pain intensity, disability 
and FAB. These gaps in knowledge are addressed and answered in this 
study.  
 
To date, there has been no previous study specifically looking at the effect 
of a physiotherapy CBCLBP programme on patients’ HLOC, and its 
relationship with other clinical outcomes. This has prompted this study with 
the research question and specific aims as the following: 
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1.7 Research question and specific aims of the study 
Research question: Does a physiotherapy CBCLBP programme alter 
patients’ HLOC? 
Aims of the study: 
1. To assess the effects of the physiotherapy CBCLBP programme on 
patients’ HLOC. 
2. To examine the effects of the CBCLBP programme on pain, 
disability and FAB. 
3. To determine if there is any relationship between patients’ HLOC 
and pain, disability and FAB. 
4. To examine patients’ self-care attitude toward their back pain in 
terms of their desire in future use of healthcare and prescription pain 
medication as a result of the programme. 
5. To investigate the cost of back care per change of ILOC, and the 
cost of the CBCLBP programme from a provider’s, patient and 
societal perspective. 
 
1.8 Conclusion 
With the clearly defined research question and study aims, this study 
intended to contribute additional evidence on the effectiveness of a 
physiotherapy CBCLBP programme conducted in a primary setting. It also 
intended to contribute new evidence regarding the potential importance (or 
not) of HLOC in the management of NSCLBP.  
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CHAPTER 2 LITERATURE REVIEW 
2.1 Introduction 
This chapter focuses on literature that is relevant to the current study. It is 
divided into two parts. Part I focuses on evidence of the group-based active 
exercise CBA intervention, which is the major management tool of 
NSCLBP employed by physiotherapists in clinical practice. This section 
includes the review of relevant evidence for its effectiveness on (1) clinical 
outcomes (Section 2.6.1 and Section 2.7); (2) HLOC (Section 2.8.1 and 
Section 2.8.2); (3) patients’ self-care attitude (Section 2.9.1), and (4) cost of 
the programme (Section 2.10.1). 
 
The influence of psychological factors in NSCLBP is well documented. 
Knowledge of these relationships may help increase our understanding of 
the underlying mechanism of how desired clinical outcomes can be 
achieved. Part II of this review focusses on the association between pain, 
disability, FAB and HLOC.  
 
Each section has its own summary which provides the themes and 
limitations that emerged from a set of selected studies accordingly:  
 
Section 2.5.2 Summary of evidence on the effectiveness of exercise 
therapy 
Section 2.6.2 Summary of evidence on the clinical effectiveness of CBA 
active rehabilitation delivered by physiotherapists 
Section2.7.1 Summary of evidence on the effectiveness of CBA 
intervention when targeting patients with psychosocial 
characteristics 
Section 2.8.3 Summary of evidence on the effect of CBA intervention in 
altering HLOC 
Section 2.9.2 Summary of evidence on the effectiveness of CBA active 
rehabilitation in patients’ self-management 
Section 2.11.4 Summary of evidence on the relationship between pain 
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intensity, disability and FAB 
Section 2.13.3 Summary of key findings of HLOC in NSCLBP 
 
An overview of summary of this literature review is drawn and presented in 
Section 2.14.  
 
Some sections of the literature review (Section 2.10.1, Section 2.11.1 and 
Section 2.11.2) are presented in table, because it was decided that relevant 
information is too lengthy to present in paragraph form whereas it is much 
clearer presented in the format of table. 
 
The amount of research on NSCLBP is substantial. There is high 
heterogeneity between studies such as: research design, patients’ inclusion 
criteria, outcome measures, interventions and statistical methods, thus 
preventing the PI from carrying out systematic review and meta-analysis. A 
meta-synthesis review is possible. However, considering the nature and 
scope of the literature relating to the research questions, a narrative review 
is more appropriate in this instance. Therefore, this is chosen as the method 
of literature review for the present study.  
 
First, a set of selected studies (including randomised controlled trial (RCT), 
cohort study, systematic review and meta-analysis) which are relevant to 
each research question are identified. Risk of bias of these studies was then 
assessed according to the Cochrane Bias Methods Group’s recommendation 
(Higgins et al., 2011). This is a seven-item checklist that covers reports on: 
sequence generation, allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete outcome data, 
selective outcome reporting and other biases. The scores are ranged from 
‘high’, ‘low’ and ‘unclear’ risk of bias. This tool is comprehensive, easy to 
use and covers a wide variety of domains allowing the PI to assess the 
relevant paper appropriately. Finally, the themes and conclusions emerged 
from the set of studies are drawn. 
 
The aim of this chapter is to provide the context and critique of what 
research has already been found, also to identify what the problems and 
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limitations are in the current evidence. The present study attempts to address 
these gaps by extending the literature and contributing new evidence. This 
chapter also gives the basis of evidence to help comparing and discussing 
the findings of the present study (Chapter 5).  
 
PART I 
2.2 LBP- The clinical problem 
Low back pain (LBP) is a common and prevalent problem throughout the 
world (Hoy et al., 2012). Although most episodes of LBP appear self-
limiting (Pengel et al., 2003; Balagué et al., 2012), recurrence is high (Costa 
et al., 2009; Stanton et al., 2010), with approximately 20% cases leading to 
NSCLBP, and 11-12% are disabled by it (Airaksinen et al., 2006; Gurcay et 
al., 2009). Most challenging is this subgroup of patients with NSCLBP. It 
accounts for three-quarters of the total direct and indirect costs of medical 
care and lost productivity (Fourney et al., 2011), and often associates with 
poor rehabilitation outcomes (Jamison, 2011).  
 
NSCLBP is now the number one cause of years lived with disability 
globally (Murray et al., 2013), with an estimated 632 million affected 
people (Lim et al., 2013). Epidemiological evidence suggests that the 
number of people seeking medical attention and the cost in economic and 
health terms still seems to be increasing (Fourney et al., 2011). In respect of 
physiotherapy, NSCLBP is one of the least successfully treated 
musculoskeletal conditions (Harland & Lavallee, 2003). In order to decrease 
burden to patients, to health professionals and to society, the use of 
intervention with demonstrated effectiveness is essential. 
 
2.3 Clinical guidelines of the management of NSCLBP  
The National Collaborating Centre for Primary Care (NCCPC) and the 
NICE guidelines group in the UK provide evidence-based guideline for the 
management of NSLBP (Savigny et al., 2009). The NICE guidelines are 
similar to most of the other guidelines (Chou et al., 2009; Koes et al., 2010), 
and are consistent with experts’ recommendations (Dagenais et al., 2010).   
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First-line recommendation 
First-line guideline recommendation for NSLBP includes: use of advice and 
educational information, promote self-management, discourage bed rest, 
advice to stay active, and offer pain medication to adequately manage pain 
so that patients could keep active (Savigny et al., 2009). 
 
Second-line recommendation 
Second-line recommendation includes the use of adjunctive analgesics, 
strong opioids, and possibly anti-depressants (Savigny et al., 2009), but 
there is a high risk of side-effects (Kuijpers et al., 2011). Recommended 
therapies include: a course of supervised exercise therapy, manual therapy 
or acupuncture (Savigny et al., 2009; Dagenais et al., 2010).  
 
Third-line recommendation 
Where patients fail to respond to at least one recommended therapies, and 
display sign of significant disability and psychosocial risk factors, the NICE 
guidelines recommend a course of combined physical and psychological 
treatment programme. This is broadly consistent to that recommended in the 
‘Recommended Guidelines for Pain Management Programmes for Adults’ 
issued by The British Pain Society (2013). 
 
The combined physical and psychological programme may be delivered in 
various forms, such as multi-disciplinary rehabilitation by a combination of 
professions as in-patient or out-patient, or delivered primarily by 
physiotherapists in a form of group rehabilitation consisting physical 
exercise and CBA education component (Savigny et al., 2009). The duration 
and intensity of the programme falls into two main categories: (1) daily 
intensive programme with more than 100 hours, and (2) once or twice 
weekly programmes with less than 30 hours, depends on clinical settings.  
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2.3.1 The 100 hours guideline recommendation  
The Cochrane Back Review Group (Sagnivy et al., 2009) stated that the best 
evidence for the combined physical and psychological programmes was of 
at least 100 hours of exposure over a maximum of eight weeks. This 
recommendation is made universal to all NSLBP patients who failed to 
improve with secondary recommendation (Sagnivy et al., 2009), without 
offering clear clarification of what level of patients’ disability or what risk 
factor profiles may be appropriate for the 100 hours therapy.  
When reviewing evidence of the 100 hours guideline (Guzman et al., 2001; 
Sagnivy et al., 2009), a number of serious limitations were identified. First, 
the NICE guideline is predominantly based on the findings of only one 
systematic review (Guzman et al., 2001), in which only a small number of 
trials (10 RCTs) were considered. Seven out of the 10 included trials in this 
review (Alaranta et al., 1994; Basler et al., 1997; Bendix et al., 1996; 
Harkapaa et al., 1989; Juckel et al., 1990; Lukinmaa, 1989 and Nicholas et 
al., 1991) did not fulfilled methodological quality criteria such as: 
concealment allocation, blinding of assessor, blinding of care provider, use 
of intention-to-treat analysis and consideration of acceptable dropout rate. 
Secondly, despite of these aforementioned biases, six out of the 10 included 
trials (Alaranta et al., 1994; Bendix et al., 1995; Lukinmaa, 1989; Mitchell 
& Carmen, 1994; Nicholas et al., 1992 and Nicholas et al., 1991) were 
regarded as high quality. This led to the question on how the methodological 
quality was assessed in this review. It was found that the authors lowered 
the cut-off points for high quality from 7 to 5 out of 10. If the cut-off was 
set at 7 or more points as recommended by the Back Review Group, all the 
trials would be considered low quality. It appears that the authors and the 
Cochrane Back Review Group applied inappropriate criteria and thereby 
misjudging the methodological quality of these included trials.  
Thirdly, much emphasis was placed on return to work as the primary 
outcome measure, while physical measurements and psychological scales 
were ignored in this review. An undue focus on return to work to define 
effectiveness of the treatment leads to low generalizability in non-workers 
such as older patients and homemakers who frequently presented in primary 
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care. Lastly, this review selectively looked at literature where patients with 
severe disabling back pain were treated in well-established daily intensive 
multi-disciplinary rehabilitation. Again, the conclusions drawn from these 
studies may not be applicable to the wider category of NSCLBP patients 
with moderate disabling back pain seen in primary care and less intensive 
programmes.     
To summarise, the guideline recommendation of 100 hours is high risk of 
bias. It did not seem to consider enough the heterogeneity of NSLBP 
patients, the variability of clinical settings, the heterogeneity of the types of 
programme and the variability of relevant clinical outcome measures. 
Lowering the cut-off point when assessing methodological quality and only 
focusing on selected clinical outcomes and selected patients sub-group in a 
relatively small number of studies may also weaken the validity of finding, 
introduce publication bias and lower generalizability to the wider population 
of NSCLBP.  Further evidence and clarification on (1) treatment hours, and 
(2) how to select the optimal level of combined physical and psychological 
based treatment for different NSCLBP patients (such as the use of screening 
tools to inform decision-making) seems to be much needed to refine the 
current NICE guideline recommendation.   
2.4 Role of physiotherapist 
Where a combination of physical factors (such as poor core strength, 
maladaptive movement, motor control impairment, spinal instability), and 
cognitive factors/ psychosocial factors are the possible underlying 
mechanism for ongoing pain, the physiotherapy CBA active rehabilitation 
may have the potential to impact on both the physical and cognitive drivers 
of NSCLBP (O’ Sullivan, 2005). 
 
Two major components of physiotherapy management in NSCLBP are: (1) 
exercise therapy, which can be delivered in the form of graded therapeutic 
exercise, functional training in self-care or home exercise programme 
(World Confederation for Physical Therapy, 2014); and (2) CBA education 
in addition to physical exercises. 
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2.5 Exercise therapy in NSCLBP management  
Based on the assumption of the biopsychosocial model (Waddell, 1987), 
patients with NSCLBP are physically de-conditioned. Lower physical 
activity level leads to physical changes such as muscle atrophy, changes in 
metabolism, decreased muscle strength and obesity, as well as psychological 
and behavioural changes such as distress, depression, anxiety and avoidance 
behaviour (Bortz II, 1984). Evidence also suggests that low level of physical 
activity is correlated with future episodes of persistent LBP (Hurwitz et al., 
2005; Thomas et al., 2007). Therefore, exercise therapy is one important 
component in NSCLBP management (Frost et al., 2000; Lively, 2002; 
Hayden et al., 2005a; Hayden et al., 2005b), and it is consistently 
recommended across various guidelines in primary care (Pillastrini et al., 
2012).   
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2.5.1 Evidence on exercise therapy in NSCLBP 
Several systematic reviews of NSCLBP (Krismer & Van Tulder, 2007; 
Hayden et al., 2005b; Liddle et al., 2004) investigated the efficacy of 
exercise therapy. These reviews consistently conclude that, even with a 
wide variety of exercise programmes, exercise therapy only demonstrates 
modest improvement in pain and function in NSCLBP. A high quality 
systematic review (Van Middelkoop et al., 2011) concluded that there is low 
quality evidence (serious methodological limitations, imprecision) for the 
effectiveness of exercise therapy when comparing to waiting list control, 
usual care (such as receiving home exercise and advise to stay active) and 
behavioural treatment on pain intensity and disability at short- and long-
term. However, it must be noted that the inclusion of different quality trials, 
the heterogeneity of included studies and the use of different quality scores 
to categorise articles in these systematic reviews may over- or underestimate 
results.  
 
A systematic review by Hayden et al. (2005b) aimed at identifying the type, 
quality and mode of delivery of exercise therapy to improve CLBP 
outcomes. The review covered 43 relevant RCTs, providing adequate 
information of the included trials, and presented their findings with 
confidence intervals. The authors concluded that the positive effect of 
exercise therapy, particularly a supervised, patient-specific, graded exercise 
programme (including stretching and strengthening) may improve pain and 
function in NSCLBP. However, the included trials of the review are 
predominantly of poor methodological quality (only 6 of the 43 trials were 
rated as high quality). The main shortcomings in methodological quality of 
these included studies were: inconsistent and poor reporting, lack of relevant 
outcome measures, unacceptable drop-out and no intention-to-treatment 
analysis. These different sources of bias may weaken the internal validity 
and result in over-estimation of the effect of exercise therapy.  
 
In contrast, the quality of included studies in the systematic review by 
Liddle et al. (2004) was reported as high and medium quality (16 RCTs). 
Their findings were in agreement with Hayden et al. (2005b), which also 
concluded the positive effect of exercise in CLBP patients in improving pain 
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and function. Although the authors clearly presented how the 
methodological quality of included studies was assessed, and demonstrated 
that they had considered the rigour of included studies, the results of this 
review was based on 16 RCTs all with positive results, leading to reference 
bias. Besides, no statistical method was used to analyse and summarise 
results. This may reduce the validity of conclusion drawn from this review.  
 
A cross-sectional study, with low risk of bias by Mannion et al (2001) 
showed that exercise reduced FAB, possibly because of the experience of 
completing the prescribed exercises without undue harm. Smeets et al 
(2006b) also found that physical exercise programme without deliberately 
targeting cognitive factors demonstrated substantial cognitive change such 
as reduction in depression and catastrophizing (i.e. holding a overly 
pessimistic interpretation of one’s symptoms and prognosis).  
 
A RCT by Smeets et al. (2006b) compared the effectiveness of physical 
treatment, CBT and a combination of both, with waiting list control group in 
212 patients with NSCLBP. It was found that all the three active treatments 
were more effective than the waiting list group in reduction in pain, 
disability and pain catastrophizing. There was no clinical relevant difference 
between the three active treatments, and only the physical treatment group 
showed a significant decrease in pain catastrophizing. The overall 
methodological quality of this study was satisfactory, including: 
concealment of randomization, clearly defined validated outcome measures, 
highly structured treatment protocols and control for patients’ expectation 
bias. There were differences in follow-up outcome data (%) between the 
three active treatments: physical treatment group (85%), compared to the 
CBT (80%) and the combined group (69%). Therefore, it is possible that 
attrition bias may over-inflate the effectiveness of the physical treatment 
group. In sum, this study provides moderate evidence that exercise therapy 
may be useful in reducing pain catastrophizing, which is a psychological 
factor significantly associated with disability in NSCLBP (Picavet et al., 
2002; Woby et al., 2004b). This study is low risk of bias.  
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2.5.2 Summary of evidence on the effectiveness of exercise 
therapy 
Overall, the quality of evidence for the effectiveness of exercise therapy on 
physical and psychological outcome in NSCLBP is low to moderate, when 
compared to no treatment, usual care and CBA treatment. In most individual 
studies and analysis, there were limitations regarding the methodological 
quality, and in most analysis, there was imprecision of data because of 
sparse data and wide confidence intervals. Additionally, there is 
heterogeneity in some of the analysis among the studies. This heterogeneity 
could have been caused by: differences in methodological qualities and risk 
of bias, variation in sample size, patient characteristics, interventions and 
choice of outcome measures. Therefore, the results of these studies should 
be interpreted with some caution.  
 
2.5.3 Role of psychological factors on the effect of exercise 
therapy 
It is noteworthy that long-term maintenance of the potential benefits of 
exercise requires patients’ motivation and patients’ beliefs towards 
behavioural change and exercise compliance. For instance, there is evidence 
to suggest that patients who demonstrate less FAB about activity are more 
likely to comply with a physical programme (Twomey & Taylor, 2000). An 
internal sense of personal control is also shown to be associated with 
positive psychological and physical adaption to illness, and more 
engagement in beneficial health behaviours (Affleck et al., 1987; Burker et 
al., 2005). Several high quality RCTs have shown that when patients with 
CLBP are taught more about their pain (by pain physiology education), their 
pain and catastrophizing reduces, and in conjunction with physiotherapy, it 
improves functional and symptomatic outcomes (Moseley, 2002; Moseley, 
2003b; Moseley et al., 2004; Moseley 2005). Changes in pain attitude and 
beliefs are directly associated with change in physical performance in 
patients with CLBP even there is no opportunity for the patients to be 
physically active during the treatment (Moseley, 2002; Moseley, 2004).  
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Collectively, this evidence suggests that patients’ beliefs (such as FAB, 
ILOC and pain perception) may be the underlying mechanism to facilitate 
the physical and psychological effects of exercise, and to achieve more 
desired symptomatic outcomes. It is well documented that psychosocial 
factors are more powerful factors than the physical ones to persistent pain 
and disability in NSCLBP (Linton, 2000; Takakura & Sakihara, 2001; 
Braman & Gomez, 2004; Waddell, 2004; Klaber Moffett et al., 2006; 
Gatchel et al., 2007; Bakker et al., 2009; Hansen et al., 2010; Foster & 
Delitto, 2011). Thereafter, the addition of CBA treatment to exercise 
therapy, as opposed to exercise therapy alone, may have more to offer to 
patients with NSCLBP and with high FAB, as recommended by most 
clinical guidelines. 
2.6 The CBA treatment in physiotherapy management of 
NSCLBP 
Since physiotherapy is the largest paramedical profession responsible for 
back pain management in the UK (Maniadakis & Gray, 2000), it is common 
for physiotherapists to receive some basic training in CBA techniques when 
treating patient with NSCLBP (Critchley et al., 2007; Johnson et al., 2007; 
Hay et al., 2005; Lamb et al., 2010). In addition, there is a wide acceptance 
that the management of LBP should begin in primary care (Koes et al., 
2010). Consequently, a group-based physical exercise combined with CBA 
programme delivered by physiotherapists in primary care has witnessed a 
rise in popularity and recognition. The following section will critically 
review the literature in detail. 
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2.6.1 Evidence on the clinical effectiveness of CBA active 
rehabilitation led by physiotherapists 
A large RCT (N=701) by Lamb et al. (2010) studying patients with subacute 
or chronic LBP. They compared the clinical and cost effectiveness between 
a 15-minute session of active management advisory consultation by primary 
care clinicians (control group), with the Back Skills Training (BeST) 
programme based on CBT principle. The BeST programme was run by 
physiotherapists, nurses, psychologists and occupational therapists, 
comprising a 5 hour initial assessment, and six sessions of group therapy 
(1.5 hour duration each). This study found that the BeST programme group 
demonstrated improvement in both disability and FAB from baseline to 3-
month, 6-month and 12-month follow up. When compared with the control 
group, the BeST programme group was statistically significantly more 
effective in reducing disability and fear-avoidance behaviour. This study 
concluded that the BeST programme, was superior to best care in primary 
care. In addition, the BeST programme also demonstrated a sustained 
positive effect at 12-month follow up. This study is low risk of bias, with a 
robust design including: use of adequate powered sample, randomisation to 
assignment, concealed allocation, clinician and assessor blinding, and 
relevant outcome measures. Sufficient detail of the intervention and long 
period of follow up were also included. However, because of the nature of 
the treatment assignment, it was impossible to mask patients which may 
introduce performance bias.  
 
A well-conducted RCT based at two London hospitals (Critchley et al., 
2007) compared the clinical and cost effectiveness of the three commonly 
used physiotherapy treatments in NSCLBP. Patients (N=212) were 
randomized to usual outpatient individual physiotherapy (included 
combination of joint mobilization, manipulation, home exercise and back 
care advice. Up to 12 sessions of 30 minutes were allowed), spinal 
stabilization class (consisted of specific exercise for spinal stabilization, up 
to 8 sessions of 90 minutes were allowed), and a physiotherapy-led pain 
management programme using group exercise and CBA education 
(consisted of 8 sessions of 90 minutes). Findings showed that all the three 
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physiotherapy regimes significantly reduced disability, with concurrent 
improvement in pain, health-related quality of life, time off work and health 
service utilization. The pain management programme was marginally more 
clinically effective from baseline to 18-month follow-up. This study 
concluded that the physiotherapy-led pain management programme, with 
simple exercise and no requirement of special equipment, produced 
clinically important improvement. Besides, it had a less health-service 
consumption and was more cost-effective than other treatments. The 
pragmatic nature of this trial in clinical practice and inclusion of moderately 
disabled NSCLBP patients represented good generalizability. This study 
was also characterized by a number of strengths, including: a thorough 
study design, adequate sample size, homogeneous population, adequate 
randomization, concealed allocation, successful assessor blinding, highly 
structured interventions, use of intention-to-treat analysis, and adequate 
reporting with sufficient data. It is noted that the response rate during 
follow-up in the pain management group was lower in comparison to other 
two groups. Many participants also withdrew from the class early (attrition 
was 17% in individual physiotherapy group; 25% in spinal stabilization 
class; 32% in pain management). However, the authors acknowledged these 
issues and mentioned inputting missing data using the last value carried 
forward method did not change any of the above conclusions. Overall, this 
study is low risk of bias. 
 
A RCT by Johnson et al. (2007) comparing the clinical and cost 
effectiveness of a group structured active exercise and CBA intervention 
(consisted of eight 2-hour sessions delivered by physiotherapist only) with 
usual care supplemented by education material (control group). Participants 
were all diagnosed with NSCLBP (N=196) and referred to out-patient 
physiotherapy by their GP. Primary outcome measure was disability as 
evaluated by RMQ. Secondary outcome measures were pain, health-related 
quality of life, and time off work. The healthcare usage such as visits to GP 
and other healthcare professions, medications usage, care from hospital was 
also collected for economic evaluation. This study found that both 
intervention and control group showed relatively substantial amount of 
improvement in pain and disability over the course of follow up (at 3-
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month, 6-month and 12-month post-treatment). However, the intervention 
group only showed a small and non-significant additional benefit in 
reduction of pain, disability and general health measures when compared to 
the control group at one year follow-up. This study partially supports the 
clinical effectiveness of the CBA intervention provided by physiotherapists, 
yet it is likely to be a cost-effective option to treat patients with NSCLBP. 
This study employed adequate sample size, homogeneous population, 
randomization, use of highly structured programme, independent review of 
treatment fidelity and relevant outcome measures. However, the authors 
were unclear about concealed allocation (selection bias), and blinding of 
outcome assessor, personnel and participants (performance bias). Besides, 
there was loss of follow-up over the study period (95%, 87% and 84% 
response rates at 3, 9 and 15 months) and poor treatment compliance of the 
study participants (attrition bias). These different sources of bias may reduce 
the validity of the findings.  This study is at moderate risk of bias. 
 
Smeets et al. (2006a and 2008) conducted a multi-centre RCT in 172 
NSCLBP patients with moderate to severe functional limitation. They 
compared the effectiveness of the three common out-patients treatment 
models: 1). the active physical treatment; 2). the CBA psychological 
treatment; and 3). the combination of both, with waiting list group. Each 
treatment was delivered three times a week for 10 weeks (exposure to CBA 
component was approximately 78 hours) by multi-disciplinary members. A 
number of outcome measures were used, including disability, pain, 
depression, patient’s global assessment, treatment satisfaction and physical 
performance tasks. At 6-month and 12-month following treatment, all the 
three treatment groups were more effective than the waiting list group. 
When comparing the three treatment groups, the combined group (active 
exercise treatment plus CBA treatment) showed no additional benefit 
statistically than the active exercise group and the CBA treatment group 
alone. There were differences in follow-up data between groups, leasing to 
attrition bias. But overall, this study demonstrated a number of strength 
including: adequate randomization, concealed allocation, highly structured 
intervention, adequate reporting of data and use of relevant outcome 
measure. Smeets et al. (2006a and 2008) had carried out rigorous blinding 
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procedure of outcome assessor and addressed expectation bias from patients 
appropriately, while other similar studies were unclear about these potential 
biases (Critchley et al., 2007; Johnson et al., 2007; Lamb et al., 2010). This 
study is low risk of bias. 
 
A multi-centre RCT compared the clinical effectiveness of an intensive 
rehabilitation programme based on CBT principles and daily exercises (five 
days a week for three consecutive week, with an average of 75 treatment 
hours, predominantly led by physiotherapists) with spinal fusion surgery 
(Fairbank et al., 2005). A total of 349 NSCLBP patients who were potential 
candidate for spinal stabilization were included. Results showed that both 
treatments demonstrated similar clinical improvement during two years of 
follow-up. The findings reported no significant difference in all outcome 
measures between the groups, except the disability score was marginally 
more in favor of surgery. In addition, nearly three quarters of patients 
allocated to rehabilitation avoided surgery by two years. This study is low 
risk of bias on account of thorough research design, randomization, 
adequate sample size and use of relevant outcome measures. However, the 
missing follow-up data in this study was high (20% loss to two-year follow-
up), and the authors dealt with missing data with multiple imputation (i.e. 
treating missing data as if they were real measurements). This consequently 
introduces attrition bias and limits the internal validity of the findings.  
 
A systematic review by Van Middelkoop et al. (2011) determined the 
effectiveness of physical and rehabilitation intervention (such as exercise 
therapy, back school, behavioural treatment and multi-disciplinary 
treatment) for NSCLBP. This review included 83 RCTs. Risk of bias of the 
included studies was assessed using criteria list outlined by the Cochrane 
Back Review Group. This review concluded that the most promising 
interventions for NSCLBP were multi-disciplinary treatment or behavioural 
treatment. In addition, there is moderate evidence that the use of behavioural 
treatment (such as CBA) combined with other treatment such as 
physiotherapy or exercise therapy can reduce pain and disability at short-
term, as well as reduce sick leave and costs due to sick leave. This 
systematic review is low risk of bias. The authors adequately reported the 
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risk of bias assessment using criteria list and considered methodological 
flaws of the included studies thoroughly. Besides, an inclusion of a 
homogenous patient population (i.e. NSCLBP) has methodological 
advantages. The quality of papers was generally poor in this review. Only a 
small number (28 out of 83) of studies were rated as high quality. Inclusion 
of low quality trials may lead to over-estimation of treatment effect. There 
may also be reference bias and reporting bias in this review, since the 
authors selectively included published trial with positive results.  
2.6.2 Summary of evidence on the clinical effectiveness of 
CBA active rehabilitation delivered by physiotherapists 
Among the seven RCTs and one systematic review being appraised, five are 
considered as low risk of bias (Lamb et al., 2010; Critchley et al., 2007; 
Smeets et al., 2006a; Smeets et al., 2008; Fairbank et al., 2005 and Van 
Middelkoop et al., 2011) and one is moderate risk of bias (Johnson et al., 
2007). Literature seems to demonstrate moderate evidence to support the 
clinical effectiveness on CBA active rehabilitation CBA delivered by 
physiotherapists.  
 
The greatest benefits were observed in studies when comparing CBA with 
waiting list or usual-care control groups (Lamb et al., 2010; Klaber Moffett 
et al., 1999; Van Middelkoop et al., 2011; Kent & Kjaer, 2012), whereas the 
least benefit when comparing CBA with other active intervention (U.K. 
Beam Trial Team, 2004a; Fairbank et al., 2005; Smeets et al., 2006a; 
Smeets et al., 2008; Johnson et al., 2007; Critchley et al., 2007).  
 
With respect to short-term and long-term effectiveness, studies that 
followed up beyond six months reported mixed results (Klaber Moffett et 
al., 1999; U.K. Beam Trial Team, 2004a; Fairbank et al., 2005; Critchley et 
al., 2007; Johnson et al., 2007; Lamb et al., 2010; Van Middelkoop et al., 
2011; Kent & Kjaer, 2012). Possible explanation for varied results between 
trials may include: inadequate sample size, level of expertise of 
professionals delivering the programme, method of delivery, component of 
the programme, rigour of the adherence to CBT principle, mix of duration 
of NSLBP population and use of heterogeneous group (i.e. including 
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patients low on psychosocial risk factors and NSLBP of any duration), 
variation in intensity and duration of programme, outcome measures, 
outcome timing and statistical methods.  
So far, the emerging picture is that the CBA interventions deliver moderate 
effect, which are mostly seen when against passive controls, and are mostly 
of short-term. So why have CBA treatments failed to deliver against active 
controls? One possible explanation could be that the majority of the trials 
targeting heterogeneous group including those patients low in psychological 
risk (e.g. low in FAB). Inclusion of patients without psychological needs to 
receive treatment that include psychology not only potentially results in 
reduced treatment effectiveness, but is also irrational and unethical (Pincus 
& McCracken, 2013).  
 
2.7 Evidence of the effectiveness of CBA rehabilitation when 
targeting patients with psychosocial characteristics 
Some primary clinicians (including the PI) are inclined to believe that 
treatment targeted to patients with particular psychosocial characteristics 
may improve patients’ outcome such as pain, disability and psychosocial 
factors (Kent & Keating, 2004). A hypothetical example would be “CBA 
provides more positive clinical outcome in patients with high FAB”.   
 
Klaber Moffett et al. (2004) conducted a RCT in 179 patients with LBP of 
mixed duration (acute, subacute and chronic). The hypothesis was that 
physical exercise classes based on CBA (active rehabilitation) were more 
effective than usual GP care, when targeted patients with high fear-
avoidance (a score of >14 on the Fear Avoidance Beliefs Questionnaire). 
The only outcome used was the RMQ, which assesses pain-related 
disability. This study demonstrated that active rehabilitation was more 
effective than GP care. In addition, the active rehabilitation group showed a 
more favourable treatment effect at all time points in the high-fear group 
than the low-fear group, and the size of effect when targeting patients with 
high fear is clinically important. However, the size of effect between two 
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groups only reached its statistical significance at one time-point (i.e. 12-
months). This study included a number of strengths including: adequate 
randomisation, concealed allocation, outcome assessor blinding and baseline 
similarity between groups. However, blinding of patients and clinicians 
were not conducted, hence introducing performance bias. Besides, the only 
outcome measure used was RMQ, which may limit reporting on other 
important outcomes. Overall, this study is moderate risk of bias. 
 
In contrast, the trial by Hough et al. (2007) reported a different finding from 
Klaber Moffett et al. (2004). Hough et al. (2007) conducted a RCT in 
patients with NSLBP of mixed duration. The hypothesis being tested was 
that physical exercise class with CBA (namely active rehabilitation) were 
more effective than manual therapy when targeting patient at high risk of 
chronicity (a score of > 106 on the Orebro Musculoskeletal Pain Screening 
Questionnaire (OMPQ) score). The OMPQ is a valid and reliable ‘yellow 
flag’ screening tool that predicts long-term disability and failure to return to 
work in workers following musculoskeletal soft tissues injury (Linton & 
Hallden, 1998). Outcome measures were pain (evaluated by VAS) and 
disability (evaluated by RMQ). This study found that active rehabilitation 
was no more effective in improving pain and reducing disability than 
manual therapy in the high-risk subgroup, and overall the treatment effect 
was not significant. The authors concluded that using active rehabilitation 
targeting patients at high risk of chronicity (OMPQ> 106) was not any more 
useful. However, this study included small sample size (only 39 patients). In 
addition, no randomisation, no concealed allocation, no patient and clinician 
blinding were conducted. The manual therapy arm was not standardised 
where physiotherapists were free to select any treatment. The authors also 
did not consider dropout rate and did not analyse data according to 
treatment allocation. This study demonstrated poor validity of their findings 
to support its conclusion. This study is high risk of bias.   
 
A systematic review (Kent & Kjaer, 2012) aimed to determine if the 
efficacy of treatment when targeting NSLBP patient (of any duration) with 
particular psychosocial characteristics (e.g. high pain-related fear, 
catastrophization, anxiety and depression). The hypothesis was that 
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psychosocial intervention was more effective when targeting patients with 
certain psychosocial characteristics. This review concluded that there was 
only limited evidence that active rehabilitation (physical exercise class with 
using CBA) was more effective than usual care at reducing activity 
limitation when targeting NSLBP patient with high pain-related fear. 
Although the authors adequately assessed the risks of bias of included 
studies (as outlined by the Cochrane Back Review Group), this review only 
included 4 RCTs (papers in English, Danish and Norwegian), hence there is 
potential for their findings to contain cultural and publication bias.  
2.7.1 Summary of evidence on the effectiveness of CBA 
rehabilitation when targeting patients with psychosocial 
characteristics 
Surprisingly, only limited literature offers evidence for the effectiveness of 
CBA treatment targeting NSLBP patients with psychosocial risk factors. 
Overall, the quality of evidence was low. Among all studies being 
appraised, the included patients were of mixed duration of NSLBP. No 
studies specifically looked at NSCLBP with psychosocial characteristics. 
This has highlighted the need for further investigation in this subgroup of 
LBP patients.  
 
Despite the limited and low quality evidence in this field, experts remained 
optimistic about the importance of this line of research and acknowledged 
the research importance of examining CBA intervention targeting at 
NSCLBP patients with high psychosocial risk factors (such as high FAB) 
(Van der Windt et al., 2008; Kent & Kjaer, 2012). This current study aims 
to extend the literature in this line.  
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2.8 Effectiveness of CBA intervention in altering HLOC 
Among the different psychological factors of NSCLBP, those of a cognitive 
nature play a prominent role, largely due to the fact that pain is a perceptual 
phenomenon. In fact, cognitive factors are largely responsible for the final 
(cortical) part of the perception process, therefore, without subtracting 
importance from the more sensorial and emotional aspects of pain, the final 
integrating point is cognitive in character (Moreno et al., 1999).  
Of the cognitive factors affecting pain experience, HLOC, which refers to a 
person’s belief in his own control over health condition (Wallston & 
Wallston, 1982), receives increasing research interest in chronic pain and 
NSCLBP. This is probably because HLOC has meaningful relationships to 
health attitudes, behaviours, coping and outcomes (Wallston & Wallston, 
1982; Armitage, 2003; Masters & Wallston, 2005; Janowski et al., 2013), all 
of which are the keys for effective management of NSCLBP.  
 
HLOC has been predominantly measured by the MHLC scale (Wallston et 
al., 1978), which is a valid and responsive assessment tool to measure 
HLOC in medical or health-related condition (Wallston et al., 1994). Studies 
with a focus on examining HLOC in patients with a medical or health 
condition often employed Form C of MHLC to assess the three subscales 
(Haldorsen et al., 1998; Sengul et al., 2010; Sengul et al., 2011; Richard et 
al., 2011; Klaber Moffett et al., 2006; Oliveira et al., 2009; Keedy et al., 
2014). 
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2.8.1 Evidence reviewing the effect of CBA intervention in 
altering HLOC using MHLC 
Limited evidence (only four studies) was found using MHLC to assess 
HLOC in NSCLBP patients following CBA intervention (Klaber Moffett et 
al., 2006; Keedy et al., 2014; Rybarczyk et al., 2001; Harkapaa et al., 1991). 
There is also heterogeneity among these studies such as: patient selection, 
research design, intervention, professionals delivering the intervention, 
outcome measures and follow-up.   
 
A RCT by Klaber Moffett et al. (2006) compared the effectiveness of a brief 
physiotherapy pain management programme using CBA (approximately 3 
hours duration) with a biomechanical hands-on physiotherapy approach 
(McKenzie treatment, 4 sessions) in patients with neck pain and back pain 
of mixed subacute and chronic duration (N=649). Each group then sub-
divided into with and without information booklet. A large number of 
outcome measures were used such as FAB (as evaluated by TSK), disability 
(as evaluated by RMQ), ILOC, CLOC and ELOC-powerful others (as 
evaluated by MHLC). Findings showed no significant difference in all 
outcomes between the two groups, except the brief pain management 
programme group (with booklet) reported significantly less reliance on 
health professional (reduction on ELOC) at any time point, compared to the 
McKenzie group. In the brief pain management group (with booklet), there 
was no improvement in ILOC and CLOC at 6-week, 6-month and 12-month 
(<3%), whilst ELOC (powerful others) steadily improved up to 6-month. 
This study included randomisation, concealed allocation and blinded 
outcome assessors. Performance bias may be present due to no blinding of 
patients and clinicians. Included patients were with neck pain and back pain 
with mixed subacute and chronic duration, hence this may introduce 
heterogeneity. A large amount of outcomes were included (14 in total) but 
the authors only selectively reported some of them (reporting bias). These 
different sources of bias weaken the validity of conclusion regarding the 
effect of CBA intervention in altering HLOC in NSCLBP. Overall, this 
study is moderate risk of bias. 
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A longitudinal study by Keedy et al. (2014) evaluated whether a two-week 
CLBP multidisciplinary intervention (MI) altered patients’ mental health, 
physical function and pain related belief (i.e. HLOC and self-efficacy). They 
also examined whether HLOC and self-efficacy predicted treatment-related 
changes in general mental health, depression and physical function 
following intervention. Sixty-one patients with CLBP completed the 80-
hours programme, delivered by physiotherapists and other multidisciplinary 
members.  A large number of outcome measures were used such as HLOC, 
self-efficacy, floor-to-waist lift (physical function), disability and 
depression. Outcome measures were taken before, after and 1-month 
following the MI programme. The study showed that the MI programme 
was effective in improving physical and mental health, as well as ILOC, 
CLOC and ELOC (for others) at 1-month. However, it had no impact on 
ELOC (for medical professionals). Regression analysis found that higher 
ILOC and lower ELOC (for medical professionals) predicted better physical 
functioning outcome at 1-month were not a predictor of mental health 
outcomes (depression and self-reported mental health). A limitation of this 
study is its short follow-up time (1-month), therefore, the effectiveness of 
the MI programme can only be suggested as short-term. This study did not 
mention blinding of outcome assessors, which may introduce detection bias. 
The dropout rate of this study was 22% from baseline to end of study (1-
month). It is unclear how the authors handled the incomplete data as the 
sample size across analysis at each time point was varied, which is likely to 
bias the results. The MI programme of this study was an intensive tertiary 
two-week rehabilitation which involved psychiatrist and vocational 
rehabilitation. Therefore, generalizability of their findings may be limited 
for primary care physiotherapy patients. Overall, this study is high risk of 
bias.   
 
A study by Rybarczyk et al. (2001) aimed to evaluate the effect of a mind-
body wellness intervention consisting of CBT and exercise component. 
They compared physical and psychological outcomes (including HLOC as 
outcome measure) between the mind-body wellness intervention and control 
group. All participants had a chronic illness (including NSCLBP, 
osteoarthritis, rheumatoid arthritis, diabetes and hypertension) and had six 
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or more primary care visits in the preceding year. The mind-body wellness 
intervention group (2 hours of eight sessions programme) showed reduction 
in CLOC and ELOC up to 1 year post-treatment. However, poor response of 
outcome data was seen in control group, resulting in attrition bias. Besides, 
this study included patients with a variety of chronic condition, hence 
findings are not solely representative of NSCLBP patients. The authors were 
also unclear with respect to their statistical methods in handling incomplete 
outcome data. These limitations may over-inflate the effectiveness of the 
intervention. This study is high risk of bias. 
 
A RCT by Harkapaa et al. (1991) examined the relationship between HLOC 
and outcome in a MI programme in patients with NSCLBP. A total of 459 
patients were randomised into three groups: a 3-week inpatient MI (included 
CBT component), a 15-session outpatient treatment (two hour sessions held 
twice a week) and a control group (received written and oral self-care 
instructions and back exercise only). Both inpatient and outpatient treatment 
groups were similar in content; both were carried out in groups of 6-8 
patients, led by physiotherapist. Outcome measures included disability, 
HLOC, psychological distress and back exercise compliance. At 3-months 
follow-up (completed by 96% of participants), the two treatment groups 
(inpatient and outpatient treatment) showed significantly greater 
improvement in HLOC and reduction in disability when compared with 
control group; significantly more inpatients than controls experienced 
greater reduction in disability; and inpatients performed their exercises 
significantly more than both outpatients and control group. With respect to 
the association between HLOC and treatment outcome, improvement of 
HLOC was found to be significantly associated with positive treatment 
outcomes (i.e. reduction in disability, more accomplishment and frequency 
of back exercises and less psychological distress), the ELOC was found to 
be significantly associated with less exercise at follow-up across treatment 
groups. The two treatment groups showed a more favourable outcome in 
HLOC, less disability and better accomplishment of back exercises at 3-
months, than the control group. The authors concluded that patients with 
higher ILOC, after the MI programme, improved more, learnt their exercises 
better, and practised them more during the follow-up. 
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Although a large enough sample size, randomisation and adequate data 
analysis were performed, the authors were unclear of the sample calculation, 
concealed allocation, and outcome assessors blinding. The follow-up period 
was only short (3-months), therefore whether these benefits will be 
sustained in longer-term is unknown. All subjects of this study were 
selected among blue-collar workers with low disability, therefore the 
finding may not be generalizable to patients in primary care setting or 
patient groups moderately or severely disabled by NSCLBP. This study is 
high risk of bias. 
 
2.8.2 Evidence reviewing the effect of CBA intervention in 
altering HLOC using composite scores or outcome measure 
that is re-constructed on the basis of MHLC 
There are other outcome measures seen in the literature that assessing 
subscale of HLOC, for example, the Multiple Pain Locus of Control 
(MPLC) and Pain Locus of Control (PLOC) are re-constructed on the basis 
of MHLC. The limitation of these outcome measures is that their 
responsiveness and validity are not established. Some authors used 
composite measures such as: the Pain Coping and Cognition List (PCCL), 
the Pain Cognition List (PCL), and the Survey of Pain Attitude (SOPA). 
Although these questionnaires provide composite scores for overall 
measurement of pain coping, pain cognitions and subscale of HLOC (such 
as ILOC and ELOC), they do not specifically assess HLOC.  
 
A possible explanation for using different outcome measures could be that 
each study was designed with other specific targets and goals, and HLOC 
(as evaluated by MHLC) is not always the focus of these studies. Therefore, 
caution should be taken when interpreting findings of these studies that 
using composite scores or outcome measure that is re-constructed from the 
MHLC. 
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A cohort study by Coughlin et al. (2000) assessed the efficacy of a MI 
programme in altering chronic pain patients’ PLOC. Participants included 
73 patients with chronic pain. Treatment was a 4-week outpatient pain 
programme (40 hours a week) based on exercise and CBA education. Two 
outcome measures: the control subscale of the SOPA and the PLOC were 
taken before and after the 4-week programme. They found that the MI 
programme simultaneously increased patients’ ILOC and decreased both 
CLOC and ELOC over pain following a MI programme. This study 
concluded that patients’ PLOC belief can be changed with MI programme. 
Included patients were with a wide variety of chronic pain, therefore 
findings were not representative of CLBP patients alone. There is also 
limitation of the outcome measures being used. First, evidence of the 
reliability and validity of the PLOC is limited (Penzien et al., 1989), 
Second, this outcome measure is not widely used in research. Hence its 
responsiveness is questionable. The authors did not mention whether there 
was any blinding of outcome assessors, any dropout of the programme and 
how incomplete data were addressed. These methodological flaws are likely 
for findings to contain detection and publication bias. This study is high risk 
of bias.  
 
A RCT (N= 148) by Spinhoven et al. (2004) aimed to evaluate whether a MI 
programme alter NSCLBP patients’ pain control belief and pain coping 
strategies. Outcome measure used in this study was PCCL, which is a 
composite measure. The PCCL was re-constructed on the basis of three 
other questionnaires (PCL, Coping Strategy Questionnaire (CSQ), and 
MPLC). This study concluded that the MI group showed significantly 
greater increase in ILOC over pain, greater decrease in ELOC, and greater 
decrease in catastrophizing than the two comparison groups (discussion 
group and waiting list group) immediately after treatment. Both ILOC over 
pain and catastrophizing showed continued significant improvement at 12-
months follow-up, whereas the reduction in ELOC over pain was no longer 
significant at 12-months. This study has a robust design including: 
randomisation, concealed allocation, blinding of outcome assessors and 
patients’ compliance and treatment integrity checks. However, 32% 
participants dropped out from pre-treatment to 12-months follow-up, hence 
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incomplete outcome data may introduce attrition bias. Despite the 
psychometric properties of the PCCL were shown to be satisfactory (Stomp-
van den Berg et al., 2001), it cannot assume that this study still yields the 
same results as found with PCCL if MHLC was administered to assess 
HLOC specifically. This study is moderate risk of bias.  
 
Smeets et al. (2006b) conducted a RCT in 211 patients with NSCLBP. This 
study compared three active treatments (i.e. active exercise treatment (1 
hour 45 minutes, 3 times a week for 10 weeks), CBT treatment (1.5 hours 
for 10 sessions), combined active exercise and CBT, with waiting list group. 
Each treatment lasted for 10 weeks. Outcome measures were taken before 
and after the 10 weeks of active treatments by research assistants who were 
blinded from patients’ assigned treatment. Outcome measures included 
disability (as evaluated by RMQ), pain (by VAS), depression (by Beck 
Depression Inventory), pain catastrophizing and internal control of pain (by 
the subscale of PCL). Findings showed that disability, pain and pain 
catastrophizing significantly reduced in all three active therapies, whereas 
internal control of pain did not change significantly in all active treatments. 
This study included use of randomization, blinded outcome assessors, 
application of intention-to-treat on patients who withdrew and with poor 
compliance. However, the authors assessed internal control of pain by using 
the subscale of PCL. Currently, there is no information about the 
responsiveness of this outcome measure, therefore the influence of CBA 
treatment on patients’ internal control of pain may not be adequately 
measured.   
 
2.8.3 Summary of evidence on the effect of CBA intervention 
in altering HLOC 
To our knowledge, there is no study in the literature examining the 
effectiveness of a physiotherapy CBA active rehabilitation (similar to the 
CBCLBP programme) in altering HLOC using MHLC specifically in 
NSCLBP patients.  
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From the seven studies being appraised (Klaber Moffett et al., 2006; Keedy 
et al., 2014; Rybarczyk et al., 2001; Harkapaa et al., 1991; Coughlin et al., 
2000; Spinhoven et al., 2004 and Smeets et al., 2006b), they all consistently 
showed evidence to support the effectiveness of CBA intervention in 
improving HLOC. However, the quality of evidence was generally poor.  
 
Among the four studies assessing HLOC by MHLC, three of them are of 
high risk of bias (Keedy et al., 2014; Rybarczyk et al., 2001; Harkapaa et 
al., 1991), whilst one is of moderate risk of bias (Klaber Moffett et al., 
2006). Of the three studies assessing HLOC using composite scores and 
outcome measures re-constructed based on MHLC, one is of high risk of 
bias (Coughlin et al., 2000), one of moderate risk of bias (Spinhoven et al., 
2004) and one of low risk of bias (Smeets et al., 2006b). Many 
methodological criteria regarding internal and external validity were not 
fulfilled in most studies. 
 
In addition, more than half (4 out of 7) of these studies had a short follow-
up period (< 3-months). Therefore, it can only be concluded that there is low 
quality evidence that the CBA intervention has a positive effect on HLOC at 
short-term, while its long-term effectiveness is unclear.   
 
The low number of relevant studies found, together with the methodological 
flaws (including lack of outcome assessors blinding, incomplete follow-up 
data, insufficient information about the intervention and data analysis, and 
selective reporting), and the heterogeneity of the reviewed studies (such as 
variation in population being studied, the professionals delivering the 
programme, the content, frequency and duration of treatment, follow-up 
period, and outcome measures), limits any valid evidence regarding the 
effect of CBA intervention on HLOC in NSCLBP patients. The need for this 
kind of data seems apparent, considering the acknowledged role of cognitive 
factors and patients’ belief structure may affect their response to treatment. 
This current study aims to contribute additional evidence in this line.          
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2.9 Importance of self-management of NSCLBP 
Self-management has been described as a model of care where patients use 
strategies to manage and monitor their own health, retaining a primary role 
in management, and where they learn skills to be used in the daily 
management of their health condition (Lorig & Holman, 2003). From the 
patients’ perspective, self-management has the advantage that patients can 
provide themselves with symptoms relief at anytime. From the healthcare 
service perspective, self-management could reduce dependence on 
healthcare services and decrease the costs of the condition (Toye & Barker, 
2012). From the societal perspective, effective self-management may have a 
positive impact on work absenteeism, future health care utilization and long-
term sickness (Linton et al., 2005).  
A RCT by Linton et al. (2005) examined the effectiveness of three types of 
intervention: minimal treatment group (examination, reassurance, activity 
advice), minimal treatment plus CBA group (physiotherapists involved, six 
sessions, once a week for 2 hours), and minimal treatment plus CBA with 
physical exercise (at least one session providing exercise programme and 
various physiotherapy treatments) in a primary care setting. A total of 158 
patients with NSLBP and neck pain completed the 1-year study. The CBA 
treatment emphasized various core self-management components such as 
problem-solving, coping skills, graded activity, relaxation and managing 
flare-ups. A total of 20 outcome measures were included, in which the key 
outcome measures were future healthcare utilization, work absenteeism, and 
long-term sickness. Results showed that although all three groups improved 
at 1-year follow-up, the two groups with “added” treatment (CBA and CBA 
with physical exercise) significantly reduced future healthcare utilization 
and work absenteeism at 1-year. The two groups with ‘added’ treatment 
were also found to reduce the risk of future long-term sickness by five-fold, 
compared to the minimal treatment group. There was no significant 
difference between the CBA and CBA with physical exercise group, despite 
the CBA with physical exercise group produced better results among the 20 
variables being studied. This study highlighted the effectiveness of CBA 
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and CBA with physical exercises, and the importance of self-management in 
reducing healthcare and economic burden of NSLBP and neck pain.  
This study included randomization, outcome assessor blinding, and use of a 
best-worst-intermediate case analysis to consider the effects of dropout 
(15% dropout at 1-year) may have on their findings. The design was 
featured with a stepped approach where each group represented additional 
care as recommended by guideline. This has the advantage of reflecting the 
primary care situation where care is normally ‘added on’ (Sagnivy et al., 
2009). However, one limitation of this study was the unequal amounts and 
intensity between the three types of interventions, therefore there was a 
possibility of demand effect (i.e. patients receive more extensive treatment 
and attention may experience higher ‘demand’ to report success) in the CBA 
and CBA with physical exercise group. Besides, participants of this study 
was made up of workers, with the mean aged of 40s’, who volunteered and 
sought help for back and neck pain. Thus, this sample may have been 
representative of younger and more motivated workers, which may limit 
generalizability of primary care patients in clinical settings. This study is 
low risk of bias.               
Despite self-management being endorsed and encouraged in most NSLBP 
guidelines (Savigny et al., 2009; Chou et al., 2007; Koes et al., 2010), the 
assumption that the use of self-management is beneficial for patients with 
NSLBP may not be as optimistic as we thought. A well-conducted 
systematic review with meta-analysis reviewing effectiveness of self-
management of NSLBP (Oliveira et al., 2012a) concluded that there was 
moderate-quality evidence showing that the use of self-management (in the 
form of rehabilitation programme, self-care booklet, online information) 
only had small effect on improving pain and disability when compared to 
minimal intervention (such as usual care and waiting list) in patients with 
NSLBP. When compared to other interventions such as physiotherapy, 
exercise, education, massage, yoga and acupuncture, there was high quality 
evidence that the effect of self-management was equally or less effective in 
reducing pain and disability. A total of 13 RCTs from the community, 
primary care services and rehabilitation clinics were included in this review 
without language restriction. Inclusion criterion were patients with NSLBP 
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of any duration and when at least one intervention was indicated by the 
authors using the terms ‘self-management’ and ‘self-care’. The mean score 
for methodological quality of included trials was 6.5 out of 10 using the 
PEDro scale. Outcome measures were pain and disability. Selection of 
literature adequately addressed the review’s question. The authors provided 
sufficient information on study population, the interventions and the 
outcome measures. Besides, the between-trial heterogeneity was also 
identified using appropriate statistical method. Although the number of 
included trials was relatively small (N=13), this was the first meta-analysis 
of self-management for NSLBP to assess the content validity of the self-
management programme. The authors have provided precise pooled 
estimates of the treatment effects of self-management compared to minimal 
intervention. Results were presented with confidence intervals; sensitivity 
analysis was also conducted to determine the effectiveness of those included 
trials fulfilling the core components of self-management. Included trials 
were from various settings, suggesting the generalizability to NSLBP 
population was good. This is a well-conducted meta-analysis with a low risk 
of bias.     
2.9.1 Evidence of the effectiveness of CBA active 
rehabilitation on patient’s self-management 
A RCT (N=187) by Klaber Moffett et al. (1999) evaluated the clinical and 
cost-effectiveness of an exercise with CBA programme versus usual 
primary care management. Findings showed that those patients with 
subacute or recurrent NSLBP who attended a physiotherapist-led CBA 
education with active exercise programme utilised fewer healthcare 
services, fewer resources and took almost 50% less working days off sick at 
12-month, than those who were under GP ‘best care’. Klaber Moffett et al. 
(1999) developed a ‘Back to Fitness’ programme, which consisted of 
exercise and CBA education (eight sessions of 60 minutes). It was found 
that the “Back to Fitness” programme was significantly more effective in 
the reduction of pain, disability, and healthcare usage, when compared to 
routine management from GP. These clinical benefits were observed at one-
year follow-up. The design of this study was a conventional RCT where 
randomization and allocation were conducted. However, double blinding 
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was not feasible, which may result in performance bias. Because of 
recruitment difficulty, this study did not achieve a desired powered sample 
size of patients. The baseline of RMQ disability score and clinical status 
(Aberdeen back pain scale) of included patients was relatively mild in the 
‘Back to Fitness’ group. Inclusion of mildly disabled sub-acute LBP patients 
may have explained why the ‘Back to Fitness’ group resulted in less 
healthcare usage. These limitations may weaken the generalizability of the 
wider population of NSLBP patients. This study is moderate risk of bias.       
 
Critchley et al. (2007) (see Section 2.6.1) provided high quality evidence 
that physiotherapy-led CBA intervention was effective in reducing 
healthcare usage in moderately disabled NSCLBP patients. This study found 
that patients with NSCLBP who attended a physiotherapy-led pain 
management programme based on CBA principles (8 sessions of 90 
minutes) reported significantly fewer secondary care visits, in-patient 
procedure and investigations, compared to patients who had individual 
physiotherapy and spinal stabilisation classes at 18-months follow-up. 
Klaber Moffett et al. (2006) reported that a brief physiotherapy pain 
management programme significantly reduced patients’ reliance on health 
profession, compared to McKenzie hands-on physiotherapy treatment at 12-
months in patients with neck and back pain with mixed subacute and 
chronic duration (see Section 2.8.1). 
 
A brief self-care intervention with CBA education (consisted of two two-
hour sessions, with 12-16 participants per group) showed modest 
improvement in reducing worries about back pain, pain intensity, activity 
limitation, fear-avoidance and improving patients’ attitudes toward back 
pain self-care (as evaluated by SCQ), when compared to usual care at 6-
months in primary care (Moore et al., 2000). A total of 226 patients 
volunteered for the study and were randomised into either self-care group or 
usual care. This study included back pain patients of > 6 weeks (i.e. mixed 
both subacute and chronic onset). Randomization and concelaed allocation 
were not clearly described in the paper. All patients, clinicians and outcome 
assosors were not blinded. Dropout and compliance rate were not discussed 
or considered in their analysis. Besides, evidence of the psychometric 
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properties of some of the outcome measures used in this study (such as back 
pain worry rating) are limited. The different sources of bias weaken the 
internal validity of their findings. This study is high risk of bias. 
 
A prospective cohort study by Van Hooff et al. (2010) evaluated the effect 
of an intensive pain management programme based upon CBT principles, 
using a multi-disciplinary approach and was of a 100 hours duration 
following NICE guideline. A total of 107 CLBP patients entered the 2-
weeks group-based residential programme (consisted of 50 hour CBT 
training, 35 hours physical activities and 15 hour education). The main 
outcome parameters were daily functioning (evaluated by RMQ), self-
efficacy (by pain self-efficacy questionnaire) and quality of life (by Short 
Form 36 Physical Component score). Outcome measures were measured up 
to one-year. Results showed that patients demonstrated significant 
improvement in daily functioning and self-management. All outcome 
parameters were sustained at 1-year follow-up. Results were also shown to 
be comparable with spinal surgery (Fairbank et al., 2005) and better than 
results from less intensive rehabilitation programme (Smeets et al., 2008). 
The authors used multivariable adjustment, sensitivity analysis when 
analysing missing data, and strict standardization of their programme. This 
therefore enhanced internal validity, and minimized the potential bias and 
confounding on the outcome factors. This study provided evidence that this 
type of intensive pain management programme could be an alternative when 
fusion surgery was considered, in a selected group of patients who were 
motivated and engaged in self-management for their CLBP problem. This 
study is low risk of bias. 
 
 
 CHAPTER 2 Literature review                                                                           Page 48 
 
 
2.9.2 Summary of evidence on the effectiveness of CBA active 
rehabilitation in patients’ self-management 
Of the seven individual studies and review examining the effectiveness of 
CBA active rehabilitation on patients’ self-management, four of them are 
considered low risk of bias (Linton et al., 2005; Oliveira et al., 2012a; 
Critchley et al., 2007 and Van Hooff et al., 2010), two were moderate risk of 
bias (Klaber Moffett et al., 1999; Klaber Moffett et al., 2006) and one was 
high risk of bias (Moore et al., 2000). Despite the variations in 
interventions, outcomes, involvement of physiotherapist in delivering the 
programme, and heterogeneous population, the literature seems to provide 
moderate evidence supporting the effectiveness of CBA active rehabilitation 
in enhancing patients’ ability to self-care their NSLBP. 
 
Self-management is a desirable ingredient in the effective management of 
NSCLBP. With the high economic and social burden of NSCLBP, effective 
self-management and better patients’ self-care attitude could at least partly 
reduce financial impact on both the healthcare system and to patients 
themselves (Chou et al., 2007).   
2.10 Cost 
According to the Health Survey for England 2011, back pain was 
responsible for 37% of all chronic pain in men and 44% in women (Bridges, 
2011). Chronic pain was highlighted as a massive socio-economic burden, it 
is estimated the cost of back pain alone are around £12.3 billion per year 
(Donaldson, 2009).  
The rising use of healthcare services  
The use of healthcare services for back pain has increased substantially over 
the past two decades. For instance, studies have documented that there is a 
greater use of spinal injection (Weiner et al., 2006; Friedly et al., 2007), 
surgery (Deyo & Mirza, 2006; Gray et al., 2006), and opioid medication 
(Luo et al., 2004). Studies have also demonstrated that there is an increased 
use of prescription medication, visits to physicians, physiotherapists and 
chiropractors (Feuerstein et al., 2004; Martin et al., 2008). Many of these 
treatments are utilised by patients with CLBP. Therefore, an evaluation of 
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prescription medication and healthcare usage should be considered as a 
means of quantifying how effective an intervention has been achieved. 
 
Increased healthcare use for CLBP could be due to: (1) a substantial 
increase in prevalence of CLBP over the past few decades (Harkness et al., 
2005; Palmer et al., 2000); (2) a larger proportion of those with CLBP who 
seek care; (3) an increased use of healthcare resources; and (4) a 
combination of these factors (Thorpe et al., 2004). One way to reduce the 
socio-economic burden and healthcare usage is to continuously seeking for 
clinical treatment improvement and cost-effective option.    
 
2.10.1 Evidence on cost evaluation of the physiotherapy-led 
CBCLBP programme 
There are four economic studies of a similar intervention conducted in a 
clinical setting (physiotherapy-delivered, combined active exercise and 
CBA education) that are relevant to the current study (Klaber Moffett et al., 
1999; Lamb et al., 2010; Critchley et al., 2007; Johnson et al., 2007). These 
studies have already been described and appraised in Section 2.6.1 and 
Section 2.9.1.  
 
Figure 2.1 summarised the relevant information of these economic studies. 
These studies did not evaluate costs from a societal perspective. i.e. indirect 
costs. The box left blanked indicates the authors did not investigate or report 
these variables. 
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Figure 2.1: Table to summarise the relevant information of these economic studies 
 RESULTS  
Author Comparative 
treatment 
Details of 
economic 
evaluation 
Follow-up Mean 
provider 
costs per 
patient to 
provide: 
Mean 
provider 
costs per 
patient 
over 1 year 
Patient 
costs 
Healthcare 
utilization 
ICER for 
treatment per 
QALY gained 
Author’s 
conclusion 
Methodological 
quality 
(CHEC-list) 
Lamb et 
al. 
(2010) 
Group CBT 
intervention 
plus advice 
(N=327) 
 
Vs  
 
Advice 
(N=163) 
Type: 
CEA/CUA 
Setting: United 
Kingdom, 
2008 
Perspective: 
healthcare 
sector 
 
12-months Group CBT 
intervention 
plus advice: 
£187 
 
 
Advice: 
£16.32 
 
 
Group CBT 
intervention 
plus advice 
group: 
£421.52  
 
Advice: 
£224.65 
 
 
 Following 
treatment, 
 
50% of all 
participants re-
visited GP 
 
19% used NHS 
physiotherapy 
 
23% used 
private 
physiotherapy 
ICER for 
group CBT 
intervention 
plus advice 
group= £1786 
per QALY 
gained (EQ-
5D) 
Group CBT 
intervention plus 
advice is likely to 
be more cost-
effective than 
other active 
intervention such 
as acupuncture, 
exercise, 
manipulation and 
postural 
approaches. 
Moderate  
Critchley 
et al.  
(2007) 
Individual 
physiotherapy 
(N=53) 
Vs 
Spinal 
stabilization 
exercise class 
(N=53) 
Vs 
Pain 
management 
programme 
using CBT 
(N=44) 
 
 
Type: 
CEA/CUA 
Setting: United 
Kingdom, 
2002-2005 
Perspective: 
healthcare 
sector 
 
18-months Pain 
management 
programme: 
£165 
 
Spinal 
stabilization 
exercise class: 
£379 
 
Individual 
physiotherapy: 
£474 
 
 Costs for all 
participants: 
 
Before 
baseline: 
£169.29 
0-6 months: 
£70.49 
6-12 
months: 
£92.14 
12-
18months: 
£103.03 
Pain 
management 
group had less 
time off work, 
less hospital 
visits, in-patient 
procedures and 
investigation, 
paid-for 
prescription 
compared to 
spinal 
stabilization 
exercise and 
individual 
physiotherapy 
Pain 
management 
group is likely 
to be the most 
cost-effective 
at all costs per 
QALY (EQ-
5D) 
Pain management 
programme 
associated with 
least costs and  it 
is likely to be the 
most cost-
effective than the 
two comparison 
groups. 
High 
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CEA-Cost-effectiveness analysis CUA-Cost-Utilization analysis  ICER-Incremental cost-effectiveness ratio CHEC-list-Consensus on Health Economic Criteria  
Continued: Results  
Author Comparative 
treatment 
Details of 
economic 
evaluation 
Follow-up Mean 
provider 
costs per 
patient to 
provide: 
Mean 
provider 
costs per 
patient 
over 1 year 
Patient 
costs 
Healthcare 
utilization 
ICER for 
treatment per 
QALY gained 
Author’s 
conclusion 
Methodological 
quality 
(CHEC-list) 
Johnson 
et al. 
(2007) 
GP care 
(N=149) 
 
Vs 
 
Exercise and 
education 
using CBT 
approach 
(N=78) 
Type: 
CEA/CUA 
Setting: United 
Kingdom, 
2002-2005 
Perspective: 
healthcare 
sector 
 
18-month     ICER for 
exercise and 
education 
using CBT 
compared to 
GP care: 
£5000 per 
QALY gained 
(EQ-5D) 
Acceptability 
curve showed the 
exercise and CBT 
education group 
was found to have 
a relatively low 
cost, but 
comparison to GP 
care was not 
provided. 
Moderate 
Klaber 
Moffett 
et al. 
(1999) 
GP care 
(N=74) 
 
Vs 
 
Exercise and 
education 
using CBT 
approach 
(N=70) 
Type: 
CEA/CUA 
Setting: United 
Kingdom, 
Year of study 
not known 
Perspective: 
healthcare 
sector 
 
12-month  GP care:  
£ 508.43  
 
Exercise 
and 
education 
using CBT 
approach: 
£360.15 
 
 Number of GP 
visits over 1-
year: 
GP care: 266  
Exercise and 
education using 
CBT approach: 
139 
 
Number of 
physiotherapy 
visits over 1-
year: 
GP care: 266  
Exercise and 
education using 
CBT approach: 
139 
 Patients in the 
exercise and CBT 
education group 
used much less 
healthcare, and 
other resources. 
They also took 
much less days 
off work, 
compared to those 
in the GP care 
group.  
 
The exercise and 
CBT education 
group was 
clinically and 
cost-effective 
than GP care. 
Moderate 
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As shown in Figure 2.1, these studies support the view that physiotherapy CBA 
active rehabilitation is cost-effective and requires less healthcare utilization, 
compared to treatment alternatives such as conventional physiotherapy 
(Critchley et al., 2007), GP care (Johnson et al., 2007; Klaber Moffett et al., 
1999), and as an addition to GP care (Lamb et al., 2010). This evidence is also 
supported by a high quality systematic review (Lin et al., 2010), which 
concluded that the guideline-endorsed treatments (such as interdisciplinary 
rehabilitation, exercise, and CBA treatment) were more cost-effective treatment 
compared to advice to stay active and a variety of treatment alternatives (such 
as massage, yoga and relaxation) in NSCLBP patients.  
 
The overall quality of this review is low risk of bias (Lin et al., 2010). It 
included 26 relevant economic evaluations alongside RCTs investigating 
clinical and cost effectiveness of the guideline-endorsed treatments. Study 
selection and quality assessment of this review was thorough. The authors used 
the criteria from the Cochrane Back Review Group (Furlan et al., 2009; Van 
Tulder et al., 2003) to assess the risk of bias, and the Consensus on Health 
Economic Criteria (CHEC-list) (Evers et al., 2005) to assess the methodological 
quality of the economic evaluation. Fifteen (out of 26) of the included studies 
had a low risk of bias, which means conclusions were predominantly drawn 
from good quality studies. Appropriate information of the included studies was 
provided. The authors also identified methodological limitations of included 
studies and acknowledged the complexity of comparing economic data between 
different settings, countries and healthcare systems. The main methodological 
flaws of the included trials are: lack of assessor blinding, incomplete reporting 
of costs and resource utilization and short follow-up period. There is also 
heterogeneity in study population, study treatments, differences in economic 
perspectives and settings. These may weaken the validity and generalizability 
of the conclusion drawn from this review. 
 
In sum, there is moderate evidence to support the cost-effectiveness of 
combined exercise and CBA intervention in NSCLBP. The advantage of being 
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cost-effective allows management to be suited to the budget of the healthcare 
provider. 
 
PART II 
The first part of this review provides the relevant evidence of the effectiveness 
of the physiotherapy CBA active rehabilitation. Next is to understand why and 
how this treatment approach works. One way is to study those factors 
associated with the maintenance of NSCLBP, and the relationship between 
them. It is beyond this present review to appraise the complex relationship of 
various factors within the biopsychosocial framework. However, one of the 
study aims is to examine the correlation and regression relationship between 
pain intensity, disability, FAB and HLOC. This second part of the review 
focuses on the relevant studies related to this aim. 
2.11 The fear-avoidance model and its constitutive components 
Based upon previous work (Lethem et al., 1983), Vlaeyen & Linton (2000) 
proposed a cognitive-behavioural model known as the fear-avoidance model. 
The fear-avoidance model proposes that the way in which pain is interpreted 
may lead to two different pathways (Figure 2.2). 
 
Figure 2.2: Fear-avoidance model (Vlaeyen et al., 1995b; Vlaeyen & 
Linton, 2000) 
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The influence of high FAB in NSCLBP is well documented. For instance, a 
high quality systematic review by Ramond et al. (2011) concluded high FAB is 
a significant predictor of persistent disability in primary care. Another high 
quality review found that low level of FAB is a significant predictor to positive 
treatment outcomes at 1-year in NSCLBP (Chou & Shekelle, 2010).  This 
evidence highlights that addressing high FAB is particularly important in 
attaining better outcome in NSCLBP patients. 
 
The fear-avoidance model has inspired a vast amount of research and has 
become the leading paradigm for understanding disability in NSCLBP. Since 
the review by Vlaeyen and Linton (2000), a large body of study attempts to 
further validate the fear-avoidance model and the relationship between the key 
elements such as pain intensity, pain-related fear and disability. 
 
2.11.1Pain intensity 
Pain intensity and disability 
In their review, Vlaeyen & Linton (2000) concluded that pain intensity is not a 
predictor to avoidance-behaviour or disability. Some studies observed a weak 
or even non-existing association between pain and disability in NSCLBP 
(Waddell et al., 1992; Waddell et al., 1993; Vlaeyen et al., 1995a; Vlaeyen et 
al., 1995b; Reneman et al., 2007; Meyer et al., 2009), whilst some reported a 
positive relationship between pain and disability (Thomas et al., 2010; Bair et 
al., 2008; Peters et al., 2005; Woby et al., 2004a; Turner et al., 2004). 
 
In regard of the predictive importance of pain intensity, evidence is also 
inconsistent. Some NSCLBP studies reported that pain intensity accounted for a 
relatively large proportion of the variance in disability (Woby et al., 2004a; 
Woby et al., 2004b; Woby et al., 2007a; Woby et al., 2008). For example, it has 
been showed that pain intensity reported an additional 27% of the variance in 
disability (Woby et al., 2007a), and reduction in pain intensity explained an 
addition of 22% of the variance in reduction in disability (Woby et al., 2008) in 
NSCLBP patients attending physiotherapy.   
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On the other hand, some have shown that pain intensity has little predictive 
value in disability (Waddell et al., 1992; Mannion et al., 2001; Meyer et al., 
2009). For instance, Waddell et al. (1992) found that pain intensity only 
explained 10% of the variance in disability. Mannion et al. (2001) found 
reduction in pain intensity only explained 16% of the variance in CLBP 
disability. Meyer et al. (2009) reported that pain made no significant 
contribution to explaining the variance in disability.  
 
Figure 2.3 summarised the key findings of the relevant studies examining the 
relationship between pain intensity and disability. Description and appraisal of 
these studies are provided later in this section. 
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Figure 2.3: An overview of relevant evidence on the relationship between pain intensity and disability 
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Secondary 
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A physiotherapy cross-sectional study by Woby et al. (2004b) examined the 
predictive relationship between pain intensity (by VAS), disability (by RMQ) 
and a number of cognitive factors (including FABs about work (FABs-W) and 
FABs about physical activity (FABs-PA), catastrophizing and perception of 
control over pain). A total of 83 NSCLBP patients were included, who were 
about to start a physiotherapy-led CBA rehabilitation programme in a hospital 
outpatient physiotherapy department. This study found that (1) pain intensity 
accounted for an additional 24% of the variance in disability; (2) the three 
psychological factors (FABs-W, FABs-PA and castastrophizing) explained an 
additional 22% of the variance in disability, but only FABs-PA was found to be 
a significant predictor to disability and, (3) FAB was not a predictor to pain 
intensity. This study concluded that pain intensity accounted for a relatively 
large proportion of the variance in disability, whilst psychological factors 
particularly FABs-PA explained a large proportion of the variance in disability. 
A number of methodological criteria regarding internal validity of this study 
were fulfilled. This included: the use of valid and reliable assessment tools, 
adequate reporting of data analysis, and low attribution bias. However, the 
authors did not report powered sample size calculation and, it was unclear 
whether blinding of outcome assessors were conducted. These biases may limit 
the validity of the findings. This study is low risk of bias.    
 
In a subsequent study, Woby et al. (2004a) conducted a prospective cohort 
study of NSCLBP patients before and after an 8-week physiotherapy-led CBA 
rehabilitation. The aim was to examine whether changes of a number of 
cognitive factors (including catastrophizing, FABs-W, FABs-PA and appraisal 
of control) were predictors of changes in pain intensity and disability. A total of 
54 NSCLBP patients were included who completed a physiotherapy-led CBA 
active rehabilitation (five sessions, 3.5 hours each, over a period of 8 weeks). 
Outcome measures were taken before and after the programme. This study 
found that (1) reduction in pain intensity was significantly predictive of 
reduction in disability, accounting for an additional 43% of the variance in 
changes in disability after controlling demographics; (2) Changes in cognitive 
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factors (particularly reduction in FABs-W, FABs-PA and increased perception 
of control over pain) were significant predictor to reduction of disability, in 
which they explained an additional 22% of the variance in changes in disability; 
(3) Changes in cognitive factors were not associated with changes in pain 
intensity and (4) Increased perception of control over pain (as evaluated by the 
subscale of Coping Strategies Questionnaire (CSQ) was related to the reduction 
of disability. This study highlighted the predictive importance of both reduction 
of FAB and increased perception of control over pain on reduction in disability. 
This study is well-conducted methodologically within the context of an existing 
physiotherapy service. A number of strengths are identified: the use of valid 
outcome measures, adequate statistical test and a comprehensive picture of the 
intervention integrity was provided. However, there was a big dropout rate in 
follow-up data (65% of the original sample). Again, there was no mention 
whether power calculation and blinding of outcome assessors were used. This 
study is moderate risk of bias. 
 
Woby et al. (2008) conducted another observational before-after study, with the 
aim to evaluate the effect of a 6-week physiotherapy-led CBA programme on 
pain intensity, disability, depression and a set of cognitive factors (including 
FAB, catastrophizing, functional self-efficacy, perception of control over pain 
and perception of ability to decrease pain). The authors also examined the 
association between them. An inclusion of 137 NSCLBP patients (of moderate 
pain and disability, and high FAB) was recruited in an outpatient physiotherapy 
department. Outcome measures were taken before and after the 6-week 
programme (five sessions, 3.5 hours each). Relevant findings of this study were 
(1) Patients demonstrated a significant cognitive improvement (significant 
reduction in FAB and significant increase in perception of control over pain and 
perception of ability to decrease pain) after the programme; (2) Reduction in 
pain intensity explained an additional 22% of the variance in reduction in 
disability and (3) Reduction in FAB and increase in self-efficacy explained a 
further 17% of the variance in disability. This study supports the clinical 
effectiveness of a physiotherapy-led CBA programme in improving NSCLBP 
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patients’ pain cognition and beliefs. It also demonstrates the predictive 
importance of FAB to reduction in disability. The methodological quality of 
this study is good, including sufficient sample size, use of valid and reliable 
assessments tools, adequate report of information of the intervention and 
appropriate use of statistical tests. The main limitations are the high dropout 
(25% dropout) and unclear of blinding of outcome assessors and personnel. 
This study is moderate risk of bias.  
    
Pain intensity and FAB 
The relation between pain intensity and FAB is mixed. Some studies observed a 
weak-moderate positive relationship between FAB and pain intensity (Guclu et 
al., 2012; George et al., 2001), whilst some reported weak association (Thomas 
et al., 2010; Crombez et al., 1999; Vlaeyen et al., 1995a; Vlaeyen et al., 1995b), 
and that FAB has no predictive importance to lower level of pain intensity 
(Woby et al., 2004b).  
 
Figure 2.4 summarised the key findings of the appraised studies examining the 
relationship between pain intensity and FAB. 
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Figure 2.4: An overview of relevant evidence on the relationship between pain intensity and FAB 
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A cross- sectional study by Guclu et al. (2012) aimed to examine the 
relationship between pain intensity, disability, quality of life and FAB in 
patients with NSCLBP. A total of 105 patients were recruited in a neurosurgery 
outpatient clinic in Turkey. A large set of valid outcome measures were used. 
Relevant findings were (1) there was a positive association between pain 
intensity (by VAS) and FAB (by FABQ), and (2) A positive association was 
found between FAB and disability (by RMQ). This study employed valid 
assessment instruments and appropriate statistical analysis. However, the 
authors did not report how the sample size was derived and how data were 
collected. These potential biases may limit the validity of the findings. Again, 
this is a cross-sectional study, therefore it does not yield information regarding 
cause-effect relation. This study is moderate risk of bias.  
 
2.11.2 Pain-related fear 
Pain-related fear has been described with a variety of conceptual definitions 
among which: pain-related fear, fear of movement, fear of work or activity, fear 
of (re)injury and kinesiophobia are the most commonly used (Turk and Wilson, 
2010; Lundberg et al., 2011). These terms are often used interchangeably in 
literature with regard to pain-related fear and FAB (Leeuw et al., 2006).  
 
FAB and disability 
The association between FAB and disability is evident even after controlling for 
pain intensity and other important co-variables in NSCLBP (Woby et al., 
2004b; Elfving et al., 2007). Persistence of FAB has also been seen even after 
spinal surgery (den Boer et al., 2006; Brox et al., 2010) and physiotherapy (Al-
Obaidi et al., 2005; Sorensen et al., 2010). In addition, high levels of FAB 
influence performance of functional physical tasks (Al-Obaidi et al., 2003) and 
are significant predictors of long-term work disability (Gheldof et al., 2005). 
Consequently, pain-related fear has become an integral part of our 
understanding in explaining disability in patients with NSCLBP. 
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The relation between FAB and disability is fairly well-established in the 
literature. A systematic review (included 18 relevant RCTs worldwide) with 
low risk of bias by Ramond et al. (2011) concluded that FAB is strongly 
correlated to disability. This review examined sixteen different psychosocial 
factors for CLBP in primary care. FAB were analyzed in seven studies of 
moderate-high quality according to the assessment criteria from the Cochrane 
Collaboration back review group for spinal disorders (Van Tulder et al., 1997). 
The conclusion of this well-conducted review is also supported by a number of 
studies (of poor to moderate methodological quality), which consistently 
observed a positive association between FAB and disability (Thomas et al., 
2010; Elfring et al., 2007; Woby et al., 2004b; Crombez et al., 1999; Meyer et 
al., 2009; Guclu et al, 2012).  
 
Figure 2.5 summarised the key findings of the appraised studies examining the 
relationship between FAB and disability. 
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Figure 2.5: An overview of relevant evidence on the relationship between FAB and disability  
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A cross-sectional study by Thomas et al. (2010) studied the correlation between 
pain (evaluated by VAS), disability (by RMQ) and a large set of psychosocial 
factors including FAB (by TSK), depression and catastrophizing. A total of 50 
CLBP patients were recruited in a specialist rehabilitation centre, where they 
were about to start a CLBP programme. Relevant findings of this study 
included: (1) Pain intensity was positively correlated with disability and 
depression, but it had no association with FAB, and (2) Disability was 
positively correlated with FAB and catastrophizing. Outcome measures used in 
this study were valid and reliable instruments. However, several 
methodological criteria regarding the internal validity were not fulfilled. This 
included selection bias (70% of the included patients were male and 62% were 
unemployed, this may not generalisable to the wider population of CLBP), 
detection bias (due to absence of blinded outcome assessors), no report of 
sample calculation and selective reporting of their results. This study is high 
risk of bias.   
 
Only few studies have shown that there is no or only a weak association 
between FAB and disability (Pincus et al., 2006; Woby et al., 2007a; Denison et 
al., 2004), and that FAB had no significant predictive importance to disability 
(Woby et al., 2007a). Conversely, a number of studies illustrated that pain-
related fear is a significant predictor to disability (Crombez et al., 1999; 
Vlaeyen & Linton, 2000; Pincus et al., 2002; Meyer et al., 2009; Woby et al., 
2004a; Woby et al., 2004b; Woby et al., 2008). 
 
A cross-sectional study by Woby et al. (2007a) examined the relation between a 
large set of cognitive factors (such as self-efficacy, catastrophizing, perception 
of control over pain and depression), and levels of pain and disability in 183 
NSCLBP patients who had been referred to a CBA intervention delivered by 
physiotherapists. Relevant findings were: (1) FAB did not emerge as a 
significant predictor to disability; (2) When pain intensity was an outcome of 
interest, the cognitive factors accounted for an additional 30% of the variance in 
pain intensity. Among all cognitive factors, both functional self-efficacy and 
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catastrophizing emerged as a stronger predictor to lower levels of pain 
intensity. However, perceptions of control over pain (as evaluated by CSQ) was 
not a significant predictor to pain, and (3) With disability as the outcome, pain 
intensity explained an additional 27% of the variance in disability, and the 
cognitive factors accounted for an additional 32% of the variance in disability. 
In particular, higher levels of functional self-efficacy and lower levels of 
depression both uniquely contributed to the prediction to disability. Again, 
perceptions of control over pain showed no predictive value to disability 
statistically. This study highlighted the significant association between 
cognitive factors and the levels of pain and disability in NSCLBP patients 
presenting for physiotherapy. However, perception of control over pain 
demonstrated no significant predictive value to both pain and disability. This 
study is methodologically sound, including adequate sample size, use of valid 
and reliable assessment tools, and sufficient information on statistical analysis. 
This study is low risk of bias. 
 
A cross-sectional study (N=35) by Crombez et al. (1999) examined the role of 
pain intensity and pain-related fear (as assessed by TSK and the two subscales 
of FABQ (FABs-W and FABs-PA) in predicting self-reported disability and 
pain intensity in NSCLBP patients. Relevant findings were (1) Correlation 
analysis revealed that pain related-fear (as assessed by TSK, FABs-W and 
FABs-PA) was significantly correlated with disability, but pain-related fear has 
no association with pain intensity; (2) Regression analysis showed that pain-
related fear is a much stronger predictor of disability than pain intensity. In 
particular, FAB (as evaluated by TSK) explained an additional 31% of the 
variance in disability after controlling age and the two subscales of FABQ. This 
study suggested that patients’ levels of disability are mainly predicted by pain-
related fear, but not by pain intensity. The overall methodological quality is 
poor in this study. The authors were unclear about whether has sample 
calculation and blinding of outcome measures were carried out. It is a relatively 
small sample size, therefore the error variability of the beta-coefficients is 
probably large. In addition, the included patients were ‘participants’ in a 
 CHAPTER 2 Literature review                                                                                  Page 66 
 
 
psychophysiological laboratory-based setting. Hence, the degree to which this 
small cohort of participants reflected those patients seen within a clinical 
treatment context is limited. This study is high risk of bias.  
 
A cross-sectional study by Meyer et al. (2009) examined the relationship 
between a range of psychological factors and self-reported pain and disability in 
78 patients who were seeking care for their CLBP in secondary care. Multiple 
regression analysis revealed that (1) demographics and psychological variables 
explained 42% of the variance in pain intensity and 59% of the variance in 
disability. Among all psychological independent variables, only FABs-W is 
significant predictors to both variances in pain intensity and disability; (2) Pain 
intensity has no predictive value to disability. This study concluded the 
predictive importance of FAB to disability and pain intensity in patients with 
CLBP. It demonstrated a number of strengths including adequate sample size, 
use of valid and reliable assessment tools, and appropriate report of data 
analysis. However, it suffered from detection bias due to absence of blinded 
outcome measures assessment. There may also be selection bias. This study is 
moderate risk of bias.  
 
2.11.3 Disability  
Disability may be the logical consequence of prolonged pain and heightened 
pain-related fear. This is evident in the aforementioned evidence, where a 
number of studies found the association between disability and pain (Thomas et 
al., 2010; Bair et al., 2008; Peters et al., 2005; Woby et al., 2004a; Turner et al., 
2004; Woby et al., 2004b; Woby et al., 2007a; Woby et al., 2008), and between 
disability and FAB (Ramond et al., 2011; Thomas et al., 2010; Elfring et al., 
2007; Woby et al., 2004a; Woby et al., 2004b; Crombez et al., 1999; Meyer et 
al., 2009; Guclu et al., 2012).  
 
Interestingly, no study can be found that reporting the predictive importance of 
disability to pain intensity and FAB in NSCLBP. This may be due to the 
sequential concept proposed in the fear-avoidance model. Disability is in the 
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last position in the model, therefore most studies may dedicate to examine it as 
an outcome, rather than as a predictor.     
 
2.11.4 Summary of the evidence on the relationship between 
pain intensity, disability and FAB 
 No firm conclusion can between drawn on the relationship between pain 
and disability, due to inconsistent evidence in literature. 
 No firm conclusion can between drawn on the relationship between pain 
and FAB, due to inconsistent evidence in literature. 
 Moderate evidence on the relationship between FAB and disability. 
 
The inconsistency is likely due to the high heterogeneity among studies, 
including difference in sample size, patients’ baseline characteristics, study 
design, outcome measures, follow-up period and methodological quality. This 
may also highlight the complexity of the relationship between these variables, 
since a wide array of physical and psychosocial characteristics of LBP have 
been identified as having some prognostic importance and mediating effect 
(Hill & Fritz., 2011). For instance, epidemiological evidence suggested that a 
strong prognostic factor for persistent LBP is depression (Croft et al., 2006). 
Self-efficacy is found to be a strong predictor to disability in NSCLBP (Woby 
et al., 2007a), and a mediator between FAB and disability (Woby et al., 2007b). 
A large and high quality prospective cohort study identified illness perception, 
self-efficacy, perception of personal control, and acute/chronic timeline, were 
independent predictors of disability at 6-months in patients with LBP (Foster et 
al., 2010). This evidence implies that variation in outcome measures and 
patients’ baseline variables are likely to be the confounding factors, which may 
distort the relationship between pain intensity, disability and FAB under 
investigation.  
 
Regarding methodological quality, most of them were suffered from moderate 
or high risk of bias. Evidence largely comes from cross-sectional studies that do  
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not allow for directional conclusion. Due to the difference in study population 
and clinical settings, these studies are also likely to have selection bias. 
Therefore, findings may have limited external validity to a wider NSCLBP 
population.  
 
2.11.5 Re-think the fear-avoidance model 
The key concept of the fear-avoidance model is the prospective, sequential 
inter-relationships between its constitutive components (Figure 2.2). However, 
the inconsistent findings between pain intensity, disability and FAB may 
suggest that this model is likely to be a far more complex dynamic interactive 
process than we thought. This is supported by Wideman et al. (2013), who 
proposed that the components in the fear-avoidance model are unlikely relate to 
one another through the simplistic pathway. Rather, other psychological risk 
factors and multiple pathways related to persistent pain and pain-related 
disability should be considered in a wider context.  
 
With clinical presentation of most of the NSCLBP patients in clinical setting 
often simultaneously face multiple factors, it is also thought that multiple 
factors anticipate the fear pathway. It is not possible for patients to avoid pain, 
but it is possible for them to avoid activities, become less engaged with positive 
behaviour and to assign management to an outside source. This is when HLOC 
may add value to the complex and dynamic relationship of pain, disability and 
FAB.    
 
2.12 HLOC- The relationship between HLOC and health-
related behaviour in patient and healthy population 
There has been a great diversity of studies attempting to relate HLOC to a host 
of health-related behavior, with the aim to demonstrate correlations with each 
subscale of HLOC. In their review, Wallston & Wallston (1982), the developer 
of the MHLC, offer a wealth of information regarding these correlations. These 
common findings are based on numerous of studies conducting in both patients 
with chronic conditions (such as chronic pain, chronic back pain, diabetes, 
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arthritis) as well as healthy population (Figure 2.6). Despite these conclusions 
not being specific to NSCLBP population, they offer some theoretical support 
for the potential importance of how HLOC may influence NSCLBP patients’ 
clinical outcomes and their responses to the CBCLBP programme and self-
management tasks.  
 
Figure 2.6: To summarise some of the common findings on the association 
between HLOC and health-related behaviour in patient and healthy 
population studies (Wallston & Wallston, 1982) 
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2.13 Evidence on HLOC in NSCLBP outcomes 
Only a limited number of studies (N=8) using MHLC to examine the 
relationship between HLOC and NSCLBP outcomes. These results generally 
support those mentioned by Wallston and Wallston (1982), in which 
improvement of HLOC may associate with positive clinical and cognitive-
behavioural outcomes in NSCLBP. Caution should be taken when interpreting 
these studies due to study heterogeneity and variation in methodological 
qualities.     
 
2.13.1 Relationship between HLOC and the clinical outcomes of 
NSCLBP 
Relationships exist between HLOC and reports of pain and disability in 
NSCLBP. Patients with higher ILOC reported less pain (Sengul et al., 2010; 
Harkapaa, 1991), and lower level of disability after treatment, than patients 
with high ELOC (Haldorsen et al., 1998). A RCT of moderate risk of bias 
(Harkapaa et al.,1991) (see Section 2.8.1) showed that higher ILOC was 
correlated with reduction in disability, less psychological distress, and more 
frequent exercising. 
 
A cross-sectional study by Sengul et al. (2010) investigated the relationship 
between HLOC and pain intensity, disability and quality of life in patients with 
CLBP (N=113). A set of valid and reliable assessment tools were used for data 
collection, included the MHLC, VAS, Owestry Disability Index (ODI) and the 
World Health Organization Quality of Life (WHOQOL) scale. Included 
patients were recruited from a neurosurgery department in Turkey; they were 
separated into two groups according to their levels of disability: high disability 
and low disability group. Key findings were: (1) Correlation analysis revealed 
ILOC was strongly correlated with pain intensity on activity, moderately 
correlated with disability and quality of life; (2) A strong correlation was found 
between ELOC and pain intensity at rest, and (3) A significant positive 
correlation was found between CLOC and pain intensity, disability and quality 
of life. A number of methodological limitations are identified in this study, 
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including selection bias, no report of sample calculation and the authors were 
unclear if blinding of outcome assessors were used. This study is high risk of 
bias. 
 
Haldorsen et al. (1998) conducted a 12-month prospective study in 260 workers 
who had been on sick leaves for 8-12 weeks due to their NSCLBP. The 
objective was to examine whether medical, psychological or social factors 
predict failure to return work within 12-month. A large set of outcome 
measures were used. Outcome measure for psychological factors was HLOC as 
evaluated by MHLC. Participants were treated with a light mobilization 
programme and were followed up one year after treatment. Results revealed 
that the most significant psychological variable in predicting return to work was 
high ILOC, while non-returners were associated with higher ELOC and higher 
CLOC. Higher ILOC was also found associated with less pain and lower level 
of disability after treatment, than patients with high ELOC and high CLOC. 
This study has a number of methodological limitations included: selection bias 
(all participants were workers referred from National Insurance offices), 
attrition bias (due to incomplete follow-up data), performance bias (no mention 
of blinding of outcome assessors, personnel and participants) and the authors 
did not give any information of the light mobilization programme being used. 
This study is high risk of bias. 
    
A longitudinal study by Keedy et al. (2014) reported that higher ILOC and 
lower ELOC predicting better physical function (floor-to-waist lift) at 1-month 
following an intensive two-week MI programme in patients (N=61) with CLBP. 
However, both changes in ILOC and ELOC did not emerge as predictor to 
mental health outcomes (depression and self-reported mental health).  As 
appraised in Section 2.8.1, this study suffered from methodological flaws that 
may limit the internal validity of their findings. This included variable sample 
size across analysis, variable time for data collection, lack of outcome assessor 
blinding, selection bias and high attribution bias. This study is high risk of bias. 
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A cross-sectional study by Sengul et al. (2011) examined if HLOC and 
disability are related to static and dynamic postural balance in patients with 
NSCLBP (N=22). Relevant findings were: (1) There was a correlation between 
CLOC and reaction time, and (2) There was a correlation between ELOC and 
CLOC with static and dynamic postural balance. This study suggested that 
ELOC and CLOC have stronger influence on patients’ physical function, than 
ILOC. However, this study has several major methodological flaws that limit 
the internal and external validity of their findings. This included: under-
powered small sample size, selection bias (as it was a laboratory-based study), 
no report of data collection method and unclear statistical reporting. This study 
is high risk of bias.    
 
2.13.2 Relationship between HLOC and cognitive-behavioural 
variables of NSCLBP 
Evidence suggested that chronic pain patients with higher ILOC use more 
active coping strategies and have less psychological distress. Conversely, those 
with stronger ELOC are associated with higher levels of helplessness, 
psychological distress and use of passive coping strategies, such as praying, to 
deal with pain (Crisson & Keefe, 1998).  Higher ILOC is associated with a 
more active approach to manage pain (Jensen & Karoly, 1991), therefore 
attribution of control to internal rather than external factors has become an 
emphasis in the clinical treatment of NSCLBP. 
 
More specifically to CLBP population, an 18-month prospective study by 
Harkapaa (1991) found that there is an association between HLOC and use of 
coping strategies in patients with CLBP. Include subjects were of blue-collar 
workers in a number of private enterprises in Finland. Data was collected via 
questionnaire and was answered by 415 subjects (87% of the original sample). 
Relevant findings included (1) Higher pain intensity was correlated with higher 
level of psychological distress, lower ILOC and higher ELOC; (2) Active 
coping strategies were related to higher ILOC, whilst higher ELOC and CLOC 
were associated with passive coping strategies, and (3) use of active self-care 
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was significantly associated with higher ILOC and lower ELOC. Several 
methodological merits were identified in this study including sufficient sample 
size, low attribution bias, use of valid outcome measures, and adequate 
reporting of statistical analysis. The main drawback is its high selection bias. 
This study only included subjects with CLBP from among blue-collar workers 
(from state railway, the post and telecommunications) who had been physically 
strenuous in their job for at least 10 years, had LBP for at least two years with 
record of sickness and absence. Mean age of included subjects was 45. Their 
results may be applicable to subjects with similar characters, but it has poor 
generalisability to NSCLBP presenting in primary setting. This study is 
moderate risk of bias.    
 
Richard et al. (2011) conducted a two-year prospective study in Canada, with 
the aim to examine the association of self-efficacy and HLOC with pain 
intensity, FABs-W, FABs-PA, and “return to work in good health” (RWGH) 
among 867 workers with occupational NSLBP and disability. RWGH is a 
composite measure of occupational outcomes for workers having back pain 
(Dionne, 2005; Dionne et al., 2007), which consists of four categories: 
occupational status, functional limitation, number of days of work absence due 
to back pain, and the presence or not of attempts to return to work. Outcome 
measures were collected via telephone interview. Relevant findings included: 
(1) ILOC was moderately correlated with FABs-PA, but it had no association 
with pain intensity; (2) ELOC was strongly correlated with both FABs-PA and 
pain intensity, and moderately correlated with FABs-W, and (3) No association 
was found between CLOC and any of the pain related measures or pain 
intensity. This study concluded that ILOC and ELOC are significantly related 
to FABs in workers with NSCLBP. Several methodological strengths were seen 
in this study including sufficient sample size, long follow-up period, use of 
valid and reliable assessment tools, use of appropriate statistical analysis and a 
relatively low attrition bias (86% of original sample completed the 2-year 
telephone review follow-up). However, the authors did not take any measure to 
control potential confounders that may influence the outcomes (such as any 
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other treatment or medication during the 2-year study peroid). There is also a 
high selective bias because included subjects were worker (mean age of 38.7) 
with NSLBP who had self-reported at least a day of incapacity due to LBP 
presenting of Emergency Department. This limited the generalisability of 
findings to a wider population of NSCLBP presenting in primary setting.  This 
study is moderate risk of bias. 
 
In term of treatment participation, Koleck et al. (2006) found that CLBP 
patients with high ELOC participated less treatment decision, whilst higher 
ILOC indicated that patients participated more in treatment decisions. Evidence 
also suggested that CLBP patients with higher ILOC were more likely to agree 
with the goal of active intervention such as motor control exercises, whilst 
those with higher ELOC were more likely to agree with the goals of passive 
treatment such as spinal mobilization (Braman & Gomez, 2004; Hashimoto & 
Fukuhara, 2004).  
 
A cross-sectional study by Oliveira et al. (2009) found that NSCLBP patients 
with higher ELOC needed to see greater improvements in symptoms to 
consider motor control exercises worthwhile. A total of 86 NSCLBP patients 
were recruited in an out-patient physiotherapy department in Brazil. The 
authors found that ELOC was the only significant predictor of patients’ 
perception of worthwhile in motor control exercises. Their results suggested 
that if physiotherapists could reduce ELOC to the lowest possible score 
(ELOC= 6, range 0-36) via their treatment, the chance of a patient being 
satisfied would increase by up to 24%. This study highlighted that patients’ 
HLOC may influence their perception of worthwhile effect of physiotherapy 
treatment, which is important for both prognosis and patients’ satisfaction in 
NSCLBP. This study demonstrated a number of strengths including sufficient 
sample size, report of power calculation, use of valid and reliable outcome 
measures, precision of data analysis, and a narrow confidence interval (95%), 
suggesting precision of findings. This study is low risk of bias.          
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2.13.3 Summary of key findings of HLOC in NSCLBP 
To summarize: Patients with NSCLBP with higher ILOC are more likely to 
describe their pain and disability as less intense (Sengul et al., 2010; Haldorsen 
et al., 1998), have more effective coping strategies to deal with pain (Harkapaa, 
1991), have less psychological distress (Harkapaa et al., 1991), have better 
physical health (Sengul et al., 2011; Keedy et al., 2014), have less pain-related 
belief (Richard et al., 2011) and are more likely to take an active role and 
engage with treatment programme (Harkapaa et al., 1991). On the other hand, 
those patients with higher ELOC and higher CLOC are more associated with 
greater pain intensity and disability (Sengul et al., 2010; Haldorsen et al., 1998), 
use of maladaptive coping strategies (Harkapaa, 1991), report of more pain-
related fear (Richard et al., 2011) and being less proactive with treatment 
(Harkapaa et al., 1991).  
 
2.13.4 Methodological consideration of evidence on HLOC in 
NSCLBP 
Among the seven studies included, four are of high risk of bias (Sengual et al., 
2010; Haldorsen et al., 1998; Keedy et al., 2014 and Sengul et al., 2011), two 
are of moderate risk (Harkapaa, 1991; Richard et al., 2011), and only one 
(Oliveira et al., 2009) is considered as low risk of bias. There is only low to 
moderate evidence to support the relationship between HLOC and NSCLBP 
variables. Many methodological criteria regarding internal and external validity 
of these studies were not fulfilled. This included: selection bias, small sample 
size, performance bias, detection bias, attrition bias, and unclear reporting of 
statistical analysis. Besides, the majority of them conducted cross-sectional 
correlation, thus preventing directional conclusions of causality between HLOC 
and NSCLBP outcomes.  
 
While the existing research on HLOC in NSCLBP population supports the 
theoretical construct of HLOC, the limited number of studies warrants more 
examination. In addition, the cross-sectional nature of these correlations may 
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also warrant further analysis, including the predictive component, to determine 
causality.    
 
2.14 Summary: Current state of knowledge relevant to present 
study 
 There is low to moderate evidence for the effectiveness of exercise 
therapy on physical and psychological outcome in NSCLBP at short-
term and long-term 
 There is moderate evidence for the effectiveness of combined physical 
exercise and CBA programme (delivered by physiotherapists with or 
without multidisciplinary members) on clinical outcomes of NSCLBP. 
Effects are mostly seen when against passive controls (i.e. usual care or 
waiting list), and are mostly of short-term.  
 There is limited and low quality evidence for the effectiveness of CBA 
intervention targeting NSLBP patients (of any duration) with 
psychosocial risk factors.  
 There is limited and low quality evidence that the CBA intervention has 
a positive effect on HLOC at short-term (< 3-months). 
 There is moderate evidence supporting the effectiveness of CBA active 
rehabilitation in enhancing patients’ ability to self-care their NSLBP (of 
any duration). 
 There is moderate evidence supporting the cost-effectiveness of 
combined exercise and CBA intervention in NSCLBP, when compared 
to GP care, conventional physiotherapy and other active modalities. 
 Regarding relationship between pain intensity, disability and FAB: 
i. No firm conclusion can between drawn on the relationship 
between pain and disability, due to inconsistent evidence. 
ii. No firm conclusion can between drawn on the relationship 
between pain and FAB, due to inconsistent evidence. 
iii. Moderate evidence on the relationship between FAB and 
disability. 
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 There is limited and low to moderate evidence supporting the 
relationship between HLOC and NSCLBP outcomes. 
 
2.14.1 Limitations of our knowledge 
Limitations in the literature that are relevant to the study have already been 
mentioned in each section. For instance, there is no study which examines the 
effectiveness of CBA intervention targeting only NSCLBP patients with 
psychosocial risk factors (such as high FAB). There is also no study which 
assesses the effectiveness of a physiotherapy CBA active rehabilitation in 
altering HLOC in NSCLBP patients. In addition, there is only limited and poor 
quality evidence to support the relationship between HLOC and NSCLBP 
outcomes. It is recommended by several authors that the dimension of personal 
sense of control warrants further evidence to delineate the specific role it plays 
in NSCLBP treatment outcome (Woby et al., 2004a; Foster et al., 2010; 
Henschke et al., 2010).  Lastly, the majority of studies in the literature were 
conducted in an ideal, controlled research condition. This may not truly reflect 
and represent how a physiotherapy CBA rehabilitation programme works in an 
ordinary clinical environment. Research that works under optimal research 
conditions may be challenging to implement in clinical practice as it may fail to 
consider the relevant clinical issues and practicalities in real practice (Chan & 
Clough, 2010). This highlights the need of research to be conducted in an 
ordinary clinical setting, where no extra resource and additional research 
manpower exist.    
 
2.15 Conclusion 
With the key themes and limitations being identified, this study was conducted 
to contribute evidence in these lines. The next chapter goes on to outline the 
methodology employed in this study, with the aim of addressing the research 
questions appropriately. 
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CHAPTER 3 METHODOLOGY 
3.1 Introduction  
The aim of this chapter is to describe and justify the methodology used in this 
study, including its research design, ethics consideration, sampling and 
recruitment procedure. This chapter also details the intervention and the five 
outcome measures used in this study. Reliability and validity of these outcome 
measures and the method of data collection are also discussed. Finally, this 
chapter outlines the data analysis employed to examine each of the research 
questions accordingly.  
 
The chosen approach and methodology of the present study was based upon the 
research questions, the relevant literature and the practicality of the busy NHS 
clinical setting. Implementation of practitioner-based research in the current 
NHS can be challenging, due to demanding clinical workload, time constraints 
and limited staffing. However, every attempt has been made to reduce potential 
sources of bias with the aim to enhance validity of the findings. 
3.2 Overall design 
A quantitative longitudinal A-B-A same-subject design was conducted in the 
Stockport NHS Primary Physiotherapy Service. Included patients were with 
NSCLBP and with TSK score more than 37 (TSK score> 37 indicating patients 
with high level of FAB due to fear of movement causing pain or (re)injury) 
(Kori et al., 1990; Swinkels-Meewisse et al., 2006).  
 
There were three major phases of this study: before (Phase A1), during (Phase 
B), and after (Phase A2) the CBCLBP programme (Figure 3.1). Phase A1 was 
the collection of the baseline data, which was four weeks before the 
programme. Phase B was the intervention phase, where participants received 
the six-week CBCLBP programme. Phase A2 was where participants 
completed the programme and outcome measures were assessed at 3 months 
and 6 months. 
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A series of reliable and valid outcome measures were obtained in a consistent 
and standardised manner during each phase of the study, including at baseline (-
4 weeks), at the beginning of the programme (week 1), at completion (week 6) 
and at 3 months and 6 months follow-up.  
 
The primary outcome measure was HLOC, evaluated by the Form C of the 
MHLC scale (Wallston et al., 1978). Secondary measures were pain evaluated 
by VAS (Huskisson, 1974), disability evaluated by RMQ (Roland & Morris, 
1983), FAB measured by the TSK questionnaire (Vlaeyen et al., 1995a) and 
patients’ attitudes toward back pain self-care were assessed by the Self-Care 
Orientation Scale questionnaire (SCQ) (Von Korff et al., 1998). At 6 months, a 
cost questionnaire developed for this study was used to examine cost of back 
care from the provider, patients’ and societal perspective. 
 
Figure 3.1: To illustrate the study design and time point at which outcome 
measures were taken 
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3.3 Methodological consideration 
3.3.1 Selection of research method 
When weighing up which research design to use, the considerations were the 
nature of the research questions, the objectives of the study and the 
practicalities of the study setting.  
 
The aim of this study is to assess the effect of the CBCLBP programme on 
HLOC and other co-variables in patients with NSCLBP before, during and after 
programme. Research designs that are often used to evaluate the effect of 
intervention in clinical settings include before and after studies, comparative 
trials and RCTs (Hicks, 2009). RCTs are widely regarded as the gold standard 
design to study the effect of an intervention in the research community. 
However, there were several reasons why RCT design was not chosen for the 
present study. First, the CBCLBP programme is a recommended second-line 
treatment in accordance with local departmental policy and evidence-based 
guidelines for NSCLBP (Savigny et al., 2009; Chou et al., 2009; Koes et al., 
2010). Since this is already an existing second-line treatment for this subgroup 
of NSCLBP following an initial contact and individual treatment with 
physiotherapists. There is no other form of second-line physiotherapy care can 
be randomised into. Second, the main intention of this study is to determine the 
effect of the CBCLBP programme over time. Therefore, a chosen method 
should allow meaningful comparison between treatment and no treatment phase 
by repeated assessment over the study period, instead of between treatment and 
no treatment group. Third, there are practical issues. RCTs are often difficult to 
conduct in terms of cost, time, manpower and resources. Besides, RCTs often 
involve a large number of patients, which is particularly challenging for a 
single-handed researcher like the PI who works in a busy NHS setting with 
limited allocated resources and time. Lastly, it can be ethically problematic 
because once patients are referred into the physiotherapy service, having “no 
treatment” control group is considered as unethical.   
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3.3.2 Same-subject design 
Alternatively, a same-subject design is a practical and useful evaluation method 
for applied research to assess effectiveness of an intervention on same group of 
subjects (Kratochwill & Levin, 2015). This methodology is often utilised by 
researchers in rehabilitation and social sciences to test the efficacy of an 
intervention on a particular problem (Backman et al., 1997; Horner et al., 
2005). It is used in many fields by various professional groups such as applied 
behaviour analysts, clinical psychologists, social workers (Kratochwill & 
Levin, 2015), and cognitive-behaviour therapists (Engel & Schutt, 2012).  
 
One of the most unique features of same-subject design is that the baseline data 
of this same group of people serves as its own control, thus error variance is 
reduced. Besides, this method is ethically safe, because all participants received 
treatment and treatment did not have to be withdrawn. In addition, it allowed 
the PI to observe the effect of the CBCLBP programme before, during and after 
the programme. Therefore, the single-subject design method is considered to be 
an appropriate design for the current study for both conceptual and practical 
reasons. 
  
3.3.3 Comparing different types of same-subject designs 
There are various types in the same-subject design, such as A-B, A-B-A, and 
A-B-A-B design (Engel & Schutt, 2012). The A-B-A design was chosen in this 
study due to three main reasons. First, this type of experimental design allows 
the changes before, during and after treatment to be observed. As a result, the 
PI can see what effect, if any, the CBCLBP programme had on the HLOC and 
other co-variables. Further, the treatment principle of the CBCLBP programme 
is based on the idea that the therapeutic effects will carry over following the 
programme (Hansen et al., 2010; Ostelo et al., 2005). By re-introducing the 
baseline condition (Phase A2) following treatment (Phase B) (see Figure 3.1), 
the effect of the CBCLBP programme may persist, and how long the effect of 
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the programme may persist up until six months post-intervention can be 
observed. 
 
Secondly, the A-B-A design is ethically safe because all study participants 
received treatments. The CBCLBP programme received by the study 
participants is the routine care provided by the Physiotherapy Department for 
patients with NSCLBP. The only difference between the study participants to 
routine patients was that the study participants were asked to complete 
additional questionnaires, and were followed up until six months following the 
programme.  
 
Finally and importantly, the normal physiotherapy service and patients’ waiting 
time were not compromised as a result of the A-B-A design because the routine 
waiting time for entering the CBCLBP programme was about 4 weeks on 
average. The PI also did the majority of the research work, and put in extra 
hours to recruit patients and collect data. Hence, no extra staffing was required. 
Both are considered to be crucial by the NHS management and the Research 
and Development (R&D) of the Trust.  
 
Comparing the A-B-A design to the basic A-B design, the A-B design only 
offers quick assessment of the programme by collecting measurements during 
the baseline phase (Phase A), and repeating the same measures during the 
intervention phase (Phase B) (Engel & Schutt, 2012). However, the A-B design 
does not provide any post-treatment follow up which examines if the effect of 
the CBCLBP programme persisted, and how long it may persist after patients 
stopped the intervention, which is the intention of this study.  
 
The A-B-A-B design is similar to the A-B-A design, except that the A-B-A-B 
design reintroduces the intervention in the second intervention period, based on 
the assumption that the effect of the treatment may reverse by withdrawing 
intervention and there may be second improvement by reintroducing treatment. 
Although the A-B-A-B design may give stronger support that changes between 
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no treatment and treatment phases are due to the intervention, and not due to the 
natural history of the condition (Engel & Schutt, 2012), there is no guarantee 
that the effect will be reversed, particularly because the CBA treatment is based 
on the practice theory that the therapeutic effect may carry over, and is designed 
to reduce the target problems without the need for ongoing intervention. 
Therefore, the A-B-A-B design was not chosen.  
 
3.3.4 Implications of the clinician-researcher dual role 
Because of the resource issues, the PI had to act as both researcher and 
clinician. The PI was involved in gaining all informed consents, carried out the 
majority of the treatment, and collected all data at 3 months and 6 months post 
intervention. There is advantage and disadvantage of the PI being a clinician-
researcher dual role in the current study. An advantage for having the PI to 
collect data helped to ensure data quality, and minimize missing data during 
follow-up. However, the disadvantage of this approach included the possibility 
of expectancy effect (Bootzin, 1985) and halo effect (Nisbett & Wilson, 1977), 
both factors would have influence on patients’ self- reported data on pain 
intensity, disability and perceived control (Klaber Moffett & Richardson, 
1997). Besides, there is detection bias due to lack of blinding of outcome 
assessors. These limitations (which are discussed in Chapter 6) may reduce the 
internal validity of the findings. It is acknowledged that it would have been 
preferable for the PI to act as an independent researcher, with no input into 
treatment and data collection. However, this was not possible in the current 
study. 
3.4 Ethical considerations 
The Bristol Research Ethics Committee reviewed and approved the present 
study; with REC reference 12/SW/0197 (Appendix 1). The Ethics Committee 
of the Manchester Metropolitan University (Appendix 2 & Appendix 2a) and 
the Research and Development (R&D) Department of the Stockport NHS 
Foundation Trust (Appendix 3) also supported and granted ethical approval for 
this study.  
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It is imperative that any piece of research fully accounts for ethical issues, and 
informed consent must be obtained from the subject prior to commencing 
(Burns, 1997; Brody, 1998). The following ethics considerations were taken: 
 
1. The study was performed in accordance with the protocol, the 
International Conference on Harmonisation (ICH) Guideline for Good 
Clinical Practice (GCP) (E6 (R1) Good Clinical Practice, 1996), and the 
Research Governance Framework for Health and Social Care 
(Department of Health, 2005). 
2. All interventions used in this study represent current best clinical 
practice in the UK (Savigny et al., 2009; Koes et al., 2010). Therefore 
participants were not disadvantaged compared to other forms of 
physiotherapy care. 
3. The PI ensured all participants fully understood the nature and risks of 
the treatment prior to giving consent. Eligible subjects were given a 
participant’s information sheet (Appendix 4) and a full verbal 
explanation about the study. They were given at least a week to consider 
whether to take part. Informed consent (Appendix 5) was obtained 
during their next visit and their GP and physiotherapist were informed 
that they had entered the study (Appendix 6). Study participants had the 
full right to withdraw at anytime during the study period without giving 
any reason and without compromising the same high standards of care 
(Wilkie et al., 2001). 
4. Patients who did not satisfy the inclusion/exclusion criteria (Figure 3.2 
in Section 3.5.3) or who did not wish to participate continued through 
the usual physiotherapy pathway without disadvantage. Therefore, the 
CBCLBP programme was not established exclusively for research 
participants. Rather, there was a mix of research participants and non-
research participants in the same group over the study peroid.   
5. All the subject recruitment, assessment and the rehabilitation 
programme were approved by the Trust (Appendix 3) to take place at 
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the Stockport NHS Primary Physiotherapy Service, where Health and 
Safety at Work Act (1974) is operated at all times. 
6. To ensure anonymity and safeguarding the confidentiality of participant 
records, all data kept complied with the requirements of the Data 
Protection Act (1998). Participants were given an identification number 
known only to the PI, her co-workers and the project supervisors. Data 
was computed and stored using identification numbers, on a password 
secure computer within the Physiotherapy Department. Hard copies of 
the research data were kept in the locked cabinet within the Department 
during the study period. All research data was then transferred off site 
and kept confidentially at the NHS designated storage site for at least 
ten years following completion of the project, so incorporating the 
requirements of the Data Protection Act (1998).  
 
3.5 Selection of participants 
3.5.1 Sample selection 
Subjects were incidentally and purposely sampled within the Stockport NHS 
Primary Physiotherapy Service between September 2012 and June 2013 (i.e. 
the last participant was recruited in June 2013). This method of sampling may 
not be representative to the wider population of NSCLBP as it is a non-
probability method of collecting a sample and the process is not random 
(Powers & Knapp, 2010; Crombie & Davies, 1996). However, this sampling 
method was chosen because this is the most appropriate and most accessible 
method of obtaining a reasonable number of targeted subjects over a limited 
period of time (Hicks, 2009). In addition, incidental sampling also reflects 
accurately what happens in the clinical situation (Burns, 1997; Hicks, 2009). A 
number of physiotherapy CLBP research studies taking place in the NHS have 
also utilised incidental sampling (Klaber Moffett et al., 2006; Critchley et al., 
2007; Johnson et al., 2007; Woby et al., 2007a, and Woby et al., 2008).  
This study aims to examine patients with NSCLBP, and who exhibit a high 
level of FAB (TSK score > 37 indicating patients show higher level of pain-
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related fear (Vlaeyen et al., 1995a). This particular population was chosen 
because: (1) patients with NSCLBP and high FAB are often considered 
challenging to treat by clinicians in clinical practice (Rainville et al., 2011); (2) 
NSCLBP is very costly to the Health Service but often with poor rehabilitation 
treatment outcome (Jamison, 2011); and (3) it is well-documented that FAB is 
one of the strong cognitive factors associated with back pain intensity, 
disability and the likelihood of treatment success or failure (Wertli et al., 2014a; 
Thomas et al., 2010; Vlaeyen et al., 1995b).  
3.5.2 Setting 
This study was conducted at the Stockport NHS Primary Physiotherapy 
Service, where the CBCLBP programme has been well-established for over 15 
years, and where the PI works. This clinical setting was chosen because it is a 
natural environment where patients with NSCLBP normally attend for their 
routine physiotherapy treatment. It is important to conduct practice-based 
research in a relevant clinical environment in order to obtain the natural 
interaction from the subjects and reflect reality. Also, due to its controlled 
clinical environment, it is also beneficial for data collection (Marrow, 1996; 
Trochim & Donnelly, 2001; Trochim, 2005). These factors are essential to 
ensure successful implementation of research findings in the future (Marrow, 
1996; Trochim, 2005). Another reason to choose this setting is because it is the 
largest department in NHS Stockport offering the CBCLBP programme to 
patients. This consequently increased the availability of eligible subjects for the 
study. The Physiotherapy Department is located in the centre of Stockport and 
it provides free on-site parking, making it easily accessible and economical for 
all patients who attended the six-week programme and their follow-up 
evaluation.   
3.5.3 Inclusion and exclusion criteria 
The inclusion and exclusion criteria (Figure 3.2) are based upon the previous 
relevant literature, the targeted population of the study, the treatment principle 
of the CBCLBP programme and the objectives of the study.  
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Figure 3.2: Inclusion and exclusion criteria of the study 
Inclusion criteria were:  
• Patients with NSCLBP with or without leg pain (Waddell, 2004), and diagnosed by their 
physiotherapists with NSCLBP; 
• Age >16years, as the Stockport NHS Physiotherapy Service is an adult service;   
• TSK score >37 (indicating that patient shows a high level fear of movement and associated 
avoidance behaviour (Vlaeyen et al., 1995a); 
• Patients were physically and medically fit to take part in the exercise programme 
(Department of Health, 2005; E6 Good Clinical Practice, 1996); and 
• Patients were able to give consent and positively opt in to the programme (Department of 
Health, 2005; E6 Good Clinical Practice, 1996). 
 
Exclusion criteria were: 
• Evidence of serious pathology (red flags) or low back pain is caused by specific spinal 
pathology such as malignancy, vertebral fracture, severe spinal stenosis, acute herniated disc 
with nerve root entrapment, rheumatoid arthritis, unstable spondylolisthesis (CSAG, 1994; 
Savigny et al., 2009); 
• Patient is not medically fit to participate in an exercise programme (Department of Health, 
2005; E6 Good Clinical Practice, 1996); 
• Unable to read and understand the English language, as it is important for patient to 
understand the education component and follow the instructions during the exercise session; 
• Patients who demonstrate psychological distress, both pain and non-pain related, which is 
beyond the scope of the physiotherapy and requires CBT delivered by psychologists or CBT 
therapists. 
• Where the assessors perceived a significant level of psychological distress based on clinical 
experience, this exclusion criterion is further assessed objectively by a score of 11 or higher on 
each subscale of the Hospital Anxiety and Depression Scale (HADS) and a score of “high risk” 
on the STarT Back Tool (Hill et al., 2011); and  
• Patients who participated in a similar type of chronic low back pain programme within the 
preceding six months. This aims to eliminate threats to internal validity by ruling out history, 
so it is possible to conclude that the treatment in this study caused the change (Engel & Schutt, 
2012).  
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3.5.4 Sample size calculation 
Sample size calculation was made on the primary outcome measure, namely the 
HLOC based on previous studies (Oliveira et al., 2008; Oliveira et al., 2009) 
utilising similar methodology and instruments. The standard deviation of the 
ILOC of 5.2 and a minimal clinically important difference (MCID) of 6.77 (in 
the ILOC) were set. Using a power calculation, a sample size with 15 
participants per subscale would have 95% power to detect a 6.77-point 
difference using a two-tailed test and 5% significance level. Considering the 
HLOC consists of three independent subscales: ILOC, ELOC and CLOC, the 
sample size of at least 45 is required to examine the relationship of each of 
these subscales with other outcome measures individually. With a 20% dropout 
rate allowance, this study aimed at recruiting 55 patients and their complete 
data to reach any statistically significant conclusion. 
 
Based on the referral rate, the average number of patients with low back pain 
referred to Stockport NHS Primary Physiotherapy Service was approximately 
250 per month. Many of them were referred onto the CBCLBP rehabilitation 
programme. Considering there were three programmes running each week, with 
each group of about 8 participants, a desired sample size of 55 participants in 
nine months was achievable and realistic. 
 
3.6 Study protocol 
3.6.1 Recruitment process 
General Practitioners (GPs) and physiotherapists working within the Stockport 
NHS were informed of the study by letter and an information sheet (Appendix 
7) detailing the aims of the study and the inclusion/ exclusion criteria (Figure 
3.2). They were made aware of the study and were encouraged to refer eligible 
patients.  
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Patients consulted their GP and were referred into the NHS Primary 
Physiotherapy Service due to their persisting back pain condition. Patients 
made at least one prior back pain visit assessed by specialist physiotherapists, 
who confirmed the diagnosis of NSCLBP. During the one-hour assessment and 
advice session, all patients were given an explanation of diagnosis NSCLBP, 
back care advice, back pain information booklet and home exercise programme.  
Following the initial one-hour assessment and advice session, patients may 
receive some form of physiotherapy treatments from their physiotherapists. The 
number of individual physiotherapy treatments that patients received depended 
on the physiotherapists’ recommendation and the severity of patients’ 
symptoms. Individual physiotherapy treatments (approximately 45 minutes per 
session) may include joint mobilisation, manipulation, home exercise 
programme and self-management advice. Number of treatments (up to a 
maximum of six sessions based on departmental policy) patients received prior 
to the entry of the CBCLBP programme was recorded. Once the individual 
physiotherapy was completed, physiotherapists then considered referring 
appropriate patients into the group therapy, i.e. CBCLBP rehabilitation 
programme, in accordance with departmental protocol (Appendix 8). The 
CBCLBP rehabilitation programme was the routine care provided by the NHS 
Physiotherapy Department, which followed the NICE guidelines for NSCLBP 
(Savigny et al., 2009) and the recommendation of the Chartered Society of 
Physiotherapy (CSP). 
 
When both physiotherapists and patients agreed to be referred onto the 
programme, patients were put on the waiting list for the CBCLBP programme 
which was about 4 weeks waiting time. This was when the baseline 
measurements were taken (4 weeks before the start of the programme). It is 
routine practice for physiotherapists to advise patients to continue their home 
exercise programme and self-management techniques while waiting to be 
entered the CBCLBP programme. 
 
 CHAPTER 3 Methodology                                                                                         Page 90 
 
 
All patients referred onto the CBCLBP rehabilitation programme were asked by 
their referring physiotherapists to complete the TSK questionnaire in order to 
assess eligibility for entering the study. Those who fulfilled the criteria relating 
to inclusion/ exclusion (Figure 3.2) and were interested in learning more about 
how to self-manage their back pain condition were invited to participate in the 
study. 
 
Eligible patients were given an invitation letter to the study (Appendix 9) and a 
participant’s information sheet (Appendix 4) and a full verbal explanation 
about the study. They were given at least a week to consider whether to take 
part. Informed consent (Appendix 5) was obtained during their next visit by the 
author. Their GP and referring physiotherapist were informed that they had 
entered the study (Appendix 6). All participants were free to withdraw from the 
study anytime during the study without giving a reason, without the standard of 
treatment and care being affected. Whether patients decided to take part in the 
study or not, they still received the same exact programme as in normal 
practice.  
 
In routine care, patients who take part in the CBCLBP programme were asked 
to complete the TSK questionnaire and the RMQ at week 1 and week 6 only, 
which is before and after the six weeks programme. This was to evaluate the 
service, as in other physiotherapy group therapy services in the Physiotherapy 
Department. With the research participants, the only difference compared to 
routine practice was that all study participants were asked to complete 
additional questionnaires (in addition to the TSK and RMQ, participants were 
asked to complete the Form C of MHLC questionnaire, VAS, and the SQC 
questionnaire) at 3 months and 6 months after the completion of the 
programme. By the end of the study, participants were given a cost 
questionnaire developed by the PI and supervisor. This was to examine patient, 
provider and societal cost of back care when participants were undertaking the 
CBCLBP programme and six months after the completion of the programme. 
Participants were also asked to attend all sessions of the six-week programme, 
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and commit to daily home exercises and homework given during the 
programme. 
 
If patients did not wish to take part in the study, they simply underwent the 
same routine CBCLBP rehabilitation programme as planned. An overview of 
the recruitment of present study is provided in Figure 3.3.  
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Figure 3.3: Recruitment of study participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
When individual physiotherapy treatments completed, patients were referred into 
the CBCLBP programme. They were advised to continue back care advice and 
home exercises while waiting the CBCLBP programme 
One-hour spinal assessment by physiotherapist, and confirmed diagnosis of 
NSCLBP.  Patients may receive some forms of individual physiotherapy 
treatments (depended on physiotherapists’ clinical decision) 
GP referred patients to Physiotherapy  
All patients referred into the CBCLBP programme completed TSK 
questionnaire. If the TSK score> 37, and patients fulfilled the inclusion and 
exclusion criteria, they were eligible for the study 
If patients agreed to take part, the P.I. obtained informed 
consent, and they entered the study 
Eligible patients were given a participant’s information 
sheet, and a full verbal explanation about the study. They 
were given at least a week to consider whether to take part 
Patients went to see GP with low back pain 
1. The six-week CBCLBP programme 
2. Participants completed the following questionnaires 4 
weeks prior to programme (-4 weeks), at the beginning 
of the programme (week 1), at completion (week 6), 3-
month and 6-month following the programme: 
 Form C of MHLC 
 VAS 
 RMQ 
 TSK 
 SCQ 
 A patient cost questionnaire at 6 months 
If patients 
did not wish 
to take 
part, they 
simply 
underwent 
the same 
routine 
CBCLBP 
programme 
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3.6.2 Intervention 
Study participants took part in a six-week (two hours weekly) CBCLBP 
programme, which is a well-established service (over 15 years) at the Stockport 
NHS Primary Physiotherapy Department. It has been developed based on the 
best available evidence (Koes et al., 2010; Savigny et al., 2009; Airaksinen et 
al., 2006), current physiotherapy practice in the UK, the recommendation from 
the NICE guidelines (Savigny et al., 2009) and the clinical experience and 
expertise within the service. 
 
3.6.3 Aims of the intervention 
The programme was based on the key features of the CBA to address patients’ 
maladaptive thoughts, feelings, and their behavioural consequences (Turner & 
Jensen, 1993). 
 
The ultimate aims of the CBCLBP programme is to: reduce disability, 
minimize pain or increase control over pain, reduce avoidance of movements 
and increase patients’ ability for self-management (Woby et al., 2004a; 
Critchley et al., 2007; Johnson et al., 2007; Woby et al., 2008; Lamb et al., 
2010). These aims were achieved by: 
 
1. Altering patients’ pain perception by increasing their understanding 
about pain physiology (Moseley, 2003a; Moseley, 2007); 
2. Addressing unhelpful thoughts and beliefs, and to promote their 
understanding of the link between thoughts, beliefs, feelings and 
behaviour (Turner & Jensen, 1993; Main et al., 2010). 
3. Reducing fear-avoidance of movement and improving physical 
performance via graded exercise programme, planning and pacing 
techniques, resumption of ceased activities/work and goal setting 
(Fordyce, 1976; Sanders, 1996).  
4. Improving patient’s perception of personal control (Main et al., 2010), 
by promoting active coping strategies (Harkapaa, 1991) and 
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emphasizing the importance of active participation toward their own 
rehabilitation, hence enabling patients to develop a sense of personal 
control over their NSCLBP (Jensen et al., 1991; Harkapaa et al., 1996; 
Coughlin et al., 2000). 
5. Empowering patients to have a primary role in their own management 
(Crowe et al., 2010) by teaching a range of self-management skills (e.g., 
cognitive restructuring techniques, positive behavioural changes, 
alternative pain relief, relaxation and physical exercises), hence 
reducing their dependence on the healthcare services (Ferreira et al., 
2010; Critchley et al., 2007). 
6. Preparing patients to independently self-manage future episodes of 
flare-up and use healthcare services appropriately in the future (Ferreira 
et al., 2010; Toye & Barker, 2012).  
3.6.4 Delivery of the intervention 
Each session consisted of a combination of education (Section 3.6.5), graded 
supervised exercise (Section 3.6.6) and homework (Section 3.6.7). It was 
delivered to groups of approximately eight patients. The programme was led by 
the PI or a trained musculoskeletal specialist physiotherapist (a Band 7 and 
above physiotherapist) and a physiotherapy assistant. All specialist 
physiotherapists involved in the study were existing staffs who delivered the 
CBCLBP programme in the Physiotherapy Department. They all had special 
clinical interest in NSCLBP, were highly experienced in managing NSCLBP, 
had training in CBA management techniques, and were experienced to deliver 
and lead the groups according to the highly structural protocol.  
 
In order to guard against threats to internal validity (Logan et al., 2008), the 
intervention and data collection were standardised. Training was given to all 
physiotherapists and assistants involved prior to the start of the study. The 
training was given by the PI, which consisted of two, two-hour sessions. It 
included aims and methodology of the study, teaching materials for each 
session, method of data collection, refreshing psychosocial risk assessment 
(yellow flags assessment) and the key principles of CBA for NSCLBP. The 
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training was to ensure that adequate skills and competencies that needed for 
professionals who delivered CBT approach in primary care (Main et al., 2007; 
Turk & Okifuji, 2003). Experts considered these competencies (Figure 3.4) 
were more important than professional background (i.e. not only for clinical 
psychologists, but also for nurses, physiotherapists, or GPs who deliver a 
primary intervention that uses a CBT approach) (Van der Windt et al., 2008).   
 
Figure 3.4: Competencies and skills needed for CBA in primary care 
(Main et al., 2007; Turk & Okifuji, 2003) 
 Being an active listener, to be caring and confident 
 Able to conduct a simple psychosocial assessment 
 Able to identify key psychosocial obstacles to recovery 
 Able to provide clear and adequate information, and explain 
physiological medical information in terms appropriate to the patient’s 
level of understanding 
 Helps patients to make an informed decision about participation in 
treatment 
 Able to integrate patients’ social circumstances into the management 
plan 
 Able to help patients to define clear, measurable and achievable 
rehabilitation goals 
 Reinforces positive behaviours and goal achievement 
 Empowers patients, encourages self-management and active 
participation for rehabilitation  
 Helps patients see an alternative scenario to incapacity- future oriented 
 Facilitates acceptance of chronic pain  
 
The CBCLBP programme was highly structured by using the same timetable, 
and standardised educational materials, audiovisual resources, activities and 
exercise components. An overview of the six sessions is provided in Appendix 
10. All study participants were also provided with an information pack 
containing written education material each week (Appendix 11), homework 
(Appendix 12) and home exercise workbook (Appendix 13). 
3.6.5 Education 
The education session was interactive and supportive. It lasted for 
approximately an hour each session, whereby participants were encouraged to 
be actively involved in the programme and took part in the discussions and 
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activities. Over the six-week programme, the perspective was to give patients 
the opportunity to develop a range of techniques and strategies that allowed 
them to minimize the impact of their pain and disability on their daily activities, 
and enable them to self-manage their condition more independently and 
confidently. Participants were given the opportunity to share experiences in the 
group on how they manage their back problems in their daily life. They were 
also offered the opportunity to discuss their personal barriers and pain-related 
fear in small groups or individually with the physiotherapist.  
 
Throughout the programme, participants addressed a variety of issues as shown 
in Figure 3.5. All the six education sessions were presented visually in a power 
point presentation. Particular attention was targeted to increase patient’s ability 
and confidence for self-management, reduce fear of movement and promote 
patients to hold more internal belief towards their NSCLBP condition. 
Participants received the support they required from the course physiotherapist 
as well as written information for each session, in order to optimise their uptake 
of the self-management tasks they learnt from the course (Oliveira et al., 
2012b).  
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Figure 3.5: Education component of the CBCLBP programme: 
Understanding 
NSCLBP 
 Overview of spinal anatomy & common causes of LBP. 
 Promote understanding on the diagnosis of NSCLBP, and clarify 
any misunderstanding on diagnostic languages. 
Explanation of 
detrimental 
effect of FAB 
and role of 
exercises 
 Detrimental effect of fear-avoidance behaviour and lack of 
movement on physical and psychological health. 
 Role of exercise- provide patients with a model of the 
relationship between graded movement and reducing pain and 
tension. 
 Explanation of “cycle of change”- to promote positive 
behavioural/ lifestyle change. 
Pain physiology 
education 
 Basic pain physiology 
 Explanation of acute pain vs chronic pain 
 Factors predisposing to chronic pain 
 Mechanism of pain gate theory and pain neuromatrix 
 Explaining sensitization 
 Explaining pain ≠ harm 
Managing and 
addressing  
negative 
thinking and 
belief 
 Identify and modify patient’s cognitions regarding their pain (the 
meaning of pain, expectations regarding control over pain). 
 Promote understanding in the link between beliefs, fears, 
thoughts, and subsequently mood and pain. 
 Helping patients to learn techniques to identify unhelpful 
thoughts, feelings and behaviour, to develop effective responses 
to challenges. 
 Introducing cognitive restructuring techniques such as imagery 
and attention diversion. 
Pacing  Activity management- planning/ pacing/ prioritising (3Ps’ 
technique). 
 Graded exposure to exercise and activity. 
Goal setting  Personal goal setting- use of short-term and long-term goal 
setting to encourage patients returning to ceased hobbies/ 
activities/ work. 
Posture  Postural workshop, lifting and handling workshop. 
Relaxation  Explore other causes of pain (e.g. stress, emotional tension, work, 
family) and address psychosocial issues accordingly. 
 Relaxation technique- introducing relaxation CD, relaxation 
breathing, and ways to aid good sleep. 
Alternative 
pain relief 
 Alternative pain relief i.e. non-pharmalogical option of pain 
control.  
Flare-up 
management 
 Flare-up plan to manage future setbacks. 
 Introduction to red flags, equip patients with knowledge to decide 
when to self-manage or to seek medical help appropriately. 
Future self-care 
plan 
 Lifestyle changes- such as weight reduction, diet, exercise & 
fitness, new activities and hobbies. 
 Discussion on self-management plan, and appropriate healthcare 
usage. 
 Explain the importance of self-care and the stability of new 
positive changes. 
 CHAPTER 3 Methodology                                                                                         Page 98 
 
 
3.6.6 Exercise 
Each session included approximately 45 minutes group exercise circuit, which 
consisted of core stability work, stretching exercise, lightweight training, and 
cardiovascular work (Appendix 14). A physiotherapist and an assistant 
supervised the exercise session in order to ensure safety and correct exercise 
technique. 
 
An operant approach formed the basis of the graded exercise programme in this 
study. The operant approach, according to a biopsychosocial model (Fordyce, 
1976; Lindström et al., 1992), implies that activity is guided by the patients’ 
functional abilities and that time-contingent methods are used to increase the 
level of the patient. The treatment philosophy focuses on reducing pain 
behaviours (operants), and increasing healthy behaviour (Fordyce, 1976; 
Lindström et al., 1992). In this study, patients were instructed to decide their 
own repetition and the level of difficulty within their comfort zone, but they 
were encouraged to build up the level gradually each week. An exercise-circuit 
diary (Appendix 14) was given to participants to record and monitor their own 
progress. A variety of exercises were included because it is believed that back 
pain patients are often fearful of activities. Therefore, it was felt that exposing 
patients to various types of activities in a graded and paced manner would help 
to reduce their pain-related fear (Woby et al., 2008). 
 
In addition to the graded exercise programme, participants also had a session of 
hydrotherapy (Appendix 15) and Pilates (Appendix 16) during the course. 
Hydrotherapy and Pilates session were run by physiotherapist who has special 
interest and qualification in teaching them. These activities were included, as it 
was felt that introducing patients a variety of exercise options would promote 
their confidence to try new activities, and reduce boredom from their normal 
exercise routine.  
 
Participants agreed to perform home exercises every day as part of their self-
management plan. They were instructed how to perform these exercises 
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correctly, and they were encouraged to increase the repetition in their own pace. 
A home exercise diary (Appendix 13) was given to participants to monitor 
their progress.  
3.6.7 Homework 
Participants were given homework (Appendix 12) most weeks. They were 
required to practice their new learnt skills and some simple behavioural 
experiments each week, including cognitive restructuring technique, paced 
activity, resumption of ceased hobbies, goal setting, relaxation and individual 
self-management plan. Participants were required to identify their own barriers 
and unhelpful thoughts about pain and activity, and they were encouraged to 
apply these simple behavioural techniques to monitor and change their 
maladaptive thoughts, feelings and behaviours. Homework was discussed at the 
beginning of each session, and problem-solving sessions were followed as a 
group or individually where appropriate.  
                                                                                                                                                                                                                                                                                                                                                                                                                                               
3.7 Outcome measures 
In order to assess the effectiveness of the CBCLBP programme and the impact 
of NSCLBP on patients’ life, a reliable and valid measurement tool that 
accurately assesses function and monitors change over time is required (Hicks, 
2009). The NICE guidelines recommend that any intervention should have a 
high impact on patients’ outcomes, particularly pain, disability and 
psychological distress (Savigny et al., 2009). Therefore this study evaluated 
these core domains of NSCLBP. 
 
There are a number of patient-based outcome measurements that are commonly 
used in research and clinical setting in the NSCLBP population. However, there 
is no consensus on which specific outcome measure(s) best measures the 
effectiveness of a therapeutic intervention. For the current study, a number of 
factors were considered when deciding which outcome measures to use.  
First, if the design of the assessment tools accurately answered the objectives of 
this study. Second, the validity and reliability of the assessment instrument. A 
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valid self-reported questionnaire measures accurately what it is supposed to 
measure, and if it is reliable, whether it can be reproduced (Berzon, 1998; Deyo 
et al., 1991). Third, the responsiveness, i.e. the ability of the instrument to 
detect real or important change over time when it has occurred (or when it has 
not occurred) (Terwee et al., 2003). This then led to a search for the minimal 
clinically important difference (MCID). The MCID is referred as the smallest 
difference in a score of a domain of interest that patients perceive to be 
beneficial (Jaeschke et al., 1989). MCID is commonly addressed in the 
NSCLBP literature, mainly because statistical significance does not correspond 
to clinical relevance of the treatment effect (Hurst & Bolton, 2004). Change in 
score on the scale of a measurement instrument exceeding the MCID is 
regarded as clinical relevant. There is no uniform method to measure MCID 
(De vet et al., 2006; Ostelo et al., 2008). However, as a general rule, an 
international consensus panel concluded that 30% change in almost any scale 
can be considered to be “meaningful” (Ostelo et al., 2008), this 
recommendation to measure MCID applied in this study where applicable. 
Finally, the ease of use of the questionnaires, including administration and 
understandability for patients, is also important to consider.  
In this study, five validated outcome measures were chosen as these five 
variables address the main domains of NSCBLP. They were administered: at 
baseline (-4 weeks), at the beginning of the treatment (week 0), at completion 
(week 6) and at 3-months and 6-months follow up (Figure 3.1). They are: 
1. HLOC, evaluated by the Form C of the Multidimensional Health Locus of 
Control (MHLC) scale (Wallston et al., 1994). 
2. Pain, evaluated by a Visual Analogue Scale (VAS) (Huskisson, 1974). 
3. Disability, evaluated by Roland and Morris Disability Questionnaire (RMQ) 
(Roland & Morris, 1983). 
4. FAB, measured by the Tampa Scale of Kinesiophobia (TSK) questionnaire 
(Vlaeyen et al., 1995a).  
5. Patients’ attitude toward back pain self-care, measured by the Self-Care 
Orientation Scale questionnaire (SCQ) (Von Korff et al., 1998).  
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Primary outcome measure is the HLOC, which is the main interest of the study. 
HLOC has been shown to be both predictors of poor outcome, as well as 
potentially modifiable through clinical intervention (Klaber Moffett et al., 2006; 
Keedy et al., 2014). However, evidence in this aspect is limited. This study 
aims to extend the current literature and specifically looked at the effect of 
physiotherapy-led intervention on HLOC.  
 
Pain, disability and FAB were secondary measures because they represented the 
complex nature of NSCLBP (Waddell, 2004). Pain intensity and disability are 
the two important domains directly related to LBP (Ostelo & de Vet., 2005), 
whereas FAB has shown to be a predictor of poor outcomes (Boersma & 
Linton, 2006a; Boersma & Linton, 2006b; Leeuw et al, 2007; Ramond et al., 
2011) and associated with back pain related disability (Thomas et al., 2010; 
Elfving et al., 2007; Woby et al., 2004b; Grotle et al., 2004; Mannion et al., 
2001; Crombez et al., 1999; Vlaeyen & Linton, 2000). Additionally, the 
objective and treatment principle of the CBCLBP programme were based on 
the idea that the therapeutic effect is to reduce pain, disability and pain-related 
fear (Guzmán et al., 2001; Ostelo et al., 2005). Therefore, it is logical to employ 
these self-reported measures to assess the effect of the programme.  
 
Self-care is an important and clinically desirable ingredient in the effective 
management of NSCLBP (Fordyce, 1976; Deyo, 1983; Von Korff, 1999). The 
SCQ was used to examine changes in healthcare utilisation and prescriptive 
medicine as a result of the intervention (Saunders et al., 1999), since patients’ 
attitude toward back pain self-care has an impact on the dependence of the 
health service (Tait & Chibnall, 1998; Saunders et al., 1999). This means better 
self-care attitude have a financial impact on both the healthcare service and to 
patients themselves. 
3.7.1 Outcome measure 1: HLOC 
HLOC was measured using Form C of the MHLC scale developed by Wallston 
et al. (1978). The MHLC scale was presented in three forms (A, B and C). The 
first two forms determined general HLOC, and have been typically used with 
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healthy individuals (Wallston, 2005). Form C of the MHLC (Appendix 17), the 
version used in this study, was specifically designed to assess HLOC beliefs in 
individuals with existing medical problems or health conditions such as chronic 
pain and CBLBP (Wallston et al., 1994). This scale has been proven to be a 
valid and responsive assessment tool to measure health locus of control beliefs 
in any medical or health-related condition (Wallston et al., 1994).  In the 
present study, Form C was used to assess HLOC in reference to NSCLBP.  
 
Form C of the MHLC scale consists of three independent, six-item subscales: 
 ILOC is measured by Item 1, 6, 8, 12, 13 and 17; individuals 
with high scores in these items believe that they are responsible 
for their own health. 
 ELOC is measured by Item 3, 5, 7, 10, 14 and 18; individuals 
with high scores in these items believe that others such as 
medical professionals or family are responsible for their health. 
 CLOC is measured by Item 2, 4, 9, 11, 15 and 16; individuals 
with high scores in these items believe that chance is responsible 
for their health. 
 
Each of the subscales were scored independently on 6-item scales that use 
Likert-type responses ranging from 1 (strongly disagree) to 6 (strongly agree). 
This gives a range of 6-36 for each subscale, with higher values reflecting 
higher level of the construct. Form C has proven to be a relatively easy 
instrument to administer, and has been successfully used with a wide variety of 
different conditions and populations, ranging from rheumatoid arthritis to HIV 
disease (Wallston et al., 1994).  
 
Regarding reliability and validity, Form C has demonstrated sufficient alpha 
reliability (with Cronbach’s alpha ranging from 0.70- 0.87) (Wallston et al., 
1994). The subscales are also considered to be moderately stable over time and 
possessed adequate construct validity and convergent validity (Wallston, 2005). 
Regarding construct validity, Form C subscale scores were shown to change in 
 CHAPTER 3 Methodology                                                                                         Page 103 
 
 
theoretically predicted direction following a six-week pain intervention (i.e. as 
the mean score of ILOC increased, ELOC and CLOC reduced significantly) 
(Wallston, 2005). With regard to convergent validity, ILOC was shown to be 
significantly and negatively correlated with pain and helpfulness; whilst CLOC 
was significantly and positively correlated with depressive symptoms and 
helpfulness in both arthritis and chronic pain subjects (Wallston, 2005). The 
study by Oliveira et al. (2008) suggested the minimal detectable change scores 
were: 6.77 for ILOC; 6.72 for ELOC; and 5.91 for CLOC.  
 
To date, MHLC is the only validated assessment tool that is specifically 
designed to assess HLOC beliefs in individuals with existing medical problems 
or health conditions such as chronic pain (Wallston et al., 1994). The original 
version of the instrument, i.e. Form A and Form B, are more or less equivalent 
in form. The only difference between the three MHLC forms is that Form A 
and Form B tap beliefs about control of one’s health status, while Form C taps 
belief about control of one’s illness or disease. Form C gives flexibility to 
further analyze ELOC dimension into two subscales: Doctors and Other people, 
each with three items (Wallston, 2005).  
 
The developer of MHLC, Wallston (1991) stated that the dimension of the 
MHLC can always be combined, but the most important differentiation is the 
internal and external domain. This is because the internal and external 
dimension shows the most potential for meaningful results in the health area 
(Wallston, 1991). The three-dimensional structure (ILOC, ELOC and CLOC) 
of the MHLC has been supported in most patients’ population studies, LBP and 
NSCLBP studies without further distinguishing the two sub-scales of ELOC 
(Doctors and Other people) (Harkapaa et al., 1991; Haldorsen et al., 1998; 
Sengul et al., 2010; Sengul et al., 2011; Richard et al., 2011; Klaber Moffett et 
al., 2006; Oliveira et al., 2009; Oliveira et al., 2012b). The current study 
therefore analyzed and reported data according to the three unique domains- 
ILOC, ELOC and CLOC.    
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Another assessment tool found in the literature that aims at detecting the extent 
of cognition to which patients can control, and decrease, their pain, is the 
Coping Strategies Questionnaire (CSQ) (Rosenstiel & Keefe, 1983). However, 
these two-single items scales possess only acceptable test-retest reliability over 
a 14-day period (Woby et al., 2004b), and more importantly, it is not designed 
to measure the HLOC specifically, which is the primary objective of this study.  
 
Some authors used Pain LOC (PLOC) (Coughlin et al., 2000; Penzien et al., 
1989) or Multidimensional Pain Locus of Control Questionnaire (MPLC) 
(Engstrom, 1983) to measures ILOC, ELOC and CLOC over pain. These 
assessment tools are re-constructed on the basis of MHLC. However, its use in 
literature appears not as dominant as MHLC. More important, evidence on their 
validity and reliability are limited.  
 
Because each study has its own targets and goals, some authors used composite 
scores which include subscale to measure patients’ pain beliefs and their 
cognitions about (in)ability to control one’s pain. Examples are the Pain 
Cognition List (PCL) (Vlaeyen et al., 1990) and the Pain Coping and Cognition 
List (PCCL) (Stomp-van den Berg et al., 2001). The PCL is a 39-item self-
report questionnaire which includes pain catastrophizing and internal control of 
pain subscales. There is evidence to support its reliability and stability in CLBP 
patients (Vlaeyen et al., 1990), however there is no information about the 
responsiveness of this scale. The PCCL is developed on the basis of three 
existing Dutch questionnaires (PCL, CSQ and MPLC). It aims to measure 
cognitions related to pain, covering four categories including: catastrophizing, 
pain coping, internal pain control and external pain control. It has been shown 
the construct validity of PCCL is satisfactory (Stomp-van den Berg et al., 
2001). However, this assessment tool measures patients’ cognition and beliefs 
in a comprehensive way and it does not measure patients’ HLOC specifically. 
Therefore, these composite assessments are not considered in current study.  
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3.7.2 Outcome measure 2: Pain intensity 
Severity of pain “today” was measured on a Visual Analogue Scale (VAS) 
(Huskisson, 1974) (Appendix 18). This scale has a 100 mm plain line with 
endpoints labelled no pain to unbearable pain, requiring patients to rate their 
pain. Higher score indicating higher pain intensity. Since pain is subjective, 
patient’s self-reporting provides the most valid measure of the experience and is 
considered as the gold standard in pain management (Ong & Seymour, 2004). 
The VAS was chosen because it is simple, easy to understand and readily 
reproduced on successive presentations. Besides, it is more sensitive to clinical 
changes than Visual Rating Scale (VRS) (Price et al., 1994) and Numerical 
Rating Scale (NRS) (Ong & Seymour, 2004). The VAS has been widely used in 
pain research (Huskisson, 1974; Jensen et al., 1986), and found to be the most 
reliable and sensitive tool for measuring pain, with test-retest reliability of >90 
(Flandry et al., 1991; Ong & Seymour, 2004), and with moderate to good 
responsiveness (Vermeulen et al., 2005; Ong & Seymour, 2004).  For patients 
with CLBP, the MCID for improvement on the 0-100mm VAS is 
approximately 20mm (Haefeli & Elfering, 2006; Ostelo & de Vet, 2005). 
 
There are some debates whether the VAS is an ordinal or interval/ratio level of 
measures (Altman, 1990; Hicks, 2009). Assessment of pain scale involves a 
distance; therefore it can be viewed as interval/ ratio scale (Myles et al., 1999; 
Hicks, 2009). However, because pain is a subjective commodity, it can be 
argued that it should be regarded as an ordinal scale (Gracely & Dubner, 1981; 
Altman, 1990; Hicks, 2009). For example, patients were asked to express the 
amount of pain they are feeling “today” on a 100 mm plain line with end-points 
labelled no-pain-to-unbearable-pain. A score of 70 mm means more pain than a 
score of 50 mm, and that is more than a score of 30 mm. But the difference 
between the 70 mm and the 50 mm may not be the same as that between 50 mm 
and 30 mm. The values simply express an order, but not the difference between 
values. In this study, the PI regards VAS as an ordinal measure (McCrum-
Gardner, 2008), and an appropriate statistical test is applied. 
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The VAS was administered consistently in the same manner over the course of 
the study period (see Section 3.8 for data collection and data management). The 
VAS scores were calculated by measuring and recording in centimetres from 
the left hand end of line to the point that the patient marks, and they were 
rounded up to the nearest half centimetres.  
3.7.3 Outcome measure 3: Disability 
The Roland and Morris Disability Questionnaire (RMQ) (Roland and Morris, 
1983) (Appendix 19) has been widely used in the clinical and research setting, 
designed to measure self-reported disability from low back pain. This measure 
has often been used in studies evaluating conservative treatments such as 
cognitive behavioural therapy and supervised exercise therapy in patients with 
chronic low back pain (Airaksinen et al., 2006; Van Hooff et al., 2010). The 
RMQ demonstrates excellent reliability, validity and responsiveness for 
functional disability (Smeets et al., 2008; Ostelo et al., 2004; Roland & 
Fairbank, 2000), with a MCID of 2-3 points (Roland and Fairbank, 2000). 
 
The Oswestry Disability Index (ODI), another widely used disability measure, 
has also shown to be valid, reliable and responsive in evaluating the extent of 
disability in patients with chronic low back pain (Roland & Fairbank, 2000). 
However, the RMQ was chosen over the ODI. This is because this study aims 
to assess conservative treatment for NSCLBP, yet the ODI has often been used 
to evaluate orthopaedic interventions such as surgery and facet steroid injection 
(Van Hooff et al., 2010).  
 
The RMQ asks patients to think of their disability due to back pain “today” 
(Roland & Morris, 1983). This measure includes 24 items of dichotomous 
(yes/no) response option. Total scores range from 0 (no disability) and 24 
(maximum disability), with higher scores indicate greater disability, and a score 
more than 13 reflecting significant disability (Roland & Morris, 1983). A 
standardised data collection and data management were carried out over the 
course of study period (Section 3.8).  
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3.7.4 Outcome measure 4: FAB 
FAB is a belief that certain activities should be avoided due to fear of causing 
pain or re-injury, and it has been suggested to predict future disability 
(Swinkels-Meewisse et al., 2003a). Fear of movement related to pain (labelled 
fear–avoidance belief) was measured using the Tampa Scale of Kinesiophobia 
(TSK) (Vlaeyen et al., 1995a) in this study (Appendix 20). The TSK is one of 
the most frequently employed measures for assessing pain-related fear in back 
pain patients (Woby et al., 2005). It is based on the model of fear avoidance, 
fear of work-related activities, and fear of movement/re-injury (Vlaeyen et al., 
1995a). It has also been linked to elements of catastrophic thinking (Burwinkle 
et al., 2005). The TSK has been recommended for the study of the role of 
general fear of movement and re-injury, reflecting patients’ somatic focus and 
activity avoidance in patients with chronic low back pain (Kori et al., 1990). 
 
The TSK is based on 17 items each with a four-point Likert scale, with scoring 
options ranging from 1 = “strongly disagree” to 4 = “strong agree”. A total 
score is calculated after inversion of the individual scores of item 4, 8, 12 and 
16. The total score ranges between 17 and 68, with higher scores reflecting 
greater level of fear avoidance (Lundberg et al., 2004). A score of 37 
differentiates between high and low level of FAB (Vlaeyen et al., 1995a).  
 
The 17-item TSK scale (Vlaeyen et al., 1995a) has good psychometric 
properties (Lundberg et al., 2004; Woby et al., 2005). It has been widely used in 
chronic low back pain researches, and demonstrates good validity (Lundberg et 
al., 2004), reliability (Bunketorp et al., 2005; Lundberg et al., 2004; Vlaeyen et 
al., 1995a) and responsiveness (Bunketorp et al., 2005). A study by Swinkels-
Meewisse et al. (2003b) reported that TSK with good internal consistency 
(range from alpha= 0.70 to 0.83), good test-retest reliability (range from r(s) = 
0.64 to 0.80 (p<0.01) and moderate concurrent validity (range from r(s) = 0.33 
to 0.59 (p<0.01).   
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Another questionnaire frequently used in assessing pain-related fear is the FAB 
Questionnaire (FABQ) (Waddell et al., 1993). The FABQ is a 16-items 
measure aimed at quantifying the beliefs about how work and physical activity 
affect pain and whether they should be avoided (Waddell et al., 1993). 
Although the FABQ is a validated assessment tool for chronic low back pain 
(Waddell et al., 1993), with good reliability (Jacob et al., 2001; Waddell et al., 
1993), and it may help identify acute back patients at risk of poor treatment 
outcome (Fritz & George, 2002). The FABQ is not designed as a tracking 
instrument. Therefore the meaningful change has not been determined for this 
questionnaire as a whole (Woby et al., 2005). In comparison, the TSK, 
frequently used in chronic low back pain research and in clinical practice, is 
designed for tracking. A change of at least 4 points on the TSK scale has been 
considered as clinically meaningful and ideal for assessing effectiveness of 
treatment (Murphy & Hurwitz, 201). Therefore, the TSK was included in the 
study over the FABQ. 
 
There have been some further modifications to the 17-items TSK scale 
described in the literature. For example, Woby et al. (2005) tested the 
psychometric properties of a shorter version of the TSK (TSK-11). They 
concluded that the original 17-items TSK and the TSK-11 both possessed 
similar psychometric properties and offered the advantage of brevity. However, 
further research is warranted to investigate the utility of TSK-11 and its cut-off 
score in a wider group of chronic pain patients in different clinical settings. 
 
3.7.5 Outcome measure 5: Attitudes Toward Back Pain Self- 
Care 
Patient attitudes and beliefs about their back pain affect treatment outcomes and 
their attitudes towards reliance on medical care and pain medications (Tait & 
Chibnall, 1998; Saunders et al., 1999). Experts generally agree that excessive 
reliance on prescription medicine and professional services for chronic pain 
control is undesirable for effective self-care and effective back pain 
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management (Fordyce, 1976; Deyo, 1983; Waddell, 1991). Consequently, a 
number of self-report instruments have been developed to assess these 
constructs. In this study, a five-item Self-Care Orientation scale questionnaire 
(SCQ) (see Appendix 21) developed by Von Korff et al. (1998), was used to 
assess patient attitudes toward the use of health care and prescription 
medications for back pain. Items included in this scale were shown to predict 
future use of health care and prescription pain medications for back pain (Von 
Korff et al., 1998). Participants indicated on a five-point Likert-scale (1 to 5 
points for each item) whether they strongly agree, agree, neutral, disagree or 
strongly disagree. Although the measure only demonstrates moderate internal 
consistency reliabilities (Saunders et al., 1999), the five items in this scale were 
shown to be sensitive to change following educational intervention, and able to 
predict future use of healthcare for back pain and/ or future use of prescription 
pain medications (Saunders et al., 1999). Besides, it is practical and easily 
administered in comparison to the Survey of Pain Attitude (SOPA) 
questionnaire.  
 
The Survey of Pain Attitudes (SOPA) is a well-researched instrument that 
assesses seven dimensions of patients’ pain attitudes. It includes: patients’ 
feelings about pain control, solicitude (solicitous responses from others in 
response to one's pain), medication (as appropriate treatment for pain), pain-
related disability, pain and emotions (the interaction between emotions and 
pain), medical cures for pain, and pain-related harm (pain as an indicator of 
physical damage or harm). The factor structure of the SOPA, however, has not 
been verified. It is longer than the SCQ and its length makes its 
administratively cumbersome (Tait & Chibnall, 1998). 
3.8 Data collection and data management 
Prior to the study, all the questionnaires used in the present study were piloted 
on the first five eligible patients (who were not included in the study). This was 
aimed at uncovering any problems relating to wording, layout, length, 
instructions or coding, so that amendments could be made accordingly. The 
questionnaires took about 20 minutes to fill in (Appendix 22). The only issue 
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reported was the faded print with photo-copying, there was no major issue 
otherwise. Therefore, the PI printed the questionnaire instead of photocopying 
during the study period, making it easier for participants to read.   
 
Study participants were asked to complete the questionnaires in the waiting area 
when they attended their rehabilitation programme. Data collection at 4 weeks 
prior to intervention, week 1 and week 6, were supervised and collected by a 
physiotherapy assistant in order to reduce experimenter bias (Burns, 1997). The 
PI then checked each of the self-reported measures after they had been 
completed and patients were required to answer any questions that they had 
missed. This ensured that completed pre- and post-treatment data was available 
for statistical analysis.  
 
After completion of the six-week rehabilitation programme, study participants 
were offered to complete their 3-month and 6-month follow-up questionnaires 
either via face-to-face appointment or by post. Participants were contacted a 
maximum of three times, inviting them to complete their post-treatment 
questionnaires. At 6 months, a patient cost questionnaire (Appendix 23) was 
used to examine patients’ cost of back care including patients’ travel costs to 
attend the programme, and any prescription charges, loss of pay, and other 
therapy charges during and up to six months following completion of the 
programme. Again, the PI checked each of the self-reported questionnaires after 
they had been completed, and patients were required to answer any questions 
that they had missed. This ensured that completed pre- and post-treatment data 
was available for all 55 patients for statistical analysis.  
 
Baseline data was collected four weeks prior to the intervention because four 
weeks was the routine waiting time for the CBCLBP programme in the 
Physiotherapy Department and this is appropriate to overcome the ethical 
dilemma. It was decided to collect data up until six months. This was based 
upon the relevant literature, time constraints and the practicalities in the clinical 
setting. Kazdin (2010) suggested that a minimum of three baseline data points 
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(no treatment time points) are required to establish dependent measure stability. 
In the current study, it involved three baseline data points (i.e. -4 weeks, 3-
month and 6-month), and the total study period for each participant was eight 
and a half months. Therefore, this is considered long enough to achieve stability 
in the dependent variables.   
 
The standardised manner of data collection method was used during both the 
baseline and intervention period in order to guard against threats to internal 
validity in the single-subject design (Riddoch & Lennon, 1994; Bithell, 1994). 
Data at each follow-up measurement was kept separately, and data was not 
analysed until end-of-study outcome measures had been collected.   
 
3.9 Data analysis 
Statistical analysis was run using IBM SPSS version 19.0 for Windows. The 
relevant part of the SPSS output was reported (see Chapter 4), with the aim of 
answering each research question clearly and accurately. Results indicating p 
≤0.05 were considered significant for all analysis.  
 
Data was re analysed in four stages. First, descriptive analysis was used to 
describe the characteristics of the sample. A series of statistical tests was also 
performed to explore whether the baseline characteristics of patients who 
completed the programme differed from those who dropped out of the 
programme. The Pearson Chi-Square and Fisher’s Exact test were used to 
explore differences in categorical measures (Bland, 2000; McCrum-Gardner, 
2008), including gender, on-set of LBP, duration of LBP, employment status, 
financial status and previous history of LBP. Mann Whitney U-tests were used 
to explore differences in continuous variables (Bland, 2000; McCrum-Gardner, 
2008), including age, ILOC, ELOC, CLOC, pain intensity, disability, FAB and 
self-care attitude. 
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Second, the Friedman’s ANOVA was computed to compare repeated measures 
of HLOC at each time point, in order to determine if significant changes had 
occurred in patients’ HLOC pre- and post- CBCLBP programme statistically 
(McCrum-Gardner, 2008). This analysis is to answer Aim 1 of the present 
study (Chapter 1, Section 1.7). The Friedman’s ANOVA was chosen, because 
Form C of the MHLC questionnaire is a Likert scale, and is regarded as ordinal 
data (Wallston & Wallston, 1981). Therefore, a non-parametric analysis is 
chosen.   
 
The Friedman’s ANOVA was also used to determine whether significant 
changes had occurred in patients’ pain intensity, disability, FAB, and back pain 
self-care attitude pre- and post- treatment. This is to answer Aim 2 and Aim 4 
of the present study (Chapter 1, Section 1.7). The Friedman’s ANOVA was 
employed because the VAS (Huskisson, 1974), the TSK questionnaire (Vlaeyen 
et al., 1995a) and the SCQ (Von Korff et al., 1998) are regarded as ordinal data. 
Therefore, a non-parametric analysis was chosen (McCrum-Gardner, 2008). 
With disability, the RMQ is considered as nominal data (Roland & Morris, 
1983). Analysis of data normality was performed using the Shapiro-Wilk test. 
The Shapiro-Wilk test indicated that the disability data was not normally 
distributed. Consequently, a non-parametric analysis was used when analysing 
disability pre- and post- treatment (Bland, 2000).  
 
For the Friedman’s ANOVA to demonstrate any significant treatment-related 
changes in HLOC, pain intensity, disability, FAB and back pain self-care 
attitude, the ANOVA was conducted post-hoc analysis using a Wilcoxon 
signed-rank test with a Bonferroni correction applied to reduce the probability 
of Type I error. The Wilcoxon signed-rank test aims to examine significant 
differences between mean scores of HLOC and other co-variables at each 
phase. More specifically, it determines where the significant treatment-related 
changes had occurred (Bland, 2000). i.e. whether it is before treatment (Phase 
A1); after treatment (Phase B), and/or 3 months and 6 months following the end 
of the programme (Phase A2) (Figure 3.1).  
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Third, the Pearson’s product-moment correlation coefficients were computed to 
investigate the inter-relation between the changes that emerged in HLOC and 
other co-variables. Change scores of these variables were calculated by 6 
months post-treatment mean score minus 4 weeks pre-treatment mean score. 
These time points (-4 weeks and 6 months) were selected as they showed how 
the HLOC and other co-variables changed from the start of the study to the end 
of it. The Pearson’s product-moment correlation was used because the Shaprio-
Wilk test indicated that change scores that emerged on each of the self-reported 
measures were approximately normally distributed. Therefore, the parametric 
Pearson’s product-moment correlation coefficients were performed to show the 
inter-relation between these variables (McCrum-Gardner, 2008).  
 
Finally, the hierarchical multiple regression analysis was performed to 
determine the extent to which a series of predictor (independent) variables (i.e. 
ILOC, ELOC and CLOC) were related to the outcome of interest (dependent 
variable) (i.e. (1) change in pain intensity; (2) disability and; (3) FAB (Bland 
2000; McCrum-Gardner, 2008),.  This is to answer Aim 3 (Chapter 1, Section 
1.7).  
 
According to the literature, HLOC beliefs are best conceptualised as 
independent variables predicting another variable (Wallston & Wallston, 1981). 
Using a hierarchical approach enabled predictor (independent) variables to be 
entered in a specific order, which enabled determination of the extent to which 
the subscale of the HLOC contributed to the outcome of interest (dependent 
variable) after controlling other potentially important variables. 
 
In the current study, a hierarchical regression was conducted for each of the 
outcome of interest, measured as: (1) change in pain intensity; (2) disability 
and; (3) FAB. A series of predictor variables was then entered in a specific 
order. Since this study has particular interest in the HLOC, change scores in 
ILOC, ELOC and CLOC were therefore entered in the final step of the 
regression analysis in order to illustrate which beliefs are affected and which do 
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not contribute to changes in pain intensity, disability and FAB beyond those 
predictor variables entered in earlier steps of the analysis. Values of p<0.05 
were considered significant.  
 
When change in pain intensity was the outcome (dependent variable), the first 
block of regression included age and sex. The second block consisted of change 
scores in disability and FAB, and the final block consisted of the change scores 
in IHLC, ELOC and CLOC.  
 
When change in disability was the outcome (dependent variable), the first block 
of regression included age and sex. The second block consisted of change 
scores in pain intensity and FAB, and the final block consisted of the change 
scores in IHLC, ELOC and CLOC.  
 
When change in FAB was the outcome (dependent variable), the first block of 
regression included age and sex. The second block consisted of change scores 
in pain intensity and disability, and the final block consisted of the change 
scores in IHLC, ELOC and CLOC.  
 
3.10 Economic evaluation 
It is apparent that the burden and the economic impact of NSCLBP are huge. 
Considering the current financial climate of the NHS, the decision-makers in 
the NHS including individual clinicians, managers or commissioners, often 
consider the cost of healthcare services (Cohen & Reynolds, 2008). Clinical 
outcomes are not the only important factors considered by clinicians and policy 
makers. Rather, the cost of services is also heavily considered when deciding 
how the limited resources can be allocated (Donaldson et al., 2002; Cohen & 
Reynolds, 2008). Therefore, it is useful to combine economic evaluation 
alongside with clinical study, in order to provide information that may help 
decision-making and evaluation of services in terms of cost (Goodwin et al., 
2003). In addition, NSCLBP is a chronic condition that often results in ongoing 
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health care, patient and societal cost. This further highlights the importance of 
examining the economic impact from a provider’s, patient and societal 
perspective as a result of the recommended form of treatment such as the 
CBCLBP programme in the present study.  
 
Following the initial NRES approval for the present study, the PI and the 
supervisory team decided to include an economic evaluation. A minor 
amendment request was subsequently submitted and an approval was obtained 
to conduct the economic evaluation of the CBCLBP programme (Appendix 
24).  
 
The objectives of the economic evaluations are: 
1. To determine the cost of a six-week CBCLBP programme from a 
provider’s, patient and societal perspective. 
2. To calculate the cost per change of ILOC. 
3. To determine the longer-term (6-months) cost of back care for 
patient and provider. 
 
A patient cost of back care questionnaire (Appendix 23) developed for this 
study was administered at 6-months. This questionnaire was aimed at 
examining: (a) the cost of back care from a provider’s, patient and societal 
perspective when patients undertaking the CBCLBP programme (Objective 1); 
and (b) the provider’s and patient cost six months following completion of the 
programme (Objective 3).  
 
ILOC was chosen to calculate cost-effectiveness ratio (Objective 2). The cost 
per change of ILOC was calculated by division of provider’s cost for the 
CBCLBP programme by change score of ILOC between week 1 and week 6. 
An alternative option to determine cost-effectiveness ratio would be the use of 
the EQ-5D questionnaire. The EQ-5D instrument is recommended by 
Department of Health (2010) and the CSP (Jette et al., 2009) to assess cost 
effectiveness in relation to musculoskeletal physiotherapy outpatient services. It 
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is also widely used in many existing studies. However, since HLOC is the 
primary outcome measure of the current study, and the PI concerned the risk of 
respondent fatigue (Lavrakas, 2008), that participants having too many 
questionnaires to complete, the ILOC was therefore chosen. 
 
Expenses associated with LBP have been studied in the context of both direct 
and indirect costs (Ekman et al., 2005). In this study, costs were referred to as: 
 Provider costs (i.e. direct medical (NHS) costs); 
 Patient costs (i.e. direct non-medical costs); and  
 Societal costs (i.e. indirect costs).   
 
 
3.10.1 Provider costs 
Provider costs are the NHS costs directly relating to the provision of the 
CBCLBP programme, the following costs were calculated such as staffing costs 
(physiotherapists, physiotherapists’ assistant and GPs’ time); departmental 
costs (allocated overheads); medication (prescribed by the GP); and equipment 
(both physiotherapy gym and hydrotherapy). 
 
Staffing costs included all NHS staffing required to provide the CBCLBP 
programme, and staffing costs incurred six months following the programme.  
 
For entering the CBCLBP programme, all patients had to visit their GP for a 
physiotherapy referral, and to be seen by a specialist physiotherapist for a full 
spinal examination. Therefore, these costs (including an average GP 
consultation of 11.7 minutes and an average specialist physiotherapy 
assessment of an hour) were included as part of the provider costs before the 
start of the programme.  
 
To provide the six-week CBCLBP programme, calculation of staffing time 
included: a Band 7 physiotherapist and a physiotherapy assistant once a week 
for six weeks, and a Band 7 physiotherapist and a physiotherapy assistant for 
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one hydrotherapy session at the end of the six-week programme. This resulted 
in a total number of seven sessions. Given each session (including 
administration time) was 2.5 hours, thus the total staffing time to provide the 
CBCLBP programme included 17.5 hours of one specialist physiotherapist and 
17.5 hours of one physiotherapy assistant.   
 
Staffing costs of GP, physiotherapist and physiotherapy assistant were based on 
the Personal Social Services Research Unit (PSSRU) (Curtis, 2013) (see Figure 
3.6). The sum included salary on costs, qualifications, indirect and capital 
overheads and training.  
 
In the six months following the completion of the CBCLBP programme (i.e. 
between week 6 and 6 months), calculation of staffing costs included: the 
number of visits made to a GP or other NHS services. GPs’ time was calculated 
from an average surgery consultation of 11.7 minutes then multiplied by the 
number of visits made. Each consultation was £45 per 11.7 minutes (Curtis, 
2013). The sum included practice expenses, qualifications, on-going training, 
capital costs and overheads. Where patients indicated in their questionnaire that 
they had visited their GP and omitted a spending on prescription charge in the 
six months following the CBCLBP programme, it was assumed that there was a 
prescription pain medication of £8.80 per head incurred out of the provider’s 
budget. The costs of other NHS services were calculated based on the actual 
amount reported by patients in their questionnaire. Any private or self-funded 
treatments were also regarded as patients’ cost.   
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Figure 3.6: To show the key items consumed during the study  
 
Item Unit Cost (£) Reference 
 
GP Per 11.7 
minutes 
45 PSSRU  
(Curtis, 2013) 
 
Prescription pain medication  Per head 8.80 NHS Information 
Centre and Office 
for Nation 
Statistics (2010-
2011) 
 
Specialist physiotherapist (Band 7) Per hour 58 PSSRU  
(Curtis, 2013) 
 
Physiotherapist’s assistant (Band 3) Per hour 21 PSSRU 
(Curtis, 2013) 
 
AWR for employer in the Northwest, 
UK 
Per hour 10.75 Office for National 
Statistics (2014) 
 
Value for non-working time (e.g. 
housework and leisure time) 
per hour 6.04 Department for 
Transport (2014) 
 
Car usage Per mile 44  
pence 
The Automobile 
Association 
Developments 
Limited (2014) 
 
PSSRU, Personal Social Services Research Unit, 2013 (Curtis, 2013) 
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Equipment Costs  
Equipment costs during the CBCLBP programme were calculated and 
expressed as Equivalent Annual Cost (EAC) (Drummond et al., 2005; 
Drummond et al., 1997). The capital outlay annuitized was calculated on a 
standardised 3.5% interest rate and assumed an equipment life expectancy of 
five years (Building Cost Information Service, 2011; Curtis, 2013). The 
formula used to calculate the EAC was:  
 
E = r (NPV) / 1-(1+r)
-n
  
E = equivalent annual cost, r = discount rate (interest) 3.5%, NPV= net present 
value, n = useful life of equipment (Drummond et al., 2005; Drummond et al., 
1997). 
 
The EAC was apportioned to reflect the time it was in use by these patients. In 
this study, this was calculated based on equipment used by each patient for two 
hours per session for seven sessions (six sessions in the gym and one session in 
the pool). Figure 3.7 showed the price of all equipments used in this study:    
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Figure 3.7: Price of gym equipments (from Pattersonmedical.co.uk) and 
hydrotherapy equipments (from JPLennard Ltd, 2012) 
 
Equipment  item 
 
Cost per 
unit (£) 
Number 
of item 
Total cost (£) Equivalent Annual  
Cost (EAC) 
(+VAT)* (£) 
Treadmill* 4635 
 
1 4635 1026.57 
Cross trainer* 695 1 695 153.93 
Trampette* 201.5 2 403 89.26 
Pulley weight* 1963 1 1963 434.77 
Bike* 495 2 990 219.27 
Dumb bell 1kg* 8.49 2 16.98 3.76 
Dumb bell 2kg* 12.17 2 24.34 5.39 
Dumb bell 3kg* 17.04 2 34.08 7.55 
Mat* 21.31 10 213.1 47.2 
Pillow 14.99 10 149.9 149.9 
Relaxation CD 12 1 12 12 
CD player 20 1 20 20 
Laptop* 442.14 1 442.14 97.93 
Projector* 510.38 1 510.38 113.04 
Theraband 4.40 4 17.6 17.6 
Gym ball 65cm* 17.41 1 17.41 3.86 
Gym ball 75cm* 21.71 1 21.71 4.81 
Step* 29.47 2 58.94 13.05 
Woggle noodles 5.9 8 47.2 47.2 
Kickboard 6.3 8 50.4 50.4 
Arm ring 3.67 16 58.72 58.72 
Pool ball 7.5 2 15 15 
Chlorination 
machine* 
520 1 
520 115.17 
Chlorine tablets 12.95 2 25.9 25.9 
Maintenance 2300 1 2300 2300 
Sodium hypochlorate 35.9 4 143.6 143.6 
Polyalum chloride 39.13 4 156.52 156.52 
Sodium bicarbonate 41.25 4 165 165 
Thyosulphate flakes 36.75 4 147 147 
Sodium biosulphate 32.62 4 130.48 130.48 
Delivery 55 4 220 220 
Plumbers 147 1 147 147 
Total EAC (£): 6141.88* 
Cost of equipment for the six-week CBCLBP programme per patient (£): 9.82 
*Total [annuitized 3.5*5 years] 
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3.10.2 Patient costs 
Patient costs (also known as direct non-medical costs) are out-of-pocket 
expenses incurred by patient, family, or partner during their attendance to the 
CBCLBP, and six months following the programme. These included travel 
costs (patients, family, or partner); lost wages (patients, family, or partner); 
prescriptions costs and other costs (such as other therapy costs that are 
indicated as self-funded). 
 
Travel costs described modes of travel to the physiotherapy department in 
Stockport. This included car, bus or train, taxi, walking and other such as 
cycling or motorbike. The cost of these journeys was doubled when patients 
indicated in their questionnaire that they were accompanied by a companion 
who did not have an appointment in the physiotherapy department. If the 
companion did have a clinical appointment, the travel costs halved. Car usage 
was at 44 pence per mile based on a petrol car costing up to £12000 travelling 
an average of 10,000 miles per year, including standing charges and running 
costs (The Automobile Association Developments Limited, 2014) (Figure 3.6). 
There is free on-site parking in the physiotherapy department, thus there should 
be no car parking fees unless patients indicated otherwise. In the six months 
following the CBCLBP programme, travel costs were taken as the actual 
amount reported in the questionnaire (i.e. Question 1 and 3). Travel costs were 
not included if the subject was eligible for reimbursement.  
 
Lost wages were regarded as patients’ cost when patients responded as taking 
‘time off with loss of pay’ for attending. This was taken as the Average Wage 
Rate (AWR) for employer in the Northwest, UK (£10.75 per hour per 
employee) (Office for National Statistics, 2014) (Figure 3.6). However, the 
AWR was substituted with the actual amount of loss of pay where it was 
indicated by patients in their questionnaire.  
 
Prescription charges from GP visits were taken as the amount reported by 
patients in the cost questionnaire. 
 CHAPTER 3 Methodology                                                                                         Page 122 
 
 
 
Other costs while attending the CBCLBP programme, in addition to travel or 
prescription costs, were gained from answers to a general question (Question 20 
and 21). Other costs during the six months following the programme were taken 
the actual amount indicated in Question 3 and Question 7.  
 
3.10.3 Societal costs 
Because of attending the CBCLBP programme, the lost productivity of a 
patient, or family member or partner were the main societal costs to be 
accounted. Such costs included: 
 
1. Value of time (refers to the cost to the patient of the time foregone 
attending the CBCLBP programme. Two aspects of time are considered: 
travel and time spent for attending the programme). 
2. Time lost from usual activities foregone attending the CBCLBP 
programme, which could be: time lost from work or time lost from non-
working activities. 
 
The total time lost from travel and attending the programme was calculated (in 
minutes). Where patients indicated that they lost time from work activities, i.e. 
those would have been in “paid occupation” during the CBCLBP programme, 
and responded as having “annual leave” and “time off without loss of pay”, this 
was regarded as time lost from work at the employers cost. The value of time 
lost at the employers cost was the AWR (£10.75 per hour in the Northwest 
UK) uplifted by 13.8% to reflect employers’ National Insurance and 
superannuation contributions (HM Revenue and Customs, 2014). Where 
patients indicated that they lost time from non-working activities or leisure, the 
value of time lost to non-working activities was calculated. This included 
those who responded ‘would otherwise be looking after children, other 
relatives, or friends’, or who responded ‘other’ or those who responded having 
a paid occupation and ‘rearranged their hours’. The value of time for non-
working time is £6.04 per hour (Department for Transport, 2014) (Figure 3.6) 
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3.11 Minimising bias and confounding variables 
In order to maximize the quality of the data, every practicable measure was 
taken to reduce bias and confounders. Particular attention was paid to control 
threats to internal validity, as internal validity is suggested to be a threat in 
single-subject design (Bithell, 1994; Logan et al., 2008). 
 
Bias was controlled by the following: 
 Strict inclusion and exclusion criteria and investigation of a 
homogenous group of subjects; 
 Standardised intervention and education materials throughout the study; 
 Standardized and consistent manner of data collection; 
 The use of different objective measurements of high validity and 
reliability in order to establish baseline stability and allow accurate 
comparison across phases; 
 Physiotherapy assistants supervised and collected data as much as 
possible, instead of the PI, to reduce experimenter bias; 
 The PI to check each of the self-reported measures after patients had 
been completed and they were required to answer any questions that 
they had missed, to reduce attrition bias; 
 Data at baseline and all follow-up measurements was kept separately;  
and 
 Data was not analysed until end-of-study outcome measures were all 
collected. 
 
3.12 Conclusion 
This chapter illustrates the methodology and data collection used for the current 
study. It demonstrates the consideration of validity issues and outcome 
measures used. Data were collected using the method as described. The next 
chapter goes on to provide the results of this study, and the analysis of data that 
answers the research questions accordingly.   
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CHAPTER 4 RESULTS 
4.1 Introduction 
This chapter provides the results and interpretation of the descriptive and 
statistical analysis conducted for the present study. It is divided into two 
sections.  
 
The first section provides: 
 A comparison of demographics and baseline characteristics between 
patients who completed the programme and those who dropped out 
(Section 4.3). 
 Baseline characteristics of included patients who completed the study 
(Section 4.4). 
The second section describes the results of statistical analysis conducted to 
examine each of the research questions, namely: 
 Aim 1: To assess the effect of the CBCLBP programme on the primary 
outcome, (HLOC) (Section 4.5); 
 Aim 2: To examine the effect of the CBCLBP programme on the 
secondary outcomes pain, disability and FAB (Section 4.6); 
 Aim 3: To determine if there is any relationship between patients’ 
HLOC and pain, disability and FAB (Section 4.7); 
 Aim 4: To examine patients’ self-care attitude toward their back pain in 
terms of their desire in future use of healthcare and prescription pain 
medication as a result of the programme (Section 4.8), and 
 Aim 5: To investigate the cost of back care per change of ILOC, as well 
as the cost of the CBCLBP programme from a provider’s, patient and 
societal perspective (Section 4.9).  
 
4.2 Overview of recruitment and data collection 
Study recruitment commenced in September 2012 and ended in June 2013. 
During this period, a total of 70 patients were initially recruited. Fifteen 
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patients dropped out of the CBCLBP programme (i.e. patients who were 
consented for the programme, but they never attended or only attended the first 
session of the programme). A total of 55 patients completed the study and all 
follow-up assessments, which is 79% of the original sample. Data collection 
was completed in January 2014. Throughout the recruitment and data collection 
period, the PI remained contactable and extra hours were put in to maximise 
recruitment and minimise loss of follow-up outcome data. 
 
4.3 Demographics and background information of recruited 
patients 
The demographics and background information of patients who completed the 
programme and those who dropped out are shown in Table 4.1, as frequency 
(N) and percentage (%).  
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Table 4.1: To show demographics and background information of patients 
completed the intervention compared with patients who dropped out 
Variables Participants 
N (%)  
Drop out 
N (%)  
Sex 
Male  
Female  
 
15 (27%) 
40 (73%) 
 
7 (46%) 
8 (53%) 
Nature of Onset  
Gradual  
Sudden  
 
52 (95%) 
3 (5%) 
 
15 (100%) 
0 (0%) 
Duration of back pain 
3-12 months  
 >12 months  
 
0 (0%) 
55 (100%) 
 
0 (0%) 
15 (100%) 
Employment status 
Employed & currently working  
Employed but currently on sick leave  
Unemployed due to back pain  
Unemployed but not due to health 
Housewife/ househusband  
Student 
Retired 
 
34 (62%) 
1 (2%) 
3 (6%) 
0 (0%) 
1 (2%) 
0 (0%) 
16 (29%) 
 
10 (67%) 
0 (0%) 
5 (33%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
Finance 
Received wage compensation 
Pursue medico-legal compensation 
Working and earning or pension 
Disabled/ retired due to back pain 
Disabled/ retired but not due to back pain 
 
4 (7%) 
0 (0%) 
48 (87%) 
3 (6%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
10 (67%) 
5 (33%) 
0 (0%) 
Previous history of back pain 
One previous episode  
Two or more previous episode 
 
3 (5%) 
52 (95%) 
 
0 (0%) 
15 (100%) 
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4.3.1Comparison of demographics and background information 
between patients who completed the programme and those who 
dropped out  
The Pearson Chi-Squared and Fisher’s exact tests were conducted to examine 
statistical differences in categorical measures, including gender, onset of LBP, 
the duration of LBP, employment status, financial status and previous history 
of LBP, between the two groups (Table 4.2). 
 
Table 4.2: To summarize the Pearson Chi-Square and Fisher’s exact tests 
to a series of categorical variables between those patients who completed 
the programme and those who dropped out the programme 
 
Categorical variables Value Degree of freedom p- value 
Gender 2.06 1 0.152 
Onset of LBP 0.86 1 0.355 
Duration of LBP 0.855 1 0.355 
Employment status 13.0 5 0.024 ⃰ 
Financial status 9.71 2 0.008 ⃰ 
Previous history of LBP 0.855 1 0.355 
⃰p < 0.05 
 
The two groups were statistically significantly different in terms of 
employment status (X (5) = 13.0, p= 0.024) and financial status (X (2) = 9.71, 
p= 0.008). Aside from these differences, there was no statistical significant 
difference found in gender (p= 0.152), onset of LBP (p= 0.355), duration of 
LBP (p= 0.355), or history of previous LBP (p= 0.355) between the two 
groups. 
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4.3.2 Comparison of baseline outcome measures between 
patients who completed the programme and those who dropped 
out of the programme 
Table 4.3 shows baseline characteristics (i.e. variables used in this study) of 
patients who completed the CBCLBP programme and those who dropped out, 
as mean and standard deviation (SD). Mann-Whitney U-test was then followed 
to examine the differences in continuous variables between those who 
completed and those who dropped out of the programme (Table 4.4).  
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Table 4.3: Baseline characteristics of patients who completed the 
intervention compared with patients who dropped out 
Variables 
Completed 
 (N= 55) 
Mean(SD) 
Dropped out 
 (N= 15) 
Mean(SD) 
p-value 
Internal locus of control (ILOC)  
[6-36; 6 = low ILOC, 36 = high ILOC] 
20.4 (7.09) 18.0 (4.96) 0.20 
External locus of control (ELOC) 
 [6-36; 6 = low ELOC, 36 = high ELOC]  
23.3 (5.55) 27.5 (4.27) 0.006 ⃰ 
Chance locus of control (CLOC) 
[6-36; 6 = low CLOC, 36 = high CLOC] 
17.7 (6.70) 18.3 (4.61) 0.57 
Pain intensity (VAS) 
[0-10; 0 = no pain, 10 = worse ever pain] 
6.04 (2.03) 6.33 (1.45) 0.58 
Disability (RMQ) 
[0-24; 0 = no disability, 24 = high disability] 
11.8 (5.55) 14.4 (3.66) 0.07 
Fear avoidance movements/ behaviour  
(TSK) 
[17-68; 17 = low pain related fear,  
68 = high pain related fear] 
42.3 (5.31) 42.3 (4.71) 0.90 
Self-care attitude (SCQ) 
[5-25; 5 = passive self-care attitude,  
25 = positive self-care attitude] 
10.3 (3.33) 10.5 (3.98) 0.92 
[VAS, Visual Analogue Scale; RMQ, Roland & Morris Disability Questionnaire; 
TSK, Tampa Scale for Kinesiophobia; SCQ, Attitude toward back pain Self-Care 
Questionnaire]  ⃰p < 0.05 
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Table 4.4: Mann-Whitney U-Test to examine the differences in continuous 
variable between those patients who completed the programme and those 
who dropped out 
 
Continuous variables Mann-Whitney U Z p-value 
Age 371.0 -0.60 0.56 
ILOC 321.5 - 1.31 0.20 
ELOC 223.5 - 2.71 0.006 ⃰ 
CLOC 372.0 - 0.58 0.57 
Pain intensity 373.5 - 0.57 0.58 
Disability 284.5 - 1.84 0.07 
Fear-avoidance belief 403.0 - 0.14 0.90 
Self-care attitude 405.0 - 0.11 0.92 
 [ILOC, internal locus of control; ELOC, external locus of control; CLOC, 
chance locus of control]  ⃰ p < 0.05 
 
Those who dropped out of the programme were more likely to have a 
significantly higher ELOC (U= 223.5, Z= -2.712, p= 0.006). But asides from 
this difference, there were no other significant baseline differences found in 
continuous variables (including age, ILOC, ELOC, CLOC, pain intensity, 
disability, FAB and self-care attitude) between the two groups. 
 
To summarize: those who dropped out of the programme (N=15) were 
significantly of (a) poorer employment status; (b) poorer financial status and (c) 
higher ELOC, compared to those who completed the study (N=55).   
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4.4 Baseline characteristics of included patients who completed 
the study 
A total of 55 patients completed the study. Prior to the baseline data taken (-4 
weeks), included patients have had an average of 4 sessions of individual 
physiotherapy treatments before referring onto the CBCLBP programme by 
their physiotherapist. During the programme (week 1 to week 6), 25% attended 
five out of six sessions, while 75% attended the full programme. Complete data 
of all outcome measures were available for each data points (i.e. -4 weeks, 
week 1, week 6, 3-months and 6-months) in all the 55 patients. 
 
Of those 55 patients who completed the study, 73% were female (N=40), and 
27% were male (N=15). They were all diagnosed with NSCLBP, 95% reported 
more than two previous episodes of back pain, and all reported back pain 
symptoms for > 1 year. The majority of patients were currently working (62%), 
only 6% reported that they are not working because of their back pain (Table 
4.1)   
 
The baseline characteristics of patients (Table 4.3) in this study were of:  
 Low level of ILOC (mean= 20.4, SD= 7.09);  
 Moderate level of ELOC (mean= 23.3, SD= 5.55);  
 Moderate level of CLOC (mean= 17.7, SD= 6.70);  
 Moderate level of pain intensity (mean VAS = 6.04, SD= 2.03); 
 Moderate level of disability (mean RMQ = 11.8, SD= 5.55); 
 High level of FAB (mean TSK= 42.3, SD= 5.31), and 
 Moderate level of self-care attitude towards back pain (mean SCQ = 
10.3, SD= 3.33).    
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4.5 Aim 1- To assess the effect of the CBCLBP programme on 
patients’ HLOC 
4.5.1 The effect of the CBCLBP programme on ILOC 
Table 4.5 gives the descriptive analysis of the ILOC data, including the mean, 
standard deviations, and interquartile ranges of pre- and post- treatment 
changes of ILOC. 
 
Table 4.5: Pre- and post-treatment mean values and standard deviation of 
Internal Locus of Control (ILOC) [6-36; 6 = low ILOC, 36 = high ILOC] 
 
N Mean SD Min Max 
Percentiles 
25th 
50th 
(Median) 75
th
 
ILOC -4 weeks  55 20.44 7.089 6 36 14.00 19.00 27.00 
ILOC week 1  55 21.36 7.317 6 36 17.00 21.00 26.00 
ILOC week 6  55 26.76 6.119 11 36 22.00 27.00 33.00 
ILOC 3 months  55 27.58 5.672 13 36 23.00 28.00 32.00 
ILOC 6 months  55 28.55 5.315 17 36 24.00 29.00 33.00 
 
The increase of ILOC over time suggested that patients’ ILOC steadily 
improved before, during and after the programme (range of ILOC 6 to 36, 6 
indicates low ILOC; 36 indicates high ILOC). The mean score at each time 
point was then plotted (Figure 4.1).  
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[ILOC 6-36: 6=low ILOC; 36= high ILOC] 
 
As shown in Figure 4.1, the mean ILOC gradually increased from – 4 weeks to 
6-months. The sharpest increase of ILOC was seen between week 1 and week 
6. This was the phase when study participants were undertaking the CBCLBP 
programme. After completion of the programme, patients’ ILOC continued to 
increase at 3-months and 6-months, but at a much slower rate. 
 
Comparison of the ILOC at each time point showed that there was a 
statistically significant change in ILCO (χ² (4) = 87.6, p< 0.001) from baseline 
to 6-months (Table 4.6).  
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Figure 4.1: Graph to show the effect of the CBCLBP programme on 
patients' internal locus ofcontrol (ILOC) 
ILOC 
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Table 4.6: To examine the significant difference of patients’ mean ILOC 
score between each phase using Wilcoxon signed-rank test 
 
  
ILOC 
 
 
-4 weeks  
and  
week 1 
 
Week1  
and  
week 6 
 
Week 6  
and  
3 months 
 
3 months  
and  
6 months 
Mean 
difference 
0.92 5.4 0.82 0.97 
Z -1.157 -4.84 -.945 -1.895 
p- value .247 <0.001 .345 .058 
[ILOC range 6-36] 
 
When examining the significant difference between each phase, ILOC had 
significantly improved (between week 1 and week 6) during the CBCLBP 
programme (Z= 4.84, p< 0.001). However, there was no statistically significant 
change between -4 week and week 1 (Z= 1.157, p=0.247) (i.e. when patients 
had had the usual physiotherapy care and were waiting for the CBCLBP 
programme), between week 6 and 3-months (Z= 0.945, p= 0.345), i.e. three 
months after completing treatment, and between 3-months and 6-months (Z= 
1.895, p= 0.058). 
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4.5.2 The effect of the CBCLBP programme on ELOC 
Table 4.7 illustrated the mean ELOC at baseline (-4 weeks), at the beginning of 
the programme (week 1), at completion (week6), and 3-months and 6-months 
after the programme. 
 
Table 4.7: Pre- and post-treatment mean values and standard deviation of 
External Locus of Control (ELOC) [6-36; 6 = low ELOC, 36 = high ELOC] 
 
N Mean SD Min Max 
Percentiles 
25
th
 
50
th
 
(Median) 75
th
 
 ELOC -4 weeks  55 23.27 5.509 13 35 19.00 22.00 27.00 
ELOC week 1  55 22.98 6.314 12 35 19.00 22.00 29.00 
ELOC week 6  55 17.49 5.091 8 28 13.00 18.00 21.00 
ELOC 3 months  55 16.42 5.469 6 31 12.00 18.00 20.00 
ELOC 6 months  55 15.98 5.370 6 26 12.00 17.00 20.00 
 
 
As seen in Table 4.7, patients’ ELOC gradually reduced from -4 weeks to 6-
months, indicating ELOC improved as a result of the CBCLBP programme 
(range of ELOC 6 to 36, 6 indicates low ELOC; 36 indicates high ELOC).  
 
Figure 4.2 illustrates the change in mean ELOC score from baseline to 6-
months. 
 CHAPTER 4 Results Page 136 
 
 
 
[ELOC 6-36: 6= low ELOC; 36= high ELOC] 
 
There was a gradual decrease of ELOC from baseline to 6-months which was 
statistically significant (χ² (4) = 91.7, p< 0.001) (Figure 4.2). The reduction 
was at its sharpest at week 6, which was just after the completion of the 
CBCLBP programme (Table 4.8).  
 
Table 4.8: To examine the significant difference of patients’ mean ELOC 
score between each phase using Wilcoxon signed-rank test 
 
 
 ELOC 
 
-4 week 
and  
week 1 
Week1  
and  
week 6 
Week 6  
and  
3 months 
3 months  
and  
6 months 
Mean difference 0.3 5.5 1 0.5 
Z -.497 -5.323 -2.467 -1.898 
p- value .619 < 0.001 .014 .058 
[ELOC range 6-36] 
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Figure 4.2: Graph to show the effect of the CBCLBP programme 
on patients' external locus of control (ELOC) 
ELOC 
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As illustrated in Table 4.8, there was no significant change (Z= 0.497, p= 
0.619) while patients completed usual physiotherapy care and were on the 
waiting list for the programme (between -4 week and week 1). A significant 
reduction of ELOC was seen during the intervention phase, which was between 
week 1 and week 6 (Z= 5.32, p< 0.001), indicating significant improvement in 
ELOC at completion of the programme. Patients’ ELOC continued to reduce 
statistically significantly at 3-months follow-up (Z= 2.467, p= 0.014). The 
reduction between 3- and 6-months was not significant (Z= 1.898, p= 0.058). 
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4.5.3 The effect of the CBCLBP programme on CLOC 
The mean CLOC at baseline (-4 weeks), at the beginning of the programme 
(week 1), at completion (week6), and 3-months and 6-months were shown in 
Table 4.9. As shown, the mean CLOC steadily improved from before, during 
and after the programme. 
 
Table 4.9: Pre- and post-treatment mean values and standard deviation of 
Chance Locus of Control (CLOC) [6-36; 6 = low CLOC, 36 = high CLOC] 
 
N Mean SD Min Max 
Percentiles 
25th 
50
th
 
(Median) 75
th
 
CLOC -4 weeks  55 17.69 6.702 6 33 13.00 17.00 22.00 
CLOC week 1  55 17.49 6.790 6 33 13.00 17.00 22.00 
CLOC week 6  55 14.13 6.313 6 36 10.00 13.00 18.00 
CLOC 3 months  55 13.13 6.287 6 28 8.00 11.00 17.00 
CLOC 6 months  55 12.56 6.137 6 29 7.00 10.00 18.00 
[CLOC 6-36: 6= low CLOC; 36= high CLOC] 
 
Figure 4.3 demonstrates the change in mean score of the CLOC from baseline 
to 6-months. 
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[CLOC 6-36: 6= low CLOC; 36= high CLOC] 
 
The mean CLOC reduced from baseline to 6-months (Figure 4.3). Again, the 
sharpest improvement was seen between week 1 and week 6, which was the 
intervention phase. Following the completion of the programme, patients’ 
CLOC continued to decrease at 3- months and 6-months, but at a slower rate. 
 
There was a statistically significant change in CLCO (χ² (4) = 41.3, p< 0.001) 
from baseline to 6-months (Table 4.10).  
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Figure 4.3: Graph to show the effect of the CBCLBP pragmme on 
patients' chance locus of control (CLOC) 
CLOC 
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Table 4.10: To examine the significant difference of patients’ mean CLOC 
score between each phase using Wilcoxon signed-rank test 
 
Chance locus of 
control (CLOC) 
[6-36, 6=low CLOC, 
36= high CLOC] 
Between  
-4 week and  
week 1 
Between  
Week1  
and  
week 6 
Between  
Week 6  
and  
3 months 
Between  
3 months  
and  
6 months 
Mean difference 0.2 3.36 1 0.57 
Z -0.223 -3.562 -0.794 -1.376 
p- value 0.824 <0.001 0.427 0.169 
[CLOC range 6-36] 
 
As shown in Table 4.10, there was no significant change (Z= 0.223, p= 0.824) 
while patients were on the waiting list for the programme (between -4 week 
and week 1). Patients’ CLOC had significantly improved during the CBCLBP 
programme, which was between week 1 and week 6 (Z= 3.562, p< 0.001). 
However, there was no statistically significant improvement after the 
programme, i.e. between 6 weeks and 3-months (Z= 0.794, p=0.427), and 
between 3- and 6-months (Z= 1.376, p= 0.169).   
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4.5.4 Summary of the effect of the CBCLBP programme on 
patients’ HLOC 
Figure 4.4 summarised the changes of the mean ILOC, ELOC and CLOC at 
baseline (-4 weeks), during (week 1, week 6) and after the CBCLBP 
programme at 3-months and 6-months.  
 
 
[ILOC 6-36: 6= low ILOC; 36= high ILOC] 
[ELOC 6-36: 6= low ELOC; 36= high ELOC] 
[CLOC 6-36: 6= low CLOC; 36= high CLOC] 
 
As seen in Figure 4.4, as the mean score of the ILOC increased, both mean 
score of the ELOC and CLOC reduced over the study period. 
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Figure 4.4: Graph to show the effect of the CBCLBP programme 
on the health locus of control (HLOC) subscale 
ILOC 
ELOC 
CLOC 
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4.6 Aim 2- To examine the effect of the CBCLBP programme on 
pain intensity, disability and fear avoidance belief 
 
Data at each time point (i.e. -4weeks, week 1, week 6, 3-months and 6-months) 
was plotted in simple line graphs and analysed for trends and to establish 
whether significant changes in pain intensity, disability, FAB had occurred 
between phases statistically as a result of the CBCLBP programme. 
 
4.6.1 The effect of CBCLBP programme on pain intensity 
Table 4.11 demonstrates the descriptive analysis of the pain intensity data, 
including the mean, standard deviations, and interquartile ranges.  
 
Table 4.11: Pre- and post-treatment mean values and standard deviation 
of pain intensity as evaluated by Visual Analogue Scale (VAS) [Range 0-
10, 0 = no pain, 10 = worst pain ever] 
 
N Mean SD Min Max 
Percentiles 
25
th
 50th (Median) 75th 
Pain [VAS] -4 weeks  55 6.04 2.027 0 10 5.00 6.00 8.00 
Pain [VAS] week 1  55 5.85 2.352 0 10 5.00 6.00 8.00 
Pain [VAS] week 6  55 3.95 2.094 0 9 3.00 3.00 5.00 
Pain [VAS] 3 months  55 3.71 2.347 0 9 2.00 4.00 5.00 
Pain [VAS] 6 months  55 3.22 2.192 0 8 1.00 3.00 4.00 
(VAS) [Range 0-10, 0 = no pain, 10 = unbearable pain] 
 
Overall, there was a gradual decrease of pain intensity from baseline to 6-months 
(range 0-10, 0 indicates no pain; 10 indicates unbearable pain). Such improvement 
was statistically significant (χ² (4) = 91.5, p< 0.001) (Table 4.11). Specifically, the 
greatest reduction was observed at week 6, which is just after the completion of the 
programme. Improvement of pain intensity was continued until 6-months follow-up 
(Figure 4.5).    
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[VAS Range 0-10, 0 = no pain; 10 = unbearable pain] 
 
Table 4.12: To examine the significant difference of patients’ mean pain intensity 
score between each phase  
 
Pain intensity 
(VAS) 
[0-10, 0=no pain, 
10= unbearable 
pain] 
Between  
-4 week 
and  
week 1 
Between  
Week1  
and  
week 6 
Between  
Week 6  
and  
3 months 
Between  
3 months  
and  
6 months 
Mean 
difference 
0.19 
 
1.9 0.24 0.49 
Z -0.657 -5.124 -0.510 -2.165 
p- value 0.511 <0.001 0.610 0.030 
[VAS Range 0-10] 
 
A significant reduction of pain intensity occurred between week 1 and week 6 
(Z= 5.124, p< 0.001), which was the intervention phase, and between 3-months 
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Figure 4.5: Graph to show the effect of the CBCLBP programme 
on patients' pain intensity as evaluated by VAS 
Pain 
intensity 
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and 6-months (Z= 2.165, p= 0.030) (Table 4.12). There was no significant 
reduction in pain intensity (Z= 0.657, p= 0.511) while patients were on waiting 
list (i.e. between -4 weeks and week 1), and between week 6 and 3-months (Z= 
0.510, p= 0.610). 
 
4.6.2 The effect of CBCLBP programme on disability 
Table 4.13 shows the mean changes in disability scores at each time point.  
 
Table 4.13: Pre- and post-treatment mean values and standard deviation 
of disability as evaluated by Roland and Morris Disability Questionnaire 
(RMQ)  
 
N Mean SD Min Max 
Percentiles 
25
th
 
50th 
(Median) 75th 
Disability RMQ) -4 weeks  55 11.84 5.547 1 23 8.00 12.00 16.00 
Disability (RMQ) week 1 55 11.60 5.656 0 23 8.00 11.00 15.00 
Disability (RMQ) week 6  55 9.15 6.148 0 24 4.00 8.00 15.00 
Disability (RMQ) 3 months  55 7.76 6.357 0 24 3.00 6.00 12.00 
Disability (RMQ) 6 months  55 7.55 5.840 0 24 3.00 6.00 12.00 
[RMQ range 0-24, 0= no disability; 24= high disability] 
 
The mean RMQ score at each time point was presented in Figure 4.6 to show 
the changes as a result of the programme. 
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[RMQ range 0-24, 0= no disability; 24= high disability] 
 
There was a gradual reduction of disability during the study period (Figure 
4.6). Such improvement from –4 weeks to 6-months was significant (χ² (4) = 
63.6, p< 0.001). More specifically, there was a significant reduction between 
week 1 and week 6 (p < 0.001), and between 6 weeks to 3-months (p = 0.016) 
(Table 4.14). 
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Figure 4.6: Graph to show the effect of the CBCLBP on  
patients' disability as evaluated by RMQ 
Disability 
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Table 4.14: To examine the significant difference of patients’ mean 
disability score between each phase using Wilcoxon signed-rank test 
 
Disability 
(RMW) 
[0-24, 0= no 
disability, 24= 
high disability] 
Between  
-4 week 
and  
week 1 
Between  
Week1  
and  
week 6 
Between  
Week 6  
and  
3 months 
Between  
3 months  
and  
6 months 
Mean 
difference 
0.24 2.45 1.39 0.21 
Z -0.891 -4.506 -2.418 -0.769 
p- value 0.373 <0.001 0.016 0.442 
[RMQ range 0-24] 
 
A significant reduction of disability occurred between week 1 and week 6 (Z= 
4.506, p< 0.001), which was the intervention phase, and between week 6 and 3-
months (Z= 2.418, p= 0.016) (Table 4.14). There was no significant reduction 
in disability (Z= 0.891, p= 0.373) while patients were on waiting list (i.e. 
between -4 weeks and week 1), and between 3-months and 6-months (Z= 
0.769, p= 0.442). 
 
 
 
 
 
 
 
 
 
 
  
 CHAPTER 4 Results Page 147 
 
 
4.6.3 The effect of CBCLBP programme on FAB 
Table 4.15 demonstrates the descriptive analysis of the FAB data, including the 
mean, standard deviations, and interquartile ranges.  
 
Table 4.15: Pre- and post-treatment mean values and standard deviation 
of fear-avoidance belief as evaluated by TSK 
 
N Mean SD Min Max 
Percentiles 
25th 
50th 
(Median) 75
th
 
Fear-avoidance 
belief(TSK)  
-4 weeks  
55 42.36 5.307 37 56 39.00 42.00 46.00 
Fear-avoidance belief 
(TSK)  
week 1  
55 41.53 6.582 27 56 37.00 41.00 47.00 
Fear-avoidance belief 
(TSK)  
week 6 
55 33.15 7.420 20 50 26.00 33.00 40.00 
Fear-avoidance belief 
(TSK)  
3 months 
55 32.27 7.109 18 47 27.00 34.00 37.00 
Fear-avoidance belief 
(TSK)  
6 months 
55 31.58 7.322 17 48 27.00 33.00 36.00 
[Tampa Scale for Kinesiophobia (TSK) Range 17-68, 17 = low pain-related 
fear; 68 = high pain-related fear] 
 
A gradual reduction of TSK score was observed over the study period (Figure 
4.7), suggesting improvement of patients’ FAB as a result of the programme. 
The mean disability score at each time point was presented in a graph to 
demonstrate the effect of the programme on patients’ FAB (Figure 4.7).  
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[Tampa Scale for Kinesiophobia (TSK) Range 17-68, 17 = low pain-related 
fear, 68 = high pain-related fear] 
 
The Freidman’s ANOVA revealed such improvement from baseline to 6-
months was a statistically significant (χ² (4) = 109.1, p< 0.001). More 
specifically, the reduction was statistically significant between week 1 and 
week 6 (p< 0.001), which was just after the completion of the six-week 
intervention (Table 4.16). 
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Figure 4.7: Graph to show the effect of the CBCLBP programme on 
patients' fear-avoidance belief as evaluated by TSK 
Fear-avoidance 
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Table 4.16: To examine the significant difference of patients’ mean fear 
avoidance belief score between each phase using Wilcoxon signed-rank test 
 
Fear-avoidance 
belief (TSK) 
 
Between  
-4 week 
and  
week 1 
Between  
Week1  
and  
week 6 
Between  
Week 6  
and  
3 months 
Between  
3 months  
and  
6 months 
Mean 
difference 
0.83 8.35 0.88 0.62 
Z -1.113 -5.851 -1.397 -1.266 
p- value .266 <0.001 .163 .206 
[Tampa Scale for Kinesiophobia (TSK) Range 17-68] 
 
A significant reduction of FAB occurred between week 1 and week 6 (Z= 
5.851, p< 0.001), which was the intervention phase. Otherwise, there was no 
significant reduction between -4 weeks and week 1 (Z= 1.113, p= 0.266), 
between week 6 and 3-months (Z= 1.397, p= 0.163) and between 3-months and 
6-months (Z= 1.266, p= 0.206) (Table 4.16). 
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4.7 Aim 3- To determine if there is any relationship between 
patients’ HLOC, pain intensity, disability and FAB 
 
Change scores of ILOC (Table 4.5), ELOC (Table 4.7), CLOC (Table 4.9), 
pain intensity (Table 4.11), disability (Table 4.13) and FAB (Table 4.15) were 
calculated by 6-months post-treatment mean score minus pre-treatment mean 
score at -4 weeks. These time points were chosen because the CBCLBP 
programme is based on the theory that the therapeutic effect may carryover. 
This is one of the objectives of the current study, which aims to examine if the 
effect of the CBCLBP may carryover up until six months when there was no 
treatment. 
 
4.7.1 Correlation 
Table 4.17 illustrates the correlation coefficients (r) between change scores that 
occurred for each of the outcome measures (they are ILOC, ELOC, CLOC, 
pain intensity, disability and FAB). A number of significant correlations were 
evident between them.  
4.7.1.1 Correlation between pain intensity, disability and FAB 
A significant relationship was evident between reduction in pain intensity, 
reduction in disability and reduction in FAB. These three variables were shown 
to be inter-related with each other.   
4.7.1.2 Correlation between HLOC and pain intensity 
Reduction of pain was related to increase of ILOC; reduction of ELOC and 
reduction of CLOC. 
4.7.1.3 Correlation between HLOC and disability 
Reduction of disability was only associated with increase of ILOC. There was 
no significant association between reduction of disability and both reduction in 
ELOC and CLOC.                                                  
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4.7.1.4 Correlation between HLOC and FAB 
A reduction in FAB was associated with increase of ILOC, reduction of ELOC 
and reduction of CLOC.   
 
None of the correlation coefficients exceeded 0.90. This indicated that the data 
was not affected by singularity, which means they could be entered as separate 
predictor variables in the regression analysis (Tabachnick & Fidell, 2007).   
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Table 4.17: Correlations between the change scores that occurred for each of the self-reported measures  
Correlations 
 
1. Δ in 
ILOC 
2. Δ in 
ELOC 
3. Δ in 
CLOC 4. Δ in pain 
 5. Δ in 
disability 6. Δ in FAB 
1. Δ in ILOC Correlation  -.371
**
 -.188 -.469
**
 -.357
**
 -.573
**
 
Sig. (2-tailed)  .005 .170 .000 .007 .000 
N  55 55 55 55 55 
2. Δ in ELOC Correlation -.371
**
  .656
**
 .340
*
 .207 .550
**
 
Sig. (2-tailed) .005  .000 .011 .129 .000 
N 55  55 55 55 55 
3. Δ in CLOC Correlation -.188 .656
**
  .344
*
 .213 .496
**
 
Sig. (2-tailed) .170 .000  .010 .119 .000 
N 55 55  55 55 55 
4. Δ in pain Correlation -.469
**
 .340
*
 .344
*
  .573
**
 .417
**
 
Sig. (2-tailed) .000 .011 .010  .000 .002 
N 55 55 55  55 55 
 5. Δ in disability Correlation -.357
**
 .207 .213 .573
**
  .332
*
 
Sig. (2-tailed) .007 .129 .119 .000  .013 
N 55 55 55 55  55 
6. Δ in fear-avoidance 
belief 
(FAB) 
Correlation -.573
**
 .550
**
 .496
**
 .417
**
 .332
*
  
Sig. (2-tailed) .000 .000 .000 .002 .013  
N 55 55 55 55 55  
**. Correlation is significant at the p < 0.01 level (2-tailed). 
*. Correlation is significant at the p < 0.05 level (2-tailed). 
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4.7.2 Hierarchical multiple regression 
Hierarchical multiple regression was to determine which of these predictor 
variable(s) (i.e. ILOC, ELOC, CLOC and other measures) was the best 
predictor of the outcome (i.e. pain intensity, disability and fear-avoidance), and 
the extent of how these predictor variables contributed to changes of these 
outcome of interest statistically. The variables used in each of the regression 
analyses had variance inflation factors that were less than 10, and tolerance 
levels that were all notably higher than 0.10, indicating that multicollinearity 
was unlikely to be a problem (Tabachnick & Fidell, 2007), and data was 
suitably examined through multiple regression.  
4.7.2.1 When pain intensity as the outcome 
Table 4.18 shows the results of the regression analysis when change in pain 
intensity was the outcome of interest. When change in pain intensity was the 
dependent variable, the first block of regression included age and sex. The 
second block consisted of change scores in disability and FAB, and the final 
block consisted of the change scores in IHLC, ELOC and CLOC.  
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Table 4.18: Hierarchical regression analysis with change (Δ) in pain 
intensity as the outcome and Δ in cognitive factors as predictor variables 
(N= 55) 
 
Step Variable R² R² 
change 
F change Β T Sig 
1 Age 
 
Sex 
0.018 0.018 0.471 - 0.036 
 
- 0.123 
- 0.256 
 
- 0.880 
0.80 
 
0.58 
2 Δ FAB 
 
 
Δ Disability 
0.340 0.371 15.160⃰⃰  ⃰  ⃰   0.248 
 
 
0.486 
2.093  
 
 
4.141  
0.041 ⃰
 
 
<0.001⃰⃰  ⃰  ⃰   
3 Δ ILOC 
 
Δ ELOC 
 
Δ CLOC 
0.367 0.060 1.720 - 0.257 
 
0.022 
 
0.183 
 
-1.823 
 
0.133 
 
1.153 
0.075 
 
0.895 
 
0.255 
 
 ⃰  p< 0.05,  ⃰  ⃰  p< 0.01,  ⃰  ⃰  ⃰  p< 0.001 
R²= amount of variance explained by IVs 
R² change= additional variance in DV 
F change= is testing whether that most recent contribution represents a 
significant improvement is the predictor power of the regression equation  
β = Standardized regression coefficient (Beta values for each variable are 
converted to the same scale so they can be compared) 
t= estimated coefficient (B) divided by its own Standard Error (SE) 
Sig= Values of p<0.05 were considered significant 
 
As shown, age and sex (block 1) were not significantly associated with changes 
in pain intensity. After controlling for these two variables, the change that 
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occurred in FAB and disability (block 2) accounted for an additional 37.1% of 
the variance in pain intensity. This block was statistically significantly 
associated with level of pain intensity, as indicated by significant F (2, 50) = 
15.160; p< 0.001). Examination of the β- value revealed that the predictor 
variables most strongly related to reduction in pain intensity were reduction of 
disability (β= 0.486, p< 0.001), and reduction in FAB (β= 0.248, p= 0.041). 
With disability recording a higher beta value, suggesting disability was a 
stronger predictor than FAB when pain intensity was the outcome. After 
adjusting age, sex, FAB and disability, the HLOC (block 3) explained a non-
significant 6% of the variance in pain intensity (F (3,47) = 1.720; p> 0.05), 
showing that the HLOC was not the cognitive variable related to a reduction in 
pain intensity. The final model explained 37% of the total variance in changes 
in pain intensity.  
 
4.7.2.2 When disability as the outcome 
When change in disability was the dependent variable, the first block of 
regression included age and sex. The second block consisted of change scores 
in pain intensity and FAB, and the final block consisted of the change scores in 
ILOC, ELOC and CLOC (Table 4.19).  
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Table 4.19: Hierarchical regression analysis with change (Δ) in disability 
as the outcome and Δ in cognitive factors as predictor variables (N= 55) 
 
Step Variable R² R² 
change 
F 
change 
Β T Sig 
1 Age 
 
Sex 
0.008 0.008 0.219 -0.027 
 
-0.083 
-0.194 
 
-0.592 
0.847 
 
0.556 
2 Δ Pain 
intensity 
 
Δ FAB 
0.339 0.331 12.503 ⃰  ⃰  
⃰   
0.525 
 
 
0.113 
4.141  
 
 
0.886  
<0.001⃰  ⃰  
⃰⃰      
 
 
0.380 
3 Δ ILOC 
 
Δ ELOC 
 
Δ CLOC 
 
0.344 0.005 0.129 -0.081 
 
-0.061 
 
0.013 
 
-0.511 
 
-0.343 
 
0.073 
0.611 
 
0.733 
 
0.943 
 
⃰  p< 0.05,  ⃰  ⃰ p< 0.01,  ⃰  ⃰  ⃰  p< 0.001 
R²= amount of variance explained by IVs 
R² change= additional variance in DV 
F change= is testing whether that most recent contribution represents a 
significant improvement is the predictor power of the regression equation  
β = Standardized regression coefficient (Beta values for each variable are 
converted to the same scale so they can be compared) 
t= estimated coefficient (B) divided by its own Standard Error (SE) 
Sig= Values of p<0.05 were considered significant 
 
As can be seen in Table 4.19, age and sex (block 1), which accounted for a 
non- significant 0.8% of the variance, were not significantly associated with 
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changes in disability. After controlling these two variables, the change that 
occurred in pain intensity and disability (block 2) accounted for an additional 
33.1% of the variance. This block was significantly associated with level of 
disability (F (2, 50) = 12.503; p< 0.001). The associated β-value revealed the 
predictor variable most strongly related to reduction of disability was the 
reduction of pain intensity (β= 0.525, p< 0.001). Specifically, lower level of 
disability was associated with lower level of pain intensity. However, the FAB 
(β= 0.113; p= 0.380) was not significantly associated with changes in 
disability. After adjusting age, sex, pain intensity and FAB, the HLOC (block 
3) explained a further non-significant 0.5% of the variance in disability (F (3, 
47) = 0.129; p> 0.05), suggesting that the HLOC was not the cognitive factor 
related to a reduction in disability. The final model explained 34.4 % of the 
total variance in changes in disability.  
 
4.7.2.3 When FAB as the outcome 
Table 4.20 shows the results of the regression analysis when change in FAB 
was the outcome. When change in FAB was the dependent variable, the first 
block of regression included age and sex. The second block consisted of change 
scores in pain intensity and disability, and the final block consisted of the 
change scores in IHLC, ELOC and CLOC.  
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Table 4.20: Hierarchical regression analysis with change (Δ) in fear-
avoidance belief as the outcome and Δ in cognitive factors as predictor 
variables (N= 55) 
 
Step Variable R² R² 
change 
F change Β T Sig 
1 Age 
 
Sex 
0.025 0.025 0.659 -0.013 
 
-0.154 
-0.097 
 
-1.111 
0.923 
 
0.271 
2 Δ Pain 
intensity 
 
Δ Disability 
0.197 0.172 5.372 ⃰  ⃰ 0.325 
 
 
0.137 
2.093 
 
 
0.886 
0.041 ⃰ 
 
 
0.380 
3 Δ ILOC 
 
Δ ELOC 
 
Δ CLOC 
 
0.516 0.319 10.328 ⃰  ⃰  ⃰ -0.407 
 
0.189 
 
0.277 
-3.314 
 
1.253 
 
1.908 
0.002⃰  ⃰ 
 
0.216 
 
0.062 
 
 ⃰  p< 0.05,  ⃰  ⃰ p< 0.01,  ⃰  ⃰  ⃰  p< 0.001 
R²= amount of variance explained by IVs 
R² change= additional variance in DV 
Β= Standardized coefficient (values for each variable are converted to the 
same scale so they can be compared) 
T= estimated coefficient (B) divided by its own Standard Error (SE) 
Sig= Values of p<0.05 were considered significant 
 
As can be seen in Table 4.20, age and sex (block 1), accounted for a non- 
significant 2.5% of the variance, which were not significantly associated with 
changes in FAB. After controlling these two variables, the change that occurred 
in pain intensity and disability (block 2) accounted for an additional 17.2% of 
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the variance in FAB. This block was statistically significantly associated with 
levels of FAB, as indicated by significant F (2, 50) = 5.372; p< 0.01. 
Examination of the β- value revealed the predictor variables most strongly 
related to reduction of FAB was the reduction of pain intensity (β= 0.325, p= 
0.041). Specifically, lower level of FAB was associated with lower level of 
pain intensity. However, disability (β= 0.137; p= 0.380) was not significantly 
associated with changes in FAB. After adjusting age, sex, pain intensity and 
disability, the HLOC (block 3) explained a further significant 31.9% of the 
variance (F (3, 47) = 10.328; p< 0.001). According to the β value, higher levels 
of ILOC (β= -0.407, p= 0.002) was uniquely related to the prediction of 
outcome. Specifically, increase in ILOC was the cognitive factor most strongly 
related to a reduction in FAB (β= -0.407, p= 0.002). The final model explained 
51.6% of the total variance in changes in FAB. 
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4.8 Aim 4- To examine patients’ self-care attitude toward their 
back pain in terms of their desire in future use of healthcare and 
prescription pain medication as a result of the programme 
This question was answered by using the five-item self-care orientation scale 
questionnaire (SCQ), which is designed to predict patients’ attitude toward 
back pain self-care and to predict their future use of health care services for 
back pain and/ or future use of prescription pain medications (Von Korff et al., 
1998; Moore et al., 2000) (see Chapter 3, section 3.7.5).  
 
Table 4.21 gives the descriptive analysis of the self-care attitude data, 
including the mean, standard deviations, and interquartile ranges of pre- and 
post- changes of patients’ self-care attitude.  
 
Table 4.21: Pre- and post- treatment mean values and standard deviation 
of self-care attitude as evaluated by the attitude toward back pain self-care 
orientation questionnaire (SCQ) [Range 5-25, 5 = passive attitude toward 
self care, 25 = positive attitude toward self care] 
 
N Mean SD Min Max 
Percentiles 
25
th
 
50th 
(Median) 75
th
 
 SCQ -4 weeks 55 10.29 3.332 5 18 8.00 11.00 12.00 
 SCQ week 1  55 10.60 3.609 5 18 8.00 11.00 13.00 
SCQ week 6 55 13.33 3.198 8 20 11.00 13.00 15.00 
SCQ 3-months 55 14.24 3.702 5 24 12.00 14.00 17.00 
SCQ 6-months 55 15.20 4.656 6 26 12.00 15.00 18.00 
 
The mean self-care orientation score increased at each time point, suggesting 
patients’ self-care attitude gradually improved before, during and after the 
CBCLBP programme. The mean score at each time point was plotted in a graph 
(Figure 4.8).  
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[Attitude toward back pain self-care orientation questionnaire (SCQ) 
Range 5-25, 5 = passive attitude toward self care, 25 = positive attitude 
toward self care] 
 
As shown in Figure 4.8, the mean self-care attitude mean score increased from 
-4 weeks to 6-months. The greatest increase was seen between week 1 and 
week 6, which was immediately after the CBCLBP programme. After 
completion of the programme, patients’ self-care attitude score continued to 
improve at 3-months and 6-months, but with a slower rate. Table 4.22 
illustrated the examination of significant difference in patients’ self-care 
attitude at each phase. 
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Figure 4.8: Graph to show the effect of the CBCLBP 
programme on patients' attitude towards back pain self-care  
Self-care 
attitude 
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Table 4.22: To examine the significant difference of patients’ attitude 
toward self-care between each phase using Wilcoxon signed-rank test 
 
Attitude toward 
back pain self-
care 
questionnaire  
-4 week 
and  
week 1 
Week1  
and  
week 6 
Week 6  
and  
3 months 
3 months  
and  
6 months 
Mean 
difference 
0.31 2.73 0.91 0.96 
Z -0.695 -4.487 -2.051 -1.606 
p- value 0.487 <0.001 0.040 0.108 
[Attitude toward back pain self-care orientation questionnaire (SCQ) 
Range 5-25] 
SCQ 5-25, 5= passive attitude, 25= positive attitude toward back care 
There was no significant improvement between -4 weeks and week 1 while 
patients were on waiting list (Z= 0.695, p= 0.487). Patients’ self-care attitude 
was then statistically significantly improved between week 1 and week 6 (Z= 
4.487, p< 0.001), which was the treatment phase. Their self-care attitude 
continued to improved significantly between 6 weeks and 3-months (Z= 2.051, 
p= 0.040). However, between 3- and 6-months after the completion of the 
programme, the improvement was not statistically significant (Z= 1.606, p= 
0.108) (Table 4.22) 
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4.9 Aim 5- To examine the cost of back care per change of 
ILOC, and the cost of the CBCLBP programme from a 
provider’s, patient and societal perspective 
The primary objective is to examine the cost of back care per change of ILOC. 
In addition to the primary objective, the cost of the six-week CBCLBP 
programme from a provider’s, patient and societal perspective, as well as the 
longer term (6-months) back care cost for patient and provider are also 
examined. Table 4.23 shows the key units that consumed over the course of the 
study period from the provider, patient and societal perspective. 
 
In order to clearly handle the aims of this question, these results are discussed 
under the following sub-headings: 
 
1. The cost of a six-week CBCLBP programme from a provider’s, patient 
and societal perspective (Section 4.9.1); 
2. The cost per change of ILOC as a result of the CBCLBP programme 
(Section 4.9.2), and 
3. The longer-term (6-months) cost of back care from a patient and 
provider’s perspective (Section 4.9.3). 
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Table 4.23: Key unit costs used that consumed during the study (Prices, 
UK £)  
Item Unit Cost (£) Reference 
 
GP Per 11.7 
minutes 
45 PSSRU (Curtis, 2013) 
 
 
Prescription pain 
medication  
Per head 8.80 NHS Information Centre 
and Office for Nation 
Statistics (2010-2011) 
 
Specialist 
physiotherapist (Band 7) 
Per hour 58 PSSRU (Curtis, 2013) 
 
 
Physiotherapist’s 
assistant (Band 3) 
Per hour 21 PSSRU (Curtis, 2013) 
 
 
AWR for employer in the 
Northwest, UK 
Per hour 10.75 Office for National 
Statistics (03 July 2014) 
 
Value for non-working 
time (e.g. housework and 
leisure time) 
per hour 6.04 Department for Transport 
(2014) 
Car usage Per mile 44  pence The Automobile 
Association Developments 
Limited, 2014 
 
Personal Social Services Research Unit (PSSRU) (Curtis, 2013) 
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4.9.1 The cost of a six-week CBCLBP programme from a 
provider’s, patient and societal perspective 
 
4.9.1.1 Provider’s cost incurred in a six-week CBCLBP programme 
 
Table 4.24: Staffing time and staffing cost to provide the six-week 
CBCLBP programme 
 
Staffing required to 
provide the six-week 
CBCLBP programme 
Staffing time  Staffing 
Costs (£) 
(per patient) 
Staffing Costs 
(£) 
(based on 8 
patients per 
group) 
 
One initial GP visit  
(GP referred to 
Physiotherapy) 
11.7 minutes 
(£45 per 11.7 minutes 
consultation) 
45 45 
One-to-one 
physiotherapist’s 
assessment and advice 
prior to the programme  
1 hour 
 
(£58 per hour 
consultation) 
58 58 
Physiotherapist 
delivering the 
programme 
 
17.5 hours 
(£58 per hour; 
7 sessions of 2.5 hours 
each) 
1015 127 
Physiotherapist’s 
assistant assisting the 
programme 
17.5 hours 
(£21 per hour;  
7 sessions of 2.5 hours 
each) 
367.5 46 
Total 36 hours and 11.7 
minutes 
1485.5 276 
 
As illustrated in Table 4.24, the staffing cost for each patient who attended the 
CBCLBP programme includes a one-to-one GP consultation, a one-to-one 
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physiotherapist assessment prior to the programme, one physiotherapist and one 
physiotherapist’s assistant who ran the programme. Each programme consisted 
of eight patients at a time, and each programme included six sessions in the 
physiotherapy gym and one hydrotherapy therapy session in the pool.  
 
The staffing cost per patient was calculated by the total amount of time of GP, 
physiotherapist and physiotherapist’s assistant involved in providing the six-
week CBCLBP programme, multiplied by their hourly or consultation rate (£) 
accordingly (Table 4.24). Since each group consisted of 8 patients on average, 
this was then divided by eight. This resulted in a total NHS staffing cost of 
£276 per patient based on treating 8 patients per group. 
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Table 4.25: Price of gym equipments (from Pattersonmedical.co.uk) and 
hydrotherapy equipments (from JPLennard Ltd, 2012) 
 
Equipment  item 
 
Cost per unit 
(£) 
Number of 
item 
Total cost (£) Equivalent 
Annual  Cost 
(EAC) (+VAT)* 
(£) 
Treadmill* 4635 
 
1 4635 1026.57 
Cross trainer* 695 1 695 153.93 
Trampette* 201.5 2 403 89.26 
Pulley weight* 1963 1 1963 434.77 
Bike* 495 2 990 219.27 
Dumb bell 1kg* 8.49 2 16.98 3.76 
Dumb bell 2kg* 12.17 2 24.34 5.39 
Dumb bell 3kg* 17.04 2 34.08 7.55 
Mat* 21.31 10 213.1 47.2 
Pillow 14.99 10 149.9 149.9 
Relaxation CD 12 1 12 12 
CD player 20 1 20 20 
Laptop* 442.14 1 442.14 97.93 
Projector* 510.38 1 510.38 113.04 
Theraband 4.40 4 17.6 17.6 
Gym ball 65cm* 17.41 1 17.41 3.86 
Gym ball 75cm* 21.71 1 21.71 4.81 
Step* 29.47 2 58.94 13.05 
Woggle noodles 5.9 8 47.2 47.2 
Kickboard 6.3 8 50.4 50.4 
Arm ring 3.67 16 58.72 58.72 
Pool ball 7.5 2 15 15 
Chlorination 
machine* 
 
520 
 
1 520 115.17 
Chlorine tablets 12.95 2 25.9 25.9 
Maintenance 2300 1 2300 2300 
Sodium 
hypochlorate 
 
35.9 
 
4          143.6 143.6 
Polyalum 
chloride 
 
39.13 
 
4 156.52 156.52 
Sodium 
bicarbonate 
 
41.25 
 
4 165 165 
Thyosulphate 
flakes 
 
36.75 
 
4 147 147 
Sodium 
biosulphate 
 
32.62 
 
4 130.48 130.48 
Delivery 55 4 220 220 
Plumbers 147 1 147 147 
Total EAC (£): 6141.88* 
Cost of equipment for the six-week CBCLBP programme per patient (£): 9.82  
 
*Total [annuitized 3.5*5 years] 
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Table 4.25 illustrates the equipment costs included both equipments used in the 
physiotherapy gym and in the pool. The equivalent cost (EAC) was calculated 
as £6141.88. This was based on five-year life spans of the equipments. 
Equipment with five-year life spans, used by each patient for two hours per 
session (six sessions in the gym and one sessions in the pool), resulted in 
costing the NHS £9.82 per patient for using the equipment during the CBCLBP 
programme.  
 
No participant reported visit to other NHS services such as GPs, other services 
or procedure while they were undertaking the CBCLBP programme. Therefore, 
the total mean provider cost to provide a six-week CBCLBP programme was 
£285.82 (i.e. staffing cost of £276 plus equipment cost of £9.82). 
 
4.9.1.2 Patient cost incurred in a six-week CBCLBP programme 
The characteristics of patient cost that may incur by patient, or companion in 
the pursuit of the six-week CBCLBP were shown in Table 4.26. 
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Table 4.26: Characteristics of patient cost (i.e. patients’ out-of pocket 
expenses) incurred during the six-week CBCLBP programme 
  
N (%) 
Method of travelling to 
physiotherapy 
 Car 
 Bus or Train 
 Taxi 
 Walk 
 Ambulance 
 Other 
 
 
47 (85%) 
5 (9%) 
2 (4%) 
1 (2%) 
0 (0%) 
0 (0%) 
Car parking fees 
 Yes 
 No 
 
0 (0%) 
55 (100%) 
Companion 
 Yes 
 No 
 
2 (4%) 
53 (96%) 
Lost earnings (including patients, 
family, and partner) whilst at 
physiotherapy 
 Yes 
 No 
 
 
 
2 (4%) 
53 (96%) 
Reimbursement 
 Yes 
 No 
 
0 (0%) 
55 (100%) 
Prescription Charges 
 Yes 
 No 
 
0 (0%) 
55 (100%) 
Other expenses 
 Yes 
 No 
 
2 (4%) 
53 (96%) 
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As shown in Table 4.26, the majority of participants were travelled to the 
physiotherapy department by car (85%). No car parking fees was reported (as 
the physiotherapy department provided free on-site parking). 96% of the 
participants (those with paid occupation) reported that there was no lost of 
earning while undertaking the CBCLBP programme. These costs are tolerated 
by society rather than patients themselves. No reimbursement and prescription 
charge during the six-week programme. Only 4% participants reported other 
expenses were spent. An actual amount reported was calculated.  
 
Table 4.27: Patient cost (i.e. patients’ out-of pocket expenses) incurred 
during the six-week CBCLBP programme 
 
 Out of Pocket Expenses Per Patient 
(£) 
Mean ± SD (Range), (N=55) 
Travel costs to physiotherapy  4.00 ± 8.25 (0 to 50.75) 
Lost earnings whilst at physiotherapy 2.55 ± 13.77 (0 to 90) 
Prescription Charges  0 
Other expenses 2.55 ± 13.77 (0 to 90) 
Total 9.10 ± 3.19 (0 to 90)  
 
Based on the data on Table 4.26, patient cost to attend the CBCLBP 
programme was calculated (Table 4.27). The mean patient cost was 
approximately £9.10 to undertake the six-week CBCLBP programme. 
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4.9.1.3 Societal cost incurred during a six-week CBCLBP programme 
 
Table 4.28: Societal cost (i.e. value of time lost from work or non-working 
activities) during the six-week CBCLBP programme 
 
 Patients who lost time 
from work activities 
Patients who lost time 
from non-working 
activities 
N = (%) 30 (55%) 25 (45%) 
 Mean ± SD (Range), 
(N=30) 
Mean ± SD (Range), 
(N=25) 
Total time lost  from 
travel & attending 
the programme 
(minutes) 
827.8 ± 67.6 (560 to 875) 824.8 ± 52.8 (735 to 
870) 
Cost of time lost per 
patient from both 
travelling and  
attending the 
programme (£) 
166.1 ± 18.06 (103 to 178) 83.08 ± 5.42 (74 to 88) 
Average societal cost per patient (£): 124.59 ± 8.94 (74 to 178) 
Table 4.28 showed the mean societal cost incurred during the six-week 
CBCLBP programme. The mean value of time lost from work activities was 
£166.1, and the mean value of time lost from non-working activities was 
£83.08. The mean societal cost for the CBCLBP programme was approximately 
£124.59.  
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Table 4.29: The cost of a six-week CBCLBP programme from a provider’s, 
patient and societal perspectives 
Costs to provide a six-
week CBCLBP 
programme 
Including Cost Per Patient (£) 
Mean ± SD (Range), 
(N=55) 
 
Provider’s cost (£) Staffing costs, and 
equipment costs 
285.82 
Patient cost (£) Travel costs, lost 
earning from 
attending the 
programme, 
prescription charge 
and other expenses 
9.10 ± 3.19 (0 to 90) 
Societal cost (£) Value of time lost 
from travel and from 
attending the 
programme 
124.59 ± 8.94 (74 to 178) 
 
Table 4.29 summarized the cost of a six-week CBCLBP programme from a 
provider’s, patient and societal perspective. To provide a six-week 
physiotherapy CBCLBP programme, the mean provider’s cost was 
approximately £285.82 per patient (based on treating 8 patients per group), the 
mean patient cost was approximately £9.10, and the mean societal cost was 
approximately £124.59 per patient. 
 
4.9.2 The cost per change of ILOC as a result of the CBCLBP 
programme  
This question was answered by calculating the division of the provider cost by 
the mean score of change in ILOC between week 1 and week 6 of the 
programme. 
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The mean ILOC was 21.36 at week 1, and 26.76 at week 6 [ILOC range 6-36, 
6=low ILOC, 36 = high ILOC] (see Table 4.5), the mean change score of ILOC 
was 5.4 points (week 6 post treatment mean score minus week1 pre-treatment 
mean score).  
 
To calculate the incremental cost/ change of ILOC ratio, this was divided the 
provider cost (£285.82) by the mean score of change in ILOC (5.4 points). 
Therefore, the incremental cost of ILOC was approximately £53. i.e. it cost the 
provider £53 for each point of ILOC improvement.  
 
4.9.3 To determine the longer-term (6-months) cost of back care 
for patient and provider 
This question was answered based on the data collected between question 1 and 
question 7 of the cost questionnaire (Appendix 23), asking patients about GP 
usage, prescription charge, travel costs and other therapy charges following 
completion of the CBCLBP up until six months. Societal cost at 6- months was 
not evaluated.  
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Table 4.30: Characteristics of healthcare services usage following the 
completion of the six-week CBCLBP programme 
 
  
N (%)  
Visit to GP (N=55) 
 Yes 
 No 
 
14 (25%) 
41 (75%) 
Total number of visit to GP (N=14) 45 (range 0-5) 
Prescription pain medication (N=55) 
 Yes 
 No 
 
15 (27%) 
40 (73%) 
Visits to other therapy (N=55) 
 Yes 
 No 
 
9 (16%) 
46 (84%) 
Type of therapy (N=9) 
 Hydrotherapy 
 Physiotherapy 
 Acupuncture 
 Osteopathy 
 Pain clinic 
 Other 
 
5 (56%) 
2 (22%) 
2 (22%) 
0 (0%) 
0 (0%) 
0 (0%) 
No of sessions of other therapy (N=9) 
 Hydrotherapy (N=5) 
 Physiotherapy (N=2) 
 Acupuncture (N=2) 
 
25 
6 
12 
Type of service of other therapy 
(N=9) 
 NHS (free) 
 Fee-paying (private) 
 
 
0 
9 
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As shown in Table 4.30, out of the 55 study participants, only 14 patients 
(25%) visited their GP again during the six months period after the completion 
of the CBCLBP, and 15 (27%) required prescription pain medication from their 
GP.  
Nine patients (16%) visited other therapy after the CBCLBP programme, this 
included hydrotherapy (56%), private physiotherapy (22%) and acupuncture 
(22%). These therapies were indicated as self-funded by patients, thus this was 
accounted as patients cost. 
No participant was reported utilising the NHS Physiotherapy service at 6 
months follow up. As a result, the NHS costs following the completion of the 
programme involved only the GP visits and the prescription pain medication.  
Table 4.31: Patient cost (i.e. patients’ out-of pocket expenses) incurred 
during the six months period following the completion of the CBCLBP 
programme 
 
 Out of Pocket Expenses Per Patient 
(£) 
Mean ± SD (Range) 
Travel and prescription costs (N=13) 27.25 ± 20.14 (8.05 to 80.05) 
 
Travel and other therapy costs 
(N=9) 
133.4 ± 120.8 (25 to 300) 
 
Total patient cost at 6-month £160.7 
Table 4.31 summarises the mean patient cost incurred six months after 
completing the CBCLBP. As shown, the mean travel and prescription cost was 
£27.25 ± 20.14, and the mean travel and other therapy costs was £133.4 ± 
120.8. Therefore, the mean patient cost was approximately £160.7 six-month 
following completion of the CBCLBP programme.  
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Table 4.32: Provider’s cost per patient (i.e. NHS cost) incurred during the 
six months period following the completion of the CBCLBP programme 
 Number of 
usage after 
completing the 
CBCLBP 
programme 
(Range) 
Total provider 
costs (£) 
Provider costs 
per patient 
following the 
CBCLBP 
programme (£) 
Mean ± SD 
(Range) 
GP usage (costs 
calculated based on 
£45 per 11.7 
minutes 
consultation) 
(N=14) 
45 
(1-10) 
2025 144.6 ± 111.9 (45 
to 450) 
Medication costs 
(costs calculated 
based on 8.80 per 
head from GP) 
(N=14) 
15 
(1-2) 
132 9.43 ± 2.35 (8.80 
to 17.60) 
Total provider’s cost following the CBCLBP programme (£): 2157 
Total provider’s cost per patient following the CBCLBP programme (£): 
154.1 ± 77.44 (8.05 to 450) 
 
25% participants reported visit to GP (Table 4.30) with a total number of 45 
consultations (Table 4.32). Where participants indicated that they visited their 
GP and there was a prescription charge reported in their questionnaire, it was 
assumed there was a medication cost incurred. The mean provider’s cost six 
months following the CBCLBP programme was approximately £154.1. 
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4.9.4 Key findings of economic evaluation  
 
 To provide a six-week physiotherapy CBCLBP programme, the mean 
provider’s cost was approximately £285.82; the mean patient cost was 
approximately £9.10, and the mean societal cost was approximately 
£124.59; 
 The incremental cost of ILOC was approximately £53. i.e. it costs the 
provider £53 for every point of ILOC gained; and 
 In the six months following the completion of the CBCLBP programme 
(from week 6 to 6-months), the mean patient cost was approximately 
£160.7, and the mean provider’s cost was approximately £154.1. 
 
4.10 Conclusion 
This chapter provides the descriptive and statistical findings drawn from the 
analysis related to the research questions. Each question was addressed 
appropriately. The next chapter goes on to discuss the interpretation of the 
results, including discussion of positive and negative findings of the present 
study, comparison with previous works and significance of these findings.   
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CHAPTER 5 DISCUSSION 
5.1 Introduction 
This chapter revisits the five key aims of the current studies and explains how 
they are answered. It discusses the key positive and negative findings, and their 
possible mechanism, in accordance with each individual research question. 
Whilst this study has confirmed some of the findings of previous studies, it 
differs from the existing literature as well. Similarities and differences in 
relation to previous work are highlighted and discussed.   
 
Aims of the study: 
1. To assess the effects of the physiotherapy CBCLBP programme on 
patients’ HLOC (Section 5.3). 
2. To examine the effects of the CBCLBP programme on pain, disability 
and FAB (Section 5.4). 
3. To determine if there is any relationship between patients’ HLOC and 
pain, disability and FAB (Section 5.5). 
4. To examine patients’ self-care attitude toward their back pain in terms 
of their desire in future use of healthcare and prescription pain 
medication as a result of the programme (Section 5.6). 
5. To investigate the cost of back care per change of ILOC, as well as the 
cost of the CBCLBP programme from a provider’s, patient and societal 
perspective (Section 5.7). 
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5.2 Comparison between patients who completed the CBCLBP 
programme and those who dropped out of the programme   
This study provided some significant baseline difference between patients who 
completed the programme and those who dropped out. This information may be 
useful for physiotherapists and managers when screening appropriate NSCLBP 
patients prior to the CBCLBP programme in their physiotherapy service.  
 
Baseline differences between patients who completed the programme and 
those who dropped out 
A total of n= 70 eligible patients with NSCLBP were initially recruited, with n= 
55 (79%) completing the study and all outcome assessments. Patients who 
dropped out of the programme (i.e. patients who were consented for the 
programme, but they never attended, or only attended the first session of the 
programme) (n= 15, 21%) were significantly: (a) of poorer employment status; 
(b) of poorer financial status; and (c) possessing a higher level of ELOC. This 
latter factor suggests that those who dropped out of the programme were 
significantly more externally orientated, i.e. held the belief that the 
responsibility for their health was assigned to other people such as medical 
professionals and families. This is supported by the literature, which suggests 
that individuals with higher ELOC are less likely to assume responsibility for 
their health, and are less likely to engage in behavioural involvement such as 
self-care and active participation in medical care (Wallston & Wallston, 1982; 
Koleck et al., 2006).  
 
Comparison to other studies 
Dropout from treatment is common problem in CBT management for CLBP 
(Glombiewski et al., 2010). In the current study, n=15 (21%) consented patients 
did not attend or only attended the first session of the programme. All 
remaining patients attended all sessions resulting our study having complete 
data at each outcome assessment (-4 week, week 1, week 6, 3-months and 6-
months) for all the 55 patients. It is suggested that a loss of ≤ 20% follow-up 
rate is acceptable in RCTs or cohort studies (Fewtrell et al., 2008). With the 
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present study has no patient dropped out during follow-up, this is considered 
acceptable and posing no serious threats to validity (Fewtrell et al., 2013). 
Compared to other high to moderate quality studies investigating NSCLBP 
patients in physiotherapy rehabilitation, the dropout rate during follow-up is 
ranging from 16% to 35% (Woby et al., 2004a; Johnson et al., 2007; Critchley 
et al., 2007; Woby et al., 2008).  
 
According to qualitative and quantitative evidence, there are many reasons for 
NSLBP patients to dropout in their rehabilitation. Examples include: patients’ 
expectation to be provided a specific diagnosis of NSCLBP (Rhodes et al., 
1999; Sloots., 2010), wanted medical treatment to cure their pain (Sloots et al., 
2009; Sloots et al., 2010), the idea that exercise does not help or aggravates 
pain (Mailloux et al., 2006), different views on responsibilities with regard to 
the rehabilitation (e.g. patients expected more responsibilities to be taken by the 
clinicians) (Sloots et al., 2009), and a lack of trust in the rehabilitation clinician 
(Sloots et al., 2010).  
 
A lower attrition found in the present study could at least be partially attributed 
by the successful change of patients’ expectation and beliefs regarding the 
nature and treatment principle of NSCLBP through the highly-structured 
programme. The PI and the physiotherapists were acutely aware of the 
importance of patient skills when delivering the CBCLBP programme (as 
described in Figure 3.4). Being an active listener, caring, confident, competent 
and acknowledging patients’ complaints may establish trust and rapport 
between physiotherapists and patients, which may then result in a higher uptake 
and adherence to the CBCLBP programme. 
 
Patients who dropped out of the programme were probably those who failed to 
change, or not ready to change their expectation and beliefs about the NSCLBP. 
It must be noted that the group-structured intervention is not universal for all 
NSCLBP patients, particularly the CBA intervention assumes that individuals 
are proactive, and places more responsibility on patients and challenges their 
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expectations about pain management and prognosis (Nordin et al., 2006; 
Waddell & Burton, 2005). For instance, it may not make much sense, from the 
patients’ perspective, to self-care, or be interested in the CBA component if 
they hold a higher level of ELOC. Therefore, an alternative such as CBT 
delivered by trained cognitive-behavioural therapists or one-to-one session 
given by experienced physiotherapist in CBA can be considered for this 
subgroup of patients with profile characteristics of poor employment and 
financial status and high ELOC. 
 
Implication for physiotherapists 
On the basis of current findings, physiotherapists could consider using 
assessment of patients’ HLOC as one alternative to reduce dropout rate in their 
CBCLBP service.  More specifically, those with a combination of poorer 
employment status, poorer financial status and higher ELOC may not be 
appropriate for a group-structured CBA approach intervention. Physiotherapists 
could also consider asking questions along the HLOC continuum. Yellow flags 
assessment questions such as “What do you currently do to help your own back 
pain?” and “What do you expect and hope to gain from physiotherapists?” are 
useful starting points to understand patients’ perception of control about their 
NSCLBP prior to referral onto the group intervention.  
 
Generalizability of included patients 
Aside from the baseline differences in employment status, financial status and 
ELOC, there were no other significant baseline differences between those who 
completed the programme and those who dropped out of the programme.  
 
The current study targeted NSCLBP patients with high FAB because this sub-
group of NSCLBP patients is more likely to benefit from psychological 
approaches such as CBA intervention (Airaksinen et al., 2006; Savigny et al., 
2009). This followed the current physiotherapy practice and NICE guidelines in 
the UK, which state those patients with significant psychological distress (such 
as high FAB), disability and failure to respond to other conservative treatments 
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are recommended to be managed by combined active exercises and CBA 
treatment (Savigny et al., 2009).  
5.3 Aim 1- The effect of the CBCLBP programme on HLOC 
This is the first study in literature demonstrating that a physiotherapy-led 
CBCLBP programme is effective in altering patients’ HLOC belief.  
 
Main finding: 
No significant improvement of HLOC was seen before the programme (Phase 
A1); significant improvement of HLOC was found immediately after the 
CBCLBP programme (Phase B), and such improvement was sustained for six 
months following the programme (Phase A2).     
 
What are the possible reasons why HLOC failed to improve during Phase 
A1 but improved during Phase B?  
 
1. Effective delivery of self-management 
Despite usual physiotherapy care (Phase A1) including giving relevant back 
care advice, information booklets and home exercise as form of self-
management, advice on self-management is not simply a matter of information 
giving. It is about ‘how’ they could be effectively delivered (Savigny et al., 
2009; Koes et al., 2010). This involves the practitioner offering affective 
communication (reducing concerns and worry, creating rapport), and cognitive 
reassurance (change in beliefs, changes in knowledge and understanding, and 
increased sense of control through education) (Pincus et al., 2013), as offered in 
the CBCLBP programme. An 18-months prospective study (Harkapaa, 1991) 
provided moderate evidence that the use of active self-care was significantly 
associated with high ILOC. It is possible that the CBCLBP programme offered 
more effective delivery of patients’ self-management. When patients are able to 
self-manage their NSCLBP and its physical and psychological consequences, it 
may give them an increased sense of responsibility and personal control 
(ILOC), as opposed to believing in external (ELCO) and chance (CLOC) 
factors.  
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2. Biomedical vs Biopsychosocial treatment approach 
Treatment modalities employed in individual physiotherapy (such as 
mobilization and manipulation) are predominantly bio-medically orientated and 
based on intervening on tissue levels, rather than bio-psychosocially oriented 
and aimed at altering patients’ beliefs as in the CBCLBP programme. 
Consequently, patients’ HLOC belief may not be fully addressed since 
cognitive factors were not deliberately targeted within the context of usual 
physiotherapy care. The improvement of HLOC observed in phase B suggested 
that the ‘top-down’ approach (Figure 1.3), such as CBA is superior compared 
to the ‘bottom-up’ approach (such as usual physiotherapy care) in altering 
patient’s HLOC.  
 
3. Physiotherapists’ skills and experiences 
The challenges for physiotherapists to embed a psychosocial element within 
physiotherapy practice are well documented (Foster et al., 2011). It may be that 
(1) physiotherapists’ biomedically orientated beliefs may influence their 
clinical reasoning process (Daykin & Richardson, 2004; Foster et al., 2011), 
and (2) a much wider range of skills, knowledge and confidence are required 
when managing relevant psychosocial factors that may be beyond the scope of 
physiotherapy (Kent et al., 2009; Foster et al., 2011). The PI and the 
physiotherapists who led the CBCLBP programme were experienced clinicians 
(with at least 12 years clinical experience, Band 7 or above physiotherapist), 
who have special interest in NSCLBP. They all have basic CBT training and 
are highly experienced in NSCLBP and in delivering the CBCLBP programme. 
This factor, along with other non-specific factors such as a clear treatment 
rationale, a standardised and highly structured programme, an emphasis on 
active participation and self-responsibility may at least partially explain why 
HLOC significantly improved as a result of the CBCLBP programme.  
 
In light of the above, it appears that the combination of (1) an effective delivery 
of self-management; (2) a biopsychosocial treatment approach treatment; and 
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(3) experienced physiotherapists in delivering the CBCLBP programme may be 
the reason for the difference in HLOC between phase A1 and phase B.  
 
What treatment components of the CBCLBP programme may account for 
the significant improvement of HLOC in Phase B? 
It is impossible to isolate the contribution each component of the programme 
made to the improvement of HLOC. However, based on the HLOC theory, 
which is about an individuals’ belief of self-responsibility and empowerment 
for their own health (Wallston et al., 1978), the treatment components that are 
likely to be contributing factors for the improvement of HLOC may have 
included those:  
1. Changing negative beliefs and attitude about pain (Foster et al., 2008); 
2. Influencing adoption of coping strategy (Main & Spanwick, 2000; 
Carroll et al., 2002) and,  
3. Self-management skills that empower patients to manage their own pain 
(Crowe et al., 2010).  
 
1. Changing negative beliefs and attitude about pain 
Patients with NSCLBP often hold various beliefs about their pain. For example, 
the belief that one has little personal control over pain (Crombez et al., 1999; 
Goubert et al., 2004a), that health professionals should “fix” their pain and 
being passive to rehabilitation (Kendall, 1997), that pain signifies harm and that 
one cannot modify one’s own experience and that pain will be an enduring part 
of life in the future (Kendall, 1997). 
 
The CBCLBP programme aims at changing patients’ negative beliefs and 
attitudes. This is achieved directly by various education components such as 
providing higher level of information about NSCLBP, addressing patients’ 
negative thoughts and beliefs, and anticipating that the key for success is 
individuals being proactive and that their beliefs and behaviour contribute to 
improved management (Waddell & Burton, 2005; Nordin et al., 2006). 
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Patients’ negative beliefs and attitudes may also modify indirectly through 
exposure to graded exercise, pacing, relaxation and techniques for goal setting. 
 
Several studies (of high to moderate risk of bias) have demonstrated that 
intervention based on CBA leads to modification of patients’ beliefs about the 
nature and treatment of their pain (Coughlin et al., 2000; Walsh & Radcliffe, 
2002; Moseley, 2002). Re-conceptualizing these negative beliefs means 
patients might become more acceptant about their NSCLBP, and hold more 
beliefs that they have a primary role and responsibility in managing and 
improving their condition.  
 
2. Self-management skills 
Several studies provided moderate quality evidence that physiotherapy 
delivered CBA intervention improved patients’ self-care (Klaber Moffett et al., 
1999; Klaber Moffett et al., 2006; Critchley et al., 2007). In the CBCLBP 
programme of the current study, patients were taught a range of self-
management skills such as alternative pain relief, relaxation techniques, 
physical exercises, relapse management, pacing and goal setting. These self-
care skills empower patients to be more autonomous and independent in their 
daily self-management and future relapses. Additionally, it also gives patients 
an advantage of maintaining some feeling of control, and enhancing the 
perception of their own ability to facilitate pain relief (Foster et al., 2010; Main 
et al., 2010).  
 
This study did not collect qualitative data. Yet, some common themes among 
participants’ informal verbal feedback during the last session of the programme 
(week 6) may give some insights into which specific aspects of the programme 
may link to improvement of HLOC beliefs. For instance, some participants 
reported that attending the course had changed the way they thought about their 
pain, and their role in the management. Reduction in negative beliefs, 
addressing unrealistic expectations from health professionals and introducing 
them to self-management techniques are frequently reported as the main 
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components that boosted their feeling of personal control and confidence in 
their ability to self-manage their NSCLBP. This informal feedback from 
patients gives some credence to support the theoretical assumption that belief 
modification and self-care components are likely to be attributed to 
improvement of HLOC beliefs in the present study. However, a future study 
combining quantitative and qualitative methods will be required to provide 
more information about the underlying mechanism and patients’ perspective to 
reason why improvement of HLOC had occurred as a result of the programme. 
 
What are the possible explanations for the sustained improvement of 
HLOC at 6-months (Phase A2)? 
The non-significant improvement of HLOC seen in Phase A2 may be explained 
by the absence of weekly physiotherapy contact and support as offered in Phase 
B. However, it is still encouraging to see HLOC continued to improve but just 
at a slower rate up to 6-months. Two possible explanations may contribute to 
the sustained improvement of HLOC observed in Phase B:  
 
1. Deep learning 
It may be that the CBCLBP programme has promoted ‘deep learning’ of our 
patients, in which information is retained, understood and applied to problems 
at hand (Sandberg & Barnard, 1997), rather than ‘superficial’ learning, in which 
information is only remembered but not understood or integrated with attitudes 
and beliefs (Evans & Honour, 1997). ‘Deep learning’ is facilitated by high 
motivation of the learner (Sankaran, 2001) and presentation of relevant and 
personal information (Moreno & Mayer, 2000). Both of which are promoted in 
the CBCLBP programme, and both of which may have an effect on sustaining 
improvement of HLOC.  
 
2. Advantages of improved HLOC 
According to the literature, there are a number of advantages of holding high 
level of ILOC, low level of ELOC and low level of CLOC in terms of NSCLBP 
management. Patients with higher ILOC are more likely to describe their pain 
and disability as less intense (Sengul et al., 2010), have more effective coping 
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strategies to deal with pain (Harkapaa et al., 1991), have less FAB at activity 
(Richard et al., 2011), have better physical functioning (Keedy et al., 2014), 
have less psychological distress (Crisson & Keefe, 1998), and are more likely 
to take an active role and engage with exercise programmes (Harkapaa et al., 
1991). The combination of these positive physical, psychological and 
behavioural consequences associated with improved HLOC possibly reinforce 
and continue to promote an individuals’ belief that their improved NSCLBP is 
attributed to internal factors as opposed to external or chance factors over time. 
Thus, a sustained improvement of each subscale of HLOC is seen.  
 
For instance, if patients with high ILOC believe that their NSCLBP has 
improved as a the result of practising daily home exercise, as opposed to a 
‘techno-fix’ from physiotherapists or due to chance, they would probably be 
more likely to practise them regularly. Taking up daily home exercise not only 
improves physical (less pain and less disability) and psychological well-being 
(less distress and more active coping), it also has an advantage that patients feel 
in control of their own NSCLBP condition, and feel capable of performing 
daily exercises to preserve their improved NSCLBP condition. Such positive 
behaviour has an influence on patients inadvertently maintaining the thoughts 
and beliefs (higher level of ILOC, lower level of ELOC and CLOC), hence 
creating a positive cycle (see Figure 5.1) as proposed by the CBT model 
(Kerns et al., 2011).  
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Figure 5.1: Positive cycle of improved HLOC 
 
 
The implication of this observation is that patients’ response to the CBCLBP 
programme may depend on which HLOC is dominant. From this knowledge, 
we may deduce that improving HLOC could be one important factor in (1) 
influencing a more successful uptake of and adherence to the CBCLBP 
programme, and (2) sustaining the effectiveness of the CBCLBP programme. 
 
ELOC dominant vs ILOC dominant 
One important finding is that patients’ HLOC changed from being ELOC 
dominant (1.62 points mean difference between ELOC and ILOC at week 1), to 
being ILOC dominant (9.27 points mean difference between ILOC and ELOC 
at week 6 and 12.57 points at 6-months; Table 4.5 and Table 4.7). This means 
that, because of the CBCLBP programme, patients became more internally 
orientated (belief that they are responsible for their own back condition), as 
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opposed to being externally orientated (belief that his/her condition is 
determined by others or luck/chance) up to 6-months after the programme.  
 
This finding supports the treatment philosophy of the CBA, which attempts to 
modify patients’ beliefs (Vlaeyen et al., 1995c). This finding also supports the 
recommendation for the management of CLBP (Chou et al., 2007), in which 
healthcare providers should encourage self-responsibility and give patients an 
independent and active role in their management (Lorig & Holman, 2003). The 
present finding showing patients became ILOC dominant at week 6 and 6-
months is the reflection of successful implementation of the programme.  
 
Comparison to other studies- validity issues 
No direct comparison can be made between this study and from existing 
evidence because this is the first study examining the effect of a physiotherapy 
programme on HLOC. However, the present findings support some previous 
studies, which found intervention with some sort of CBT component leads to 
change in HLOC beliefs in chronic pain and CLBP (Harkapaa et al., 1991; 
Coughlin et al., 2000; Rybarczyk et al., 2001; Spinhoven et al., 2004; Klaber 
Moffett et al., 2006; Keedy et al., 2014).  
 
It must be considered that heterogeneity is among these studies, including 
variation in interventions, clinical setting, professions who delivered the 
programme and the reporting of the outcomes. In addition, the average quality 
of the available evidence is of high to moderate risk of bias. These 
methodological limitations include heterogeneous group (Klaber Moffett et al., 
2006), selective bias, short follow-up (Keedy et al., 2014; Harkapaa et al., 
1991), under-powered sample size (Coughlin et al., 2000); inappropriate 
outcome measures (Coughlin et al., 2000) and high dropout (Spinhoven et al., 
2004). Compared to the current study, which uses appropriate validated 
outcome measure to assess HLOC, powered sample size,  longer follow-up 
period (6-months) and complete follow-up data (no follow-up dropout), these 
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methodological strengths mean our findings are likely to have a higher internal 
validity compared to previous studies.  
 
This current study partly supports the findings of Klaber Moffett et al. (2006), 
which showed a physiotherapy pain management programme using CBA 
improved ELOC, but not in both ILOC and CLOC at 6-months. However, it 
must be noted that the pain management programme employed by Klaber 
Moffett et al. (2006) was only brief (2-3 hours), whereas the patients’ contact 
time of the CBCLBP programme in the present study was approximately 13 
hours. This might imply that the duration of the intervention needs to be 
sufficient (at least 13 hours) to bring favourable and consistent changes in 
patients’ HLOC beliefs. Another major weakness of study by Klaber Moffett et 
al. (2006) is that they have included patients with neck pain and back pain of 
mixed subacute and chronic duration, this may explain why the MHLC is lack 
of sensitivity to change.   
 
It is acknowledged that the HLOC construct is only one piece of the much 
wider and more complex psychological context in understanding patients’ with 
NSCLBP. However, considering HLOC beliefs are associated with the 
clinically important outcomes of NSCLBP (including pain intensity, disability 
and FAB), and positive health-related behavioural changes (such as better self-
care and active coping) that both patients and physiotherapists seek to address 
in their treatment, improvement of HLOC should be regarded as a successful 
treatment outcome for physiotherapy.   
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5.4 Aim 2- To examine the effect of the CBCLBP programme on 
pain intensity, disability and FAB 
Main finding: 
No significant improvement of pain intensity, disability and FAB were seen 
before the programme (Phase A1); significant improvement of all three 
outcome measures was observed immediately after the CBCLBP programme 
(Phase B). Such improvement was sustained for six months following the 
programme (Phase A2).     
 
Why pain intensity, disability and FAB failed to improve during Phase A1, 
but improved in Phase B? 
  
1. ‘Bottom-up’ vs ‘Top-down’ approach 
In our study, all NSCLBP patients were with high FAB. Patients with high FAB 
probably consider pain as more threatening, more catastrophic thoughts, less 
likely to confront pain problem and be less active in coping (Jackson et al., 
2005). Although the usual physiotherapy care attempts to address the sensory 
and biomedical aspects of pain, it predominantly utilises a ’bottom-up’ 
treatment approach (i.e. intervene pain on tissues levels such as manual therapy, 
electrotherapy and exercises). This therapeutic approach could be inadequate 
for NSCLBP patients with high FAB, in which cognitive and behavioural 
factors are likely to be more an enduring barrier and an important part their pain 
experience and persistent disability (Chou & Shekelle, 2010; Ramond et al., 
2011). This may explain why our patients responded better to a ‘top-down’ 
approach (Figure 1.3), such as the CBCLBP programme that directly addresses 
the cognitive and behavioural aspect of pain. The difference between Phase A1 
and Phase B illustrates that the ‘top-down’ treatment approach have more to 
offer to this sub-group of NSCLBP patients, than the traditional ‘bottom-up’ 
treatment model (Moseley, 2003b).  
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2. Reduction of threatening input 
It is documented that the threat value of pain in NSCLBP patients is more likely 
to be contributed by psychological, behavioural and cognitive realm (such as 
attitudes and beliefs) rather than the physical one (Moseley, 2003a; Moseley, 
2007). Increased threatening input of the brain results in overprotective 
responses such as: fear, anxiety, negative beliefs, avoidance behaviour and 
hypersensitivity of pain neuromatrix.  
 
One focus of the CBCLBP programme is to address pain belief and attitude by 
increasing patients’ understanding about pain, and help patients to recognise the 
complex physical and psychological consequence that drives ongoing pain. 
This approach may lower the perceived degree of threatening input of the brain, 
resulting in less pain sensitivity, less fear and better physical performance. In 
contrast, although manual therapy strategies given during usual physiotherapy 
care may have an inhibitory effect on nociceptive input which gives short-term 
pain relief  (Vicenzino et al., 1998), such therapeutic approach do not address 
the non-nociceptive input of pain (cognitive-evaluative) (Moseley, 2003a). In 
addition, the biomedical oriented treatment approach may reinforce patients’ 
negative belief about their pain such as something is wrong and damage in their 
tissues. This may in turn activate the threatening input and exaggerate 
overprotective responses, hence result in lack of improvement across sensory, 
physical and psychological domains as observed in Phase A1.  
 
3. Multi-dimensional treatment approach 
The CBCLBP programme in the current study consisted of various components. 
This means that the multi-factorial nature of NSCLBP is more fully addressed 
by the CBCLBP programme than individual physiotherapy. This result is partly 
consistent with the study by Klaber Moffett et al. (2004), which reported  active 
exercise plus CBT education was more effective than usual GP care at reducing 
disability at 12-months to patients with subacute CLBP and high FAB. 
 
Although all patients were given basic pain education, self-management advice 
and home exercise programme during Phase A1, there was no significant 
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physical and psychological improvement. This may imply that the additional 
use of CBA education component and supervised graded exercise component 
introduced in Phase B may have a bigger and possibly a more direct impact on 
patients’ physical and psychological health, than individual physiotherapy care 
which is without these components.  
 
4. Individual vs Group therapy 
The biggest advantage of group therapy is probably helping patients to realise 
that he or she is not alone, and there are other people who have a similar 
problem. This often can be a huge belief for patients with NSCLBP when they 
may face similar issues such as FAB, anxiety and catastrophizing.  
 
Being in a group may also give patients an opportunity to open up and 
communicate their thoughts and feelings, and to provide mutual support to each 
other and offer suggestion to problem-solve and deal with a particular problem 
that patients may not have thought of. 
 
For instance, during the CBCLBP programme, there were group discussions 
and group problems solving on: identifying and challenging unhelpful thoughts, 
personal barriers of against physical activities, over-/ under- activity, goal 
setting, and discussion on group experience of alternative pain control and self-
management. Physiotherapists acted as a moderator and facilitator for each 
theme during the group activities. These exercises in a dynamic and supportive 
group environment may facilitate patients to change their old way of thinking, 
feeling and behaving in favour of more positive and productive ways. The 
advantage of being in group therapy, as opposed to individual therapy, may be 
one of the contributing factors in explaining the difference between Phase A1 
and Phase B.  
 
From the clinical perspective, it is reasonable to suggest that physiotherapists 
should consider referring those NSCLBP patients with high FAB onto the 
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CBCLBP programme as their first-line intervention, as opposed to their last 
option when patients fail to respond individual physiotherapy.    
 
What treatment components may account for the significant improvement 
observed in Phase B?  
Despite recognizing the importance and benefits of both physical and 
psychological elements, until now, it is unclear whether clinical improvement is 
reached by the CBA education itself, or the exercise therapy, or the 
combination of both (Mannion et al., 2001; Smeets et al., 2006a). 
 
The various treatment components of the CBCLBP programme probably break 
the vicious physical and psychological cycle as described below (Figure 5.2).  
 
Figure 5.2 Physical and Psychological vicious cycle of pain (Newell, 2011) 
 
 
It is impossible to isolate the contribution that which specific components of the 
programme made to the improvement of pain, disability and FAB, since it is 
likely due to the combination of the following components and their effect from 
a neurophysiological, cognitive/behavioural and physical perspective of pain.  
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1. From a neurophysiological perspective 
The vicious cycle has been found to be broken with pain neuroscience 
education (Nijs et al., 2011; Moseley, 2004). Studies in patients with NSCLBP 
have shown that education on pain physiology improves patients’ pain-related 
attitudes and beliefs (Nijs et al., 2011; Moseley, 2004), and is directly 
associated with better symptomatic and physical outcomes even when there is 
no opportunity to be physical active (Moseley, 2004; Moseley et al., 2004).  
 
The usual physiotherapy care may include some basic physiology of pain and 
anatomy of the spine. However, the problem in NSCLBP patients is ‘how’ to 
explain the cause of their pain when no obvious anatomic defect or tissue 
damage can be found. The CBCLBP programme provided high-level of pain 
physiology information such as explanation of central sensitization, mechanism 
of acute pain vs chronic pain, and pain neuromatrix. It also clarifies patients’ 
misunderstanding about pain. The complex concept of chronic pain was 
delivered using patients’ lay-language and metaphor based on the book 
‘Explained Pain’ (Butler and Moseley, 2003). For instance, the complex 
concept of sensitization is explained as a burglar house alarm which set too 
sharp, which leads to constant ‘false’ alarming of the house even there is no 
break-in. The purpose of the house alarm is no longer useful, which in turn may 
result in unnecessary fear, stress and anxiety- all the factors that amplify the 
sensitivity of CNS (O’Sullivan, 2005; Woolf, 2011). 
 
The education of pain physiology may alter knowledge about pain states and 
convince patients that (1) hypersensitivity of CNS rather than local tissue 
damage is the cause of their presenting symptoms, and (2) that there are many 
factors that contribute to the maintenance of pain (Gracely et al., 2004). When 
pain is appraised as less dangerous by the patient, the threatening input to the 
brain reduces. Positive cognitive and emotional factors (such as less fear, less 
conscious need for protection, positive coping, realistic beliefs, awareness of 
pain mechanisms, positive emotions) then modulate pain in a positive way via 
forebrain (O’Sullivan, 2005; Woolf, 2011) as well as de-activate the pain 
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neuromatrix (Moseley, 2003a). Hence, lowering sensitivity of CNS (Woolf, 
2011) and increasing pain threshold at which subsequent improvement of pain 
intensity, disability and FAB are seen as a result of the programme.  
 
Patients who have pain want to have a satisfactory explanation for their pain 
(Ring et al., 2005). In comparison with basic pain education in usual 
physiotherapy care, it is possible that higher level of pain education provides 
patients with a physical cause of their ‘non-specific’ pain. A common example 
might be: abnormal regulation of pain signals within the CNS, which become 
sensitized. Rather than leaving patients feeling concerned about their ongoing 
pain, and ‘shop’ to seek a satisfactory explanation for their pain and treatment. 
When patients acknowledge the complexity of pain, and that the influence of 
physical, psychological and behavioural factors can be related to the existence 
of chronic pain, it might motivate them to engage with the CBA education and 
physical components of the CBCLBP programme, hence allowing for a better 
physical and psychological outcome.  
 
2. From a cognitive and behavioural perspective  
A variety of the CBA education components were used in the current study 
(Figure 3.5). These components were not designed to treat pain and disability 
directly as in the biomedical model (which assumes individuals are the passive 
recipients, and expect symptoms to recover by receiving specific therapy such 
as medication (Nordin et al., 2006). Rather, the CBA treatment philosophy 
aimed to address the underlying psychological and behavioural factors (such as 
patients’ belief about pain, passive coping and FAB), hence the associated pain 
and disability were reduced.  
 
For example, the operant component of the CBCLBP programme such as 
pacing, goal setting and graded activity management aim to reinforce health 
behaviour and reduce pain behaviour (Ferster & Skinner, 1957). This enables 
patients to return to a more active lifestyle, and increases their range and style 
of active coping. The cognitive component such as explanation of pain 
physiology, fear-avoidance model, and skills for managing unhelpful patterns 
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of thinking (for example, belief that one is disabled by pain; or that pain 
signified damage) may influence patients’ adoption of coping strategies, reduce 
FAB and their psychological impact associated with pain and disability (Beck, 
1979b; Walsh & Radcliffe, 2002) The respondent component such as use of 
relaxation technique helps to reduce stress, pain-related muscular tension and 
aid sleep (Henschke et al., 2010).  
 
As mentioned, psychological factors including emotions, stress, illness 
perception, pain cognition and pain behaviour are potential sustaining factors of 
central sensitization (Curatolo et al., 2006; Diatchenko et al., 2006). The 
various CBA education components covered in the CBCLBP programme as 
well as the exercise component, are also likely to directly or indirectly decrease 
the hypersensitivity of the CNS (Nijs and Van Houdenhove, 2009; Nijs et al., 
2009).  
 
3. From a physical perspective 
Exercise component 
A graded supervised exercise programme (including stretching, postural 
control, muscle strengthening, core stability exercises and aerobic exercises) 
and a home exercise programme were used in this study (Section 3.6.6). 
Exercise therapy is shown to improve physical pain and disability (Liddle et al., 
2004; Hayden et al., 2005a; Hayden et al., 2005b; Krismer & Van Tulder, 
2007), as well as reducing FAB (Mannion et al., 2001), depression and 
catastrophizing (Smeets et al., 2006b). However, it cannot assume that the 
observed positive outcome is directly attributable to changes in the 
musculoskeletal system. In fact, evidence emerged from systematic reviews 
(Steiger et al., 2012; Airaksinen et al., 2006) and individual study (Renkawitz et 
al., 2006) did not strongly support the relationship between changes in clinical 
outcome (pain, disability) and changes in physical function (range of motion, 
strength and muscular endurance). This may imply that the improvement in 
pain, disability and FAB observed in Phase B may not be the sole result of 
musculoskeletal changes of exercise therapy. Rather, it may be other changes 
elicited by exercise therapy responsible for these self-reported improvements 
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such as: improvement in self-efficacy, coping strategies and fear-avoidance 
(Mannion et al., 2001), modification of motor control patterns as a 
consequences of re-weighing of sensory input (Popa et al., 2007), improvement 
in motor control impairment resulted in less ongoing abnormal tissue loading 
and peripherally driven nociceptive sensitization (O’Sullivan, 2005), altered 
cortical representation of the back (Crombez et al., 1999; Woby et al., 2008) or 
simply from a positive patient/ therapist relationship/ interaction (Klaber 
Moffett & Richardson, 1997).  
 
Several systematic reviews of NSCLBP (Krismer & Van Tulder, 2007; Hayden 
et al., 2005b; Liddle et al., 2004; Van Middelkoop et al., 2011) concluded that 
exercise therapy only demonstrates modest improvement in pain and function 
in NSCLBP. The difference observed in Phase A (without CBA component) 
and Phase B (with CBA component) may suggest that the beneficial effects of 
exercise therapy are more due to the central effect (i.e. involving cognitive, 
psychological and neurophysiological (cortical organisation), rather than local 
(such as muscles and joints) in this subgroup of NSCLBP patients.  
 
Changing patients’ beliefs such as FAB (Twomey & Taylor, 2000) and pain 
perception (Moseley, 2002; Moseley 2004) are associated with better physical 
performance in CLBP patients. If the ultimate goal of exercise therapy in the 
CBCLBP programme is to get patients moving again, and be able to confront 
their fear and avoidance about physical activities, then the benefit of 
conventional exercise therapy will only be succeeded by supplemented with the 
CBA intervention in this subgroup of NSCLBP patients. An additional CBA 
component may be the underlying mechanism to facilitate the physical and 
psychological effects of exercise, and to achieve more desired symptomatic 
outcomes. 
 
During the CBCLBP programme, patients were instructed to safely break the 
fear-avoidance cycle and physical deconditioning by engaging a supervised 
graded exercise programme. Although exercise therapy directly aims at 
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improving patients’ physical functional ability, patients’ experience of 
completing the prescribed exercises in a paced and graded manner without 
experiencing undue harm may decrease pain behaviour and reduce their FAB, 
hence may lead to less pain and less disability, as proposed in the fear-
avoidance model (Figure 2.2) (Lethem et al., 1983; Vlaeyen & Linton, 2000).  
 
From a neurophysiological perspective, with experiencing no harm in 
completing exercises in a graded exposure manner means reducing the threat 
associated with exercises via both nociceptive and non-nociceptive mechanism 
(Moseley, 2003a). The consequence of these responses is likely to: decrease 
sensitivity of CNS (Woolf, 2011), de-activate pain neuromatrix (Moseley, 
2007) and influence pain modulation (secondary to cognitive and emotional 
factors) (O’Sullivan, 2005; Zusman, 2002). This in turn increase pain threshold, 
increase tissue nociceptive tolerance and facilitate the positive cognitive-
evaluative factors such as positive coping, positive beliefs and positive 
emotions.     
 
In addition, with physiotherapists monitored progress weekly and provided 
appropriate reinforcement for compliance, correction of misperception of pain 
following exercise and problem-solve barriers to adherence, patients may gain 
trust in the function of their back, hence adjust their negative cognitions (such 
as FAB) and appraisals (Mannion et al., 2001), while simultaneously producing 
benefit in other outcome domains such as pain and disability.   
 
The exercise component of the CBCLBP programme also included a session of 
Pilates and hydrotherapy. These other choices of exercises may shift patients’ 
emphasis from the ‘reversal of physical de-conditioning’ to the ‘adoption of 
enjoyable physical exercises’. It may also open up the array of potential choices 
of different exercises to be carried out, hence allowing patients to consider 
issues of cost, patients’ preferences and access to facilities, which are all 
important considerations for continued self-care in the future.    
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Long-term maintenance of benefits from exercise requires patient compliance 
and active engagement. It has been shown that patients who have less FAB 
about activity have better compliance with a physical programme (Twomey & 
Taylor, 2000). Higher level of ILOC is also associated with more engagement 
in beneficial health behaviours such as regular exercise (Affleck et al., 1987; 
Burker et al., 2005). In view of this, both increases in ILOC and reduction of 
FAB reported in the current study may imply that our patients were probably 
more likely to gain the physical and psychological benefits from exercise and 
more likely to maintain these benefits in the longer-term. This may partly 
explain why patients’ self-reported pain intensity, disability and FAB continued 
to improve at 3-months and 6-months follow-up. 
 
Self-management component 
It has been reported that enhancing self-management skills showed modest 
improvement in pain intensity, disability and FAB, compared to usual care 
(Moore et al., 2000). When compared to treatments such as physiotherapy, 
exercise and acupuncture, the effect of self-management was equally or less 
effective in reducing pain and disability (Oliveira et al., 2012a). A number of 
self-management techniques (such as information booklet, pain control, 
relaxation, problem solving, pacing, regular exercise, managing flare-up and 
relapse prevention) were introduced with the aim of empowering patients to 
take responsibility and self-care in managing symptoms. By being more 
knowledgeable about their chronic condition and encouraging patients to take 
lead in self-management result in positive reinforcement, greater confidence 
and independence. Having a more positive belief (higher ILOC, lower ELOC, 
lower CLOC and less FAB) may also aid patients approach to their self-
management with a more positive attitude or ‘getting on with it’ rather than 
conceived of self-management as a ‘fight’ and becoming overwhelmed by it. 
These cognitive, behavioural and emotional responses from effective self-
management may improve the physical and psychological consequence of 
NSCLBP. 
 
 CHAPTER 5 Discussion Page 201 
 
 
What are the possible explanations for non-significant but sustained 
improvement during Phase B?   
Beliefs lie at the heart of the CBA treatment because how patients think and 
feel about their pain affects what they do about it (Beck, 1979a; Beck, 1979b). 
Thoughts, beliefs, emotions and behaviours interact with each other and are 
targeted for improvement using a variety of methods and skills as discussed. 
The sustained improvement observed at 6-months is likely to be the reflection 
of a maintenance cycle effect (Figure 5.3). The variety of treatment 
components either change patients’ behaviour directly, or change behaviour 
indirectly by changing their beliefs. When positive behaviour inadvertently 
reinforces positive beliefs and emotions, this creates the positive cycle which 
results in the maintenance of improved pain, disability and FAB.   
 
Figure 5.3: Positive cycle in sustaining the improvement of pain intensity, 
disability and FAB 
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Between 6 weeks and 3-months 
Only disability showed significant further improvement at 3-months, while both 
pain intensity and FAB did not. This further significant improvement in 
disability at 3-months perhaps indicates that the various treatment component 
of the CBCLBP programme is mostly effective in reducing pain-related 
disability. It is also a reflection that patients are doing more and having better 
function even with some extent of pain.    
 
The reason for non-significant further improvement in pain intensity and FAB 
at 3-months may have something to do with the much improved pain intensity 
and low FAB immediately after the programme (mean VAS= 3.95 and mean 
TSK= 33.15 at week 6). Given pain is a multi-faceted experience emerging 
from the dynamic interplay of a patient’s physiological state, thoughts, 
emotions, behaviours and social influences, it is unrealistic to expect patients 
with NSCLBP to be pain-free and have no maladaptive cognitions such as 
FAB. The already mild pain intensity and lower FAB at week 6 may be the 
reason for no further significant improvement at 3-months.    
 
Between 3-months and 6-months 
It is unexpected to find that pain intensity showed significant further 
improvement at between 3-months and 6-months, because the CBCLBP 
programme did not target pain relief specifically. One possible explanation for 
this late positive result could be that patients in the study may develop more 
effective self-care techniques and coping strategies over time, which allows 
them to minimize the impact of their pain on their daily activities. Beliefs about 
pain have also been shown to play a significant role in persistence of pain, and 
how people adapt to it (Pincus & Morley, 2002; Walsh & Radcliffe, 2002). 
Therefore, it is also possible that patients’ negative pain beliefs are successfully 
modified following participation of the CBCLBP programme and patients 
become more acceptant about their pain with time, as previously mentioned in 
the literature (Aldrich et al., 2000; McCracken et al., 1998).   
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Both disability and FAB showed no further significant reduction between 3-
months and 6-months. This may be partly due to the absence of regular 
physiotherapy contact and support as provided in Phase B. This may also be 
due to the already low FAB (mean TSK= 32.27) and low disability level 
(RMQ= 7.76) at 3-months. Hence the potential to further improve disability and 
FAB at 6-months may be lessen. Study has shown FAB to be present in pain-
free people (Houben et al., 2005). Pain-free people in the general population 
reported pain-related fear comparable to, or only slightly lower, than acute and 
chronic pain patients (Houben et al., 2005).  
 
Influences of improved HLOC related to sustained improvement at 6-
months 
In agreement with the present study, evidence suggested that improved HLOC 
is associated with pain reduction (Sengul et al., 2010), disability (Sengul et al., 
2010; Haldorsen et al., 1998), and FAB (on activity) (Richard et al., 2011). 
Therefore, it is possible that the sustained HLOC improvement seen in Phase 
A2 may also contribute to the sustained effect of pain intensity, disability and 
FAB observed in Phase A2. 
 
Comparison to other studies- similarities and differences 
In comparison with other physiotherapy studies using comparable outcome 
measures, with similar interventions and follow-up period, the present study 
showed 45% reduction in pain intensity (as evaluated by VAS) between week 1 
and 6-months (Table 4.11), while the study by Johnson et al. (2007) found 42% 
pain intensity reduction and Critchley et al. (2007) found 29% pain intensity 
reduction at 6-months in the pain management arm.  
 
In respect of disability, our study demonstrated 35% reduction in disability 
score (as evaluated by RMQ) between week 1 and 6-months (Table 4.13), 
while the study by Johnson et al. (2007) revealed 39% improvement, and the 
pain management arm by Critchley et al. (2007) showed 46% reduction in 
disability score at 6-months.  
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The present findings achieved similar improvement in pain intensity and 
disability between week 1 and 6-months when compared to these previous 
studies. Possible explanation could be due to the similarities between them, 
including (1) use of validated outcome measures for measuring pain (evaluated 
by VAS or NRS) and disability (by RMQ); (2) similar baseline pain and 
disability score of included patients (patients of mild/moderate pain, and 
moderate level of disability); (3) similar intervention (highly structured 
programme of similar treatment rationale, content, duration and method of 
delivery), and (4) led by physiotherapists in a clinical environment. 
Collectively, this evidence may imply that the physiotherapy CBCLBP 
programme is effective in reducing pain and disability in this subgroup of 
patients with a highly-structured programme of 12- 16 hours of duration. 
   
The current study showed a 24% improvement in FAB (as evaluated by TSK) 
from week 1 to 6-months (Table 4.15). Comparing to Lamb et al. (2010), who 
demonstrated a 48% reduction in FAB (as evaluated by FABQ), the current 
finding is less favourable comparatively. It is noteworthy that patients in the 
present study had a high baseline of FAB (mean TSK = 42.3; a cut-off score of 
≥ 37 reflect high level of FAB), and investigated patients with NSCLBP only 
(i.e. at least more than 3-month duration of LBP). In contrast, Lamb et al. 
(2010) reported a lower baseline FAB value (mean FABQ = 6.3 as evaluated by 
FABQ 0-24; a cut-off score of ≥ 14 reflect high level of FAB about physical 
activity) (George et al., 2010), and included both subacute and CLBP patients 
(minimum of 6 weeks duration of LBP). 
 
It is acknowledged that the TSK and FABQ are different instruments for 
measuring pain-related fear. However, it has also been shown that both 
measurements have an adequate concurrent validity (i.e. there is consistent 
relationship between the scores from the two measurement procedures) 
(Swinkels-Meewisse et al., 2003b). This gives confidence that both instruments 
are measuring the same construct (Lundberg et al., 2011). Therefore, it is 
plausible that the baseline difference of FAB and duration of LBP might 
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explain a less favourable improvement in the current study when compared to 
the study by Lamb et al. (2010).  
 
Targeting NSCLBP patients with psychological risk factors  
High baseline FAB and longer duration of NSLBP may hamper the potential to 
improve FAB outcome. A systematic review assessing the influence of FAB on 
the outcome of various treatments in RCTs in patients with LBP (Wertli et al., 
2014b), concluded that those patients with high baseline scores of FAB (as 
evaluated by TSK and FABQ) had more pain and/ or disability and were less 
likely to return to work. The greatest treatment efficacy (graded activity and 
physiotherapy CBA education) was seen when high FAB was addressed in 
those patients presenting relatively early in their presentation (i.e. LBP less than 
6 months duration), but not in those with LBP for more than six months. The 
present finding shows that patients with high FAB and more than 6-months 
duration also produce favourable result following the programme. However, 
since there is no ‘low fear’ comparison group in the current study, we cannot 
conclude that the CBCLBP programme targeting patients with high FAB is any 
more useful than patients with low FAB.  
 
The significant difference between Phase A1 and Phase B suggested that the 
CBCLBP programme is more effective than usual physiotherapy care in 
patients with high FAB. This is in contrast with some existing evidence, which 
concluded that active rehabilitation (physical exercise class with using CBA) 
has no effect when compared to manual therapy (Hough et al., 2007), and little 
effect when compared to usual care (Kent & Kjaer, 2012) at reducing activity 
limitation when targeting NSLBP patient with psychosocial characteristics. 
However, it must be noted that these studies included a mixed duration of 
NSLBP population. Acute/sub-acute and chronic LBP patients differ in all 
physical and most psychological variables (Grotle et al., 2010). Heterogeneity 
in patient’s population may dilute the effect of the CBA active intervention. 
Inclusion of a homogenous population (i.e. NSCLBP) in this study has 
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advantages to draw more focused conclusion specific to the characteristics of 
this challenging subgroup of NSLBP population.  
 
Questioning the current guideline of 100 hours 
The total duration of the programme in the current study was approximately 13 
hours (i.e. six two-hour sessions CBCLBP programme and one, one hour 
session of hydrotherapy). This is substantially less than the NICE guideline 
recommendation, which suggests use of intensive combined exercise and CBA 
treatment for 100 hours over up to 8 weeks (Savigny et al., 2009). However, 
such a recommendation from NICE guideline is predominantly based on the 
findings of only one systematic review on CLBP (Guzmán et al., 2001), in 
which 10 RCTs were considered. Methodological flaws included: lowering the 
cut-off point in the assessment of methodology quality, an undue focus on 
selected clinical outcomes and selected patients sub-group, may also weaken 
the validity of their conclusion. Therefore, the guideline recommendation of 
100 hours drawn from this systematic review (Guzmán et al., 2001) is highly 
questionable and is high risk of bias. 
 
The guideline of 100 hours over 8 weeks per patient for an NHS physiotherapy 
outpatient setting is also challenging (i.e. approximately 12.5 hours per week 
per patient). For instance, many NHS physiotherapy outpatient departments 
would not be able to provide the guideline value. According to a survey of NHS 
Physiotherapy waiting times, workforce and caseload conducting between Year 
2010 and 2011 in the UK (CSP, 2011), musculoskeletal physiotherapy had the 
highest caseload among all other physiotherapy outpatient services. The waiting 
time for the majority of musculoskeletal outpatient service in the UK was 6-8 
weeks, the mean patients referrals into musculoskeletal outpatient 
physiotherapy was 11668 per year, and 32% respondents (outpatient 
physiotherapy managers) reported that waiting times had increased compared to 
the previous year (CSP, 2011). Possible reasons for increased waiting time 
included: staffing related issues, increased referrals, changes in service 
organisation (e.g. merger) and changes in commissioning/ planning. The low 
capacity and high demand of the NHS musculoskeletal service under the 
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current financial climate of the NHS means that the provision of 100 hours over 
8 weeks is highly difficult, especially for the big referrer such as NSCLBP.  
 
Findings of the current study, and evidence of previous studies with similar 
interventions and baseline profiles show that 78 hours (Smeets et al., 2006a); 12 
hours (Critchley et al., 2007); 16 hours (Johnson et al., 2007) and 9 hours 
(Lamb et al., 2010) are adequate durations to demonstrate effectiveness. This 
raises the question whether the NICE guideline value of 100 hours intensive 
rehabilitation is necessary for all NSCLBP patients with moderate/ high level of 
symptoms and psychosocial distress presenting in out-patient physiotherapy?  
 
NICE is currently updating its 2009 guidelines on NSLBP management 
(Savigny et al., 2009), and has published draft recommendations for public 
consultation in March 2016. In their draft recommendation on NSLBP and 
sciatica, the use of combined physical and psychological programme (such as 
the CBCLBP programme) remains in the recommendation. However, it is no 
longer specified the required hours for the use of combined physical and 
psychological programme for any produced effect as stated in its 2009 
guideline (Savigny et al., 2009). Based on our present findings and other 
available evidence, we suggest that treatment hours of approximately 13 hours 
may be sufficient for producing positive clinical outcomes for this subgroup of 
NSCLBP patients (i.e. with moderate level of pain, moderate level of disability 
and high FAB).  
 
Refinement of the NICE guidelines is much needed to illustrate which type of 
patients may benefit from less intensive rehabilitation and can be treated by 
physiotherapists, such as the CBCLBP programme, and which type of patients 
may need 100 hours intensive multi-disciplinary rehabilitation or onward 
referral to psychologists or cognitive-behavioural therapists. This would further 
improve clinical decision-making and avoid long treatment hours unnecessarily. 
Such an idea also concurs with the current NICE draft guideline (March 2016), 
which adding the recommendation of using risk assessment tool such as the 
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STarTback tool to inform decision-making about stratified management. 
However, the NICE guideline draft has just finished the public consultation 
period in May 2016. Hence any change and update have not yet been published.    
 
5.5 Aim 3- To determine if there is any relationship between 
patients’ HLOC, pain intensity, disability and FAB 
This question was answered by examining two relationships: (1) the correlation 
that existed between changes in HLOC, pain intensity, disability and FAB; and 
(2) to what extent changes in ILOC, ELOC, CLOC and other variables (i.e. pain 
and/or disability and/or FAB), can predict changes in pain intensity, disability 
and FAB (i.e. outcome of interest).  
Main findings on the correlation between pain intensity, disability, FAB 
and HLOC 
 A significant relationship was found between reduction of pain 
intensity, reduction of disability and reduction of FAB. This suggests 
that these three key clinical elements of NSCLBP were inter-related. 
 Increase in ILOC, reduction in ELOC and reduction in CLOC were 
significantly associated with reduction in pain intensity. 
 Increase in ILOC was significantly associated with reduction in 
disability, but reduction in disability showed no significant relationship 
with reduction in ELOC and reduction in CLOC. 
 Increase in ILOC, reduction in ELOC and reduction in CLOC were 
significantly associated with reduction in FAB.    
 
5.5.1 Correlation between HLOC, pain intensity, disability and 
FAB 
Correlation between FAB and disability 
Reduction of FAB was associated with reduction of disability in this study. A 
possible explanation could be that the vicious cycle of the fear-avoidance model 
is broken. i.e. as FAB decreased, threat perception, avoidance behaviour and 
hypervigilance also decreased, which consequently reduced disability. This 
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finding lends further support to the fear-avoidance model, which proposed that 
fear of movement or (re)injury is associated with disability (Vlaeyen et al., 
1995a; Vlaeyen & Linton, 2000). This present finding is also in agreement with 
systematic review (Ramond et al., 2011), and other individual studies, which 
consistently reported a positive relationship between disability and FAB 
(Crombez et al., 1999; Thomas et al., 2010; Elfving et al., 2007; Woby et al., 
2004b; Grotle et al., 2004). 
 
Interestingly, studies that showed FAB is weakly correlated to disability often 
included the examination of both FAB and self-efficacy within the same study 
(Woby et al., 2007a; Pincus et al., 2006; Denison et al., 2004). The discrepancy 
with these previous work may suggest the possibility that self-efficacy could be 
a factor that mediating between FAB and disability.  
 
Correlation between pain intensity and disability 
In the current study, reduction of pain intensity was related to reduction of 
disability. This is consistent with a number of studies which reported a positive 
relationship between pain intensity and disability (Thomas et al., 2010; Bair et 
al., 2008; Peters et al., 2005; Woby et al., 2004a; Turner et al., 2004). However, 
there are also other studies reported weak or even non-existing associations 
between pain and disability (Meyer et al., 2009; Reneman et al., 2007; Waddell 
et al., 1992; Waddell et al., 1993; Vlaeyen et al., 1995a; Vlaeyen et al., 1995b). 
There seems to be no common ground to explain the similarities and 
differences between the current study and previous studies. The relationship 
between pain and disability is not straight-forward, particularly in NSCLBP 
patients. The inconsistent finding highlights the complexity between pain and 
disability. A possible explanation for inconsistent finding could be that LBP is 
associated with a number of physical, psychological and social factors (Gatchel 
et al., 2007; Waddell, 1992), which are also associated with disability (Pincus et 
al., 2002; Waddell & Waddell, 2000). With heterogeneity among studies such 
as variation in NSLBP population, variation in patients’ baseline characteristics 
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and different study designs, this may distort the relationship between pain 
intensity and disability. 
 
Another possible explanation could be that there are other factors may mediate 
the relationship between pain intensity and disability. For instance, it has been 
shown that employment status (Van den Hout et al., 2001) and ILOC and 
catastrophizing (Spinhoven et al., 2004; Smeets et al., 2006b) maybe the factor 
that mediates the relation between pain and disability.      
 
Correlation between FAB and pain intensity 
An association was found between reduction of FAB and reduction of pain 
intensity in this study, suggesting that as FAB decreased, so did the level of 
pain intensity, and vice versa. Severity of pain is determined by patients 
subjectively, and patients’ evaluation of pain affect the level of pain-related fear 
that may develop, and hence the behaviour of avoidance of movement 
(Asmundson et al., 2004). From a neurophysiological perspective, FAB is a 
negative cognitive factor that can drive and amplify pain through the CNS via 
the forebrain (Zusman, 2002; O’Sullivan, 2005). Therefore, when FAB reduces, 
pain intensity may also reduce due to decrease in hypersensitivity marked by 
central sensitization. From a physical perspective, less FAB may imply less 
physical de-conditioning and less guarded movements. With stronger stability 
and increased motor control within the back, it may influence loading of lumbar 
spine and reduce the production of peripheral nociceptive input (O’Sullivan, 
2000; O’Sullivan, 2005), hence pain intensity may reduce.  
 
Previous studies reported a positive relation between FAB and pain intensity 
(Guclu et al., 2012; George et al., 2001), while some reported a weak or no 
association between them (Thomas et al., 2010; Crombez et al., 1999; Vlaeyen 
et al., 1995a; Vlaeyen et al., 1995b; Woby et al., 2004b).  
 
Thomas et al. (2010) had a very similar baseline patient profile (TSK = 46, 
VAS= 6.04, RMQ= 13.94) as well as that in Crombez et al. (1999) (TSK= 44.4, 
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VAS= 61.7, RMQ= 14.1) when compared to the present study (TSK= 42.3, 
VAS= 6.04, RMQ= 11.8). However, both Thomas et al. (2010) and Crombez et 
al. (1999) found no association between FAB and pain intensity. A possible 
explanation for this inconsistent finding may be that study by Thomas et al. 
(2010) and Crombez et al. (1999) were cross-sectional, where measurement of 
FAB and pain intensity were only taken as a snapshot. In contrast, the current 
study is longitudinal where correlation between changes of FAB and changes in 
pain intensity were considered over time. Since repeated measurements were 
taken, the present results should be more valid than cross-sectional data. The 
different results may suggest that the pain intensity-FAB association is 
dynamic, and it could change over time, and with the CBCLBP programme.        
 
Correlation between HLOC and pain intensity 
The present study found that improvement of ILOC, ELOC and CLOC were 
significantly associated with reduction of pain. This indicates that higher level 
of ILOC, lower level of ELOC and lower level of CLOC are linked with pain 
reduction. This result is in direct agreement with Sengul et al. (2010), which 
also reported a relation between pain intensity and ILOC, ELOC and CLOC, 
and partially consistent with Harkapaa (1991) who found a relationship 
between pain and ILOC and ELOC. 
 
Compared to the study by Sengul et al. (2010), which suffered from selection 
bias and between-group variability, the A-B-A design of the current study has 
more advantage as it is the same group of patients serves as its own control. 
Hence, our result is likely to have a higher internal validity.  
 
A possible explanation for the relationship between HLOC and pain intensity 
could be that higher level of ILOC, lower level of ELOC and lower level of 
CLOC reflect more self-responsibility, and patients beliefs that their own 
behaviour is more likely to impact their pain, as proposed by the HLOC theory 
(Wallston et al., 1976). Engaging more positive behaviours (such as regular 
mild aerobic exercise) reduce the heightened reactivity of the CNS, hence leads 
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to reduction in pain mediated by central sensitization (Busch et al., 2007). In 
addition, there is also evident that an individuals’ perception of control may 
have a direct or indirect effect on pain intensity reporting, hence patients may 
report more intense pain due to their feeling of lack of control and inability to 
influence the pain sensations (Pellino & Oberst, 1992).       
Correlation between HLOC and disability 
The correlation between HLOC and disability is weak. Disability is only 
associated with increased ILOC, but there is no significant relation between 
reduction of ELOC and CLOC.  This finding indicates that disability may be 
more influenced by internal beliefs, rather than external and chance beliefs. The 
relation between reduction of disability and increased ILOC may be explained 
by individuals with higher level of ILOC being more likely to attempt and 
complete activities, as they believe their own behaviour and responsibility 
accounts for outcome, as opposed to those who believe in external and chance 
factors, where passivity and inactivity are more likely to occur. Besides, it was 
suggested that patients who have higher ILOC have higher self-motivation and 
more active involvement in healthcare treatment (Wallston & Wallston, 1982). 
This means that patients with higher ILOC are more likely to benefit from the 
CBCLBP programme, which aims at reducing disability.   
 
There are only three studies (Harkapaa et al., 1991; Haldorsen et al., 1998; 
Sengul et al., 2010) in the literature examining the relationship between HLOC 
and disability in NSCLBP. The present finding is in direct agreement with 
Haldorsen et al. (1998) and Harkapaa et al. (1991), both also reported disability 
was related to ILOC only. Sengul et al. (2010) reported ILOC and CLOC were 
positively correlated with disability in NSCLBP patients, but not with ELOC. 
The discrepancy of findings between studies may be explained by the 
heterogeneity of patient baseline characteristics, variation in research design, 
number of variables included in analysis and statistical methods. Besides, there 
is variation in methodological quality among studies (of high/ moderate risk of 
bias), which weaken the validity and strength of support for the HLOC 
construct.  
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So far, the emerging evidence seems to support the relationship between ILOC 
and disability. However, with the limited amount of available evidence, this 
area warrants further research to support the relationship between HLOC and 
disability in NSCLBP. 
Correlation between HLOC and FAB 
An association was found between improvement of ILOC, ELOC and CLOC 
and reduction of FAB. This is the first study within literature showing that 
improved HLOC are associated with reduced FAB in patients with NSCLBP.  
 
Richard et al. (2011) reported a correlation between FABs-PA and ILOC and 
ELOC (but not CLOC). However, the included patients of this study were only 
workers (mean age of 38.7) with NSLBP who had self-reported at least a day of 
incapacity due to LBP. Therefore, their findings cannot be generalised to a 
wider population with NSCLBP presenting in primary care, who are generally 
older and experienced LBP for more than three months. 
 
The mechanism underlying this association is unclear and it has not been 
discussed in the literature. However it could be hypothesised that reduction of 
FAB has impact on the three responses to fear, which are: (1) 
psychophysiological (e.g. less muscle reactivity); (2) behavioural (less 
avoidance behaviour and more active coping); and (3) cognitive elements of 
fear (e.g. less catastrophizing thoughts) (Leeuw et al., 2006). All these 
responses may result in internal belief that pain can be controlled by oneself 
(ILOC), rather than external factors (ELOC and CLOC). The reverse is also 
true. If patients believe they are the one responsible for their back condition, 
and that own behaviour determined outcome (as opposed to external factors), 
they are probably more likely to employ active coping and less likely to avoid 
activities despite pain, thus resulting in less FAB.  
 
Another possible explanation for this relation can be explained from the 
neurophysiological perspective. The pain neuromatrix contributes to the 
experience of pain. But much of the pain neuromatrix are also the areas that 
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control decision-making, learning, goal-orientation, attention, cognition and 
emotion (Melzack, 1999). When these areas are colonised by selective 
attentional focus on pain, particularly individuals with high levels of fear of 
excessive attention and protection (Keogh et al., 2001; Dehghani et al., 2003), it 
limits the higher mental processes in the brain such as learning and planning. 
This is why patients with high FAB are challenging to treat. Patients may find it 
difficult to comply with treatment advice such as taking self-responsibility, 
thinking positive and behaving positive, all can influence one’s HLOC in a 
negative manner.  
 
In contrast, lower levels of FAB may orientate attention away and disengaging 
thoughts from pain. Hence enhancing patients’ capacity and learning with 
therapeutic instructions and advice, which then likely to influence one’s HLOC 
is a positive manner. Therefore, it is reasonable to propose there is a 
relationship between HLOC and FAB in NSCLBP patients with high FAB.        
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Figure 5.4: Correlation between reduction in pain intensity, reduction in 
disability, reduction in FAB and improvement in HLOC subscales 
 
 
In sum, it is acknowledged that the development and maintenance of NSCLBP 
is multi-factorial, and it could be due to a complex combination of biological, 
psychological and social factors (Gatchel et al., 2007). The correlation data of 
the present study provides evidence on the link between pain, disability, FAB, 
and HLOC, following the implementation of the CBCLBP programme. As 
shown in Figure 5.4, these variables of NSCLBP interact and correlate with 
each other. 
 
As discussed in earlier sections, this study extends a previous study that found 
an association between reduction in pain intensity, reduction in disability and 
reduction in FAB in NSCLBP.  
 
Both reduction in pain and reduction in FAB were found to be associated with 
all HLOC subscales whereas disability was associated with increased ILOC. 
Patients that we see in clinical practice often simultaneously have multiple 
psychological factors that may impair outcomes. Consideration of the 
relationship between improvement of HLOC and improvement of pain 
intensity, disability and FAB enable us to further understand the underlying 
mechanism of how desired treatment outcomes can be attained. 
Pain
Disability FAB
ILOC
ILOC
ELOC
CLOC
ILOC
ELOC
CLOC
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5.5.2 To determine what extent changes of ILOC, ELOC, 
CLOC and other variables can predict changes in pain 
intensity, disability and FAB 
5.5.2.1 When pain intensity is the outcome 
The present study found that both reduction of FAB and reduction of 
disability were the significant predictors of reduction in pain intensity 
(Table 4.18). Both variables accounted for an additional 37% of the 
variance in changes in pain intensity, after adjusting for demographics. 
Examination of beta weights, however, revealed that reduction in disability 
(β=0.486, p< 0.001) was a much stronger predictor than FAB (β=0.248; p< 
0.05) when pain intensity is the outcome.  
 
A number of mechanisms may explain why reduction in FAB and reduction 
in disability emerged as significant predictor to reduction in pain intensity. 
According to the fear-avoidance model (Vlaeyen et al., 1995b; Vlaeyen & 
Linton, 2000), patients with higher levels of FAB become excessively 
attentive to their bodily symptoms, and have a tendency to monitor signs of 
bodily threat periodically. This dysfunctional attentional style to detect 
potential pain-threatening information is known as hypervigilance. 
Hypervigilance results in a greater chance of reporting and exacerbating 
pain sensation and disability levels. Accordingly, it is plausible that 
reduction in disability and reduction in FAB might reduce patients’ 
hypervigilance, hence reducing their misinterpretation or exaggeration of 
pain sensation. 
 
Disability means restricted activities. Restricted activities lead to 
physiological changes such as spinal stiffness, decreased muscle atrophy 
and strength, loss of fitness and function, decreased co-ordination and 
balance, and weight gain. These physiological factors are shown to have 
some impact on chronic low back pain (Verbunt et al., 2003). The stress 
from FAB is also shown to exacerbate the reactivity of the CNS, leading to 
increased pain associated with central sensitization (Curatolo et al., 2006). 
In addition, it has also been reported that pain-related fear is linked with 
pain and disability through muscular reactivity (Vlaeyen et al., 1999). 
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Collectively, it is feasible that reduction in disability and reduction in FAB 
lead to lower level of pain intensity.  
 
This result suggests that employing treatment components that target 
disability and FAB would potentially achieve better pain outcome in 
patients with NSCLBP. For example, by educating that pain physiology 
alters pain beliefs and attitude (Moseley et al., 2004), and in conjunction 
with physiotherapy, it improves symptomatic and functional outcomes in 
CLBP (Moseley, 2002; Moseley et al., 2003b). By encouraging patients to 
complete various type of exercises and functional activities in a graded and 
paced manner help to reduce pain behaviour (Ferster & Skinner, 1957; Nijs 
et al., 2011). Stress management, explanation of FAB model and relaxation 
are likely to decrease pain hypersensitivity of CNS (Nijs and Van 
Houdenhove., 2009; Nijs et al., 2009).  
 
Rightly, some NSCLBP patients need passive treatment such as hands-on 
mobilisation and manipulation to facilitate their rehabilitation, especially 
when they struggle with their pain. However, passive treatment should be 
minimally used because of their cost, lack of long-term effectiveness and 
lack of significant impact on functional outcomes and return to work (Chou 
et al., 2007; Chou & Shekelle, 2010). The message of using self-care 
techniques, keeping active and paced activities should be emphasized 
consistently by clinicians and it should be seen as a proactive alternative 
method to manage pain by NSCLBP patients.   
 
HLOC accounted a non-significant 6% of the variance in pain intensity. All 
subscales of HLOC (i.e. ILOC, ELOC and CLOC) were found to have no 
predictive value of reduction in pain intensity, after accounting for 
demographics, FAB and disability (Table 4.18). This finding suggests that 
change in HLOC has no predictive importance in the reduction of pain 
intensity. No direct comparison can be made as relevant literature is very 
limited. Some previous studies used composite assessments to measure 
patient perception of control, as opposed to MHLC scales. For instance, a 
cross-sectional study by Woby et al. (2004b) found that patients’ perception 
of ability to decrease pain (as evaluated by CSQ) explained an additional 
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6% of the variance of pain intensity. A subsequent cross-sectional study by 
Woby et al. (2007a) demonstrated that a number of cognitive factors 
(including perceptions of control) accounted for an additional 30% of the 
variance in pain intensity, however perceptions of control over pain (as 
evaluated by CSQ) were not a significant predictor to pain intensity. So far, 
it appears that HLOC beliefs have no significant predictive value in pain 
intensity. This might suggest that improving patients’ HLOC beliefs is 
unlikely to have a major impact upon pain reduction in patients with 
NSCLBP.  
5.5.2.2 When disability is the outcome 
After controlling for demographics, the current study found that reduction in 
pain intensity and reduction in FAB accounted for an additional 33.1% of 
the variance in disability. However, only pain intensity (β=0.53, p< 0.001) 
emerged as a significant predictor of disability (Table 4.19). This suggested 
that pain intensity is a unique predictor relating to reduction of disability as 
outcome. This is in direct agreement with the two previous cohort studies 
(of moderate risk of bias) conducted in physiotherapy department, which 
also reported pain intensity accounted for a relatively large proportion of the 
variance in disability (Woby et al., 2004a; Woby et al., 2008). Compared to 
these previous studies, which have a short follow-up period (6-8 weeks), 
and higher follow-up dropout rate (25-35% dropout in follow-up data), our 
study may provide a more valid evidence due to a longer follow-up period 
(6-months) and low attrition bias (completed follow-up data).   
 
Woby et al. (2004a) reported that reduction in pain intensity accounted for 
an additional 43% of the variance in reduction in disability in a cohort of 
NSCLBP patients presenting in physiotherapy, while Mannion et al. (2001) 
found reduction in pain intensity only explained 16% of the variance in 
reduction in CLBP disability. The inconsistent findings of the predictive 
relationship between change in pain intensity and change in disability 
appears to be affected by the baseline levels of disability. Patients recruited 
in Mannion et al. (2001) reported a comparatively lower level of disability 
(mean RMQ=7.6), the present study reported moderate levels of disability 
(mean RMQ=11.8), whereas Woby et al. (2004a) reported a relatively 
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higher levels of disability (mean=13.1). In view of this, it is possible that 
baseline values of disability may influence the relation between changes in 
disability and changes in pain intensity.  
 
Another possible explanation for inconsistent findings of pain predicting 
disability could be that other factors may mediate the relation between these 
two constructs. For example, catastrophizing and internal control might be a 
factor that mediates the relation between pain intensity and disability 
(Spinhoven et al., 2004; Smeets et al., 2006b). Employment status may also 
be a factor mediates the relation between pain and disability (Van den Hout 
et al., 2001). A more recent systematic review reported that self- efficacy, 
psychological distress and fear may also mediate the relation between pain 
and disability (Lee et al., 2015). It is acknowledged that these potential 
mediators may over- or under-estimate the predictive importance of pain 
intensity in reduction of disability between studies. However, the data of the 
present study derived from a homogenous cohort of NSCLBP patients, 
hence the bias due to these potential confounders should not affect the 
present reporting. Further investigation includes the application of 
mediation analysis and assessment of the possible effect of uncontrolled 
confounders using sensitivity analysis would be required to provide 
understanding of the underlying causal mechanism between pain intensity 
and disability (Imai et al., 2010).       
 
Despite the present finding suggesting that pain relief may be important in 
achieving reduction in disability, treatments directly aimed at pain relief are 
often unsuccessful in patients with NSCLBP (Waddell, 2004), and are 
contra-indicated to the theoretical approach of CBT based intervention. In 
fact, it has been suggested that successful management of chronic pain is 
solely due to patients’ acceptance of their pain, rather than a reduction in 
their pain intensity per se (Aldrich et al., 2000; McCracken, 1998).  
 
Some studies reported the significant predictive importance of FAB in 
disability (Crombez et al., 1999; Vlaeyen & Linton, 2000; Pincus et al., 
2002; Woby et al., 2004a; Meyer et al., 2009), while some trials have found 
a weak association between FAB and disability (Reneman et al., 2003; 
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Burton et al., 2004; Pincus et al., 2006; Woby et al., 2007a; Woby et al., 
2007b).   
 
In the present study, reduction in FAB did not emerge as a unique predictor 
of reduction in disability (P>0.05). It is noteworthy that whilst not a 
significant predictor, there was a significant association between these two 
variables (p= 0.013) (Table 4.17). This potentially implies that reduction of 
FAB might only exert an indirect influence on disability via the effect it has 
on other cognitive factors. Referring to correlation data, the only cognitive 
factor that has association with both reduction of FAB and reduction of 
disability is increase in ILOC (Figure 5.4). On this basis, it is possible that 
increase in ILOC could be the intermediary link between the causal 
relationship of reduction in FAB and reduction in disability. However, this 
hypothesis can only be confirmed by applying mediation analysis in future 
work.  
 
HLOC only explained a further non-significant 0.5% of the variance in 
disability. All subscales of HLOC were found to have no predictive value to 
reduction of disability, after accounting for demographics, pain intensity and 
FAB (Table 4.19). This finding suggests that change in HLOC has no 
impact on the reduction of disability in our patients. A possible explanation 
could be that disability is a complex and multi-dimensional phenomenon, in 
which both physiological and a variety of psychosocial factors determine 
disability. Secondly, HLOC may only exert an indirect influence on 
disability via the effect it has on other factors, therefore the predictive 
importance of HLOC have reduced when assessed alongside factors that 
have a direct effect on disability. For example, pain intensity (Woby et al., 
2004a; Van den Hout et al., 2001) and FAB (Crombez et al., 1999; Meyer et 
al., 2009) have been shown to account for a relatively large proportion of 
variance in disability.      
 
No existing evidence can be found to make direct comparison regarding the 
predictive value of HLOC beliefs to change of disability. Some studies 
reported that perceptions of control (measured by composite measures) 
showed no predictive value to disability statistically (Woby et al., 2007a; 
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Mannion et al., 2001). On the other hand, Sengul et al. (2010) found a 
correlation between disability and both ILOC and CLOC (but not ELOC) in 
patients with CLBP. A cohort study by Foster et al. (2010) that examined a 
comprehensive range of psychological variables in patients with both 
subacute and chronic LBP demonstrated that patients’ weak perception of 
personal control was a significant and strong predictor in LBP disability 
outcomes at 6-months. However, this study assessed perception of personal 
control by IPQ-R, which is a composite measures consisting of 12 subscales 
and 8 patients’ illness perception (Moss-Morris et al., 2002). Therefore, the 
IPQ-R cannot conclude the independent predictive importance of HLOC, as 
in MHLC. Limited and inconsistent evidence in this area warrants further 
examination regarding the predictive relationship between changes in 
HLOC and changes in disability in NSCLBP population. So far, the relation 
between HLOC and disability appears rather weak.    
 
It is noteworthy that both reduction in pain and reduction in FAB explained 
an additional 33.1% of the variance in disability, and HLOC explained a 
further 0.5%, thus indicating that reduction in disability must be influenced 
by other factors. There is evidence suggesting self-efficacy may be a 
stronger determinant of disability, than those factors (such as 
catastrophizing and fear of movement/ (re-) injury) within the fear-
avoidance model (Ayre & Tyson, 2001; Denison et al., 2004; Woby et al., 
2007b). However, further study will be required to clarify this. 
5.5.2.3 When FAB is the outcome 
It was found that both reduction in pain intensity and reduction in disability 
accounted for 17.2% of the variance in FAB. Examination of beta weights, 
however, showed that only reduction of pain intensity (β=0.325, p<0.05) 
emerged as a significant predictor to reduction in FAB (Table 4.20). This 
result is in contrast to those observed in a number of other studies, which 
have shown that FAB has a greater effect on disability than pain intensity 
(Wideman et al., 2009; Gheldof et al., 2010; Jensen et al., 2010). A possible 
explanation of this could be that pain is an important reason for avoiding 
movements in our patients who have a high baseline value of FAB. With 
reduction in pain intensity, it is probable that patients are more likely to 
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confront pain problems, develop active coping, which ultimately leads to 
less FAB (Vlaeyen et al., 1995a). This result implies that adequate pain 
relief and changing maladaptive pain cognition may be particularly 
important to address when managing patients with high FAB.      
 
After accounting for demographics, pain intensity and disability, the HLOC 
showed an additional 31.9% of the variance in reduction in FAB. Among 
the three subscales of HLOC (i.e. ILOC, ELOC and CLOC), increase in 
ILOC emerged as a unique predictor related to a reduction in FAB (β=-
0.407, p<0.01) (Table 4.20). This suggests that patients’ reduction in FAB 
is largely related to one’s internal belief (ILOC), rather than influenced by 
external orientation belief (i.e. ELOC and CLOC). Furthermore, a much 
larger proportion of the variance explained by the improvement in HLOC 
(31.9%) was seen, in comparison to reduction in pain intensity and disability 
(17.2%), indicating that change in HLOC has a larger effect on reduction in 
FAB, than change in pain intensity and disability. 
 
This is the first study which shows that HLOC explains a considerable 
proportion of the variance in reduction in FAB, and it is also the first study 
which demonstrates that increase in ILOC is significantly predictive of a 
reduction in FAB.    
 
The underlying mechanism between HLOC and reduction in FAB has not 
been discussed in the literature. However, existing evidence may explain 
why improvement of HLOC beliefs leading to reduction in FAB occurred in 
the present study. It has been suggested that coping strategies significantly 
improved following multidisciplinary CBT approach pain management 
(Jensen et al., 2007). Active coping strategies involve taking responsibility 
for treatment, having a higher level of engagement in beneficial health 
behaviours, and attempting to function or stay active despite pain. In 
contrast, passive coping strategies reflect assigning management to an 
outside source, taking less time to evaluate a problem situation and have a 
lower engagement in beneficial health behaviours (Brown & Nicassio, 
1987).  
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There is also evidence indicating that there is an association between HLOC 
and use of coping strategies (Harkapaa et al., 1991). Specifically, 
individuals with higher levels of ILOC are more likely to employ active 
coping strategies, whereas ELOC and CLOC beliefs reflect passive coping 
strategies. In light of the above, it is possible that because patients with 
ILOC believe their actions and behaviour are responsible for outcome, they 
are then more likely to engage in active coping and attempts to function, 
despite pain. This may in turn reduce their avoidance behaviour and FAB. 
On the other hand, patients with higher external control orientation believe 
that the responsibility for one’s health is assigned to other people, or luck 
and fate. Consequently, they are more likely to use passive coping, have less 
attempts to control pain and be more likely to avoid increasing activities. 
This may then lead to increased FAB.   
 
In addition, it has been suggested that ILOC are related to positive 
adjustment to illness and less psychological distress in medical populations 
(Burker et al., 2005). An increased perception of control may also reduce 
feelings of being threatened and challenged by a stressful situation (Lazarus 
& Folkman, 1984). For many NSCLBP patients, performing many daily 
living activities is considered to be stressful. Therefore, it is plausible that 
patients with higher level of ILOC are more likely to confront pain, and 
feeling less threatened and less distressed by their pain. According to the 
fear-avoidance model theory, this “good” coping and confrontational style 
results in less FAB.  
 
FAB is a known powerful psychological factor in persistent pain and 
disability in NSCLBP as shown in high quality systematic reviews (Ramond 
et al., 2011; Chou & Shekelle, 2010). The consequences of high FAB 
include disability (Crombez et al., 1999; Rainville et al., 2011), 
exaggerations in pain perception (Lethem et al., 1983; Crombez et al., 1999; 
Goubert et al., 2004b), decreased performance of physical tasks (Al-Obaidi 
et al., 2003), passive coping (Lethem et al., 1983), reduced psychological 
well-being, dependence on medications, and excessive utilization of medical 
services (Derebery & Tullis, 1983; McGrail Jr et al., 2002). Because of the 
consequences of high level of FAB, the persistence of it could dampen the 
 CHAPTER 5 Discussion Page 224 
 
 
effectiveness of NSCLBP treatment and have a negative impact on both 
patients and health care providers. Therefore, it would seem beneficial to 
explore other factors that may anticipate the reduction in FAB, such as 
higher ILOC as found in the present study. This is supported by Wideman et 
al. (2013), who challenged the sequential and simplistic fear-avoidance 
model, and suggested that the fear-avoidance model should be seen as a 
more complex and dynamic multiple relationship in which other factors are 
likely to be involved.    
 
From a clinical perspective, this result may suggest that treatment targeted 
to increase ILOC could facilitate improvement in FAB in NSCLBP patients 
with high FAB. This is useful information for clinicians working with 
NSCLBP with high FAB, because this is the sub-group often considered 
challenging to treat (Rainville et al., 2011). In addition, pain-related fear is a 
crucial aspect in patients’ disability, which needs to be addressed in order to 
achieve optimal outcomes (Lundberg et al., 2011). Further research is 
warranted to support the view that ILOC predicts better FAB outcomes and 
more remains to be learned through future research regarding its underlying 
mechanism. It is proposed that components modifying various maladaptive 
pain beliefs and enhancing self-management are likely to have some impact 
on patients’ ILOC beliefs. Clinicians could consider placing more focus on 
these components (as detailed in Section 5.3) to facilitate FAB outcomes in 
patients with high FAB.    
 
Overall, changes in HLOC accounted for further 6%, 0.5% and 31.9% 
variance in changes in pain intensity, disability and FAB respectively. This 
finding demonstrates that HLOC (particularly ILOC) has significant 
predictive value in reducing FAB, however it shows no significant 
predictive value to both reduction in pain intensity and reduction in 
disability. A possible explanation for this could be that both HLOC and 
FAB are psychological factors (both constructs concerning patients’ belief 
about their pain), while pain intensity and disability are physical factors 
associated with NSCLBP. This result supports the current understanding of 
NSCLBP, that when NSLBP becomes chronic, the psychosocial factors are 
more powerful factors in the development and persistence of NSCLBP and 
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disability, than the physical factors (Waddell, 2004; Koleck et al., 2006; 
Bakker et al., 2009). This finding is also in direct agreement with the 
treatment philosophy of the CBA, where emphasis is placed to address 
patients’ maladaptive belief, feelings and behaviours (Airaksinen et al., 
2006; Henschke et al., 2010).    
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5.6 Aim 4- To examine patients’ self-care attitude toward 
their back pain in terms of their desire in future use of 
healthcare and prescription pain medication as a result of the 
CBCLBP programme 
 
Main finding: 
No significant improvement of self-care attitude was seen before the 
programme (Phase A1); significant improvement of self-care attitude was 
found immediately after the CBCLBP programme (Phase B), and such 
improvement was sustained for six months following the programme (Phase 
A2). 
     
What are the possible reasons for patients’ self-care attitude failing to 
improve during Phase A1 but improving significantly during Phase B?  
 
1. Self-management component 
Despite usual physiotherapy care (Phase A1), which included a variety of 
self-management components, none of the strategies were cognitive and 
behavioural in nature such as relaxation, distraction, personal goal setting 
and problem solving techniques. This may imply that the cognitive-
behavioural elements of self-management in the CBCLBP programme may 
be important in improving patients’ perception of their need for self-
management, at least with respect to this subgroup of NSCLBP patients 
with moderate level of pain, moderate disability and high FAB. 
 
Self-management is concerned with managing the day-to-day impact of 
NSCLBP. In NSCLBP, functional limitations (i.e. disability level) are more 
closely associated with cognitive and behavioural aspect of pain, rather than 
the sensory and biomechanics one in NSCLBP (Campbell & Edwards, 
2009; Gatchel et al., 2007). This may suggest that patients’ self-care attitude 
is more likely to be enhanced, by giving cognitive-behavioural elements of 
self-management in addition to the patients’ information and education 
provided traditionally in one-to-one physiotherapy.  
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2. Relationship between HLOC and use of self-care 
Harkapaa (1991) reported that use of self-care was significantly associated 
with higher ILOC and lower ELOC. Therefore, it is possible that an 
increased ILOC and decreased ELOC during Phase B may have something 
to do with patients being more actively adopted self-management strategies, 
and patients’ perception of need for self-management has improved, hence 
reflecting on their improved self-care attitude. 
  
3. Patients/ physiotherapist relationship 
Self-management involves five key elements: problem-solving, decision-
making, resource utilization, forming a patient/healthcare provider 
relationship, and taking action (Lorig & Holman, 2003). The success of 
effective self-management therefore depends on the collaboration between 
patients and healthcare providers (Bodenheimer et al., 2002). Being on a 
weekly 2-hourly programme for six consecutive weeks may be more 
effective in helping patients to acquire the problem solving skills and the 
confidence to self-manage their NSCLBP, than 4 sessions of individual 
physiotherapy as shown in the current study.  
 
Being in a group may also facilitate the improvement in self-care attitude. A 
RCT involving 812 patients with arthritis in primary care concluded that the 
self-management arthritis programme reduced patients’ anxiety and 
improved participants perceived self-efficacy to manage symptoms 
(Buszewicz et al., 2006). Although this study showed no significant effect 
on pain, physical functioning or number of GP consultation in primary care, 
it highlights that a self-management programme delivered in a group can 
impact on patients’ psychological well-being such as anxiety, depression 
and self-efficacy. With NSCLBP being chronic condition liked arthritis, it is 
possible that the psychological benefits from being in a group may improve 
patients’ self-attitude towards their back pain.  
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What treatment components of the CBCLBP programme may 
contribute to improved self-care attitude? 
Improved self-care attitude towards back pain requires (1) change of self-
management behaviour and (2) increased individual’s ability to self-manage 
their NSCLBP.  
 
1. Self-management behaviour 
Self-management behaviour refers to the actions and thoughts that a patient 
uses to self-manage their condition (Summers et al., 2014). These 
behaviours may include: (1) knowledge and ability to control pain using 
pharmalogical and non-pharmalogical pain relief; (2) strategies to cope with 
stress such as relaxation and effective communication with friends, family 
and health professionals; (3) strategies to maintain a positive outlook and 
motivation to self-management such as distraction, pacing activities, 
problem-solving and goal setting and; (4) ability to handle flare-ups such as, 
plans of action to manage setbacks and equip patients with knowledge to 
decide when to self-mange, or to seek help appropriately (such as 
introducing “red flags”). These various physical and CBA activities should 
not be seen as mutually exclusive as the spectrum of approaches often 
compliments one another when used simultaneously (Lawn & Schoo, 2010).  
 
2. Increased individual’s ability to self-manage their NSCLBP 
It was suggested that even individuals who are less motivated and less 
confident initially, can develop new skills and competencies through 
supported self-management (Hibbard & Greene, 2013). Supported self-
management comes in many forms. It can range from verbal and written 
education materials, health-professional led physical and psychological 
intervention, to specifically designed exercise classes and personalised 
support and advice (Du et al., 2011).  
 
For instance, it has been shown that exercise is one of the most commonly 
used self-management strategies in NSCLBP patients; however patients are 
only likely to do exercises that fit in with their lifestyle or make sense to 
them (Cooper et al., 2009), or the experience of exercise without feeling fear 
and undue harm (Mannion et al., 2001). This implies that physiotherapists 
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should be flexible and cater for patients’ individual needs, and should not 
assume a “one size fits all” approach in their treatment. The CBCLBP 
programme included the opportunity to review home-exercises (Appendix 
13) and overcome patients’ personal physical and psychological barriers 
which would compromise their self-management tasks. This was well 
received by patients. Various types of graded exercise such as core stability 
work, stretching exercise, lightweight and cardiovascular training 
(Appendix 14) were included in the 45 minutes supervised exercise circuits. 
Pilates and hydrotherapy are particularly welcomed by patients. This study 
showed that 56% of the participants continued hydrotherapy 6-month 
following the programme. Collectively, these observations may suggest that 
some form of ‘personalised’ approach in home exercise programme and 
introducing new activity (such as hydrotherapy and Pilates) that differs from 
patients’ normal home exercise routine seems to help facilitating self-care 
attitude. 
 
Why there is difference between statistical significance and clinical 
significance during Phase B? 
In terms of statistical significance, the effect of the CBCLBP programme 
has yielded a statistically large improvement of self-care attitude between 
week 1 and week 6. This finding replicates the positive results of previous 
studies which also demonstrate the effectiveness of the physiotherapy-led 
CBA programme in improving self-care (Klaber Moffett et al., 1999; 
Critchley et al., 2007), and the effectiveness of group-based self-
management education programme in primary care (Von Korff et al., 1998; 
Moore et al., 2000). Despite variations in interventions, patients’ 
characteristics, reporting of the outcomes, involvement of physiotherapist in 
delivering the programme, and methodological qualities among studies in 
current literature, this study lends further support to the effectiveness of 
CBA active rehabilitation in enhancing patients’ ability to self-care. 
 
However, in terms of clinical relevancy, the effect of the CBCLBP 
programme resulted in 20% improvement in self-care attitude, which is not 
considered to be clinically relevant (MCID= 30%, Ostelo et al, 2008). This 
means that the treatment effect size for self-care attitude that occurred in 
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Phase B is unlikely to be clinically important to patients. This finding was 
unexpected, due to the goal of the CBCLBP programme is to empower 
patients to take responsibility for their pain management. Keedy et al (2014) 
found that NSCLBP patients have significantly higher ILOC but no 
improvement in ELOC (for medical professionals) following an intensive 
two-week MI programme. This may suggest that it is possible for patients to 
experience increased ILOC, but not necessarily abandon their external 
expectancies related to the future desire of using healthcare and prescription 
medication. Despite an increase in ILOC and decrease in ELOC during 
Phase B, this finding may exemplify a case in which increase in ILOC and 
decrease in ELOC does not imply better self-care attitude perceived by 
patients, at least with respect to their desire in future healthcare and 
prescription usage. 
 
Another possible explanation could be the limitation of the SCQ, which was 
the outcome measure used for assessing patients’ self-care attitude. The 
majority of the outcome measures (VAS, RMQ and TSK) are well-known 
and have well-documented reliability and validity. In comparison, the SCQ 
has not been as well studied, and has less well documented psychometric 
properties.  
 
Firstly, the SCQ demonstrates moderate internal consistency reliabilities (α= 
o.51-0.61), and it was shown to predict future use of health care for back 
pain and/ or future use of prescription pain medications in two different 
samples (Saunders et al., 1999). This means that all the five-items of the 
SCQ deal with patients’ self-care attitude. However, it must be noted that a 
measure is only reliable for use with a particular population (Roach, 2006). 
Since the SCQ is developed and validated mainly based on patients with 
NSCLBP (Von Korff et al., 1998; Saunders et al., 1999; Moore et al., 2000), 
it is possible that the SCQ lacks sensitivity when assessing NSCLBP with 
high FAB specifically as in the present study.  
 
Secondly, it may be the responsiveness of the SCQ, which refers a 
measure’s ability to accurately detect changes when it has occurred (Beaton 
et al., 2001). A number of factors may influence the responsiveness of a 
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measure; for instance, patients were rated on a 5-point scale of the SCQ, 
whether they strongly agreed, agreed, were neutral, disagreed or strongly 
disagreed with the five-items statements. The stated capacity of patients 
may improve or decline within the responses [‘strongly agreed’ or ‘agreed’] 
or [‘strongly disagreed’ or ‘disagreed’], because these responses do not give 
enough boundaries, and large changes in patients’ subjective perception on 
self-care attitude are required to change categories. Thus, the SCQ may be 
less responsive because the scoring of some of the five items of the SCQ is 
unlikely to change in response to the CBCLBP programme.    
 
What are the possible reasons for the sustained improvement in self-
care attitude during Phase A2?  
1. Developed self-management that fits one’s life 
Self-management behaviours develop over time, based on both incremental 
learning from experience and evaluation of actions (Ong et al., 2011). 
Audulv et al. (2012: 331) identified four phases of self-management over 
time: 
 ‘Seeking effective self-management strategies 
 Considering costs and benefits 
 Creating routines and plans of action 
 Negotiating self-management that fit’s one life’ 
 
The final phase is of particular interest to explain the sustained improvement 
in self-care attitudes. Once patients had identified self-management 
strategies that worked for them, a final phase of adjustment occurred in 
order to fit with patients’ day-to-day lives. Over time (even after completion 
of the CBCLBP programme), patient may embed some of the self-
management behaviours into their lives, and that likely become a routine. 
Patients may learn, adapt, modify the self-management skills, which make 
them feel more confident and motivated towards their self-care that suits 
their individual needs, thus feeling less desire to visit health care services 
and use prescription pain medications.  
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2. Stages of behavioural change 
Maintenance of effective self-management only succeeds if the patient is 
motivated and ready to make behavioral or life-style changes. Five stages of 
behavioural changes have been identified across multiple studies including 
smoking cessation, exercise and diet (Prochaska & DiClemente, 1983; 
Prochaska et al., 1991).  
Five stages of change (Kerns et al., 1997) (Figure 5.5): 
1. Precontemplation- the stage where individuals have little 
interest in changing specific behavior; 
2. Contemplation- the stage where individuals think about 
behavioural change but unlikely to make that change soon; 
3. Preparation- the stage where individuals actively consider 
behavioural change and prepare for the change; 
4. Action- the stage where individuals actively work toward 
changing their behavior; 
5. Maintenance – the stage where individuals maintain changes in 
behaviour. 
 
      Figure 5.5: Cycle of change (Kerns et al., 1997) 
 
 
 
 
Preparation 
Action 
Maintenance 
Relaspe 
Pre-
comtemplation 
Comtemplation 
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The CBA perspective in NSCLBP is entirely consistent with this theoretical 
framework. The CBCLBP programme proceeded through a series of phases 
that begin with helping patients to reconceptualise negative thoughts and 
feelings and encourage change in beliefs and commitment to change to 
enhance their self-care ability. This is followed by a set of CBA skills 
practice (such as cognitive restructuring, relaxation, pacing activities and 
exercises) that help promotes and maintains changes in self-management. 
For instance, patients may have no interest to take up daily exercise when 
they first attended the CBCLBP programme (Pre-contempletation). With the 
various CBA components and supervised exercise in the programme, 
patients may start considering daily exercise (Contempletation), take active 
steps to change such as joining the gym and living in a more active lifestyle 
(Action) and finally attempt to maintain those changes such as attending 
gym regularly and living healthy (Maintenance).  
 
As shown, relapse is part of the cycle. It was reported that maintenance of 
heath behavioural changes (such as smoking cessation) may take individual 
at least six times to achieve long-term changes (Prochaska & DiClemente, 
1983; Prochaska et al., 1991). Patients in the CBCLBP programme were 
reassured that relapse is a natural part of the cycle, and episode of relapse 
should be viewed as a positive learning experience (i.e. why relapse and 
how to address it), then re-entering the cycle with better preparation. The 
sustained improvement in self-care at 6-months is likely due to patients 
were in the ‘maintenance’ stage. 
 
Advantages of improved self-care attitude 
The findings of the present study demonstrated that with this subgroup of 
NSCLBP patients (with moderate pain, moderate disability and high FAB), 
the CBCLBP programme is more effective in improving their back pain 
self-care attitudes (in terms of future use of healthcare and/or prescription 
pain medications), than usual physiotherapy at 6-week and 6-months.  
The sustained 6-months improvement in self-care attitude results in a 
number of advantages to both patients and healthcare providers. First, a 
more active self-care attitude implies that patients showed less desire to 
utilise healthcare and prescription pain medications (as evaluated by SCQ) 
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following the programme. This leads to reduced associated costs for 
healthcare services and healthcare usage, which give social and economic 
benefits. Second, when patients were able to treat themselves without 
excessive or unnecessary reliance on professional care and/ or prescription 
medications, it gives them the feeling of being in personal control. This is 
supported by the increased ILOC and decreased ELOC found in the current 
study during Phase B and Phase A2. From the patient’s perspective, being 
able to manage day-to-day impact of the condition, and to perform 
functional activities including work and hobbies has both physical and 
psychosocial benefits.  
 
Informal feedback from patients which may give alternative 
explanation for sustained self-care ability 
Interestingly, the informal feedback from many participants reported that 
their brief return visits for follow-up assessment at 3-months and 6-months 
as part of the study provided them with motivation and reassurance to 
continue self-care. This is congruent with some qualitative studies, which 
also show that participants expressed their wish for follow-up following 
discharge to support self-management of CLBP (Cooper et al., 2009; Liddle 
et al., 2007). Telephone review services have been used for patients with 
acute LBP whilst they were awaiting physiotherapy appointments (Taylor et 
al., 2002), therefore it may be worthwhile exploring its use in supporting 
NSCLBP patients’ self-care following discharge from the CBCLBP 
programme in future work. Alternatively, further work could be considered 
to study if telephone, group-based or electronic [Skype] follow-up would 
facilitate continued ability to self-care in NSCLBP patients following 
participation of the CBCLBP programme.  
 
Promoting self-care is an important objective in the CBCLBP programme. 
A UK policy document has emphasized the importance of self-management 
of long-term conditions (Department of Health, 2006), in which patients are 
encouraged to take an active role for continued self-care. Consequently, one 
of the measures of successful treatment outcome is whether patients take 
over their self-management, and if they are able to rely less on professional 
care and/ or prescription medications as reported in current study.  
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5.7 Aim 5- The cost per change of ILOC as a result of the 
CBCLBP programme   
The primary objective was to examine the cost of back care per change of 
ILOC. In addition, the cost of the six-week CBCLBP programme from a 
provider’s, patient and societal perspective as well as the longer term (6-
month) back care cost for patient and provider were examined.  
5.7.1 The cost of a six-week CBCLBP programme from a 
provider’s, patient and societal perspective 
From a provider’s perspective, the total cost to the NHS of providing a six-
week, 7-session of 2 hours [14 hours] CBCLBP programme was £285.82 
per patient (based on treating 8 patients per group), the mean patient cost 
was £9.10, and the mean societal cost was £124.59 (Table 4.29).  
 
Provider’s cost for the physiotherapist-delivered programme 
comparison to other studies  
There are no published studies evaluating the cost of a six-week 
physiotherapy CBCLBP programme. There are also only a limited number 
of economic studies of physiotherapy CBA active rehabilitation within the 
literature. Therefore, the PI can only make comparison with studies of 
similar intervention, treatment rationale and patient population that included 
economic evaluation. These previous studies concluded that the 
physiotherapist-delivered CBA intervention is less costly than individual 
physiotherapy (Critchley et al., 2007); spinal stabilisation class (Critchley et 
al., 2007), and other active treatments for LBP (Lamb et al., 2010). Figure 
5.6 summarized the comparison of provider cost between the present study 
and previous studies. 
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Figure 5.6: Comparing the provider’s cost with previous studies 
 
Study Patients’ 
characteristics 
Total 
treatment 
time  
Delivered by Provider 
costs per 
patient  
Provider 
costs per 
hour 
Current 
study 
NSCLBP 
patients with 
moderate pain, 
moderate 
disability and 
high FAB 
14 hours 
(8 patients 
per group) 
Band 7 or 
above 
physiotherapist 
and band 4 
physiotherapy 
assistant 
£285.82 £20.42 
Critchley 
et al. 
(2007) 
NSCLBP with 
moderate pain 
and moderate 
disability 
12 hours 
(unclear 
of number 
of patients 
per group) 
Senior 
physiotherapist 
with at least 
two years 
clinical 
experience and 
physiotherapy 
assistant 
£165 £13.75 
Lamb et 
al. 
(2010) 
Subacute and 
chronic 
NSLBP 
patients with 
moderate pain, 
moderate 
disability and 
lower FAB 
9 hours 
(8 patients 
per group) 
Physiotherapist, 
nurse, 
psychologist 
and 
occupational 
therapist 
£187 £20.78 
 
As shown, the current study has almost the same provider’s cost per hour as 
the study by Lamb et al. (2010). i.e. it costs the provider approximately £20 
per hour to provide a CBA active rehabilitation programme. In comparison, 
Critchley et al. (2007) has the lowest provider’s cost per hour (£13.75). A 
possible explanation for the difference could be that the current study 
included a session of hydrotherapy in our CBCLBP programme, which is 
relatively more expensive than the physiotherapy gym and equipment that 
were predominantly used by Critchley et al. (2007). Another possible 
explanation could be the cost of staffing. The programme of Lamb et al. 
(2010) was delivered by multi-disciplinary members, whereas the present 
study was delivered by Band 7 or above musculoskeletal specialist 
physiotherapists with at least 10 years’ clinical experience. The pain 
management programme by Critchley et al. (2007) was delivered by senior 
physiotherapists (unclear of banding) with at least two years’ experience, 
which possibly cost less. In addition, it may have something to do with the 
number of patients per class. Provider’s cost is calculated based on the 
number of patients per class, the higher the number of patients per class, the 
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lower cost it is likely to be. Critchley et al. (2007) was unclear about the 
number of patients per class in their pain management programme, whereas 
the present study and Lamb et al. (2010) both were based on 8 patients per 
class. Finally, inflation should be considered, since these previous studies 
(Critchley et al., 2007; Lamb et al., 2010) were conducted more than six 
years ago. An average inflation in the U.K. has been fluctuated between 
0.05% and 4.48% in the last ten years (Worldwide inflation data, 2010), 
which likely to have a direct impact on cost difference between studies.     
 
How to keep cost down? CBCLBP programme vs Individual 
Physiotherapy 
The provider’s cost of £285.82 per patient is based on 8 participants per 
class. However, this cost would be increased if there are less than eight 
patients being treated. For instance, if there are only 4 patients per group, 
the provider’s cost would be raised to £458.46 per patient. This study did 
not compare the cost between group-based treatments to individual 
physiotherapy treatment. By taking an example of the normal practice in 
Stockport NHS physiotherapy, a band 7 physiotherapists (costs £58 per 
hour, (Curtis, 2013)) averagely treats a NSCLBP patient individually for 6 
hours from referral to discharge, this works out physiotherapy staffing cost 
of £348 per patient. This implies that group-structured treatment will only 
be less costly than individual physiotherapy if each programme takes up to 
6-8 patients per group. This highlights the importance of careful selection 
and appropriate referral to the group-structured CBA intervention. Clinical 
decision-making for the CBA programme referral can be aided by NICE 
guideline recommendation and use of validated screening tools such as 
STarTback (Hill et al., 2011). Consideration of patients’ preference for the 
programme was also shown to be clinically important in reduction in pain 
and disability (Johnson et al., 2007). Therefore, good communication and to 
understand patients’ preference prior to referral should also be considered.     
 
Group-structured and CBA treatment is not for every patient. For example, 
some patients simply prefer not being treated in a group, or those with 
multiple problems or having difficulties in understanding English language 
may find group-based intervention unsuitable. CBA intervention challenges 
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patients’ beliefs and behaviours about their back pain, and emphasizes self-
responsibility and self-care. Therefore, if patients do not prefer group-based 
treatment, or do not engage with the general goal of the CBA rehabilitation, 
they are probably more likely to fail to attend the CBA based group 
intervention. This consequently leads to higher provider’s cost due to 
attrition and small group size.  
 
It was recommended by The British Pain Society (2013) that the appropriate 
group size for the CBA programme should aim to have 8-12 participants. 
This is not only for economic benefit for the provider. But an appropriate 
group size can be useful for group influence such as maximizing the 
opportunity to drawn on the experiences of group members,  providing a 
natural social environment to address cognitive and behavioural change, and 
help normalizing pain experience. If the group size is too small or large, it 
may weaken the potentially useful group influence (The British Pain 
Society, 2013).   
 
Mean patient cost attending the programme 
The mean patient cost during the programme was £9.10, which includes 
travel costs, lost wages, prescription costs and other out-of-pocket expenses 
incurred during the six-week programme. No direct comparison can be 
made within literature. The mean patient cost of £9.10 means a low 
financial burden to patient. 
 
An explanation for low travel cost could be the easy access and central 
location of the physiotherapy department, which is located in the town 
centre. Besides, 85% of the study participants travelled by car, and the car 
parking of the physiotherapy department is free of charge, with plenty of 
spaces. Therefore, there is no car parking fees incurred and no stress in 
looking for a car parking space. A well-conducted transport study showed 
that there is a strong link between transport or transport related factors and 
missed NHS appointment (Hamilton & Gourlay, 2002). The ease of access 
and low travel cost for patients may have an indirect impact on their 
attendance. 
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Only 4% participants reported lost wages to attend the CBCLBP 
programme. This could be explained by offering participants three available 
class times to choose from, so that they could attend the programme without 
direct personal financial sacrifice (62% patients were working). No 
prescription charges were reported, and only 4% reported other costs 
incurred when undertaking the six-week programme. This demonstrates a 
low utilisation of other health services during the CBCLBP programme, 
possibly because patients feel that they are able to cope better with their 
NSCLBP and they establish more positive outlook towards their self-
management when having regular physiotherapy contact during the 
programme. 
 
Mean societal cost 
The mean societal cost was £124.59 per patient during the programme. This 
includes the value of time lost to travel and time spent in the physiotherapy 
department. The AWR for employer in the Northwest UK is £10.75 per 
hour (Office for National Statistics, 2014). To reflect the employers’ cost, 
this rate was uplifted by 13.8% to reflect employers’ National Insurance and 
superannuation contributions (HM Revenue and Customs, 2014). On the 
other hand, the value for non-working time (e.g. housework and leisure 
time) was multiplied by £6.04 (Department for Transport, 2014).  
 
The present findings showed that the mean societal cost due to lost time 
from work (£166) was almost double compared to the mean societal cost 
due to lost time from non-working time (£83). An explanation for this result 
could be that 96% of participants with paid occupation responded as making 
arrangement such as “time off without loss of pay” or “annual leave” to 
attend the programme (Table 4.26). This cost is tolerated by society rather 
than patients themselves, which is more beneficial from the patients’ cost 
perspective. 
 
Compared to some LBP economic surveys conducted in the context of 
Germany primary care, Becker et al. (2010) reported that the mean societal 
cost per patient per year was €936 (£743) in a sample of 451 CLBP patients. 
A large cost survey of LBP (N=5650) by Wenig et al. (2009) reported that 
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the mean societal cost was €1322 (£1049) per patient per year in Germany. 
In the present study, with the mean societal of £124.6 per patient for the six-
week programme in primary care, it can be annualised to the mean societal 
cost of £1080 per patient per year. This is similar to the findings by Wenig 
et al. (2009), but it is more expensive than the report by Becker et al. (2010). 
A possible explanation could be that in the survey by Becker et al. (2010), 
over 50% of the CLBP patients only used drugs as form of CLBP 
management and only 4% of them participated in a rehabilitation 
programme in the survey. This may consequently reduce the indirect cost 
such as taking time off from work for appointment, travel and lost 
productivity. The inconsistent findings can also due to the differences in 
patients’ characteristics, treatments received by patients, and structure of 
healthcare systems in different countries. 
 
5.7.2 The cost per change of ILOC as a result of the CBCLBP 
programme 
The ILOC was used to measure the incremental cost-effectiveness of the 
CLBP programme. We found it costs the provider £53 for every unit of 
improvement of ILOC.  
 
This is the first study which has reported the cost per change of ILOC, 
providing a bench mark for future studies. However, the potential benefit of 
improvement of ILOC is evident in this study, including (a) Improvement in 
ILOC is found to be significantly associated with improvement in pain 
intensity, disability and FAB in this study and (b) improvement in ILOC 
was shown to be a significant predictor to reduction in FAB.  
 
Other studies reported in the literature have also demonstrated evidence of 
the benefits of improving ILOC in NSCLBP. For example, ILOC was 
positively correlated to quality of life (Sengul et al, 2010), active coping 
strategies (Harkapaa et al, 1991), less psychological distress (Crisson and 
Keefe, 1998), information seeking and prediction of better outcome (Main 
and Waddell, 1991). Given that an incremental cost of ILOC of £53 may 
potentially gain the aforementioned clinical benefit, this may provide a 
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useful and alternative way for managers and clinicians to consider the cost-
effectiveness of the CBCLBP programme.  
 
To put our finding of cost per change of ILOC into context, Hollinghurst et 
al. (2008) conducted a cost effectiveness analysis to compare the cost to the 
NHS with the primary outcome of the RMQ and the number of days free of 
pain. A total of 579 patients with NSCLBP in primary care who randomised 
into: exercise, six sessions of massage, and six sessions of Alexander 
technique, as single and combined intervention. Their findings revealed that: 
(1) Incremental costs to the NHS of every point reduction in disability score 
were: £61 per point on disability score by exercise alone; £64 per point by 
Alexander techniques plus exercise, and £448 per point by massage alone; 
(2) Incremental costs to the NHS of additional pain-free day were: £9 per 
additional pain-free day by exercise, £43 per additional pain-free day by 
combined Alexander techniques and exercise, and £26 by massage alone. 
With an incremental cost to the NHS of every point of improvement in 
ILOC of £53, it seems to be a good value option for the provider 
comparatively.     
 
During the planning of the economic evaluation of this study, it was 
suggested that the use of EQ-5D would be a useful outcome measure. 
However, the PI was concerned about the risk of respondent fatigue 
(Lavrakas, 2008). If EQ-5D was included, each participant would have a 
total of seven questionnaires to complete. This may have resulted in 
reluctance by participants to complete the outcome measures, which may 
have led to poor response rate and poor data quality (Lavrakas, 2008). In 
addition, the PI felt that it is important for clinicians and policy makers to 
consider a range of outcomes when drawing conclusions about the cost 
effectiveness of an intervention (Coast, 2004). Therefore, the cost per ILOC 
was chosen. 
 
The PI acknowledged that the use of EQ-5D to calculate quality of life 
adjusted years (QALYs) will be a better option than ILOC in order to 
provide data that can be compared across studies. The EQ-5D instrument is 
recommended by Department of Health (2010) and the CSP (Jette et al., 
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2009) to assess cost effectiveness in relation to musculoskeletal 
physiotherapy outpatient services. It is also widely used in many existing 
studies. The current study can be replicated by using EQ-5D so that a 
standardised and direct comparison with other studies and other treatments 
for NSCLBP can be made.  
 
5.7.3 The longer-term (6-months) cost of back care from a 
patient and provider’s perspective 
NSCLBP is a chronic condition that often results in ongoing providers’ and 
patients’ costs. This highlights the importance of evaluating the economic 
impact in a longer term as a result of the CBCLBP programme. In the 6-
months period following completion of the CBCLBP programme, the mean 
patient’s cost was £160.7 (including prescription charge, travel costs and 
therapy charge) (Table 4.31), and the total mean provider’s cost (including 
GP visits and any utilisation of NHS service) per patient was £154.1 (Table 
4.32).  
 
Hollinghurst et al. (2008) reported the mean provider’s cost for patients’ 
normal GP care (when patients received no active NHS treatment for their 
LBP) was £55 per year, and the mean patient cost at one-year was £375, 
with £170 (45%) of this relating to expenditure on private therapies. To 
compare these data to our mean provider’s cost (£308) and patient cost 
(£321) at one-year (by doubling our six-month figures), the provision of the 
CBCLBP programme is much more expensive for the provider, however it 
is cheaper for patients’ out of pocket expenses at one-year if patients 
received the CBCLBP programme.  
 
It must be noted that there may be other potential cost in long-term (> 1-
year) if patients did not receive appropriate treatment. For instance, it was 
suggested that the total UK low back pain related cost, including private 
care and societal cost such as loss of productivity are between 4.7- 10 times 
more than NHS cost (Koes et al., 2001). While commissioners and 
managers are actively seeking evidence for clinical and cost effectiveness 
for NSCLBP treatments, the financial burden of NSCLBP is far more 
complex due to its high societal cost, patient cost and potential provider’s 
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cost in long-term. The saving for providers, patients and the society are 
likely to be greater over time by implementing appropriate treatments.  
 
Mean patient cost at 6-months: comparison with other studies 
Critchley et al. (2007) reported the total mean patient cost from baseline to 
6-months was £70.49 following participation of a physiotherapy-led CBT 
rehabilitation, whereas the total mean patient cost of current study was 
£160.70 at 6-month. When comparing the baseline between two studies, 
pain intensity and disability scores were very similar (VAS= 59mm and 
RMQ= 11.5 (Critchley et al., 2007), VAS= 60.4mm and RMQ= 
11.5(current study)). The duration of both programmes also had similar 
content and similar treatment duration. Travel cost is unlikely to be the 
reason of a higher mean patient cost found in our study. This is because the 
present study took place in Stockport, which is cheaper to travel, whereas 
study by Critchley et al. (2007) was in London, which is more expensive for 
patient to travel. 
 
One explanation for higher mean patient costs in the present study could be 
that all those nine patients (only 9 out of 55 patients went for other therapy 
6-months following the CBCLBP programme) self-funded their therapy 
(Table 4.30). Interestingly, the majority of the patient cost (£133.4 out of 
£160.7) was spent on “travel and other therapy”, rather than “travel and 
prescription costs”. Besides, amongst “type of other therapy’, 56% of 
patients opted for self-funded hydrotherapy, 22% private physiotherapy and 
22% self-funded acupuncture (Table 4.30). This observation implies that 
despite patients in the present study reviewing higher mean patient cost than 
Critchley et al. (2007), the majority of patient chose proactive treatment (i.e. 
hydrotherapy) to continue self-care, rather than opting for passive 
treatments such as private physiotherapy and acupuncture. It was found that 
use of self-care was significantly associated with high ILOC and low ELOC 
(Harkapaa, 1991). It is possible that the steady increase in ILOC and 
decrease in ELOC found in the present study may partly explain the 
increase in self-care attitude at 6-months following the CBCLBP 
programme.     
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Mean provider cost at 6-months: compared with other studies 
Lamb et al. (2010) reported that mean provider cost at one year was £234.51 
per patient in their advice plus CBT intervention group. Klaber Moffett et 
al. (1999) reported mean provider cost was £334.95 per patient at one year 
in their exercise and CBT group. Both of these studies examined patients 
with a mix of subacute and chronic LBP, and only reported provider cost at 
one-year. This present study reported £154.1 for six months period in 
NSCLBP patients following the CBCLBP programme. Direct comparison 
with other studies is difficult due to difference in LBP population being 
studied, economic evaluation design, clinical setting and follow-up period. 
There is also evidence to suggest that age, gender, social class and 
employments are also determinants of utilisation of primary care services 
(Field & Briggs, 2001). However, if it is doubled the six-month mean 
provider cost of the present study, it gives £308.2 at one-year which is 
similar to those reported by Klaber Moffett et al. (1999).  
 
Healthcare utilization at 6-months 
Patients with CLBP are likely to seek care (Mortimer et al., 2003; 
IJzelenberg & Burdorf, 2004), and more likely to use health care services 
(Carey et al., 1995; Carey et al., 1996; Von Korff et al., 2007). In the six 
months after completing the CBCLBP programme, 25% participants re-
visited their GP, 27% required prescriptive pain medication, no participants 
reported use of NHS therapy services (including physiotherapy and 
secondary care), and 22% reported private physiotherapy services (Table 
4.30).  
 
Lamb et al. (2010) studying patients with subacute and chronic LBP, 
reported 50% of participants re-visited their GP at least once during follow-
up, 19% used NHS physiotherapy and 23% private back pain services. As 
shown, our finding of NHS utilization is comparatively much lower than the 
study by Lamb et al. (2010). The different findings may be explained by the 
different employment status between the two studies. A higher rate of GP 
consultation is shown to be associated with unemployment (Carr-Hill et al., 
1996; Field & Briggs, 2001). Lamb et al. (2010) reported 9% of participants 
were unable to work because of back pain and 7% unable to work due to 
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other illness. In the present study, 2% were on sick leave, 6% were 
unemployed due to back pain and no participant was unemployed due to 
other illness (Table 4.1). Unemployment implies a life event of change, and 
such change may cause stress, increased tendency to sick role behaviour and 
increased perception by patients that there is a need and benefit to consult 
their doctors (Westin, 1993). The lower unemployment rate (62% were 
employed and currently working) in this study could at least be the reason 
for less GPs consultation at 6-months.  It is acknowledged that other factors 
such as cultural difference, physical and psychological health, social 
security needs and financial and family hardship may also affect GP 
consultation (Westin, 1993; Carr-Hill et al., 1996; Field & Briggs, 2001). 
However, they are not always easy to disentangle in research due to its 
complexity and the consideration of these factors is beyond the scope of 
present study.  
 
Another explanation for the lower healthcare utilization in current study 
may be related to the significant improvement in ELOC. It has been 
suggested that higher consultation is associated with externalised beliefs 
regarding pain management in LBP patients (Wallston & Wallston., 1982; 
Waxman et al., 1998). In the present study, significant reduction in ELOC 
was observed at week 6 and 3-months; a slow but non-significant reduction 
in ELOC continued until 6-months (Table 4.8). Although the correlation 
between healthcare utilization and ELOC was not examined in this study, 
these two factors may be associated, as suggested in the literature (Wallston 
& Wallston, 1982; Waxman et al., 1998).  
 
84% of the participants did not consult other therapy following the 
CBCLBP programme at 6-months. This can be seen as a reflection that 
participants are self-managing satisfactorily (Table 4.30). 16% of the 
participants visited other therapy following completion of the programme, 
yet all were self-funded. Of the different therapies patients visited during the 
six-month period, hydrotherapy appears to be the most popular (56%); 
private physiotherapy and acupuncture accounted for 22% and 22%, 
respectively. It is unclear why so many patients opted for hydrotherapy 
following the CBCLBP programme. A RCT concluded that hydrotherapy 
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produced better improvement in disability and quality of life in patients with 
CLBP than physiotherapy home-based exercise (Umit et al., 2009). It is also 
noteworthy that informal feedback from patients found hydrotherapy 
particularly enjoyable, and beneficial to their NSCLBP condition both 
physically and psychologically; and many of them saw it as part of their 
self-management rather than a therapeutic treatment. A great interest opting 
for hydrotherapy following the CBCLBP programme suggests that patients 
became more independent about their future self-management and they 
developed their own preferred self-care strategies which is healthy, 
proactive and fun.  
 
With the demand for evidence-based practice in physiotherapy, combined 
with the need for the best use of both public and private resources, 
policymakers and commissioners understandably require physiotherapists to 
demonstrate their service and expertise are efficacious and effective, and 
supported by evidence. The present findings provide a benchmark for the 
cost of a six-week physiotherapy CBCLBP programme from a provider and 
patient perspective in both short-term and longer term (6-months). It also 
included the societal cost per patient to attend the programme. It must be 
noted that careful selection when referring NSCLBP patients onto group-
based intervention is important in keeping the provider cost down. The low 
healthcare utilisation six months following the programme could be seen as 
a reflection of how successfully the various components of the CBCLBP 
programme have been achieved.  
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER 6 Summary, recommendations and conclusions Page 247 
 
 
CHAPTER 6 SUMMARY, RECOMMENDATIONS 
AND CONCLUSIONS 
6.1 Introduction 
Despite a large body of studies supporting the positive effect of the CBA 
active rehabilitation in NSCLBP, there is limited evidence for the 
effectiveness of CBA treatment targeting NSCLBP patients with 
psychosocial risk factors such as high FAB. Besides, the overall quality of 
existing evidence relating to this field is poor, with the majority associated 
with mixed duration of NSLBP patients. Therefore, this study focussed on 
NSCLBP patients characterized with high FAB, which is a challenging 
subgroup of LBP patients for primary physiotherapists encountered in 
clinical practice. 
Only a limited number of studies have investigated the effects of CBA 
treatment on HLOC, and the association between HLOC and the key 
clinical elements of NSCLBP. Existing evidence is overall low in quality. 
These studies do not allow us to determine the potential importance of 
HLOC in the physiotherapy management of NSCLBP. On the basis of 
HLOC concerns of individuals’ beliefs about self-responsibility, and 
whether one’s actions and behaviour may influence outcomes (Wallston & 
Wallston, 1982), HLOC may be a contributing factor or underlying 
mechanism of how desired outcomes can be achieved. Therefore, this study 
has chosen HLOC as the primary outcome and examined its relationship 
with other NSCLBP co-variables. 
The majority of LBP patients are seen in primary care, and the cost is 
substantial (Becker et al., 2010). It is important that a treatment achieves 
‘value for money’ in the current financial climate. Therefore, a cost study 
was also included in this study, with the aim of providing a benchmark to 
managers and policy-makers when allocating their limited budget and 
resources. This final chapter presents a summary of the findings, 
recommendations, strengths, limitations, key learning and conclusions 
drawn from the present thesis.          
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6.2 Summary- Aims and key findings of the study 
Aims of the study were to: 
1. Assess the effects of the physiotherapy CBCLBP programme on 
patients’ HLOC. 
2. Examine the effects of the CBCLBP programme on pain, disability 
and FAB. 
3. Determine if there is any relationship between patients’ HLOC and 
pain, disability and FAB. 
4. Examine patients’ self-care attitude toward their back pain in terms 
of their desire in future use of healthcare and prescription pain 
medication as a result of the programme. 
5. Investigate the cost of back care per change of ILOC, and the cost of 
the CBCLBP programme from a provider’s, patient and societal 
perspective. 
 
Key findings of the study 
1. The physiotherapy CBCLBP programme has significantly improved 
patients’ HLOC, with such improvement being sustained for six 
months. 
2. The physiotherapy CBCLBP programme has significantly improved 
patients’ pain intensity, disability and FAB, with such improvement 
being sustained for six months. 
3. (i) A significant relationship was found between reduction of pain 
intensity, reduction of disability and reduction of FAB. 
(ii) Increase in ILOC was significantly associated with reduction in 
pain intensity, disability and FAB. 
(iii) Reduction in ELOC and reduction in CLOC were both 
significantly associated with reduction in pain intensity and FAB, 
but they had no significant relationship with reduction in disability.   
(iv) All subscales of HLOC (i.e. ILOC, ELOC and CLOC) were 
found to have no predictive value of reduction in pain intensity and 
reduction in disability, after accounting for demographics and other 
co-variables. 
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(v) Increase in ILOC has emerged as the unique and significant 
predictor of reduction in FAB, after accounting for demographics 
and other co-variables. 
4. The physiotherapy CBCLBP programme has significantly improved 
patients’ self-care attitude towards back pain, with such 
improvement being sustained for six months. 
5. (i) To provide a six-week physiotherapy-led CBCLBP programme, 
the mean provider cost was approximately £285.82; the mean patient 
cost was approximately £9.10, and the mean societal cost was 
approximately £124.59; 
(ii) The incremental cost of ILOC was approximately £53. i.e. it 
costs the provider £53 for every point of ILOC gained; and 
(iii) In the six months following the completion of the CBCLBP 
programme, the mean patient cost was approximately £160.7, and 
the mean provider cost was approximately £154.1. 
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6.3 Strengths and weaknesses of the study 
6.3.1The innovations and benefits of the study 
This is the first study to examine the effects of a physiotherapy led 
CBCLBP programme on HLOC in NSCLBP patients. There are a limited 
number of studies in the literature evaluating interventions with a CBA 
component on HLOC in NSCLBP. Evidence consistently supported the 
positive effect of CBA intervention on HLOC. However, the quality of 
evidence was generally poor. Methodological limitations of previous 
relevant studies include: (1) short follow-up period (< 3-months) (Keedy et 
al., 2014; Harkapaa et al., 1991); (2) use of heterogenous group of back pain 
patients (Klaber Moffett et al., 2006; Rybarczyk et al., 2001); and (3) 
incomplete follow-up data (Keedy et al., 2014; Rybarczyk et al., 2001). The 
present study is likely to provide more valid findings than these previous 
works because of the use of a homogenous group of patients (NSCLBP with 
high FAB), a longer follow-up period (6-months) and complete follow-up 
data were obtained. 
This study is also the first that has shown increase in ILOC was the unique 
and significant predictor of reduction in FAB. Again, evidence in this line is 
limited. There is only low to moderate quality evidence to support the 
relationship between HLOC and NSCLBP variables. Many methodological 
criteria regarding internal and external validity of these previous studies 
were not fulfilled. Besides, the majority of them conducted cross-sectional 
correlation, thus preventing directional conclusions of causality between 
HLOC and NSCLBP outcomes. The present study has an advantage that it 
includes a predictive component, to determine causality. 
The following chain (Figure 6.1) is proposed to summarise the predictive 
relationship of increase of ILOC, reduction in FAB, reduction in pain 
intensity and reduction in disability, following the CBCLBP programme.    
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Figure 6.1: The predictive relationship of an increase of ILOC, 
reduction in FAB, reduction in pain intensity and reduction in 
disability. 
 
 
As shown in Figure 6.1, this study found that the CBCLBP programme was 
effective in enhancing ILOC; increase of ILOC predicting reduction of 
FAB; reduction in FAB predicting lower pain intensity, and lower pain 
intensity predicting lower disability.  
 
The CBCLBP programme may directly improve these physical and 
psychological outcomes (as shown in Section 5.3 and Section 5.4). 
However, it is also possible that the physical outcomes (pain intensity and 
disability) improved via the intermediate link of psychological improvement 
(i.e. increase of ILOC and reduction in FAB). The sequential and directional 
relationship as seen in Figure 6.1 highlight the importance of improving 
patients’ ILOC and FAB, and they could be the underlying factors 
influencing patients’ responses to pain and disability. An important message 
here is that unless the psychological aspects are taken care of first (such as 
ILOC and FAB), the physical components (pain intensity and disability) 
may not be addressed and followed.  
 
This finding is entirely consistent with the treatment philosophy of the 
CBA, where the emphasis is to address patients’ maladaptive beliefs, 
feelings and behaviours (Airaksinen et al., 2006; Henschke et al., 2010).  
 
CBCLBP 
programme ILOC FAB Pain    Disability 
Psychological Physical 
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The new findings of this thesis provide an increased understanding of 
HLOC in relation to the key clinical elements of NSCLBP. It adds new 
knowledge to the current evidence that increased ILOC predicts better FAB 
outcome in NSCLBP. This may be particularly beneficial from a clinical 
perspective. Intervention strategies can be extended to the development of a 
sense of personal control over pain, whilst simultaneously eliminating fear-
avoidance mechanisms and improving overall physical function (which we 
already knew). HLOC may be one important underlying factor to help 
achieve the desired treatment outcomes in NSCLBP patients with high FAB. 
Clinicians could consider addressing patients’ HLOC more fully and more 
specifically during their physiotherapy CBA rehabilitation (see Section 
6.5.1 Implication for practice).  
 
No previous work has examined the effectiveness of CBA treatment 
targeting only NSCLBP patients with psychosocial risk factors such as high 
FAB. This is another major advantage of the present study, which concluded 
that the CBCLBP programme was more effective than usual physiotherapy 
care at reducing pain, disability, FAB, and improving HLOC and self-care 
attitude in NSCLBP patients with high FAB. This has highlighted that the 
CBCLBP programme is more appropriate for this subgroup of patients in 
improving the physical and psychological aspects of their NSCLBP. This 
finding is beneficial for both clinicians and policy-makers during clinical 
reasoning and design of patients’ care pathway. This may also prompt 
appropriate treatment for appropriate patients, so that unnecessary waste of 
time and resources maybe saved for the patient, provider and the society.  
6.3.2 Strength of the study 
Strength relating to methodological quality  
1. Strength of A-B-A design: high in internal validity 
The use of A-B-A design offers a number of strengths in terms of validity of 
the present findings. Firstly, it studies the same group of patients under 
treatment and no treatment condition, and having the same group of patients 
acts as its’ own control (Engel & Schutt, 2012). Therefore, this inherently 
reduces most threats to internal validity that may have been caused by 
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sampling bias and between-group variability. Secondly, the use of same 
subject design means there is no need for randomization and allocation 
concealment. Therefore, selection bias reduces and this consequently 
increases the internal validity. Thirdly, replicating the CBCLBP programme 
over the course of study period to patients of different baseline 
characteristics enhances external validity (Kazdin, 2010). These advantages 
strengthen the internal and external validity of the findings. It allows the PI 
to make confident statements that changes in outcome measures between 
phases are due to the effect of the CBCLBP programme but not some other 
factors.  
 
A desirable quality of baseline data is stability, because this implies that 
data displays limited variability (Byiers et al., 2012). With stable baseline 
data (Phase A1 and Phase A2) and with three baseline data points (-4 weeks, 
3-months and 6-months) as in this current study, stability has been achieved 
and an appropriate basis has been formed for comparison. Therefore, any 
change of trend over the study period is likely to be attributed to the effect 
of the CBCLBP programme (Phase B), and any trend observed in the 
absence of the programme is likely to be the continuation of treatment effect 
(Byiers et al., 2012). This ‘good’ quality baseline data strengthens the 
validity of the present findings about the effect of the CBCLBP programme 
on HLOC and other outcome measures.  
 
2. Good generalizability 
This study also has good generalizability. The PI believes that the results of 
the present study are applicable to the population of NSCLBP patients with 
high FAB presenting for primary physiotherapy. This is because: (a) 
participants were recruited from Stockport, with a variety of socio-economic 
classes from a range of rural and urban, affluent and deprived areas of 
Stockport; (b) the baseline characteristic differences between those who 
completed the programme and those who dropped out of the programme 
only presented significant differences in employment status, financial status 
and ELOC. But aside from these differences, there are no other significant 
differences between them. This suggests that data of the present study is 
derived from patients who were representative of the original sample, 
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indicating the results of good generalizability; (c) baseline profile of the 
included patients is appropriate for the CBA active rehabilitation in 
accordance to clinical guidelines (Savigny et al., 2009), and therefore the 
generalizability of the current findings for clinical practice is probably high; 
(d) this study was conducted within the context of an existing intervention 
(i.e. the CBCLBP programme) in a busy primary NHS physiotherapy 
department with no extra resource or research manpower. The PI had to 
consider and manage practical issues such as time, resource and other 
clinical caseload. All physiotherapists involved in the study were 
experienced physiotherapists with no addition research training. Therefore, 
the programme and the current findings could easily be replicated in any 
primary physiotherapy department as it is a reflection of real-life practice, 
and (e) the CBCLBP programme was not exclusive for research purpose due 
to political and ethical consideration. Patients attended the CBCLBP 
programme during study peroid were a mix of research participants and 
non-participants. Thus, the present findings are more likely to reflect reality 
and natural interaction of patients and physiotherapists compared to 
evidence emerged from an RCT research environment. Because of its 
practice-based nature, it may be beneficial when implementing the current 
findings in future clinical practice (Chan & Clough, 2010).  
 
3. Low attrition 
Another important strength of the present study is its low attrition bias. 
Although CBT treatment for CLBP tends to have high attrition 
(Glombiewski et al., 2010), all participants in this study managed to 
complete the CBCLBP programme (25% attended five out of six sessions; 
75% attended all six sessions). In addition, the response rate at each follow-
up evaluation (week 6, 3-months and 6-months) was 100%. From a patients’ 
perspective, completion of the programme enables participants to optimize 
benefits from the programme components. From a research perspective, 
complete outcome data allowed the PI to have all necessary pre- and post-
treatment data for statistical analysis and adequate reporting, which in turn 
strengthens the validity of the findings. An explanation of excellent 
attendance could be that the PI was able to offer participants three available 
classes of different times each week, which enabled participants to attend 
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the programme without compromising work or family life. The PI also 
offered patients to complete their questionnaires either via face-to-face 
appointment at their convenient time (including out-of-hour) or by post, 
which gives participants the flexibility and availability to respond to their 
questionnaires. This suggests that one key for low attrition is to offer 
flexible timetable of the programme.     
 
Another possible explanation for low attrition could be that patients were 
motivated, and had a realistic expectation of the CBCLBP programme. The 
PI regularly stressed the importance to all physiotherapists in the 
physiotherapy department that each potential referred patients should be 
thoroughly explained the nature of the CBCLBP programme (alongside 
written information), and showing willingness to take part. So, those who 
decided to attend the programme were probably less likely to drop-out 
because they had a good understanding and correct expectation of the 
programme. 
 
4. Care taken to reduce methodological limitations 
Despite being a single-handed researcher and clinician in a busy NHS 
physiotherapy department, the PI has taken every possible measure to 
ensure methodological quality of this study. Methodological strength of this 
study includes:  
 Pilot study on the first five eligible patients (who were not included 
in the study);  
 Adequate powered sample size based on powered calculation; 
 Use of strict selection criteria and investigation of a homogenous 
group of subjects (i.e. patients with NSCLBP with high level of 
FAB); 
 The use of A-B-A same study design that strengthen the internal 
validity of findings; 
 Use of a wide range of relevant outcome measures of high validity 
and reliability, which capture the main domains of NSCLBP, and are 
important to both patients and clinicians;  
 The application of highly-structured and standardized intervention; 
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 Standardized manner of data collection consistently throughout the 
study period; 
 A reasonable length of follow-up period; 
 Low attrition bias due to completed outcome data at all time-points; 
 Application of appropriate statistical analysis; 
 Careful interpretation of the data; 
 Good generalizability for clinical practice. 
Based on the Cochrane Bias Methods Group’s recommendation for risk of 
bias assessment (Higgins et al., 2011), it is reasonable to state the evidence 
which emerged from this current study is valid, is of good methodological 
quality. 
 
Strength relating to impact on practice  
1. The CBCLBP programme is more clinically effective than usual care 
This current study challenges the effectiveness of individual physiotherapy 
in improving NSCLBP outcomes. Prior to the CBCLBP programme (Phase 
A), patients had an average of four sessions of individual physiotherapy 
treatment (such as joint mobilisation, manipulation, written home exercise 
programme, and back pain information booklet). However, patients showed 
no significant improvement in all outcomes. During the programme (Phase 
B), all outcomes improved significantly, with a sustained effect to 6-months. 
This implies that the CBCLBP programme is more effective than the usual 
individual physiotherapy care, at least with respect to this subgroup of 
NSCLBP patients with high FAB. This is an important take home message 
for clinicians, because many physiotherapists still regard the CBCLBP 
programme as a last resort when treating NSCLBP patients.  
 
2. Questioning guideline recommendation of 100 hours treatment time 
This study challenges the guideline value of 100 hours over up to 8 weeks in 
the delivery of active exercise CBA rehabilitation (Savigny et al., 2009). 
The total duration of the CBCLBP programme in present study is 
approximately 14 hours over 6 weeks, which demonstrates significant 
clinical improvement in this subgroup of NSCLBP patients with moderate 
pain, moderate disability and high FAB presenting for primary 
physiotherapy. Currently, there is no consensus about the duration, 
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frequency and intensity of the programme in clinical practice. Further work 
and refinement of NICE guidelines is needed to determine a more concrete 
reference regarding the intensity and duration of the programme, and “what 
works for whom” to avoid long treatment hours unnecessarily. 
 
3. Reinforced clinical effectiveness of physiotherapy CBA programme 
at low provider cost 
This study lends further support to previous physiotherapy studies of high 
quality in terms of clinical effectiveness and costs (Critchley et al., 2007; 
Johnson et al., 2007; Lamb et al., 2010). The present study demonstrates 
that the physiotherapy CBCLBP programme is clinically effective and has a 
sustained effect at 6-months on the key clinical elements of NSCLBP. 
Further, it costs less for the provider to provide a six-week CBCLBP 
programme (£285.82 per patient based on 6-8 patients per group), compared 
to individual physiotherapy (£348 per patient based on the routine 6 hours 
physiotherapist’ time from receipt of referral to discharge from the service). 
In addition, the CBCLBP programme is ran by experienced physiotherapists 
alone with CBA training. There is no involvement of pain consultants, 
cognitive-behavioural therapists, other multi-disciplinary members and 
ongoing secondary care referral. This consequently cuts cost for the health 
service and optimises the use of health resources. This is positive for the 
physiotherapy profession, particularly NHS physiotherapists who are under 
constant pressure to prove their treatment can be clinically effective, as well 
as an inexpensive treatment to the provider. 
6.3.3 Weakness of the study 
1. Weakness of A-B-A design compared to RCT 
Despite the various methodological strengths of the same-subject A-B-A 
design over the between-subjects design such as the RCT (see Section 6.3.2 
Strength of the study), it is acknowledged that the same-subject design 
also has its weaknesses when compared to the between-subjects design. 
First, subject dropout is more problematic in the same-subject design (Nunn, 
1998). In the between-subjects design, there will be at least twice as many 
participants than the same-subject design, since there will be two or more 
arms of participants. A fundamental inferential statistics principle is that: as 
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the number of subjects increases, the power increases and the probability of 
type II error reduces. In contrast, there is only single group of patients in the 
same-subject design. If the smaller sample size reduces due to dropout, 
statistical power of the experiment reduces, and the probability of type II 
error also increases. The loss of one patient has double the impact and a 
higher probability of committing type II error.  
 
Secondly, although all research designs are susceptible to some extent of 
carryover effect (practice and fatigue effect), the same-subject design is 
particularly susceptible since participants are subjected to both control and 
treatment condition (Gonzalez, 2009). Either participants will become more 
accomplished through practice and experience, having a positive effect of 
their self-reported score, or they will experience fatigue from taking the 
same tests, having a negative effect of their self-reported scores. These 
factors may skew the results and weaken the validity of the findings. A 
between-subject design does not induce a carryover effect because each 
participant is only subjected to a single condition, either being part of the 
treatment or control condition. 
 
Another disadvantage of the same-subject A-B-A design is its inability to 
deal with treatments that have irreversible effects on patients (Cunningham 
et al., 2013). For example, the same-subject design would not be appropriate 
to examine the efficacy of an invasive brain surgery. Once a patient had 
surgery, it is likely to lead to irreversible change. The same-subject design 
does not permit the ability to detect changes in variables between treatment 
(e.g. brain surgery) and no-treatment condition (post brain surgery). On the 
other hand, because a between-subjects design compares treatment and 
control condition, thus it has an advantage to be used in treatments that have 
irreversible effects. However, such limitation should not corrupt the findings 
of the present study since the CBCLBP programme is unlikely to produce 
irreversible effect on a complex chronic condition such as NSCLBP.  
Finally, the same-subject design can be ethically problematic, for not 
providing alternative treatment, as opposed to a between-subjects design, 
where alternative is available for study participants. However, this should 
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not be an ethical concern for our participants because the CBCLBP 
programme is a recommended second-line physiotherapy treatment in 
accordance with evidence-based guidelines for NSCLBP (Savigny et al., 
2009; Chou et al., 2009; Koes et al., 2010).   
2. Clinician-researcher dual role 
Experimenter bias 
The main limitation of the present study is that the PI acted as both 
researcher and clinician. Due to limited staff resources, it was necessary that 
the PI took the dual role of the researcher and clinician. The PI was involved 
in gaining all informed consents, carried out the majority of the treatment, 
and collected all data at 3-months and 6-months follow-up. This may have 
potentially introduced experimenter bias effect as the PI was aware of the 
hypothesis being tested, and may potentially have had a set of expectations 
and predictions about the treatment outcome (Burns, 1997).   
 
Expectancy and Hawthorne effect 
The PI’s personal belief and enthusiasm for the CBCLBP programme may 
have influenced patient’s attitude and behaviour, hence may influence 
patient’s pain and disability reporting. Patients may also have a tendency to 
work harder and give better reporting because they knew they are under 
study, and were being investigated (i.e. Hawthorne effect) (Earl-Slater, 
2002). Both the Hawthorne effect and the PI personal belief for the 
programme are known to affect the outcome of the treatment (Klaber 
Moffett & Richardson, 1997). This is referred to as the expectancy effect. 
Expectancy has direct effects on cognitions and indirect effects on 
behaviour (Bootzin, 1985). Both the patients and the health professionals’ 
enthusiasm play an important role in positive outcome to treatment (Petrie 
& Hazleman, 1984; Klaber Moffett & Richardson, 1997). 
 
Halo effect 
The PI is an experienced clinician specializing in treating patients with 
NSCLBP delivering the CBCLBP programme for over twelve years. The 
quality of the communications, the delivery of the education, and the 
interaction between the PI and patients is likely to be positive and pleasant 
for patients. The consistent clinical input from a single relatively 
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experienced and approachable physiotherapist with a special interest in 
NSCLBP may result in halo effect (Nisbett & Wilson, 1977). Such factor 
may have an influence on the outcome of treatment particularly on reporting 
of pain, disability and perceived control (Klaber Moffett & Richardson, 
1997).  
 
These potential biases would have reduced the validity of the findings. 
Therefore, it would have been preferable for the PI to have acted as an 
independent researcher, with no input into treatment and data collection. 
This may have enabled a better approximation of objectivity (the so-called 
'Archimedean point') and would have increased the chances that our results 
can be generalised. However, this was not possible in the current study. 
A major advantage of being a dual role of clinician-researcher is that it 
enables the development of a stronger relationship between patients and the 
PI, which may facilitate treatment attendance, the follow-up process and 
minimize the potential for loss to follow up. By having the PI collect 3-
month and 6-month data also helped ensure data quality, and minimize 
missing data. These factors may explain low attrition and no missing data 
during the study. 
 
3. Potential mediators 
This study aims at examining specific variable(s) predicting outcome of 
interests. However, it is acknowledged that these direct causal associations 
may be mediated by other factors, which is beyond the remit of the current 
study. For example, self-efficacy, psychological distress and fear may 
mediate the relation between pain and disability (Lee et al., 2015).  Future 
work using mediation analysis is needed to study the mechanism underlying 
these associations, and to determine whether any specific factors play an 
intermediate role that explains how the predictor variable(s) leads to 
improvement of clinical outcomes.       
 
4. Selection bias 
According to the inclusion criteria of the CBCLBP programme, participants 
had to be positively opted-in to the programme, and had to be motivated to 
change behaviours. Since our patients already showed self-motivation when 
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they entered the CBCLBP, and all managed to complete the programme and 
the 3-months and 6-months follow-up, there is a high possibility that 
patients in the current study may represent a motivated subgroup. This may 
result in selection bias which may explain the favourable outcome in this 
study (Higgins et al., 2011).  
 
5. Lack of qualitative data 
Unfortunately, this study did not collect qualitative data of why and how 
patients’ various pain beliefs may change over time in the context of their 
physiotherapy treatment experience. The current study can be replicated by 
using a mixed qualitative and quantitative method. Over the course of the 
study period, the PI had many informal verbal feedbacks from the 
participants about their experience and beliefs about pain. Their views 
added much richness in addition to the quantitative findings. The subjective 
experience of patients may help: (1) explain the positive outcomes of the 
current study from the patients’ perspective; (2) understand the underlying 
mechanism of why and how the CBCLBP programme works; and (3) 
identify specific treatment components that can be targeted to improve 
treatment outcome.  
 
For example, reduction in negative beliefs, addressing unrealistic 
expectations from health professionals and a variety of self-management 
skills, are frequently reported by patients (informal feedback during the 
programme) as important components that boost their ILOC beliefs. Pain 
education and explanation of sensitization were also well-received by 
patients. Many said understanding pain was the turning point for them to 
become more engaged and empowered in their own NSCLBP management. 
This information gives some insights into the underlying mechanism 
between changes in ILOC and specific aspects of the programme. 
Therefore, it is recommended that a mixed qualitative (for example, the use 
of focus group and semi-structured interviews) and quantitative method can 
be used in future studies, because each method is capable of providing 
valuable information and are complimentary to each other (Hicks, 2009).  
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6. Possible confounding variables  
Confounding variables were not controlled for, such as advice and other 
treatments received prior to the programme, and six months after the 
programme, which may influence treatment outcomes. However, these 
confounders are difficult and impractical to control. Besides, it is unethical 
to stop patients seeking advice and/or other treatments before and after their 
CBCLBP programme. Other factors, such as patients’ expectations to 
treatment and various biopsychosocial factors may also affect their response 
to self-reported outcomes over the study period. Importantly however, in 
either case a potential influence on outcomes should not corrupt the main 
findings of this present study because we have the same group of patients 
serves as its own control. Hence the change of trend over the study period is 
likely due to the effect of the CBCLBP programme. 
 
7. Follow-up and single site 
The follow-up period was six months. Considering NSCLBP is a chronic 
condition, a longer follow-up period would have been ideal to give more 
relevance to the data, which could give more validity to the findings. 
However, a follow-up period over more than six months was impractical 
and challenging for a single-handed PI. Besides, the period between 
completion of the CBCLBP programme and end of study period (six month) 
should be long enough to eliminate preservation or performance bias.  
 
The current study was conducted in single site, which has several 
advantages over multi-centres such as: (a) it is logistically easier; (b) it is 
cheaper; (c) it does not require prolonged negotiations on study protocol and 
ethics approval;(d) it simplifies data collection; (e) it is likely to deal with 
less heterogeneous patient population, hence diminishes confounding 
factors. However, it must be noted that the most shortcomings of single-site 
studies is their limited external validity (Bellomo et al., 2009). This is 
because conducting a study in a single clinical environment may not be 
generalizable to a broader population of NSCLBP patients with high FAB. 
Besides, it tends to give a more dramatic and larger treatment effect size, 
compared to multi-centres study (Bellomo et al., 2009). The PI has made 
attempts to determine external validity of the findings by comparing other 
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previous published studies. Further larger, multi-centred with a longer 
follow-up period will be valuable to confirm the present findings.      
 
8. Limitation of the cost study 
Unfortunately we did not include EQ-5D questionnaire, which would have 
allowed us to calculate cost per QALY. We also did not collect costs during 
Phase A1 because the cost study was newly introduced several months after 
patient recruitment. The economic analysis could be improved by using the 
use of EQ-5D. It is acknowledged that ILOC is an unusual choice of cost 
study outcome measure, and its use would not allow direct comparison of 
cost effectiveness with other NSCLBP treatments. This is a drawback of the 
present cost study. However, as previously mentioned, the PI was concerned 
about the risk of respondent fatigue, which may have led to poor response 
rate and poor data quality (Lavrakas, 2008). In addition, the PI reasoned that 
HLOC is the primary outcome measure and the main interest of the present 
study. Therefore, the cost per ILOC was chosen. Replication of the current 
study could be improved by using the EQ-5D to calculate QALYs, thus a 
standardised and direct comparison with other studies and other treatments 
for NSCLBP can be made, which is of great importance for the provider and 
policy decision-maker. However, it could also be argued that it is important 
for clinicians and policy-makers to consider a range of relevant outcomes 
(such as HLOC) when making decisions about how to spend their limited 
healthcare resources. 
 
Another limitation of the cost study is the reliance on patients to recall the 
amount of healthcare utilisation of all types, travel and loss of productivity. 
It is possible that inaccurate or biased recall reduce the validity of the cost 
data.    
6.4 Key learning from the research 
Belief is at the heart of chronic back pain, i.e. how people think and feel 
about their pain affects what they do about it. Every patient’s pain 
experience is unique. The journey of this research started as very 
impersonal, with a belief that an ‘all-round’ clinician should be play a 
proactive and reflective role in relation to our skills and patient’s care. Not 
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only being ‘research-minded’, but becoming actively involved in carrying 
out research and implementing evidence in our professional practice. 
 
The research questions of the current study are based on clinical observation 
and experience. It occurred to the PI that a patient’s belief of who is 
responsible and who has control over their back condition makes a 
difference in their treatment outcome. For instance, those patients who 
believe their actions and own responsibility will improve their NSCLBP 
outcome generally do better than those who feel disempowered. Some 
patients believe it is the physiotherapist’s responsibility to fix their back 
condition. Some patients believe their back pain is just a matter of bad luck 
or fate, and have very little control over it. This study has confirmed that 
HLOC does have a relationship with patients’ main complaint of NSCLBP 
such as pain, functional limitation and avoidance of movement. This 
learning has extended our understanding of HLOC in relation to NSCLBP, 
and HLOC can be an important consideration during the design and delivery 
of the physiotherapy CBCLBP programme.    
 
Managing patients with NSCLBP can be challenging, yet highly rewarding 
at times. Appropriate referral of the right patients at the right time enhances 
the chance of successful outcomes. It is the treating clinicians’ role to decide 
what dominant factors within the complex context of the biopsychosocial 
framework may drive their patients’ NSCLBP and the associated physical 
and psychological consequences.  
 
Often at the start of the programme (session 1), at least one patient may 
question why someone in pain will engage with treatment that is aimed at 
their thoughts, beliefs and behaviours. This may be unsurprising as most 
patients have real pain, but not just think they have pain. Over the study 
period, the PI realised that the explanation of pain physiology, pain 
neuromatrix and sensitization model of the programme is a powerful ice 
breaker, as it gives patient a physical cause of their ‘non-specific’ pain, 
rather than ‘it is all in the head’. Hence patients are more willing to engage 
with the various components of the programme. Several RCTs and 
individual studies have already investigated the efficacy of higher level of 
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pain education in LBP with promising evidence (Moseley, 2002; Moseley, 
2003a; Moseley, 2004; Moseley et al., 2004; Ryan et al., 2010). The effect 
of the CBA and combined exercise rehabilitation seems to be complimented 
by the effect of higher level of pain physiology education. An interesting 
area to look at in a future study is to see whether the addition of higher level 
of pain education to usual physiotherapy care may improve patients’ 
NSCLBP outcome. There is evidence to suggest that health professionals 
who had formal training in pain science education performed much better 
than those who were untrained (Moseley et al., 2003c). All the 
physiotherapists who delivered usual physiotherapy care did not have 
formal or professional training in pain science, as opposed to those who 
delivered the CBCLBP programme. This may highlight the need for pain 
science training in all musculoskeletal physiotherapists working in the pain 
field, or consider making it a core competence training.     
 
Dissemination, publication and implementation 
Implementation of research evidence can be challenging in musculoskeletal 
physiotherapy practice. Barriers may include: (1) organisational barriers 
such as limited time, resource and support, and (2) cultural barriers within 
the profession such as peer resistance, reluctance of changing established 
practice and changing work culture (Chan & Clough, 2010). However, there 
are ways to help bridge the gap between research evidence and clinical 
practice.  
 
Future plans to disseminate and implement the current findings include: (1) 
presenting the current findings in a user-friendly manner and making it 
relevant, practicable and applicable for clinicians and commissioners (Chan 
& Clough, 2010), (2) involvement in patients’ care pathway design, (3) 
publishing in appropriate journals, (4) presenting in musculoskeletal 
physiotherapy and pain conferences, and (5) sharing findings with 
appropriate personnel in clinical interest groups via social media. It is of 
great personal interest to the PI to conduct further clinical research in the 
future, help bridging clinical expertise and research evidence to improve 
quality of patients’ care in physiotherapy. 
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6.5 Implications and recommendations 
6.5.1 Implication for practice 
1. The CBCLBP programme should be considered as first-line 
treatment  
Despite calls from clinical guidelines recommendation (Savigny et al., 
2009) and a large body of existing evidence, many physiotherapists in 
clinical practice still view the CBA active rehabilitation (such as the 
CBCLBP programme) as a last resort for their NSCLBP patients. There are 
a number of possible explanations for this. For instance, this may be due to 
the physiotherapists’ biomedical orientated pain beliefs which may 
influence their clinical reasoning process (Daykin & Richardson, 2004; 
Foster & Delitto, 2011). A study in the UK reported that healthcare 
providers’ beliefs influence their judgement and clinical decision about what 
treatments are given to patients with CLBP (Corbett et al., 2009). In 
addition, patients often hold certain expectations and pre-conceptions about 
their physiotherapy treatment (Hills & Kitchen, 2007), which consequently 
may interfere with the clinician’s choice of treatment. Several physiotherapy 
studies have reported that patients are more satisfied with a hands-on 
treatment approach, compared to active rehabilitation programme (Hay et 
al., 2005; Klaber Moffett et al., 2006). However, passively treating patients 
unnecessarily may over-medicalise their NSCLBP condition, and reinforce 
passive coping (Waddell, 2004). 
 
The study concluded that the CBCLBP programme has a bigger and 
possibly more direct physical and psychological impact on this subgroup of 
NSCLBP patients with high FAB, than usual physiotherapy care. This could 
be the CBA education and the multi-dimensional nature of the CBCLBP 
programme, is more adequately and appropriately address the complexity of 
NSCLBP. It is also likely to have something to do with the positive group 
influence and the interaction with others who face similar problems. This 
finding has an important clinical implication for physiotherapists: that the 
CBCLBP programme should be employed more regularly in this subgroup 
of NSCLBP patients. The PI highly recommends that the CBCLBP 
programme should be seen as a first-line treatment by physiotherapists, 
rather than a last resort.  
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2. Careful patient’s selection to attain low attrition 
A high attrition rate of group-based intervention, particularly the CBA 
intervention for NSCLBP patients is a common problem in clinical practice. 
The current findings imply that the assessment of HLOC may be a useful 
screening tool to aid appropriate referral onto the group-based CBA active 
rehabilitation. The present findings show that those patients who had a 
combination of poor employment status, poor financial status and high 
ELOC are significantly more likely to drop out of the programme (i.e. 
patients who were consented for the programme, but they never attended or 
only attended the first session of the programme). These patients may still 
be beneficial from the treatment philosophy and components of the 
CBCLBP programme. However, group therapy may not be the preferred 
treatment for them. Clinicians should acknowledge this and consider 
referring these patients for CBT or providing one-to-one physiotherapy 
CBA treatment where appropriate.  
 
Clinicians could consider using MHLC scale, ‘yellow-flag’ interview 
questions along the HLOC continuum, in conjunction with a validated 
screening tool such as STarTback tool (Hill et al., 2011) in order to match 
patients more closely to appropriate treatment with less likelihood of drop-
out. Careful selection of right patients for the right treatment is not only 
important for patients in terms of receiving appropriate back care, it is also 
important for clinicians in terms of clinical decision-making and 
unnecessary waste of service capacity. In addition, appropriate referral 
means more likelihood of low attrition, which in turn would be more 
economical from the provider’s perspective. Attrition can be minimised by 
implementing a number of classes of different times (for instance, the late 
afternoon class of the CBCLBP was very popular and patient friendly) in 
order to suit individual patients’ needs.  
 
3. Low cost option for the provider 
This study reports the provider costs of the six-week CBCLBP programme 
(£285.82 per patient), which is lower than individual physiotherapy (£474) 
(Critchley et al., 2007), spinal stabilization class (£379) (Critchley et al., 
2007), GP best care plus exercise (£486) (UK BEAM Trial Team, 2004b), 
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and GP best care plus manipulation (£541) (U.K. Beam Trial Team, 2004b). 
This study provides a benchmark to provider and policy-maker, in which the 
CBCLBP programme is likely to be a low cost treatment option. However, 
as previously mentioned, appropriate referral and low attrition are keys to 
keeping the cost down. Therefore, it is important that clinicians carefully 
select appropriate patients on to the group-based treatment, and explain to 
patients clearly the nature of the programme, so that a realistic patients’ 
expectation is set.  
 
4. Treatment approach to target ILOC 
Key findings that may be useful in improving existing practice include:  
 Increase in ILOC is significantly correlated to reduction in pain 
intensity, reduction in disability and reduction in FAB;  
 Improvement in HLOC beliefs accounts for a considerable 
proportion of the variance (31.9%) in reduction in FAB, whereas 
there is no significant predictive importance to both reduction in 
pain intensity and disability 
 An increase in ILOC is a unique predictor to reduction in FAB, 
which means improvement of ILOC exerts a significant influence 
upon reduction of FAB.  
 
On the basis of these findings, it would seem reasonable to suggest that 
improvement in ILOC should be seen as an important cognitive factor to 
target in the physiotherapy rehabilitation programme. For instance, 
clinicians may inform patients of the potential impact of their level of ILOC 
versus ELOC on the uptake of, and responses to CBCLBP programme and 
self-management tasks.  
 
Patients could also be provided with the research findings, such as those in 
the current study to increase their understanding regarding the influence of 
HLOC beliefs toward the key clinical elements of NSCLBP. In addition, an 
introduction of the influence of internal/external beliefs on feelings and 
behaviours, and addressing patients’ external and/ or chance beliefs may 
also be useful in enhancing feelings of personal control. Raising patients’ 
awareness of the role of HLOC may promote more engagement in 
 CHAPTER 6 Summary, recommendations and conclusions Page 269 
 
 
rehabilitation and active health behaviour, which is important for 
rehabilitation outcome.  
 
The present finding that ILOC has a significant predictive importance to 
reduction in FAB would seem beneficial for clinicians as one alternative to 
improve FAB outcome. In current practice, treatment components designed 
to reduce FAB such as pacing activities, graded exposure to exercise and 
fear-avoidance model are well-recognised by physiotherapists specializing 
in NSCLBP. On the basis of the current findings, it is recommended that 
clinicians could consider targeting treatment components that enhance 
ILOC to optimise FAB outcomes in patients with high levels of FAB. Based 
on the treatment philosophy, it is proposed that modification of pain beliefs 
and the variety of self-management skills may be of particular importance in 
enhancing ILOC. This is because both these components have an impact on 
improving an individual’s belief that their own actions and behaviours 
attribute to outcome and their NSCLBP, which also gives them an 
advantage of maintaining some feeling of control. There is an association 
between ILOC and active coping (Harkapaa et al., 1991). Individuals with a 
higher level of ILOC are more likely to use active coping strategies, which 
means they are more likely to develop effective problem-solving and 
functions despite pain, which may in turn lead to less avoidance of 
behaviour and FAB.  
 
5. Impact on physiotherapy practice locally  
The positive results of this present study have prompted the physiotherapy 
department in Stockport to make several changes to improve practice: (1) a 
new back pain triage clinic was set up. This aims to assess NSCLBP 
patients promptly so that they can refer for appropriate treatment. Patients 
were triaged using the STarT back screening tool and the TSK. 
Physiotherapists were also encouraged to use the MHLC scale and ‘yellow 
flags’ questions relating to HLOC; (2) A new patients’ care pathway was re-
designed with the CBCLBP programme is considered as a first-line 
treatment for NSCLBP patients with high FAB; (3) Education components 
were re-designed, with the emphasis on improving ILOC. Components such 
as pain education, inform patients of potential benefits of increased LIOC 
 CHAPTER 6 Summary, recommendations and conclusions Page 270 
 
 
versus ELOC and CLOC and self-management skills of cognitive-
behavioural elements were emphasized. Education components were also 
facilitated by videos and quiz to enhance patients’ ILOC with regard to 
engagement in the CBCLBP programme, and (4) there were several in-
service training sessions for physiotherapists in the Trust, so that clinicians 
were aware the study findings, the current state of knowledge and their 
further training needs.  
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6.5.2 Implication for research 
1. This study produces favourable results for patients with high FAB. This 
may suggest that the CBT based intervention produces better outcome in 
patients with high FAB. Replication of the current study by including a 
high, medium and low FAB group in future work would be useful to see 
if clinical outcomes following the CBCLBP programme, and the 
predictive relationship between HLOC and other variables would be 
different from the present results. The differentiation of psychological 
profile of patients would help to refine management guidelines on which 
type of patients may mostly benefit the CBCLBP programme. In 
addition, further examination of the predictive value of HLOC in 
relation to other key variables in NSCLBP would help to establish if 
HLOC would (or would not) have predictive importance in patients of 
different levels of FAB. 
 
2. This study should be replicated with the addition of qualitative research 
to explore both patients’ and practitioners’ beliefs and attitudes about 
their NSCLBP treatment, and how these influence their health and 
practice behaviour. The qualitative data from both patients and 
practitioners might help to: (1) understand the response and action from 
their perspectives and personal experiences; (2) explain the positive and 
negative findings observed in the current study, hence increase the 
comprehensiveness of the present findings, and (3) create openness and 
give opportunity to both patients and practitioners to expand their 
response or new dimensions of the research topic that may not be 
considered by the P.I. 
 
3. It is acknowledged that examining HLOC alone only offers a small 
piece of the picture in terms of predicting outcome for NSCLBP patients 
following the CBCLBP. Some authors (Oberle, 1991; Luszczynska & 
Schwarzer, 2005), and the developers of the MHLC scales (Wallston et 
al., 1978) mentioned the importance of assessing the influence of other 
variables in addition to HLOC. For example, self-efficacy maybe a 
stronger predictor of health behaviour changes than HLOC 
(Luszczynska & Schwarzer, 2005). Self-efficacy refers to an 
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individuals’ beliefs regarding their confidence and ability to perform a 
particular behaviour (Bandura, 1977).  Therefore, it is possible that the 
prognostic importance of ILOC found in the current study would be 
different if self-efficacy is included. Replication of the current study 
with the inclusion of self-efficacy is recommended in order to further 
examine the role of HLOC in NSCLBP patients. 
 
4. The effect of the CBCLBP programme seems to be complimented by the 
effect of higher level of pain physiology education. Having a deeper 
understanding of chronic pain may be an important part of rehabilitation 
for NSCLBP patients. An interesting area to look at in a future study is 
to see whether the addition of higher level of pain education to usual 
physiotherapy care (having musculoskeletal physiotherapists to have 
extra pain neuroscience training) may improve patients’ NSCLBP 
outcome. 
6.6 Conclusion 
Belief is a powerful driving force in one’s behaviour. HLOC, which refers 
to a person’s belief over their health conditions and a person’s perception of 
who is responsible for his or her health condition (Wallston and Wallston, 
1982), is a significant concept. This is because HLOC has a meaningful 
relationship with health attitude, behaviours, coping styles and the clinically 
important outcomes of NSCLBP, which are all the key components in 
attaining successful treatment outcomes of the CBCLBP programme. 
 
This study supports the positive effects of a physiotherapy CBCLBP 
programme, both clinically and economically in the short-term (6-week) and 
the intermediate term (6-month). It also offers evidences that HLOC may 
provide helpful constructs in facilitating appropriate referrals and improving 
treatment outcomes in NSCLBP patients with high levels of FAB.   
 
This study highlights that improvement in ILOC has a significant 
relationship with the key elements of NSCLBP including pain intensity, 
disability and FAB. In particular, increased ILOC was found to be 
significantly predictive of reduction in FAB at 6-months, however it shows 
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no significant predictive value to both reduction in pain intensity and 
reduction in disability. A possible explanation of this could be that both 
HLOC and FAB are psychological factors (both constructs concerning 
patients’ belief about their pain), whilst pain intensity and disability are 
physical factors associated with NSCLBP. This result supports the current 
understanding of NSCLBP, that when NSLBP becomes chronic, the 
psychosocial factors are more powerful factors in the development and 
persistence of NSCLBP and disability, than the physical factors (Waddell, 
2004; Koleck et al., 2006; Bakker et al., 2009). This finding is also in direct 
agreement with the treatment philosophy of the CBA, where emphasis is 
placed to address patients’ maladaptive belief, feelings and behaviours 
(Airaksinen et al., 2006; Henschke et al., 2010).    
 
From a clinical perspective, it would seem reasonable to suggest that 
improvement in ILOC could be seen as a potentially important cognitive 
factor to target in physiotherapy rehabilitation programmes as an alternative 
pathway to optimising FAB outcome. Treatment components that are likely 
to enhance ILOC (such as patient education about potential impact of levels 
of internal versus external HLOC, addressing unhelpful external and chance 
orientated beliefs, high level of pain education, pain belief modification, 
adoption of active coping and self-management skills) could be considered 
to add to and be emphasized in the existing programme. These components 
can also be considered to integrate in physiotherapists’ training competence. 
This may be particularly beneficial for NSCLBP patients with high levels of 
FAB.   
  
From a research perspective, these findings provide new knowledge and 
extend the current limited evidence regarding the role of HLOC in 
NSCLBP. Specifically, the findings demonstrate that HLOC beliefs are 
modifiable by a physiotherapy intervention underpinned by CBA principles. 
HLOC is associated with the key clinical elements of NSCLBP and has 
significant predictive importance in improving FAB outcomes. It is 
acknowledged that HLOC is only one piece of the much wider and complex 
psychological context in understanding NSCLBP. However, these findings 
may provide a new dimension for both researchers and clinicians when 
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addressing treatment effectiveness and prognosis of NSCLBP. Evidence in 
this aspect of care remains very limited. Further research is needed to 
support these relationships and the role of HLOC in NSCLBP management.     
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6.7 Key messages 
 Physiotherapy departments should routinely consider the CBCLBP 
program as a first-line intervention in patients with NSCLBP, rather 
than regarding it as a last resort as is currently frequently the case.   
 Careful selection, appropriate patient referral and offering flexible 
timetables of programme are likely to be keys for low attrition and 
keeping costs down from the provider’s perspective. 
 Belief is the main driving force for behaviour. Assessment of HLOC 
and addressing HLOC can be integrated into the existing 
physiotherapy CBCLBP programme to improve treatment outcomes 
and optimise self-care. 
 Increased in ILOC predicts better FAB outcomes. Education content 
that enable patients to understand the impact of internal versus 
external beliefs in relation to NSCLBP management, high level of 
pain education, modification of pain belief, and self-management 
skills of cognitive-behavioural elements, may potentially enhance 
patients’ ILOC, hence improving FAB outcomes.   
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APPENDIX 4: Participants' Information sheet 
 
 
                                              
PARTICIPANT INFORMATION SHEET 
 
RESEARCH TITLE: Does a cognitive-behavioural chronic low back pain programme 
alter patients’ health locus of control? 
 
CHIEF INVESTIGATOR:  
Sharon Chan 
Doctoral student and musculoskeletal specialist 
Physiotherapy Department, Stockport NHS Foundation Trust 
1/F Kingsgate House 
Wellington Road North 
Stockport  SK4 1LW 
Work contact telephone number: +44 (0)161 4265445/ 5446 
sharon.chan1@nhs.net 
 
Please note that this study is being completed as part of the Professional 
Doctorate qualification. 
 
INVITATION: You are being invited to take part in a research study. Before you decide 
whether or not to take part, it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Ask us if there is anything that is not clear 
or if you would like more information. Part 1 tells you the purpose of the study and what 
will happen to you if you take part. Part 2 gives you more detailed information about the 
conduct of the study. 
 
PART 1 
 
WHAT IS THE PURPOSE OF THE STUDY?  
The aim of this study is to investigate how a cognitive-behavioural chronic low back pain 
programme may alter patients’ “locus of control”, i.e. the extent to which patient’s believe 
they can control their own health. Such psychosocial factor is important for attaining 
successful treatment outcome and improving the prognosis of chronic low back pain. 
This study aims to improve the management of those patients with chronic low back 
pain. The outcome of this study will provide appropriate evidence to establish the 
importance (or not) of the health locus of control in the back rehabilitation programme, 
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and thus enable effective and evidence-based interventions to be developed in this field 
of physiotherapy practice. 
 
WHY I HAVE BEEN INVITED? 
You have been invited to participate because you are eligible to this study. For this 
research, we would like to include at least 60 patients, who have low back pain with or 
without leg pain, for more than three months, and with no serious pathology.  
 
Inclusion criteria: patients with low back pain for more than 3 months with or without 
leg pain, aged over 18 years, with disability and distress primarily caused by chronic 
low back pain, as perceived by patient and assessor, with Tampa Scale of 
Kinesiophobia (TSK) score more than 37 (indicating patient shows fear of movement 
and associated avoidance behaviour) and able to give consent.  
 
Exclusion criteria: patients who are diagnosed with serious spinal pathology such as 
malignancy and vertebral fracture, acute herniated disc with nerve root entrapment, 
unstable spondylolisthesis, TSK score less than 37, health conditions that prevented 
them from exercising safely, language problems, age less than 18 years, and patients 
unwilling to participate the programme. 
 
DO I HAVE TO TAKE PART? 
It is up to you to decide whether or not to take part. If you do decide to take part, you 
will be given this information sheet to keep and asked to sign a consent form. If you 
decide to take part, you are still free to withdraw at any time and without giving a 
reason. A decision to withdraw at any time, or a decision not to take part will not affect 
the standard care that you receive. 
 
WHAT WILL HAPPEN TO ME IF I TAKE PART?  
If you do decide to take part, you will undergo the routine cognitive-behavioural chronic 
low back pain rehabilitation programme, which is the normal care provided by the 
physiotherapy department, Stockport NHS Trust for patients with chronic low back 
pain, however there will be an addition of completing some questionnaires before and 
after the programme. The back rehabilitation programme has been in place for a 
number of years in the physiotherapy department in line with the UK guidelines; it is 
based on best available evidence and current best practice in the UK.  
 
To summarise: Whether you decide to take part in the research or not, you will still 
receive the same exact programme as in normal care, the only difference is that 
participants in the study will be asked to complete some questionnaires. If you decide 
not to take part, you will simply undergo the same routine back rehabilitation 
programme as planned. 
 
The back rehabilitation programme is a 6-week (two hours weekly) programme 
consisting of exercise and education. If you do decide to take part, you will be asked to 
complete some additional questionnaires relevant to your chronic low back pain 
condition. The questionnaires will take about 20 minutes to complete at baseline (4 
weeks prior to the programme), at the beginning of the programme (week 0), at 
completion (week 6) and at 3-months and 6-months follow-up. Please refer to the 
diagram below: 
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The programme is based on the best available evidence, which aim to promote positive 
coping strategies, improve general function, and enhance your confidence in self- care. 
Through the programme, a variety of issues including mechanisms of chronic pain, 
anatomy and diagnosis, techniques for activity management, pacing, goal setting, 
stress management, relaxation, challenging negative thoughts and behaviours, lifestyle 
changes such as graded exercises, weight reduction return to normal activities and 
hobbies, acceptance of chronic back pain condition, problem solving and developing 
coping skills will be addressed. In addition to the education component, you will also 
exercise as a group including core stability work, stretching exercise, cardiovascular 
exercise circuit, aqua aerobics and Pilates.   
 
WILL MY EXPENSES BE COVERED FOR TAKING PART IN THIS STUDY? 
No, your travel expenses will not be covered by the research team. Your attendance to 
the back rehabilitation programme is no different from patients who attend the ordinary 
NHS physiotherapy appointment, except we will ask you to fill in some questionnaires 4 
weeks and immediately prior the programme, and at 3-months and 6-months follow-up.    
 
WHAT DO I HAVE TO DO? 
You will be asked to try your best to attend all the six sessions of the programme in 
order to gain the maximum benefit from it. If you decide to take part in this study, you 
will also be asked to complete and return the questionnaires at each evaluation (see 
diagram). Your completed questionnaire is very important for the data analysis of the 
research.  
 
WHAT ARE THE POSSIBLE DISADVANTAGES AND RISKS OF TAKING PART? 
There are no disadvantages and risks from taking part. All the subject recruitment, 
assessment and the rehabilitation programme will take place at the physiotherapy 
department, Kingsgate House, Stockport NHS Foundation Trust, where Health and 
Safety at Work Act (1974) is operated all the time. 
Diagram to illustrate the study design
Phase A1
No treatment
(Participants on waiting list)
Phase B
Treatment
(Participants having back rehabilitation)
Phase A2
No treatment
(Participants completed back rehabilitation)
-4
 w
e
e
ks
W
e
e
k 0
W
e
e
k 6
3
 m
o
n
th
s
6
 m
o
n
th
s
Outcome measures will be taken at:
• - 4 weeks (Baseline)
• Week 0 (Before treatment)
• Week 6 (After treatment)
• 3 months after completing treatment
• 6 months after completing treatment 
 APPENDICES Page 288 
 
 
 
WHAT ARE THE POSSIBLE BENEFITS OF TAKING PART? 
We cannot promise that this study will help you, however the back rehabilitation 
programme to be delivered in this study represents current recommendation by UK 
guidelines and it is a well-established service in the physiotherapy department. 
Therefore, you would learn strategies that are based on best available evidence and 
current best practice in the UK. 
 
Through the programme, a variety of topics will be addressed and will be targeted 
including pain beliefs, fear avoidance behaviours, sense of personal control, your 
thoughts, feelings and coping strategies. Therefore, there will be intended benefit to 
improve your confidence and positivity in self- management skills, the sense of 
personal control over your chronic back problem and your confidence and fitness on 
exercising by taking part in this study. 
 
WHAT HAPPENS WHEN THE RESEARCH STUDY STOPS? 
Once you have completed the six-week back rehabilitation programme and the 6-
months follow up questionnaires, you would be discharged from the physiotherapy 
service, as in normal practice and in compliance with the departmental policy. 
However, if there is any reason you would like to access the physiotherapy service 
when the research study stops, you could consult the research physiotherapists and/or 
your General Practitioners (GPs).  
 
WHAT IF THERE IS A PROBLEM? 
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. The detailed information on this is given in 
Part 2.  
 
WILL MY TAKING PART IN THE STUDY BE KEPT CONFIDENTIAL? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2. 
 
PART 2: 
 
WHAT IF RELEVANT NEW INFORMATION BECOMES AVAILABLE? 
Sometimes we get new information about the treatment being studied. If this happens, 
we will tell you and discuss whether you would like to continue in the study. If you 
decide not to carry on, we will make arrangements for your care to continue in the 
physiotherapy service. If you decide to continue with the study, we may ask you to sign 
an agreement outlining the discussion. 
 
WHAT WILL HAPPEN IF I DON’T WANT TO CARRY ON WITH THE STUDY? 
You have full right to withdraw from the study at any time without giving any reason. If 
you decide to withdraw, please inform the Chief Investigator at the earliest possible 
opportunity. If you withdraw, it may be beneficial to use your data already collected up 
to the point of withdrawal but all other data will be destroyed. The data that have been 
collected will only be retrieved and analysed using the subject identification number 
assigned to your data set, and your anonymity will be maintained at all times. 
 
WHAT IF THERE IS A PROBLEM?  
Because of our strict safety policy, we do not anticipate that you will be harmed in any 
way by taking part in this study. If you have any concern about any aspect of this study, 
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you should ask to speak to the Chief Investigator, Sharon Chan, who will do the best to 
answer your question. Please ring 0161 4265445 or e-mail on sharon.chan1@nhs.net. If 
you remain unhappy and wish to complain formally, you can follow the NHS Stockport 
Complaints Procedure by contacting the Complaints Department on 0161 4265888 or 
via e-mail on Compliants.email@nhsstockport.nhs.uk 
 
WILL MY TAKING PART IN THE STUDY BE KEPT CONFIDENTIAL? 
To ensure anonymity, all data collected will be kept strictly confidential and 
anonymous. You will be given an identification number known only to the Chief 
Investigator and the research physiotherapy team. No one will be able to access your 
personal data and trial data, except the Chief Investigator, your General Practitioner 
(GP) and the member of the direct care team in physiotherapy. Data will be stored, 
using identification number, on a password secure computer within the physiotherapy 
department, and hard copies will be kept in the locked cabinet within the department. 
The Chief Investigator will use the trial data appropriately and publish findings where 
optimal use can be made of them such as journal publication, disseminating findings to 
practice and implementing changes for more effective practice, also for general public 
in an understanding manner. Once the results are reported, it will not be possible to 
identify individual persons.  
 
When the research data are no longer required for the conduct of data analysis after 
the study has ended, the hard copies and the electronic data will be destroyed and 
disposed of by the Chief Investigator securely, as adhere The Records Management: 
NHS Code of Practice (2006) guidelines.  
 
WILL MY GENERAL PRACTITIONER/ FAMILY DOCTOR (GP) BE INFORMED MY 
PARTICIPATION OF THE STUDY? 
Your General Practitioner (GP) will be notified of your participation in the study, and we 
would seek your consent to do so. The information to be exchanged between the Chief 
Investigator and your General Practitioner (GP) is no different from that which 
physiotherapists would normally send to your GP following your treatment in the NHS 
Stockport physiotherapy service.  
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? 
The results obtained will used as part of the Doctoral dissertation. It will be published 
as a scientific article in peer reviewed journals and will also be presented at 
professional conferences. You are welcome to obtain a copy of the publication by 
contacting the Chief Investigator You will not be able to be identified from the 
publication.  
 
WHO IS ORGANISING AND FUNDING THE RESEARCH? 
This research is organised by the Chief Investigator, Sharon Chan, along with the 
research supervisor team, Dr. Peter Goodwin and Dr Christopher Wibberley from the 
Faulty of Health, Psychology and Social Care, Manchester Metropolitan University. No 
funding is required as the intervention and manpower used in this study are part of the 
ordinary NHS Stockport physiotherapy practice and patients’ routine care. 
 
 
WHO HAS REVIEWED THE STUDY? 
This study has reviewed and approved by the Research Ethics Committee of the 
Manchester Metropolitan University, the National Research Ethics Committee (NREC) 
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and the NHS. The ethical approval process is carried by an independent group of 
professionals to protect your safety, rights, wellbeing and dignity.  
 
FURTHER INFORMATION AND CONTACT DETAILS 
When you have completed the back rehabilitation programme, time will be allowed for 
you to ask questions about the research. For further information about this research 
project, please contact the Chief Investigator. 
 
WHAT IF THERE IS A QUERY?  
If you have a concern about any aspect of your participation or any other queries, 
please raise this with the Chief Investigator, Sharon Chan, or contact the research 
supervisors Dr Peter Goodwin and Dr Christopher Wibberley of the Manchester 
Metropolitan University. 
 
If you would like some independent advice about this research project, you can contact 
the research supervisors Dr Peter Goodwin and Dr Christopher Wibberley or the 
Patient Advice Liaison Service (PALS) in Stockport, Contact details are as followed: 
 
Patient Advice Liaison Service (PALS) Stockport telephone number: 0161 4265631 
www.nhsstockport.nhs.uk/PALS.aspx 
 
Director of Study: 
Dr. Peter Goodwin 
Faculty of Health, Psychology & Social Care, Elizabeth Gaskell Campus 
Manchester Metropolitan University 
Hathersage Road, M13 OJA 
p.goodwin@mmu.ac.uk  0161 2472941 
 
Supervisor of Study: 
Dr. Christopher Wibberley 
Faculty of Health, Psychology & Social Care, Elizabeth Gaskell Campus 
Manchester Metropolitan University 
Hathersage Road, M13 OJA 
c.wibberley@mmu.ac.uk  0161 2472522 
 
Please keep this information sheet safe so that if you decide to participate, you can 
refer to it at any time. If you take part in this study, you will also be given a signed 
consent from to keep. 
 
Thank you for taking time to read this information and considering this study 
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APPENDIX 5: Informed consent letter 
     
 
Study Number: REC reference: 12/SW/0197  R&D: 2012020     
Centre: Physiotherapy Department, Kingsgate House      
Patient Identification Number for this trial:  
 
CONSENT FORM 
 
Title of Project: Does a cognitive-behavioural chronic low back pain programme alter 
patients’ health locus of control? 
 
Name of Researcher (Chief Investigator): Sharon Chan 
Please initial box  
 
1. I confirm that I have read and understand the information sheet dated 17.07.12 (version 3) 
for the above study. I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from the sponsor of the trial (Manchester 
Metropolitan University) and responsible persons authorised by the sponsor, from 
regulatory authorities or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records.  
 
4. I agree to my GP being informed of my participation in the study.  
 
5. I agree to take part in the above study.  
 
 
            
Name of Patient    Date    Signature  
 
            
Name of Person    Date    Signature  
taking consent (Chief Investigator) 
 
When completed: 1 for participant; 1 (original) for researcher site file; 1 to be kept in 
medical notes. 
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APPENDIX 6: Letter to inform GPs/physiotherapists that their patients 
entered the study 
 
                                                                     
  
Dear Doctor/ Colleagues, 
 
RE: Patient’s name………………………..Date of Birth………………………….. 
 
With the above named patient’s agreement and consent, I am writing to inform you that 
the above named patient is eligible and agreed to participate in the research study, 
which aims to investigate if a cognitive-behavioural chronic low back pain programme 
may alter patients’ locus of control, and its associated impact on clinical outcomes. 
This study has been reviewed and approved by the Research Ethics Committee of the 
Manchester Metropolitan University, the National Research Ethics Committee (NREC)  
with reference number……………..and the NHS.  
 
Interventions used in this study represent current best available evidence. Participants 
will have full rights to withdraw anytime during the study without giving any reason, yet 
they will still receive the same high standard of care.  
 
Please do not hesitate to contact me on 0161 4265445 or via e-mail on 
sharon.chan1@nhs.net if you have any question about my research study.  
 
Many thanks 
 
Kind regards 
 
 
 
Sharon Chan 
Chief Investigator & Musculoskeletal Specialist 
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APPENDIX 7: Letter to inform GPs/physiotherapists about the study 
 
 
                                                                       
  
INFORMATION FOR GPs and Physiotherapists 
RESEARCH TITLE: Does a cognitive-behavioural chronic low back pain 
programme alter patients’ health locus of control? 
 
Dear Doctor/ Colleagues, 
 
I am conducting a research study as part of the Doctorate qualification. The aim of this 
study is to investigate how a cognitive-behavioural chronic low back pain programme 
may alter patients’ health locus of control, and its associated impact on clinical 
outcomes.  
 
The current back rehabilitation programme run by the physiotherapy service represents 
the recommendation by the UK guidelines. For the purpose of this study, the 
intervention will still be based on the best available evidence, but particular attention 
will be paid to target patient’s belief, fear avoidance behaviours, internal focus of 
control and positive coping strategies. This research aims to provide an improved form 
of management for patients with chronic back pain. There will therefore be benefits to 
those patients who participate and a potential improvement in the care of patients 
following this study. 
 
You can refer your patient with chronic low back pain into the physiotherapy service 
following the usual pathway and those who are interested in learning more about how 
to self-manage their back pain condition, and who fulfil the inclusion/ exclusion criteria 
(see enclosed attachment) will be invited to participate in the study. Eligible patients 
will be given an information leaflet and a full verbal explanation about the study. They 
will also be given at least a week to consider whether to take part. Informed consent 
will be obtained prior to the entry. With the patient’s agreement and consent, you will 
be informed of any patient you referred who agreed to participate in this study.  
 
Patients who agreed to take part in this study will be invited to attend a 6-week (two 
hours/ week) programme consisting of exercise and education. Patients will not be 
disadvantaged compared to standard care, except we will ask him/ her to fill in some 
questionnaires 4 weeks prior the programme and at 3-month and 6-month follow-up.  
 
This study has been reviewed and approved by the Research Ethics Committee of the 
Manchester Metropolitan University, the National Research Ethics Committee (NREC) 
with reference number 12/SW/0197 and the NHS. Please do not hesitate to contact me 
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on 0161 426 5445 or via e-mail on sharon.chan1@nhs.net if you have any questions 
about my research study.  
 
Many thanks 
 
Kind regards 
 
 
 
Sharon Chan 
Chief Investigator & Musculoskeletal Specialist 
 
 
Inclusion & exclusion criteria of the chronic low back pain study 
 
Inclusion criteria will be:  
 Patients with low back pain >3 months with or without leg pain 
 Age >18years 
 Disability and distress primarily caused by CLBP, as perceived by patient and 
assessor, Tampa Scale of Kinesiophobia (TSK) score >37 (indicating patient 
shows fear of movement and associated avoidance behaviour) 
 Able to give consent  
 
 
Exclusion criteria will be: 
 Patients who are diagnosed with serious spinal pathology such as malignancy 
and vertebral fracture, acute herniated disc with nerve root entrapment, unstable 
spondylolisthesis 
 TSK score < 37 
 Health conditions that prevented them from exercising safely 
 Language problems 
 Age <18 
 Patients unwilling to participate the programme 
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APPENDIX 8: Departmental protocol of the back rehabilitation programme in 
Stockport NHS 
 
 
Departmental Protocol 
Inclusion & exclusion criteria of the Back Rehabilitation Programme 
 
Inclusion criteria will be:  
 Patients with non-specific low back pain >3 months with or without leg pain 
 Age >18years 
 Disability and distress primarily caused by CLBP, as perceived by patient and 
assessor 
 Patients medically fit to take part in the exercise programme 
 Able to give consent  
 
 
Exclusion criteria will be: 
 Evidence of red flags indicating serious pathology 
 Patient is not medically fit to participate in an exercise programme  
 Patients who are diagnosed with serious or specific spinal pathology such as 
malignancy, vertebral fracture, spinal stenosis, acute herniated disc with nerve 
root entrapment, rheumatoid arthritis, unstable spondylolisthesis 
 Health conditions that prevented them from exercising safely 
 Language problems 
 Age <18 
 Patients who are demonstrating psychological distress, both pain and non-
pain related, which is beyond the scope of the physiotherapy-led back pain 
rehabilitation. 
 Patients unwilling to participate the programme 
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Appendix 9: Invitation letter to eligible participants  
 
 
Date…………………….. 
 
Dear potential research participant, 
 
Invitation to the study of chronic low back pain 
 
 
You are being invited to take part in a research study on chronic low back pain. Following the 
initial assessment with physiotherapist, you are identified as a possible participant of this study.  
 
Before you decide whether or not to take part, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the Participant’s 
Information Sheet attached carefully and discuss it with others if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Part 1 tells you the purpose of 
the study and what will happen to you if you take part. Part 2 gives you more details information 
about the conduct of the study. 
 
The aim of this study is to investigate how a cognitive-behavioural chronic low back pain 
programme may alter patients’ health locus of control, and its associated impact on clinical 
outcome. This study will help develop a more effective rehabilitation programme to improve the 
management of those patients with chronic low back pain. 
 
It is up to you to decide whether or not to take part. If you do decide to take part, you will be 
asked to keep the attached Participant’s Information Sheet and asked to sign a consent form. If 
you decide to take part, you are still free to withdraw at any time and without giving a reason. A 
decision to withdraw at any time, or a decision not to take part will not affect the standard care 
that you receive. 
 
If you have any questions or problems, please contact me on 0161 4265445 or via e-mail on 
sharon.chan1@nhs.net.  
 
Yours sincerely  
 
 
 
Sharon Chan 
Chief Investigator, Doctorate student and musculoskeletal specialist 
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Appendix 10: Overview of the CBCLBP programme 
 
 
              
 
 
 
 
  
 
 
SESSION 1   
Overview of basic anatomy and function of the spine 
Common diagnosis of back pain and clarify any misunderstanding of diagnostic 
language 
Explain primary and secondary “suffering” - physical, mental and emotional 
reaction to pain                                     
Introduce Fear-avoidance model and explain its detrimental effect 
Emphasis on Pain ≠ harm    
Teach home exercises 
Mat work and exercise circuit in the gym 
 
SESSION 2   
Quick recap on session 1 and question 
Introducing cognitive restructuring technique such as imagery and attention 
diversion 
Difference between acute and chronic pain 
Explaining pain- Pain gate theory, pain neuromatrix, sensitization 
Relationship between pain and inactivity 
Alternative pain control 
Importance of staying active 
Cycle of change 
Importance of improved self-management 
Mat work and exercise circuit in the gym 
 
SESSION 3 
Quick recap on session 2 and question 
Relationship between thinking, feeling and behaviour 
Introduce helpful and unhelpful cycle 
Relationship between pain and stress 
Explore other causes of pain 
Stress and relaxation 
Relaxation practise - diaphragmatic breathing exercises technique, three minutes 
breathing space and relaxation CD (20 minutes) 
Mat work and exercise circuit in the gym 
 
SESSION 4   
Quick recap on session 3 and question 
Relationship between pain and poor posture 
Posture - sitting, standing and lying  
Safe moving and lifting technique 
Sleep - pillow and mattress 
Reinforce technique of postural stretches 
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Pilates  
Body Scan CD (20 minutes) 
 
SESSION 5  
Quick recap on session 4 and question 
Activity management and 3Ps (Planning, Pacing and Prioritizing) technique 
Work out tolerance level 
Personal goal setting - SMART goal 
Role of exercise 
Rules for exercising 
Benefit of exercise 
Mat work and exercise circuit in the gym 
 
       
SESSION 6   
Quick recap on session 5 and question 
Future self-management and flare-up plan 
Top tips for future management and lifestyle change 
Information on PARIS – exercise prescription scheme 
Hydrotherapy- introduction and arrange session of hydrotherapy 
Feedback from patients- what and how the CBCLBP programme beneficial them 
Question time 
Mat work and exercise circuit in the gym 
 
After SESSION 6 
Hydrotherapy session (as allocated) 
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Appendix 11: Patients’ written information and education materials of the 
CBCLBP programme (week 1 to week 6) 
 
Session 1 
Slide 1 
Back Rehabilitation 
Programme
Physiotherapy Service
Stockport NHS Foundation Trust
Session 1
Jul-15
 
 
Slide 2 
Back Rehabilitation Programme
WELCOME EVERYONE
 
 
Slide 3 
Why are you here?
 Diagnosed with chronic back pain by your 
physiotherapist and GP, and that serious pathology is 
excluded
 There are various treatment options, but only a few of 
evidence-based interventions, supported by good 
quality research, are considered to be clinically 
effective and being viewed as a positive experience 
by patients. 
 The group structured education and exercise 
programme, using a cognitive-behavioural therapy 
approach is one of the recommended treatments 
following the UK clinical guidelines 
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Slide 4 
Due to the complexity of the 
condition: 
A COMBINATION of 
various
Intervention 
is required
Medical facet
e.g. adequate pain 
control
Physical facet
e.g. regular exercise &
Keep active!
Psychological facet
Think positive &
Being active towards
your rehab
 
 
Slide 5 
What will the programme involve?
 All based on best available evidence and 
current best practice in the UK
 6 sessions of exercise and education based 
on cognitive-behavioural principle
 Relaxation session
 Hydrotherapy (optional)
 Combination of listening, talking, discussing 
& sharing experience
 
 
Slide 6 
In the education sessions, 
you’ll learn about:
 Mechanism of chronic pain, anatomy and diagnosis
 Activity management and pacing
 Benefit of exercise
 Personal goal setting
 Pain control- medicine & alternative pain relief
 Stress management and relaxation technique-
breathing exercise and relaxation CDs
 Healthy lifestyle- getting active, trim and healthy!
 Postural, Lifting & handling workshop
 Develop coping skills and self- help techniques
 Promote positive attitude and sense of control over 
your chronic back pain condition
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Slide 7 
In the exercise sessions:
 Mat work- core stability and stretching 
exercise
 Cardiovascular exercise circuit in the 
gym
 Pilates
 Hydrotherapy (optional on Week 7)
 
 
Slide 8 
Objectives of the programme:
 ↑ Understanding of chronic pain and acceptance of 
the condition
 ↑ Understanding of anatomy
 ↑ Physical fitness, endurance & flexibility
 Help you return to normal activities & hobbies
 Learn relaxation skills & stress reduction
 Learn good posture & safe lifting technique
 Learn alternative methods of pain relief
 Feel more confident to self- manage your back 
condition
 Feel more in control & positive about the outlook of it
 
 
Slide 9 
ICE BREAKER
Speak to the person who is sitting next to you
Tell each other 3 things about yourself, 
EXCEPT your low back pain!
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Slide 10 
Content of session 1
 Basic anatomy and function of the spine
 Common diagnosis of back pain
 Explain primary & secondary “suffering”-
physical, mental and emotional reaction 
to pain or fear avoidance
 Pain Harm
 
 
Slide 11 
Anatomy of a healthy spine
 Consists of 33 
vertebrae lying in 5 
region 
 7 cervical vertebrae
 12 thoracic 
vertebrae
 5 lumbar vertebrae
 5 fused vertebrae-
sacrum
 4 fused vertebrae-
coccyx  
 
Slide 12 
Structures in the spine
 Vertebrae
 Intervertebral disc
 Spinal cord
 Spinal nerves
 Ligaments
 Muscles
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Slide 13 
Function of the spine
 One of the strongest part of the body
 Supports the weight of your upper body 
& transfers weight to your lower limbs
 Vertebral bodies & discs allow strength 
& flexibility
 Reinforced by strong ligaments & 
powerful muscles
 Protects the spinal cord
 
 
Slide 14 
What are the common causes of low 
back pain?
 
 
Slide 15 
Common cause of back pain
 Osteoarthritis
 Degenerative disease/ Wear 
and tear
 Spondylosis
 Slipped disc/ Bulging disc
 Nerve root irritation/ trapped 
nerve. E.g. sciatica
 Osteoporosis 
 Habitual poor posture
 Tension & emotional Stress
 The majority of back 
pain is mechanical in 
nature, & NOT due to 
serious disease.
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Slide 16 Avoidance of movement-
Physical and Emotional Impact                      
Pain
It hurts to move
Rest
Do less & less
Deconditioning
Muscle weaken
Joint stiffness
↓General fitness
Negative feeling
Emotional impact-
feeling frustrated, low, anxious
 
 
Slide 17 
Feel more comfortable
& no increased pain 
after exercise/ activities
Feel more confident
Feel good
Will do a little bit more & more
Plan and Pace yourself 
with exercises/ activities
To break the 
vicious cycle 
of fear-
avoidance
 
 
Slide 18 
Primary and secondary 
“suffering”
 Primary “suffering”
 Basic unpleasant 
sensations
 Secondary 
“suffering”
 Mental, emotional 
and physical 
reactions that you 
could change and 
overcome
 Being positive and 
acceptance helps
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Slide 19 
Positive Notes
 You may not be able to get rid of 
the basic unpleasant sensations, but 
it is within your control to help the 
secondary mental, emotional and 
physical reactions
 The coming sessions will discuss what 
might help overcome and address 
these reactions 
 
 
Slide 20 
Pain Harm
Hurt  Harm
Tips of the day
 
 
Slide 21 
 Being positive and acceptance helps 
overcome the secondary 
“suffering”- they are within your 
control and you could make changes!
Tips of the day
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Appendix 11  
Session 2 
Slide 1 
Back Rehabilitation
Session 2
Jul-15
 
 
Slide 2 
Content
Difference between acute & chronic pain
Pain gate theory
Relationship between pain and inactivity
Cycle of change
Key to improved self-management
Pain control - medicine and alternative 
pain relief (non-pharmalogical)
 
 
Slide 3 
Pain…..What is it……….?
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Slide 4 
Pain is………………
 Personal - very individual & subjective
 Difficult to define
 A sensory experience: unpleasant, sharp, dull 
aching pain
 An emotional experience: depressed, worried, 
frustrating
 Two types of pain: Acute & Chronic
May or may not be caused by physical 
damage 
 
 
Slide 5 
Acute Pain
Presence of inflammatory sign
Pain, redness, swelling, heat & loss of 
function
 Indicating body damage
A warning sign to protect your body -
useful!! 
Short lasting < 3 months
 
 
Slide 6 Example of acute pain-
Sprained ankle
 Structures in the 
ankle damaged  
 Signals to the brain →
stop walking to 
prevent further 
damage
 Allows body to heal
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Slide 7 
How do we feel pain?
 Pain transmitted through the nervous system
 Changes in the body are detected by sensors
 Stretch or pressure → message to spinal cord 
and brain → which tells body to stop
 Series of connections called gates
Gate open = pain messages get through
Gate closed = pain message is stopped
 
 
Slide 8 
Pain Gate Theory
 
 
Slide 9 
Chronic Pain
May be primary diagnosis e.g. OA/disc 
protrusion
Chronic pain = the pain receptors become 
over sensitised 
Body has healed but pain gate remains 
open
Problem with the pain processing circuit 
not the tissues.
E.g. phantom limb pain, post op pain
 
 
 APPENDICES Page 309 
 
 
Slide 10 KEY to recovery from Chronic Back 
Pain
 Acceptance - understand primary pain (not 
going to go away completely) and the secondary 
“suffering” (which is within your control and you 
can change them!).
 Adjustment - pacing activities, modifying 
activities
 Identify your personal barriers/resistance
 
 
Slide 11 
Secondary “suffering”/ experience
 Fear
 Feeling low and depressed
 Feeling stressed
 Frustrated
 Lack of sleep
Worried about job
 Family issues/ pressure
DISCUSS - Identify if you may have any 
secondary “suffering” and how you might 
overcome them? 
 
 
Slide 12 
Things that OPEN the pain gate
 Emotional stress
 Fear
 Anger, worry, tension 
 Low mood
 Thinking about pain
 Inability to cope
 Boredom due to minimal involvement in life activities 
 Maladaptive attitudes 
 Being deconditioned (stiff joints, tight muscles, low 
muscle tone)
These secondary 
“experiences”
something you 
can control and 
change
 
 
 APPENDICES Page 310 
 
 
Slide 13 
Things that CLOSE the pain gate
 Application of Heat or Ice 
 Relaxation
 Medication 
 Appropriate activity level- exercise & stretching 
 Avoiding excessive emotions 
 Making time to focus on positive emotions (keep a gratitude journal for 
example) 
 Managing stress properly 
 Distraction away from Pain 
 Increased Social Activities 
 Practicing Positive Attitude 
 Appropriate Exercise 
 Increased Positive Life Activities 
 Healthy Eating 
 Refraining from Unhealthy Habits 
 Having a communicative outlet to share thoughts and feelings 
These are also 
things you could 
actively do and 
within your 
control!
 
 
Slide 14 
What can I do??
Exercise has 
been shown to 
help physically 
and 
psychologically
Being fit & 
healthy makes 
you feel good 
too!
 
 
Slide 15 
DISCUSS - why you may be 
afraid to move?
•What are the potential barriers that may stop you 
moving/exercising?
•Physical or emotional barriers?
•How may you overcome these barriers?
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Slide 16 How may you overcome these 
barriers? 
Adequate pain control
 Pace yourself - do what you feel comfortable 
and gradually increase the amount of 
activities in your own pace
 Keep positive & be confident of yourself
Make time for it
 Reward yourself
 Do something fun and enjoyable!
 Exercise with others
 
 
Slide 17 
Pain Harm
Some post exercise soreness for a 
day or two is NORMAL if your joints 
are a bit stiff and muscles a bit 
weak. Don’t Panic! 
 
 
Slide 18 
Avoidance of movement
Pain
It hurts to move
Rest
Do less & less
Deconditioning
Muscles weaken
Joint stiffness
↓General fitness
Negative feeling
 
 
 APPENDICES Page 312 
 
 
Slide 19 Adequate Pain Control is important 
to allow you to start exercising!
Medicine & 
management of chronic pain
 
 
Slide 20 
Medicine
Adequate pain relief is essential for 
successful rehabilitation
Analgesics have a variety of side-effects & 
interactions with other drugs.
Patients should always be referred to the 
GP/pharmacist if medication needs 
changing
 
 
Slide 21 The WHO (World Health Organisation) 3 
steps Analgesic Ladder (1986)
 
 
 APPENDICES Page 313 
 
 
Slide 22 Commonly prescribed analgesia-
Paracetamol
 Indication: mild to moderate pain. 1st line 
treatment for Osteoarthritis
 Additional information: many over the counter 
medications e.g. Lemsip, which patients can buy 
themselves, contain paracetamol, this should 
NOT be taken with paracetamol.
 
 
Slide 23 Commonly prescribed analgesia -
mild opioids
 Indication: moderate to severe pain.  Or 
patients who have an inadequate response to 
“step 1” analgesics
 Example: codeine, dihydrocodeine, tramadol
 Additional information: often combined with 
paracetamol e.g. Co-codamol, Co-dydramol, 
Tramoxet
 
 
Slide 24 Commonly prescribed analgesia -
NSAIDs - Ibuprofen, Naproxen, 
Diclofenac (Voltarol)
 Indication: mild to moderate pain. 
Commonly used for back pain & other 
musculoskeletal disorders. E.g. arthritis, 
bone pain, inflammatory pain 
Additional information: always take the 
tablets with food
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Slide 25 Commonly prescribed analgesia -
low dose anti-depressants
 Indication: nerve pain, night pain, 
relaxation and help sleeping
Examples: Amitriptylline, nortriptylline, 
imipramine, clomipramine
Problem: tend to make people drowsy#
Anti-epileptic drugs
 Indications: Epilepsy & nerve pain
Example: Gabapentin, Pregabalin
 
 
Slide 26 Commonly prescribed analgesia -
Skeletal muscle relaxants
 Indication: acute pain, severe muscle 
spasm
Example: Diazepam, Temazepam, 
Nitrazepam 
Additional Information: can be useful in 
extreme cases of muscle spasm during 
flare up, and should limit intake to a few 
days only, then reduce gradually
 
 
Slide 27 
Tips on pain control
If you reduce your medication at a 
controlled rate, it is unlikely to 
increase your pain levels, and you may 
even feel better in yourself
Using other pain management skills 
can help you to reduce pain medication
Ideas of alternative pain relief?
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Slide 28 Non- Pharmalogical pain relief-
Discuss in group
Heat/Cold
Physiotherapy
Osteopathy/Chiropractic treatment
Acupuncture
TENS
Reflexology, massage, Reiki
Relaxation techniques
 
 
Slide 29 
 Acceptance - understand primary pain (not 
going to go away completely) and the secondary 
“suffering” (which is within your control and you 
can change!).
 POSITIVE thinking, feeling and behaviour 
 Adjustment - pacing activities, modifying 
activities
 Identify your personal barriers/resistance, and 
try to overcome them
 Distraction of pain
Tips of the day
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Appendix 11 
Session 3 
Slide 1 
Back Rehabilitation
Session 3 
Stress and Relaxation
Jul-15
 
 
Slide 2 
Content of session 3
 Relationship between pain & stress
 Thoughts & feelings - helpful & 
unhelpful cycle
 Relaxation techniques - introduce 
THREE minutes space,diaphragmatic 
breathing & relaxation CD
 
 
Slide 3 
Stress and Pain
 Thoughts, Feelings, 
Attitude and Stress 
affect how we 
manage pain. 
 How you think 
affects how you feel
 How you feel affects 
how you behave 
 Stress affects pain
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Slide 4 
Things that OPEN the pain gate
 Stress
 Fear
 Anger 
 Low mood
 Thinking about pain
 Inability to cope
 Being deconditioned (stiff joints, tight 
muscles, low muscle tone)
 
 
Slide 5 
Thoughts 
Behaviour 
Feelings
Role of thoughts and feelings
 
 
Slide 6 
Thinking negatively
 Extreme thoughts 
 Black and White thinking
 Unhelpful thoughts
 Negative thoughts
How does pain feel when we’re in a bad 
mood?
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Slide 7 Negative thoughts = 
BEHAVIOUR changes
 Reduced activities
 Avoid activities
 Become deconditioned
 Pain increases
This will have a detrimental affect on pain
 
 
Slide 8 
Unhelpful cycle
Do less & less 
Withdrawn from 
activities
Feel low & 
negative
Thinking 
becomes 
negative “I 
can’t cope”  
 
Slide 9 
Helpful cycle
Feel positive & 
believe that you 
can control it 
better
I can cope 
as long as I 
pace & plan 
Feeling good
Sense of 
achievement and 
personal control
Feel confident  
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Slide 10 
Stress <=> Pain
Stress Response
 ↑ Heart rate
 ↑ Breathing rate, 
more shallow
 ↑ Muscle tension
 Sweat
 Butterflies in your 
tummy
 
 
Slide 11 
Stress response
 However stress response can be 
constructive and non-constructive.
Stress response -
Constructive Vs Non-constructive
 
 
Slide 12 
Constructive Non-Constructive
 Flight or Fight
 Prepares us for 
danger
 Useful
 Short duration 
 Occurs in response to 
normal every day 
activities 
 Habit forming
 Not useful
 Build up of tension = 
person becomes 
unaware of the stress
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Slide 13 
How do you cope 
with stress?
 
 
Slide 14 
Why Relax?
 Lowers stress levels
 Breaks cycle of 
stress = ↑ pain
 ↓ Muscular tension 
 
 
Slide 15 
Diaphragmatic Breathing
Deep breathing technique
Uses the sheaf of muscle between lungs 
and stomach
Combats shallow & rapid breathing 
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Slide 16 
How to do it?
 Comfortable and relaxed 
position
 Hands over your ribcage
 Breathe in through the nose 
trying to expand ribcage 
laterally
 Breathe out feel ribcage drop
 Equal movement of both 
sides
 Practice no more than 4 a 
day
 
 
Slide 17 
Three minutes 
breathing space
 A “three minute breathing space” is a “pause”
from activity, where you stop doing everything 
and simply be quiet for three minutes
 Easy to do at regular intervals throughout the 
day. E.g. once every hour
 Can be quite powerful - makes you feel 
calmer and more relaxed
 
 
Slide 18 
Three minutes breathing 
space- How to do?
1. Sit/lie down in a comfortable position, with your eyes 
closed
2. Focus on your natural even breathing, and allow 
yourself to feel the gentle movements of your ribs as 
you breathe
3. Try to take your attention to the area with muscle 
tension and pain, and let your muscle tension and 
pain soften on your out breath
4. You can also be aware of what you are feeling 
emotionally, and what sort of thoughts are passing 
through your mind
5. Remain aware of your breathing as well as your 
sensations, feelings and thoughts for three minutes, 
you will probably become more “centred”, calm, and 
relax  
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Slide 19 
Why practice breathing 
techniques?
 Promotes a natural even movement of 
breath
 Strengthens the nervous system
 Relaxes the body
 Supplies body with O²
 Improves circulation to the abdominal 
muscles by its massaging action
 Breaks cycle of pain = stress
 
 
Slide 20 
But if you are stressed….
 Increased tension 
 Hyperventilated breathing
 Tense up abdominal muscles, and use more 
accessory muscles. So your diaphragm is not 
at its optimal function
 More energy is required to “breath”
 Reduced oxygen supply to the body
 
 
Slide 21 
CBT (Cognitive Behavioural 
Therapy)
 Talking therapy which helps people 
understand the links between your symptoms, 
thoughts and feelings, behaviour and how this 
affects your life.
 There are group and 1:1 sessions which may be 
of interest to you, which we can discuss 
towards the end of the programme.
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Slide 22 
Learning to reduce stress and relax, 
and combined with exercise can 
relieve back pain
It can start you on the road to 
a happier and healthier 
lifestyle!
 
 
Slide 23 
Stress
Increased 
Muscle Tension
PAIN
To counteract 
stress-
RELAXATION
Tips of the day
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Appendix 11 
Session 4 
Slide 1 
Back Rehabilitation
Session 4 
Jul-15
 
 
Slide 2 
Content of session 4
 Relationship between pain & poor 
posture
 Posture - sitting, standing & lying
 Sleep - pillow & mattress
 Safe lifting technique
 Pilates
 
 
Slide 3 
What is Good Posture?
 Maintenance of the 3 
natural curves of the 
spine
 Optimum functioning of 
the spine
 Spinal alignment
 Strong flexible muscles
 Ligaments and soft 
tissues not 
overstretched
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Slide 4 
Why good posture is important for 
people with back pain?
 When your spine is at the normal “S”
shaped curvature, the muscles work the 
most efficiently without getting painful & 
tired. Also the ligaments and other soft 
tissues are at their optimum length, and 
they are not overstretched.
 GOOD Posture - ↓PAIN & muscle 
tension
 
 
Slide 5 
 
 
Slide 6 
Consequences of poor posture
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Slide 7 
Consequences of poor posture
 Worsens back pain
 Accelerate degenerative changes
 ↑ Risk of injury
 Tight & imbalanced muscles 
 ↑ Stiffness = ↓ functioning of spine
 Weakened intervertebral discs
 Could lead to “Dowager’s hump”
 
 
Slide 8 
Causes of poor posture
 
 
Slide 9 
Posture that works
 Good standing, sitting & sleeping
 Good posture in motion
 Postural exercises
 Regular stretches
 Mini breaks & “Active” rest
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Slide 10 
Posture checklist - Sitting
 
 
Slide 11 
Posture checklist - Standing
 
 
Slide 12 
Posture checklist - Lying
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Slide 13 
Posture checklist - Everyday 
activities
Emptying the washing machine
Gardening
Doing the dishes
Cleaning
D.I.Y around the house
Any other activities?
 
 
Slide 14 
To learn good posture may 
feel strange at first
But you’ll be surprised at 
how quickly it becomes a 
comfortable habit, and 
how good it looks and 
feels. 
 
 
Slide 15 
Lifting
Back injuries can result from poor lifting
Bad lifting
Bending over the load
Twisting
Holding object at arms length
Not using the large leg & buttock muscles
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Slide 16 
Safe lifting
 
 
Slide 17 
Safe lifting
 
 
Slide 18 
Safe lifting
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Slide 19 
Safe lifting
 
 
Slide 20 
How to lift properly
Get a firm footing
Bend your knees
Tighten stomach muscles
Lift with your legs
Keep the load close
Keep your back straight
 
 
Slide 21 
Regular stretches
 Get up and stretch 
regularly, every 20-
30 minutes.
 This can reduce 
accumulated tension 
and allow you to feel 
more relax.
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Slide 22 
Exercise to encourage good posture
 
 
Slide 23 
Every move you make during the day at work 
and at home depends on your back
Keep your back & posture in 
mind throughout the day while 
you sit, stand, lift & carry
Tips of the day
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Appendix 11 
Session 5 
Slide 1 
Back Rehabilitation 
Programme
Session 5
Jul-15
 
 
Slide 2 
Content of session 5
Activity management 
3P’s technique - Planning, Pacing and 
Prioritising
Personal goal setting - SMART goal
Benefits of exercise
 
 
Slide 3 
Activity management
3P’s techniques
Pacing Planning Prioritising
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Slide 4 
Purpose of 3P’s management
 3P’s enables you to 
avoid over-activity/ 
under activity
 Take back control 
over your life & stop 
pain controlling you
Over-activity
Increased pain
Under-activity
E.g. prolonged rest & medication
 
 
Slide 5 
Activity cycle
Good day- Do too much. Bad day- suffering
Activity level
Time
Good day
Bad day
Basic daily activities
Aim to level out the curve
Aim to gradually increase 
activity level in the future
 
 
Slide 6 
To increase the consistency of activity 
level:
3P’s – Pacing, Planning, Prioritizing
Work out your tolerance level
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Slide 7 
Tolerance level
What is tolerance 
level?
 It is how much can be 
done at the moment 
without over-doing it.
 How to set your 
baseline tolerance?
Worksheet in your 
education pack
Good 
Day
(mins)
Bad 
Day
(mins)
Baseline 
tolerance
= (Good 
day+ bad 
day)/ 2
Sitting
Standing
Walking
 
 
Slide 8 
Cycle of Change
Pre contemplation
No interested in changing behaviour
Contemplation
Thinking about change
Preparation
Ready to change
Action
Making changes
Maintenance
Maintaining change
Pausing/ Relapse                                 Outcome
Relapsing                          Long termed behavioural change
 
 
Slide 9 
Healthy Stockport
Healthy Stockport:
Free confidential local support 
service to help you make 
lifestyle changes e.g. smoking 
cessation, weight loss.
Contact: 0161 426 5085
www.healthystockport.co.uk
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Slide 10 Goal Setting
SMART GOAL
S - Specific
M - Measurable
A - Achievable
R - Realistic
T - Time- specific
 
 
Slide 11 
GOAL:
 Homework - Set a 
SMART goal
Week 1
Week 2
Week 3
Week 4
Week 5
Week 6
 
 
Slide 12 
BENEFITS OF EXERCISE
WE all know the many benefits of 
exercise. However not everyone 
can keep up exercise regularly.
WHY?
So what are your reasons against 
exercise?
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Slide 13 
Reasons against exercise
FEAR & Increase PAIN!
Laziness
Lack of motivation & time
Work & family commitments
Lack of confidence, not sure what is safe 
to do
ANY OTHER BARRIERS?
 
 
Slide 14 Deconditioning & lack of exercise can 
lead to……..
 ↓ Activity level & weight gain
 ↓ Physical fitness & ↓endurance
 ⁭ Joint stiffness & weaken muscles
 Weak bones
 Depression/ ⁭ risk of depression
 Low energy & ⁭ tiredness
 Poor sleep
 ↓ Ability to cope stress
 ⁭ Sensitivity of pain receptors
 ⁭ PAIN
 
 
Slide 15 TO ADDRESS THESE 
PROBLEMS, exercise has 
shown to have a beneficial 
effect - both physical & 
psychological aspects
Pain Harm
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Slide 16 
Benefits of exercise
 Improved muscle strength, endurance and flexibility
 Improvement of co-ordination & functional activity
 Increased general fitness and cardiovascular function
 Improved circulation
 Increased level of energy
 Improved balance and walking pattern
 Potential increase in bone mass and reduce risk of injury
 Weight loss
 Reduction in levels of stress
 Increased feeling of well-being and self-confidence
 Potential improvement in the quality of sleep
 Reduction in pain
 
 
Slide 17 
Tips to start exercising!!
Set simple & achievable goals
Pace yourself
Add variety to prevent boredom
Exercise with others
Be flexible
Track your progress
Reward yourself
Exercise prescription - PARIS scheme
 
 
Slide 18 
Any Questions?
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Appendix 11 
Session 6 
Slide 1 
Back Rehabilitation
Session 6
Jul-15
 
 
Slide 2 
Content
 Management of flare up 
- Relapse plan
 Future management
 Continuity following back 
rehabilitation - PARIS
 To fill in: Post 
assessment 
questionnaire & 
evaluation form
 Certificate 
 
 
Slide 3 Managing setbacks
 Relapse is the nature 
of back pain
 Self-management 
skills would help to:
 ↓ Duration of bad 
days
 ↓ Frequency of bad 
phrase
 ↓ Severity of pain
 Feel more in control
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Slide 4 
Flare up plan
DON’T PANIC & STAY POSITIVE
 Painkillers & NSAIDs
 Heat/Ice
 Regular change of position & stretches
 Keep active but ↓ amount of activity, then 
gradually ⁭ as pain get easier
 3P’s - Pace, Plan & Prioritise
 Relaxation
 Positive thinking - you can manage it!
 
 
Slide 5 
Warning signs
 Having severe pain that gets worse over several 
weeks instead of better
 Feel generally unwell with back pain
 Difficulty passing urine or controlling urine
 Numbness around your back passage or 
genitals
 Numbness, pins & needles or weakness in both 
legs
 Unsteadiness on your feet
These symptoms are very RARE. Don’t let that 
list worry you too much!
 
 
Slide 6 How to look after your back in 
day-to-day activities?
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Slide 7 
Regular stretches
Get up and stretch 
regularly, every 20-30 
minutes
Micro-breaks in 
between work, 
especially after 
prolonged position
 Look at ergonomic 
design at work 
 
 
Slide 8 
Relaxing/ sleeping
Make sure your 
mattress is firm 
enough so that your 
spine is well-
supported.
 
 
Slide 9 
Heat
 A good way to reduce 
pain, joint stiffness 
and relax your 
muscles
 Hot water bottle, 
wheat pack, hot 
shower or bath
 Pleasantly warm
 15-20 minutes
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Slide 10 
Keep fit and active
 Keeping active, 
physically fit & trim 
will help you avoid 
back pain.
 You can reduce your 
risk of back pain by 
improving the 
strength and flexibility 
of the muscles 
supporting your spine. 
 
 
Slide 11 
Safe lifting
 
 
Slide 12 
Safe lifting
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Slide 13 
Referrals:
Healthy Stockport- helps you to make 
lifestyle changes e.g. smoking cessation, 
weight loss
 Cognitive Behavioural Therapy (CBT) referral-
may help if you have anxiety, stress and 
depression as a result of chronic pain
 PARIS scheme: Physical activity referral in 
Stockport. Referral to gym to continue with 
exercise
 
 
Slide 14 
Remember:
 Back pain is common, it’s rarely due to serious 
disease & the long - term outlook is good
Hurt ≠ Harm
 Bed rest more than a day or two is usually bad 
for you. Staying active will help you get 
better faster. The sooner you get going, the 
faster you will get better
 Regular exercise & staying fit helps general 
health & your back
 You have to get on with your life. Don’t let 
your back take over
 
 
Slide 15 
Any Question?
Well done & 
we hope you 
enjoyed the 
course!!
All the very 
best to you!
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Slide 16 
Future activity: What now?
 Lifestyle change - taking up 
exercise, pacing activities
 3P’s & activity management
 Goal setting 
 Stay active & fit
 Be positive
 Practise relaxation
 Don’t panic when flare - up
 Take up exercise - PARIS 
scheme, aqua aerobics, 
pilates, walking.
 
 
Slide 17 
Certificate & Evaluation form
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Appendix 12: Homework of the CBCLBP programme 
 
Homework 1 
 
 
 
GOAL:  
 
 
WEEK 1 
 
 
 
WEEK 2 
 
 
 
WEEK 3 
 
 
 
WEEK 4 
 
 
 
WEEK 5 
 
 
 
WEEK 6 
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Homework 2: 
 
TOLERANCE LEVEL WORK SHEET 
 
Most people find prolonged sitting, standing or walking aggravates their back pain. Pacing 
involves gradually increasing the tolerance for a particular task, therefore work out a 
tolerance level or time limit at standing, sitting and walking are helpful. 
 
What is tolerance level? 
It is how much can be done at the moment without overdoing. 
 
How to set your baseline tolerance? 
Write down how long you can sit, stand and walk for a good day, then do the same for a 
bad day. Then work out the average between those two values, hence you got your baseline 
tolerance (the maximum time you will do that activity). This could ensure you don’t 
overdo on a good day. 
 
 
 
 Good Day Bad Day Tolerance 
level = (Good  
day +  
bad Day)   2 
Sitting    
Standing    
Walking    
 
 
Suggestion:  
 You could use of timer initially to help stick to your tolerance 
level. 
 Once you happy with the baseline tolerance level, you can 
gradually increase your tolerance level by effective pacing. 
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Homework 3 
Managing Setback- What I would do? 
 
 
Strategy During acute 
flare-up 
Day 1- 3 
Day 3 onward 
1   
2   
3   
4   
5   
6   
 
 
                                                            
 APPENDICES Page 347 
 
 
Appendix 13: Home exercise workbook 
 
 
 
STOCKPORT NHS TRUST PHYSIOTHERAPY SERVICE 
 
 
 
BACK REHABILITATION 
PROGRAMME 
 
 
Getting started with 
your home exercises & 
postural stretches 
everyday  
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Getting started 
Establish your baseline repetition i.e. the number of times you can do an exercise 
without overdoing it.  It is very important to set your baseline at an easily achievable level 
to help you gain confidence and reduce ‘fear’ of exercising e.g. each exercise is performed 
10 times, hold the stretch for 5 seconds (twice a day)  
 
Consider using 15-20 minutes of heat treatment such as a hot water bottle, wheat pack, 
hot shower/bath, on your back before you do your home exercises.  Or try taking some 
painkillers beforehand if appropriate.  The heat helps to relax the muscle tension and 
reduce the pain, and it will help you to perform your exercises more effectively and 
comfortably  
 
When you carry out the stretching exercises remember the 3 “S” - “S” Slow, “S” 
Sustained and “S” Steady. 
 
Move slowly into the stretch position. 
 
Sustain (hold) the stretch for a slow count of 5 seconds.  You will feel some stretching 
sensation but that is entirely normal.  Please ensure that you do these exercises within 
your comfortable range.  
 
Steadily release the stretch and return to the start position.  The physiotherapist will 
demonstrate and advise you about the correct technique of the exercise 
 
Progressing 
Progress by gradually building the length of time you hold each stretch up to 20 seconds.  
You can also gradually build up the number of repetitions 
 
Set yourself exercise targets each week - they can be general, e.g. “work up to 19 
repetitions of each exercise by the end of the week”. 
 
Record your achievements daily on the chart provided so you can see your progress and 
gain confidence 
 
Reward yourself for sticking to your plan - treat yourself if you managed to stick to your 
exercise plan, you deserve it.  Use rewards after an exercise session, at the end of the 
week or at the end of the month. 
 
Physical activity is good for everybody and too much rest can lead to stiffness in your 
muscles and joints.  Research shows that exercise is the most important way that you can 
help yourself if you have back pain.  Exercise might make your back feel a bit sore at first 
but it doesn’t cause any harm - so don’t let it put you off!  Start off slowly and gradually 
increase the amount of exercise you do.  Also make your exercise enjoyable!  Over time, 
your back will get stronger, more flexible and this should reduce pain and help to make 
you feel like you can manage more with your back pain condition. 
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HOME EXERCISE PROGRAMME 
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Postural stretches 
Maintaining good upright posture is crucial when you experience back pain.  Poor posture 
affects the soft tissues supporting your back and that will increase your pain, and may 
also lead to muscle tightness and weakness, stiff joints and deconditioning. 
 
Try to maintain good posture when sitting, standing and walking.  It may feel a bit strange 
to start with, but you will be amazed how quickly your body adapts to good posture and 
how good you look! 
 
Practise the following postural stretches regularly throughout the day e.g. 3 repetitions of 
each stretch every hour.      
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Monitor & record your home exercise progress 
 
Date: ………………………………………… 
How many times have you done each exercise today? 
 
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Pelvic 
tilting 
       
Hamstrings 
stretch 
       
Bridging        
Knees to 
chest 
stretch 
       
Knees roll 
side-to-
side  
       
Back 
extension 
in standing 
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Appendix 14: Exercise circuit sheet of the CBCLBP programme 
 
 
CBCLBP programme exercise circuit sheet 
 
Name: …………………………      D.O.B: ……/…… /……   NHS No.: ……………………… 
 
Number of week Week:  
Date: 
Week: 
Date: 
Week: 
Date: 
1. Cross Trainer (minutes)   
 
  
2. Exercise bike (minutes)  
 
  
3. Trampet (minutes)  
 
  
4. Lunge (reps)     
5. Wall press up  (reps)  
 
  
6. Wall slide with small gym ball 
(reps) 
   
7. Gym Ball - in sitting & straighten 
your knee (reps) 
   
8. Rowing with pulley (reps and 
weight)  
   
9. Treadmill (minutes/speed) 
 
   
10. Core stability: 
      a) half bridge in lying (reps) 
      b) four-point kneeling (reps) 
 
a) 
 
b) 
a) 
 
b) 
a) 
 
b) 
Comments    
Physiotherapist’s 
Signature: 
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Appendix 15: Hydrotherapy Exercise 
 
1.   Walking forwards, sideways, backwards, walking with high knees.   
 
2.   Holding Woggle float at either end walk forward and place one end of float into 
water arm stretched forwards, pull it towards you as you step and reach out 
with opposite side and do the same , continue walking.  
 
3.  Stood with feet shoulder width apart and flat on the floor, arms resting on  
 float, rotate left and right.  
 
4.  Stood with feet flat and shoulder width apart, holding float by your side with 
elbow straights, bend down to side of float and slowly up, repeat on both sides.   
 
5.  Feet shoulder width apart maintain good back posture, hold woggle towards 
middle in both hands and push into the water with the ends out of the water 
and bring out slowly, repeat and keep straight back. 
 
6.   As above half submerge float, keep submerged and slowly rotate left and right 
keeping feet flat on floor.  
 
7.  Keep feet slightly apart, arms by your side.  Lean sideways sliding your hand 
down the outside of your leg and then straighten and repeat the same 
movement to the other side.   Repeat 10 times to each side. 
 
8.  Stand sideways to the rail holding on with one hand, feet at the side of pool, 
lean your hips in towards the centre of the pool.  Hold for 5 seconds then 
straighten.   Repeat 5 times then turn and do the same with the other side.  
 
9. Facing the rail hold on with both hands standing with feet away from the wall.  
Drop your back into a hollow bringing pelvis towards wall and arch back and 
then return to your start position.  Repeat 10 times.  
 
10.  Facing rail hold on with both hands and walk feet up wall, bend your knees 
and curl your back to wall and then straighten out knees and arms and stretch 
out, repeat 10 times. 
 
11.  Holding square float in two hands keep good back posture, feet hip width apart 
push float out and back against the water, maintain upright position. 
  
 
13.  Rest float on surface of water hands flat on float and arms extended out in 
front, push float into water to submerge it slowly and then slowly bring up. 
 
14.    Position as above bend knees and stick bum out as if to sit down then 
straighten up, repeat squats. 
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15.  Stood with good posture hold float out to side in one hand, bring under water in 
front of you and swap hands bring float out of water on other side and then lift 
above your heard, swap hands again and bring down back into the water, 
repeat going both ways. 
 
16.  Stand sideways with your right leg straight and your foot pulled up towards 
you.  Swing the right leg forwards and backwards 10 times.  Repeat with the 
left leg. 
  
17. Stand sideways and draw big circles round with your right leg in front and then 
behind you, repeat 10 times then do with left leg 
 
18.  With back against wall hold onto rail and put a float under your feet, move legs 
from side to side.  
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Appendix 16: Pilates 
 
Back Rehabilitation Pilates Class:     
Date and Time:    Physiotherapist/Pilates Instructor:  
Patient Name:     DOB:   NHS No: 
The above named patient attended an’ Introductory Pilates for LBP’ session at Kingsgate House as 
part of the back rehabilitation programme. The following ‘ticked’ exercises show the programme that 
was followed under the supervision and guidance of a Qualified APPI Pilates Instructor.  
Stand, find neutral spine position, ‘centre set’, Pelvic triangle and Trans-Abs 
Warm-Up: 
- Marching/ walking series  
- Mermaid in Standing 
- Foot Series 
- Side Plié 
- Dumb waiter 
- Cx Retractions/Rot/SF 
- Roll down 
Main Body: 
4-Point kneeling… 
- Thread the needle  
- Cat stretch  
- Superman 
Prone… 
- Swimming 
- Breast Stroke 
- Swan Dive 
Side Lying… 
- Clam 
- Side Kick 
- Arm Opening 
Supine… 
- Scissors 
- Hip twist 
- Shoulder Bridge 
- 100’s 
- Abdo Prep 
Stretches / cool down:   
- Gluteal stretch  
- Mermaid stretch  
- Spine stretch  
- Re-cap Posture in standing  
Physiotherapist Signature:…………………………………… 
 APPENDICES Page 357 
 
 
Appendix 17: Primary outcome measure: Form C of MHLC (measure of HLOC) 
Participant Study Identification Number: ……………………………………… 
DATE…………………….. 
Form C of the Multidimensional Health Locus of Control Scale 
Instructions: Each item below is a belief statement about your medical condition with which you may 
agree or disagree. Beside each statement is a scale which ranges from strongly disagree (1) to strongly 
agree (6). For each item we would like you to circle the number that represents the extent to which you 
agree or disagree with that statement. The more you agree with a statement, the higher will be the 
number you circle. The more you disagree with a statement, the lower will be the number you circle. 
Please make sure that you answer EVERY ITEM and that you circle ONLY ONE number per item. 
This is a measure of your personal beliefs; obviously, there are no right or wrong answers. 
1=STRONGLY DISAGREE (SD) 
2=MODERATELY DISAGREE (MD) 
3=SLIGHTLY DISAGREE (D) 
4=SLIGHTLY AGREE (A) 
5=MODERATELY AGREE (MA) 
6=STRONGLY AGREE (SA) 
 
  SD MD D A MA SA 
1 
If my condition worsens, it is my own behavior which determines how 
soon I will feel better again. 
1 2 3 4 5 6 
2 As to my condition, what will be will be. 1 2 3 4 5 6 
3 
If I see my doctor regularly, I am less likely to have problems with my 
condition. 
1 2 3 4 5 6 
4 Most things that affect my condition happen to me by chance. 1 2 3 4 5 6 
5 
Whenever my condition worsens, I should consult a medically trained 
professional. 
1 2 3 4 5 6 
6 I am directly responsible for my condition getting better or worse. 1 2 3 4 5 6 
7 
Other people play a big role in whether my condition improves, stays the 
same, or gets worse. 
1 2 3 4 5 6 
8 Whatever goes wrong with my condition is my own fault. 1 2 3 4 5 6 
9 Luck plays a big part in determining how my condition improves. 1 2 3 4 5 6 
10 
In order for my condition to improve, it is up to other people to see that the 
right things happen. 
1 2 3 4 5 6 
11 
Whatever improvement occurs with my condition is largely a matter of 
good fortune. 
1 2 3 4 5 6 
12 The main thing which affects my condition is what I myself do. 1 2 3 4 5 6 
13 
I deserve the credit when my condition improves and the blame when it 
gets worse. 
1 2 3 4 5 6 
14 
Following doctor's orders to the letter is the best way to keep my condition 
from getting any worse. 
1 2 3 4 5 6 
15 If my condition worsens, it's a matter of fate. 1 2 3 4 5 6 
16 If I am lucky, my condition will get better. 1 2 3 4 5 6 
17 
If my condition takes a turn for the worse, it is because I have not been 
taking proper care of myself. 
1 2 3 4 5 6 
18 
The type of help I receive from other people determines how soon my 
condition improves. 
1 2 3 4  5  6 
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Appendix 18: Secondary outcome measure 1: VAS (measure of pain intensity) 
 
The Visual Analogue Scale (VAS) for pain            
 
Participant Study Identification Number: 
………………………………………  
 
DATE…………………….. 
 
 
 
This scale lets us know the level of your pain today. Please place a mark 
on the line below which best describe your pain TODAY.  
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Appendix 19: Secondary outcome measure 2: RMQ (measure of disability) 
The Roland-Morris Low Back Pain and Disability Questionnaire 
Participant Study Identification Number: ……………………………………… 
DATE…………………….. 
Below are some of the comments which people have used to describe themselves.  Read the list, think 
of yourself TODAY, mark the box with either 1 (True) or 0 (False), whichever describes you TODAY. 
0 = False  1 = True 
1. I stay at home most of the time because of my back pain.  
2. I change position frequently to try and get myself comfortable.  
3. I walk more slowly than usual because of my back pain.  
4. Because of my back, I am not doing the jobs I usually do around the house.  
5. Because of my back, I use a handrail to get upstairs.  
6. Because of my back, I lie down to rest more often.  
7. Because of my back, I have to hold on to something to get out of an easy chair.  
8. Because of my back, I try to get other people to do things for me.  
9. I get dressed more slowly than usual because of my back.  
10. Because of my back, I try not to bend or kneel down.  
11. I find it difficult to get out of a chair because of my back.  
12. I am in pain almost all the time.  
13. I only stand up for short periods of time because of my back.  
14. I find it difficult to turn over in bed because of my back.  
15. My appetite is not very good because of my back.  
16. I have trouble putting on my socks/tights because of the pain in my back.  
17. I only walk short distances because of my back pain.  
18. I sleep less well because of my back pain.  
19. Because of my back trouble, I get dressed with help from someone else.  
20. I sit down for most of the day, because of my back.  
21. I avoid heavy jobs around the house because of my back.  
22. Because of my back, I am more irritable than usual.  
23. Because of my back I go upstairs more slowly.  
24. I stay in bed most of the time because of my back.  
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Appendix 20: Secondary outcome measure 3: TSK (measure of FAB) 
 
The TSK Questionnaire     
Participant Study Identification Number: ……………………………………… 
DATE…………………….. 
 
This section lets us know how you are dealing with the back pain. 
Please circle the number most appropriate for each statement. 
 
 Strongly 
Disagree 
Somewhat 
Disagree 
Somewhat 
Agree 
Strongly 
Agree 
1. I am afraid that I might injure myself if I 
exercise 
1 2 3 4 
2. If I were to try to overcome it, my pain 
would increase 
1 2 3 4 
3. My body is telling me I have something 
dangerously wrong. 
1 2 3 4 
4. My pain would probably be relieved if I 
were to exercise. 
1 2 3 4 
5. People are not taking my medical condition 
seriously enough. 
1 2 3 4 
6. My accident/back problem has put my 
body at risk for the rest of my life. 
1 2 3 4 
7. Pain always means I have injured my body. 1 2 3 4 
8. Just because something aggravates my pain 
does not mean it is dangerous. 
1 2 3 4 
9. I am afraid that I might injure myself 
accidentally. 
1 2 3 4 
10. Simply being careful that I do not make 
any unnecessary movements is the safest 
thing I can do to prevent my pain from 
worsening. 
1 2 3 4 
11. I would not have this much pain if there 
wasn’t something potentially dangerous 
going on in my body. 
1 2 3 4 
12. Although my condition is painful, I would 
be better off if I were physically active 
1 2 3 4 
13. Pain lets me know when to stop exercising 
so that I do not injure myself. 
1 2 3 4 
14. It is really not safe for a person with a 
condition like mine to be physically active. 
1 2 3 4 
15. I cannot do all the things normal people do, 
because it is too easy for me to get injured. 
1 2 3 4 
16. Even though something is causing me a lot 
of pain, I do not think it is actually 
dangerous 
1 2 3 4 
17. No one should have to exercise when 
he/she is in pain. 
1 2 3 4 
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Appendix 21: Secondary outcome measure 4: SCQ (measure of attitudes toward back pain self-care) 
 
Attitudes Toward Back Pain Self- Care Questionnaire (Von Korff et al, 1998) 
 
Participant Study Identification Number: ……………………………………… DATE…………………….. 
 
Below is a five-item Self- Care Orientation Scale to assess people attitudes toward self-care for back pain. 
Please read carefully and indicate on a five-point scale (1-5 points for each item) whether you strongly agree, 
agree, neutral, disagree or strongly disagree with the following statements: 
 
 Strongly 
agree 
1 
Agree 
 
2 
Neutral 
 
3 
Disagree 
 
4 
Strongly 
disagree 
5 
1. For your back pain problem, prescription pain relievers are 
necessary to control the pain when it is really bad. 
 
     
2. Your back problem requires ongoing attention and advice from a 
physician. 
 
     
3. You have found that things you do on your own are more helpful 
than medical treatments. 
 
     
4. You feel able to care for your back problem on your own. 
 
     
5. You would avoid using prescription medicines for your back 
pain, even if it were severe. 
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Appendix 22: Participants’ outcome measures collection booklet 
 
 
 
 
RESEARCH TITLE: Does a cognitive-behavioural chronic low back 
pain programme alter patients’ health locus of control? 
 
Data Collection Booklet 
 
 
Participant study number 
 
  
Back rehab class- which group &  
Name of physiotherapist 
  
  
  Tick if  
Completed  
Date of Consent taken 
 
  
Date of assessment: 
4 weeks prior to back rehab 
  
Date of assessment: Week 1 
 
  
Date of assessment: Week 6 
 
  
Date of assessment: 3 months 
 
  
Date of assessment: 6 months 
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RESEARCH TITLE: Does a cognitive-behavioural chronic low back pain 
programme alter patients’ health locus of control? 
 
 
DATA COLLECTION 
BOOKLET 
 
Data Collection on 
-4 weeks, week 1, week 6, 3 months or 6 months 
Please tick as appropriate 
 
Date completed:  
 
 
 
Participant Study Identification Number: ……………………………………… 
DATE……………………..(Week…..) 
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1. Form C of the Multidimensional Health Locus of Control Scale (Wallston et al, 1978) 
Instructions: Each item below is a belief statement about your medical condition with which you 
may agree or disagree. Beside each statement is a scale which ranges from strongly disagree (1) to 
strongly agree (6). For each item we would like you to circle the number that represents the extent 
to which you agree or disagree with that statement. The more you agree with a statement, the 
higher will be the number you circle. The more you disagree with a statement, the lower will be the 
number you circle. Please make sure that you answer EVERY ITEM and that you circle ONLY 
ONE number per item. This is a measure of your personal beliefs; obviously, there are no right or 
wrong answers. 
1=STRONGLY DISAGREE (SD) 
2=MODERATELY DISAGREE (MD) 
3=SLIGHTLY DISAGREE (D) 
4=SLIGHTLY AGREE (A) 
5=MODERATELY AGREE (MA) 
6=STRONGLY AGREE (SA) 
 
  SD MD D A MA SA 
1 
If my condition worsens, it is my own behavior which determines 
how soon I will feel better again. 
1 2 3 4 5 6 
2 As to my condition, what will be will be. 1 2 3 4 5 6 
3 
If I see my doctor regularly, I am less likely to have problems with 
my condition. 
1 2 3 4 5 6 
4 Most things that affect my condition happen to me by chance. 1 2 3 4 5 6 
5 
Whenever my condition worsens, I should consult a medically trained 
professional. 
1 2 3 4 5 6 
6 I am directly responsible for my condition getting better or worse. 1 2 3 4 5 6 
7 
Other people play a big role in whether my condition improves, stays 
the same, or gets worse. 
1 2 3 4 5 6 
8 Whatever goes wrong with my condition is my own fault. 1 2 3 4 5 6 
9 Luck plays a big part in determining how my condition improves. 1 2 3 4 5 6 
10 
In order for my condition to improve, it is up to other people to see 
that the right things happen. 
1 2 3 4 5 6 
11 
Whatever improvement occurs with my condition is largely a matter 
of good fortune. 
1 2 3 4 5 6 
12 The main thing which affects my condition is what I myself do. 1 2 3 4 5 6 
13 
I deserve the credit when my condition improves and the blame when 
it gets worse. 
1 2 3 4 5 6 
14 
Following doctor's orders to the letter is the best way to keep my 
condition from getting any worse. 
1 2 3 4 5 6 
15 If my condition worsens, it's a matter of fate. 1 2 3 4 5 6 
16 If I am lucky, my condition will get better. 1 2 3 4 5 6 
17 
If my condition takes a turn for the worse, it is because I have not 
been taking proper care of myself. 
1 2 3 4 5 6 
18 
The type of help I receive from other people determines how soon my 
condition improves. 
1 2 3  4   5  6 
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2. The Visual Analogue Scale (VAS) for pain            
 
Participant Study Identification Number: 
………………………………………  
 
DATE……………………..(Week…….) 
 
 
 
This scale lets us know the level of your pain today. Please place a 
mark on the line below which best describe your pain TODAY.  
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3. The Roland-Morris Low Back Pain and Disability Questionnaire 
Participant Study Identification Number: ……………………………………… 
DATE……………………..(Week…) 
Below are some of the comments which people have used to describe themselves.  Read 
the list, think of yourself TODAY, mark the box with either 1 (True) or 0 (False), 
whichever describes you TODAY. 
0 = False  1 = True 
1. I stay at home most of the time because of my back pain.  
2. I change position frequently to try and get myself comfortable.  
3. I walk more slowly than usual because of my back pain.  
4. Because of my back, I am not doing the jobs I usually do around the house.  
5. Because of my back, I use a handrail to get upstairs.  
6. Because of my back, I lie down to rest more often.  
7. Because of my back, I have to hold on to something to get out of an easy chair.  
8. Because of my back, I try to get other people to do things for me.  
9. I get dressed more slowly than usual because of my back.  
10. Because of my back, I try not to bend or kneel down.  
11. I find it difficult to get out of a chair because of my back.  
12. I am in pain almost all the time.  
13. I only stand up for short periods of time because of my back.  
14. I find it difficult to turn over in bed because of my back.  
15. My appetite is not very good because of my back.  
16. I have trouble putting on my socks/tights because of the pain in my back.  
17. I only walk short distances because of my back pain.  
18. I sleep less well because of my back pain.  
19. Because of my back trouble, I get dressed with help from someone else.  
20. I sit down for most of the day, because of my back.  
21. I avoid heavy jobs around the house because of my back.  
22. Because of my back, I am more irritable than usual.  
23. Because of my back I go upstairs more slowly.  
24. I stay in bed most of the time because of my back.  
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4. The TSK Questionnaire     
Participant Study Identification Number: ……………………………………… 
DATE……………………..(Week….) 
 
This section lets us know how you are dealing with the back pain. 
Please circle the number most appropriate for each statement. 
 
 Strongly 
Disagree 
Somewhat 
Disagree 
Somewhat 
Agree 
Strongly 
Agree 
1. I am afraid that I might injure myself if I 
exercise 
1 2 3 4 
2. If I were to try to overcome it, my pain 
would increase 
1 2 3 4 
3. My body is telling me I have something 
dangerously wrong. 
1 2 3 4 
4. My pain would probably be relieved if I 
were to exercise. 
1 2 3 4 
5. People are not taking my medical condition 
seriously enough. 
1 2 3 4 
6. My accident/back problem has put my 
body at risk for the rest of my life. 
1 2 3 4 
7. Pain always means I have injured my body. 1 2 3 4 
8. Just because something aggravates my pain 
does not mean it is dangerous. 
1 2 3 4 
9. I am afraid that I might injure myself 
accidentally. 
1 2 3 4 
10. Simply being careful that I do not make 
any unnecessary movements is the safest 
thing I can do to prevent my pain from 
worsening. 
1 2 3 4 
11. I would not have this much pain if there 
wasn’t something potentially dangerous 
going on in my body. 
1 2 3 4 
12. Although my condition is painful, I would 
be better off if I were physically active 
1 2 3 4 
13. Pain lets me know when to stop exercising 
so that I do not injure myself. 
1 2 3 4 
14. It is really not safe for a person with a 
condition like mine to be physically active. 
1 2 3 4 
15. I cannot do all the things normal people do, 
because it is too easy for me to get injured. 
1 2 3 4 
16. Even though something is causing me a lot 
of pain, I do not think it is actually 
dangerous 
1 2 3 4 
17. No one should have to exercise when 
he/she is in pain. 
1 2 3 4 
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5. Attitudes Toward Back Pain Self- Care Questionnaire (Von Korff et al, 1998) 
 
Participant Study Identification Number: ……………………………………… 
DATE…………………(Week…….) 
 
Below is a five-item Self- Care Orientation Scale to assess people attitudes toward self-care for back pain. 
Please read carefully and indicate on a five-point scale (1-5 points for each item) whether you strongly agree, 
agree, neutral, disagree or strongly disagree with the following statements: 
 
 Strongly 
agree 
1 
Agree 
 
2 
Neutral 
 
3 
Disagree 
 
4 
Strongly 
disagree 
5 
1. For your back pain problem, prescription pain relievers are 
necessary to control the pain when it is really bad. 
 
     
2. Your back problem requires ongoing attention and advice 
from a physician. 
 
     
3. You have found that things you do on your own are more 
helpful than medical treatments. 
 
     
4. You feel able to care for your back problem on your own. 
 
     
5. You would avoid using prescription medicines for your 
back pain, even if it were severe. 
     
  
 APPENDICES Page 369 
 
 
Appendix 23: Cost questionnaire 
 
 
 
 
Study Title:  
Does a cognitive-behavioural chronic low back pain programme alter 
patients’ health locus of control 
Patient Cost Of Back Care Questionnaire 
 
Participant study number :.................. 
 
We are interested in what it has cost you to attend the back rehabilitation programme. We are 
interested in travel costs, prescription charges, loss of pay and possibly other therapy 
charges up to six months after the completion of the back rehabilitation programme.  
 
The information you provide will be treated in complete confidence and will not affect the 
service you receive.  Thank you for your help. 
 
 
We would like you to think about the 6-month period after your back rehabilitation 
classes. Please tick the appropriate box: 
 
1. Have you visited your GP in the 6 months since attending your back rehabilitation 
classes? 
 
Yes No 
    
 
 
2. If YES, how many times? 
 
______  
 
 
3. How much did you spend on travel and prescription charges in total?     
 
£______ 
 
 
4. Have you had any other type of treatment (other than GP visits) for your low back pain 
in the 6 months since completing your back rehabilitation classes?  
 
Yes No 
    
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5. If YES what type of treatment was it? 
 
_______________________________ 
 
 
6. How many sessions did you attend? 
 
______ 
 
 
7. How much did you spend on travel and therapy charges in total?  
 
£______ 
 
 
 
 
We would like you to think about the journey you made to attend your back 
rehabilitation programme: 
 
 
8. How did you travel to and from the hospital? (You may tick more than one box, if 
appropriate) 
 
Car Bus or train Taxi Walk Ambulance  Other  
Journey to                         
Hospital 
 
Journey                          
From  
Hospital 
 
 
9. If you ticked ‘Other’ Please specify:  
 
......................................................................................................................................... 
  
 
10. If you ticked ‘bus or train’, or ‘taxi’, please indicate the approximate return fare: 
 
£................. 
 
 
11. Were you eligible for reimbursement for the costs you incurred in attending the 
classes? 
 
Yes No 
  
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12. How long was the journey from home to hospital? Please give the approximate time. 
from door to door: 
 
................. hours .................minutes  
 
 
13. Approximately, how far did you travel from home to the hospital? 
 
................... miles 
 
 
14. If you came by car, how much have you had to pay for parking?  
 
 
£.................. 
 
 
15. Did someone accompany you to the hospital?  
 
 
 Yes No  
  
 
 
16. If you were accompanied, did your companion also have an appointment at the 
hospital? 
 
 
Yes No 
  
 
 
17. What would you (and your companion, if relevant) normally have been doing had you 
not had to visit the hospital? (Please tick the appropriate boxes). 
 
 
 
 
 
Self 
 
Companion 
 
Paid Occupation 
 
 
 
 
 
 
Looking after children, 
other relatives, friends 
 
 
 
 
 
Other (please describe) 
 
............................ 
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18. If you have ticked 'Paid Occupation' above, please indicate what arrangements you 
made to be absent from work.  (Please tick the appropriate boxes). 
 
 
 
 
Self 
 
Companion 
 
Annual Leave 
 
 
 
 
 
Hours rearranged 
 
 
 
 
 
Time off without loss of pay 
 
 
 
 
 
Time off with loss of pay 
 
 
 
 
 
Other (please describe) 
 
............................ 
 
 
 
 
 
 
 
19. If you have ticked 'Time off with Loss of Pay', please indicate the approximate sum 
you have lost. 
 
 
£..................... 
 
 
20. Were there any other costs involved in visiting the hospital that have not been covered 
above?  If so, please give details. 
 
................................................................................................................................... 
 
................................................................................................................................... 
 
 
21. What was the total cost incurred by these other expenses? 
 
 
£...................... 
 
 
22. Please give the total time, in minutes, spent at the physiotherapy department when 
attending the back rehabilitation classes (excluding travelling time). 
 
 
...................minutes 
 
 
THANK YOU FOR COMPLETING THE QUESTIONNIARE 
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Appendix 24: NRES amendment approval letter for economic evaluation and 
cost questionnaire 
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